
<html lang="en"     class="pb-page"  data-request-id="36e121d7-e1bd-44a1-b413-2ca521ac0889"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;article:article:10.1021/acs.jmedchem.8b01754;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2019.62.issue-3;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Discovery of Selective Toxoplasma gondii Dihydrofolate Reductase Inhibitors for the Treatment of Toxoplasmosis" /></meta><meta name="dc.Creator" content="Allen T.  Hopper" /></meta><meta name="dc.Creator" content="Adam  Brockman" /></meta><meta name="dc.Creator" content="Andy  Wise" /></meta><meta name="dc.Creator" content="Julie  Gould" /></meta><meta name="dc.Creator" content="Jennifer  Barks" /></meta><meta name="dc.Creator" content="Joshua B.  Radke" /></meta><meta name="dc.Creator" content="L. David  Sibley" /></meta><meta name="dc.Creator" content="Yongmao  Zou" /></meta><meta name="dc.Creator" content="Stephen  Thomas" /></meta><meta name="dc.Description" content="A safer treatment for toxoplasmosis would be achieved by improving the selectivity and potency of dihydrofolate reductase (DHFR) inhibitors, such as pyrimethamine (1), for Toxoplasma gondii DHFR (T..." /></meta><meta name="Description" content="A safer treatment for toxoplasmosis would be achieved by improving the selectivity and potency of dihydrofolate reductase (DHFR) inhibitors, such as pyrimethamine (1), for Toxoplasma gondii DHFR (T..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="January 9, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b01754" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta><meta name="citation_fulltext_world_readable" content=""/></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01754" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b01754" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b01754" /></link>
        
    
    

<title>Discovery of Selective Toxoplasma gondii Dihydrofolate Reductase Inhibitors for the Treatment of Toxoplasmosis | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b01754" /></meta><meta property="og:title" content="Discovery of Selective Toxoplasma gondii Dihydrofolate Reductase Inhibitors for the Treatment of Toxoplasmosis" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0013.jpeg" /></meta><meta property="og:description" content="A safer treatment for toxoplasmosis would be achieved by improving the selectivity and potency of dihydrofolate reductase (DHFR) inhibitors, such as pyrimethamine (1), for Toxoplasma gondii DHFR (TgDHFR) relative to human DHFR (hDHFR). We previously reported on the identification of meta-biphenyl analog 2, designed by in silico modeling of key differences in the binding pocket between TgDHFR and hDHFR. Compound 2 improves TgDHFR selectivity 6.6-fold and potency 16-fold relative to 1. Here, we report on the optimization and structure–activity relationships of this arylpiperazine series leading to the discovery of 5-(4-(3-(2-methoxypyrimidin-5-yl)phenyl)piperazin-1-yl)pyrimidine-2,4-diamine 3. Compound 3 has a TgDHFR IC50 of 1.57 ± 0.11 nM and a hDHFR to TgDHFR selectivity ratio of 196, making it 89-fold more potent and 16-fold more selective than 1. Compound 3 was highly effective in control of acute infection by highly virulent strains of T. gondii in the murine model, and it possesses the best combination of selectivity, potency, and prerequisite drug-like properties to advance into IND-enabling, preclinical development." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b01754"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b01754">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b01754&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b01754&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b01754&amp;href=/doi/10.1021/acs.jmedchem.8b01754" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1562-1576</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.8b01742" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.8b01825" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Selective <i>Toxoplasma gondii</i> Dihydrofolate Reductase Inhibitors for the Treatment of Toxoplasmosis</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Allen T. Hopper</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Allen T. Hopper</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vyera Pharmaceuticals, LLC, 600 Third Avenue, 10th Floor, New York, New York 10016, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Phone: 617-840-6026. E-mail: <a href="/cdn-cgi/l/email-protection#8cede0e0e9e2a2e4e3fcfce9feccffedebe9fef4a2efe3e1"><span class="__cf_email__" data-cfemail="0d6c616168632365627d7d687f4d7e6c6a687f75236e6260">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Allen+T.++Hopper">Allen T. Hopper</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8797-7882" title="Orcid link">http://orcid.org/0000-0001-8797-7882</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Adam Brockman</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Adam Brockman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vyera Pharmaceuticals, LLC, 600 Third Avenue, 10th Floor, New York, New York 10016, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Adam++Brockman">Adam Brockman</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Andy Wise</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Andy Wise</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Evotec (UK) LTD., Alderley Park, Cheshire SK104TG, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andy++Wise">Andy Wise</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Julie Gould</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Julie Gould</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Evotec (UK) LTD., Alderley Park, Cheshire SK104TG, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Julie++Gould">Julie Gould</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jennifer Barks</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jennifer Barks</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Microbiology, Washington University School of Medicine, 660 S. Euclid Avenue, St. Louis, Missouri 63130, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jennifer++Barks">Jennifer Barks</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joshua B. Radke</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joshua B. Radke</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Microbiology, Washington University School of Medicine, 660 S. Euclid Avenue, St. Louis, Missouri 63130, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joshua+B.++Radke">Joshua B. Radke</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">L. David Sibley</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">L. David Sibley</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Molecular Microbiology, Washington University School of Medicine, 660 S. Euclid Avenue, St. Louis, Missouri 63130, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=L.+David++Sibley">L. David Sibley</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7110-0285" title="Orcid link">http://orcid.org/0000-0001-7110-0285</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Yongmao Zou</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Yongmao Zou</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">WuXi AppTec (Tianjin) Co., Ltd., 168 NanHai Road, 10th Avenue, TEDA, Tianjin 300457, P. R. China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Yongmao++Zou">Yongmao Zou</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Stephen Thomas</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stephen Thomas</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Vyera Pharmaceuticals, LLC, 600 Third Avenue, 10th Floor, New York, New York 10016, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stephen++Thomas">Stephen Thomas</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01754&amp;href=/doi/10.1021%2Facs.jmedchem.8b01754" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1562–1576</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">January 9, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>11 November 2018</li><li><span class="item_label"><b>Published</b> online</span>9 January 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 14 February 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b01754" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01754</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/page/rightslinkno.jsp">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"><a href="/page/policy/authorchoice/index.html"><img src="/pb-assets/images/programsLogos/OA_Icons_Ac-1612971054130.svg" alt="ACS AuthorChoice" /></img><span>ACS AuthorChoice</span></a><span class="article_header-cc-by text">with CC-BY<a href="/page/policy/authorchoice_ccby_termsofuse.html" title="License">license</a></span></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b01754"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">2644</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">11</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b01754" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Selective Toxoplasma gondii Dihydrofolate Reductase Inhibitors for the Treatment of Toxoplasmosis&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Allen&quot;,&quot;last_name&quot;:&quot;T. Hopper&quot;},{&quot;first_name&quot;:&quot;Adam&quot;,&quot;last_name&quot;:&quot;Brockman&quot;},{&quot;first_name&quot;:&quot;Andy&quot;,&quot;last_name&quot;:&quot;Wise&quot;},{&quot;first_name&quot;:&quot;Julie&quot;,&quot;last_name&quot;:&quot;Gould&quot;},{&quot;first_name&quot;:&quot;Jennifer&quot;,&quot;last_name&quot;:&quot;Barks&quot;},{&quot;first_name&quot;:&quot;Joshua&quot;,&quot;last_name&quot;:&quot;B. Radke&quot;},{&quot;first_name&quot;:&quot;L.&quot;,&quot;last_name&quot;:&quot;David Sibley&quot;},{&quot;first_name&quot;:&quot;Yongmao&quot;,&quot;last_name&quot;:&quot;Zou&quot;},{&quot;first_name&quot;:&quot;Stephen&quot;,&quot;last_name&quot;:&quot;Thomas&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;01&quot;,&quot;day&quot;:&quot;09&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;1562-1576&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b01754&quot;},&quot;abstract&quot;:&quot;A safer treatment for toxoplasmosis would be achieved by improving the selectivity and potency of dihydrofolate reductase (DHFR) inhibitors, such as pyrimethamine (1), for Toxoplasma gondii DHFR (TgDHFR) relative to human DHFR (hDHFR). We previously reported on the identification of meta-biphenyl analog 2, designed by in silico modeling of key differences in the binding pocket between TgDHFR and hDHFR. Compound 2 improves TgDHFR selectivity 6.6-fold and potency 16-fold relative to 1. Here, we report on the optimization and structure–activity relationships of this arylpiperazine series leading to the discovery of 5-(4-(3-(2-methoxypyrimidin-5-yl)phenyl)piperazin-1-yl)pyrimidine-2,4-diamine 3. Compound 3 has a TgDHFR IC50 of 1.57 ± 0.11 nM and a hDHFR to TgDHFR selectivity ratio of 196, making it 89-fold more potent and 16-fold more selective than 1. Compound 3 was highly effective in control of acute infection by highly virulent strains of T. gondii in the murine model, and it possesses the best combination of&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01754&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01754" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01754&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01754" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b01754&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01754" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b01754&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b01754&amp;href=/doi/10.1021/acs.jmedchem.8b01754" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b01754" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b01754" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (2 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01754&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b01754%26sid%3Dliteratum%253Aachs%26pmid%3D30624926%26genre%3Darticle%26aulast%3DHopper%26date%3D2019%26atitle%3DDiscovery%2Bof%2BSelective%2BToxoplasma%2Bgondii%2BDihydrofolate%2BReductase%2BInhibitors%2Bfor%2Bthe%2BTreatment%2Bof%2BToxoplasmosis%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D3%26spage%3D1562%26epage%3D1576%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291430" title="Infectious diseases">Infectious diseases</a>,</li><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291454" title="Solubility">Solubility</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/jmcmar.2019.62.issue-3/20190214/jmcmar.2019.62.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01754&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A safer treatment for toxoplasmosis would be achieved by improving the selectivity and potency of dihydrofolate reductase (DHFR) inhibitors, such as pyrimethamine (<b>1</b>), for <i>Toxoplasma gondii</i> DHFR (<i>Tg</i>DHFR) relative to human DHFR (<i>h</i>DHFR). We previously reported on the identification of meta-biphenyl analog <b>2</b>, designed by in silico modeling of key differences in the binding pocket between <i>Tg</i>DHFR and <i>h</i>DHFR. Compound <b>2</b> improves <i>Tg</i>DHFR selectivity 6.6-fold and potency 16-fold relative to <b>1</b>. Here, we report on the optimization and structure–activity relationships of this arylpiperazine series leading to the discovery of 5-(4-(3-(2-methoxypyrimidin-5-yl)phenyl)piperazin-1-yl)pyrimidine-2,4-diamine <b>3</b>. Compound <b>3</b> has a <i>Tg</i>DHFR IC<sub>50</sub> of 1.57 ± 0.11 nM and a <i>h</i>DHFR to <i>Tg</i>DHFR selectivity ratio of 196, making it 89-fold more potent and 16-fold more selective than <b>1</b>. Compound <b>3</b> was highly effective in control of acute infection by highly virulent strains of <i>T. gondii</i> in the murine model, and it possesses the best combination of selectivity, potency, and prerequisite drug-like properties to advance into IND-enabling, preclinical development.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_07017" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_07017" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Toxoplasmosis is caused by the protozoan parasite <i>Toxoplasma gondii</i> (<i>T. gondii</i>), an obligate intracellular parasite capable of infecting a wide range of hosts and many different types of cells.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Approximately one-third of the population worldwide is chronically infected with various strains of <i>T. gondii</i>.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Infections occur through consuming contaminated food or water and mother-to-child (congenital/vertical) and iatrogenic (transplanted organs and blood transfusion) transmission.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> The parasitic infection is kept in check by the immune system where it exists in a latent bradyzoite form contained within tissue cysts that are commonly found in skeletal muscle and the central nervous system (CNS).<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> However, in cases where the immune system is compromised, such as in a developing fetus or in patients with HIV, undergoing cancer chemotherapy or immunosuppressive treatment for organ transplantation, the parasite can transition to an active, fast replicating, and tissue damaging tachyzoite form.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Depending upon localization of the tachyzoites, active infection can cause, among other conditions, myocarditis, blindness, and encephalitis and is associated with a high mortality rate for HIV patients, even for those on active antiretroviral treatment.<a onclick="showRef(event, 'ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref5 ref6 ref7 ref8">(5−8)</a></div><div class="NLM_p">The recommended first-line treatment for toxoplasmosis is a combination therapy based on pyrimethamine (<b>1</b>) and sulfadiazine, supplemented with leucovorin (also known as folinic acid) to protect against bone marrow suppression.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Pyrimethamine and sulfadiazine act synergistically on the folate metabolic pathway thereby inhibiting <i>T. gondii</i> proliferation and survival.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> The drugs inhibit DHFR and dihydropteroate synthase (DHPS), respectively, and consequently block the synthesis of tetrahydrofolate, a key cofactor for thymidylate synthase. Thymidylate synthase is a methyl transferase that produces deoxythymidine monophosphate from deoxyuridine monophosphate. In many organisms including <i>T. gondii</i> and humans, this pathway is the only means by which thymidine can be supplied, making it essential for DNA synthesis and cellular proliferation.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> Importantly, although the combination of pyrimethamine and sulfadiazine can control actively proliferating forms such as tachyzoites, these agents have little effect on the semidormant bradyzoite stages within tissue cysts and hence do not cure infection.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div class="NLM_p">Adverse events associated with pyrimethamine-based therapy in toxoplasmosis often result in a need to reduce dosing or discontinue therapy.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The adverse events are mainly mechanism-based related to inhibition of folic acid metabolism in host tissues with high metabolic activity (e.g., epithelium and bone marrow).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> In mice, pyrimethamine has only about a 3-fold safety multiple between minimal effective dose and maximum tolerated dose.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Leucovorin, a form of tetrahydrofolate that is selectively taken up by human cells, is often coadministered to help alleviate the impact of mechanism-based toxicity to the host.<a onclick="showRef(event, 'ref16 ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref16 ref17 ref18 ref19">(16−19)</a> The use of pyrimethamine is also not suitable during the first trimester of pregnancy owing to its inhibition of human DHFR which can impact fetal organogenesis.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> In addition, about 3% of the general population and 30% of patients with HIV/AIDS have a hypersensitivity reaction to the sulfonamide component of the treatment regimen.<a onclick="showRef(event, 'ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref20 ref21 ref22">(20−22)</a> Therefore, finding a standalone treatment would be of significant benefit to the HIV patient population most at risk of toxoplasmosis encephalitis and sulfa hypersensitivities. Finally, high doses of pyrimethamine can induce seizures, a likely consequence of off-target pharmacology.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The adverse events associated with pyrimethamine and sulfadiazine therapy could be reduced or eliminated by selectively inhibiting only the parasite DHFR. There have been numerous attempts to discover more selective inhibitors of <i>Tg</i>DHFR but with limited success.<a onclick="showRef(event, 'ref24 ref25 ref26 ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26 ref27 ref28">(24−28)</a> Recently, the crystal structure of <i>Tg</i>DHFR was solved.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> This finding has enabled comparative modeling between the human and <i>T</i>. <i>gondii</i> enzymes, leading to the design and discovery of more selective <i>Tg</i>DHFR small molecules such as TRC-19 (<b>2</b>).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a></div><div class="NLM_p">Ideally, a next generation <i>Tg</i>DHFR inhibitor would have sufficient selectivity so that maximal parasiticidal activity would occur without concomitant inhibition of human <i>h</i>DHFR. Therefore, we hypothesized it would be important that the compound exhibit <i>Tg</i>DHFR to <i>h</i>DHFR selectivity of at least 150-fold, which is about 10-fold greater than that of pyrimethamine, and possess low clearance to minimize maximal plasma concentrations while achieving a long duration of maximally effective exposure. Given the ability of parasites to invade the CNS, it is also necessary that the compound readily penetrate the blood–brain barrier. Finally, improving <i>Tg</i>DHFR potency can reduce effective dose levels and decrease the likelihood of compound related off-target pharmacology and associated side effects and toxicity.</div><div class="NLM_p last">In this study, we report on the SAR and lead optimization strategy underlying the discovery of 5-(4-(3-(2-methoxypyrimidin-5-yl)phenyl)piperazin-1-yl)pyrimidine-2,4-diamine <b>3</b>, a selective and potent <i>Tg</i>DHFR inhibitor with properties consistent with those outlined above supporting the first standalone treatment for toxoplasmosis.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52484" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52484" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Pyrimethamine Selectivity and Potency</h3><div class="NLM_p">Pyrimethamine <b>1</b> is reported to be 7.6-fold more selective for <i>Tg</i>DHFR compared to <i>h</i>DHFR with a <i>h</i>DHFR IC<sub>50</sub> of 760 ± 130 nM for inhibiting conversion of dihydrofolate to tetrahydrofolate.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> More recently, the <i>K</i><sub>i</sub> for hDHFR was reported to be 470 nM.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> In our hands, <b>1</b> has an IC<sub>50</sub> for inhibiting <i>Tg</i>DHFR of 139 ± 49 nM (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which makes it 12-fold more potent for inhibiting <i>Tg</i>DHFR over <i>h</i>DHFR. Although this level of selectivity is sufficient to make <b>1</b> a preferred DHFR inhibitor for the treatment of toxoplasmosis, as can be seen in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>, it is not sufficient to preclude inhibition of hDHFR and associated dose limiting mechanism-based toxicity.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> The concentration of <b>1</b> that gives significant inhibition of <i>Tg</i>DHFR, i.e., > IC<sub>80</sub>, begins to also inhibit <i>h</i>DHFR by 5–35%. On the basis of these data, it seemed reasonable that at least an order of magnitude and preferably 20-fold increase in selectivity in a new compound would be sufficient to overcome the mechanism-based toxicity issues observed with <b>1</b> and possibly enable a standalone therapy.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Dose–response curve of <b>1</b> for inhibition of <i>T. gondii</i> DHFR and human DHFR. The shaded blue area represents the concentration of <b>1</b> with >80% inhibition of <i>Tg</i>DHFR and 5–35% <i>h</i>DHFR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01754&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> Early Profiling Data for Lead <b>2</b> and Comparison to DHFR Inhibitor Reference Standard Drugs</h3><div class="NLM_p">The structures of lead <b>2</b><a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> and DHFR inhibitor reference compounds pyrimethamine (<b>1</b>), trimethoprim (<b>4</b>), methotrexate (<b>5</b>), and trimetrexate (<b>6</b>) are shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>. The DHFR inhibitory activity and selectivity, kinetic solubility, human liver microsomal intrinsic clearance, and permeability and efflux across an MDR1-MDCK cell monolayer for lead <b>2</b> and reference compounds <b>1</b>, <b>4</b>, <b>5</b>, and <b>6</b> are shown in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>. Lead <b>2</b> has a <i>Tg</i>DHFR IC<sub>50</sub> of 8.76 ± 1.0 nM with 79-fold selectivity relative to the human enzyme. This is 6.6-fold more selective than <b>1</b>. Although this improvement in selectivity was encouraging, in our view is insufficient to achieve a stand-alone treatment. Trimethoprim <b>4</b>, sometimes used off label in combination with sulfamethoxazole for the treatment of toxoplasmosis,was about 240-fold less potent against <i>Tg</i>DHFR than <b>1</b> with an IC<sub>50</sub> of 33 100 nM and selectivity index of 15. Methotrexate <b>5</b> was far more potent than <b>1</b>, <b>4</b>, or <b>2</b> for inhibiting <i>h</i>DHFR with an IC<sub>50</sub> of 4.74 nM. Interestingly, <b>5</b> has the opposite selectivity profile as compared to <b>1</b>, where it is 17-fold less potent for inhibiting <i>Tg</i>DHFR (IC<sub>50</sub> of 78.3 nM), giving a selectivity ratio of 0.061. Trimetrexate <b>6</b>, which structurally is a combination of the diaminopteridine head of <b>5</b> and trimethoxybenzyl tail of <b>4</b>, is nearly equally active at <i>Tg</i>DHFR and <i>h</i>DHFR with respective IC<sub>50</sub>’s of 1.35 and 4.07 nM, giving a selectivity index of 3.0.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Reference compounds pyrimethamine (<b>1</b>), trimethoprim (<b>4</b>), methotrexate (<b>5</b>), trimetrexate (<b>6</b>) and initial lead TRC-19 (<b>2</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01754&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Evaluation of Comparator Compounds on DHFR Inhibition, Kinetic Solubility, Clearance in Human Liver Microsomes, and MDR1-MDCK Permeability</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>Tg</i>DHFR<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a> IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>h</i>DHFR<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a>IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">selectivity index<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">solubility<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a> (μM)</th><th class="colsep0 rowsep0" align="center">HLM (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center">MDR1-MDCK<a class="ref internalNav" href="#t1fn4" aria-label="d">d</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">139 ± 14</td><td class="colsep0 rowsep0" align="left">1680 ± 230</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">184</td><td class="colsep0 rowsep0" align="left"><8.6</td><td class="colsep0 rowsep0" align="left">36 (0.83)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">8.76 ± 1.0</td><td class="colsep0 rowsep0" align="left">689 ± 39</td><td class="colsep0 rowsep0" align="left">79</td><td class="colsep0 rowsep0" align="left">3.9</td><td class="colsep0 rowsep0" align="left">28.4</td><td class="colsep0 rowsep0" align="left">2.7 (0.62)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="left">33,100 ± 3400</td><td class="colsep0 rowsep0" align="left">503,000 ± 51,000</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"><8.6</td><td class="colsep0 rowsep0" align="left">7.5 (3.5)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="left">78.3 ± 6.7</td><td class="colsep0 rowsep0" align="left">4.74 ± 0.36</td><td class="colsep0 rowsep0" align="left">0.061</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="left">1.35 ± 0.07</td><td class="colsep0 rowsep0" align="left">4.07 ± 0.11</td><td class="colsep0 rowsep0" align="left">3.0</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Average of at least three independent replicates ± SEM.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Selectivity index (SI) is the <i>h</i>DHFR IC<sub>50</sub>/<i>Tg</i>DHFR IC<sub>50</sub>, determined within the same experiment.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">Kinetic solubility.</p></div><div class="footnote" id="t1fn4"><sup><sup>d</sup></sup><p class="last">A:B (<i>P</i><sub>app</sub> 10<sup>–6</sup> cm/s) (ER), where ER is efflux ratio defined as permeability in B:A/A:B directions.</p></div></div></div><div class="NLM_p">Further characterization of <b>1</b> and <b>2</b> was performed to benchmark and guide a lead optimization strategy (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). Lead <b>2</b> has low kinetic and thermodynamic solubility (<4 μM), high clearance in human liver microsomes (HLM) (i.e., > liver blood flow), and low to moderate MDCK-MDR1 permeability, all areas for improvement during lead optimization. Interestingly, <b>1</b>, which was discovered and developed in the 1940s, has near ideal CNS drug properties in terms of solubility, HLM stability, and MDR1-MDCK permeability. Properties for <b>1</b> and <b>2</b> are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, with the main differences being an increase in both MW and log <i>P</i> for <b>2</b>, which likely contributes to its undesirable solubility, metabolic stability, and permeability profile. On the basis of these data, lead optimization was initially focused on understanding the SAR underlying selectivity and potency while simultaneously designing analogs with lower cLogP and higher calculated solubility in an effort to improve physical chemical properties.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Properties of <b>1</b> and <b>2</b><a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">MW</th><th class="colsep0 rowsep0" align="center">cLogP</th><th class="colsep0 rowsep0" align="center">log <i>P</i> <a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">TPSA</th><th class="colsep0 rowsep0" align="center">cSol (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">248.7</td><td class="colsep0 rowsep0" align="left">3.00</td><td class="colsep0 rowsep0" align="left">2.71</td><td class="colsep0 rowsep0" align="left">76.8</td><td class="colsep0 rowsep0" align="left">135</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">346.4</td><td class="colsep0 rowsep0" align="left">3.74</td><td class="colsep0 rowsep0" align="left">3.38</td><td class="colsep0 rowsep0" align="left">83.2</td><td class="colsep0 rowsep0" align="left">3.09</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Calculated properties were performed using ChemDraw Professional software version 17.0.0.206 (121).</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Measured log <i>P</i> was performed at pH 11.0 in octanol/buffer.</p></div></div></div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Structure–Activity Relationships for Analogs of <b>2</b></h3><div class="NLM_p">Structure–activity relationship (SAR) data based on <b>2</b> for inhibition of <i>Tg</i>DHFR and selectivity relative to <i>h</i>DHFR are shown in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>–<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. Initial optimization of <b>2</b> focused on a systematic approach to gain a better understanding of its SAR with emphasis on improving DHFR selectivity (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). As a basis for comparison, unsubstituted analog <b>7</b> was prepared and found to lose potency (IC<sub>50</sub> = 209 nM) but maintained a similar selectivity index (59-fold) relative to initial lead <b>2</b>. Ortho-phenyl <b>8</b> and para-phenyl <b>9</b> were both about 4-fold less potent (IC<sub>50</sub> ∼ 30 nM) than <b>2</b> but differed in their selectivity profiles. Ortho-phenyl <b>8</b> maintained similar selectivity as <b>2</b> at 58-fold, whereas para-phenyl <b>9</b> had reduced selectivity at 11-fold. These data are consistent with modeling predictions of the binding cavity.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Replacing the distal meta-phenyl of <b>2</b> with an ortho-methyl <b>10</b> or ortho-chloro <b>13</b> resulted in complete loss of activity at the highest doses tested. This result is surprising considering ortho-phenyl analog <b>8</b> had a <i>Tg</i>DHFR IC<sub>50</sub> of 31 nM. Meta-methyl and meta-chloro analogs <b>11</b> and <b>14</b> respectively were more potent and selective than corresponding para-substituted compounds <b>12</b> and <b>15</b>, supporting the hypothesis based on modeling that meta-substituents would be preferred. Encouragingly, meta-methyl <b>11</b>, while 8-fold less potent than <b>2</b>, maintained equivalent selectivity of 79-fold. On the basis of these findings, design focused on meta-substituents to further probe this apparently important pocket for both selectivity and potency. Meta-methoxy <b>16</b>, meta-trifluoromethyl <b>17</b>, meta-trifluoromethoxy <b>18</b>, and meta-cyclopropyl <b>19</b> all had reduced potency and selectivity as compared to meta-phenyl lead <b>2</b>. Adding a methyl or ethyl to the 6-position of the diaminopyrimidine group, giving <b>20</b> and <b>21</b> respectively, maintained or slightly improved potency over <b>2</b> but with a slight loss in selectivity.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Structure–Activity Relationships of Phenylpiperazine Analogs on Inhibition of <i>Tg</i>DHFR and <i>h</i>DHFR</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0010.gif" alt="" id="GRAPHIC-d7e1149-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center">R<sup>1</sup></th><th class="colsep0 rowsep0" align="center"><i>Tg</i>DHFR<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>h</i>DHFR<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">selectivity index<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">3-phenyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">8.76 ± 1.0</td><td class="colsep0 rowsep0" align="left">689 ± 39</td><td class="colsep0 rowsep0" align="left">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>7</b></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">209 ± 28</td><td class="colsep0 rowsep0" align="left">12,500 ± 1200</td><td class="colsep0 rowsep0" align="left">59</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="left">2-phenyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">30.9 ± 2.2</td><td class="colsep0 rowsep0" align="left">1790 ± 190</td><td class="colsep0 rowsep0" align="left">58</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="left">4-phenyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">31.5 ± 2.7</td><td class="colsep0 rowsep0" align="left">347 ± 23</td><td class="colsep0 rowsep0" align="left">11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>10</b></td><td class="colsep0 rowsep0" align="left">2-Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>10000</td><td class="colsep0 rowsep0" align="left">>30000</td><td class="colsep0 rowsep0" align="left">not available</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="left">3-Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">75.3 ± 5.5</td><td class="colsep0 rowsep0" align="left">5980 ± 320</td><td class="colsep0 rowsep0" align="left">79</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>12</b></td><td class="colsep0 rowsep0" align="left">4-Me</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">181 ± 14</td><td class="colsep0 rowsep0" align="left">3260 ± 110</td><td class="colsep0 rowsep0" align="left">18</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="left">2-Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">>10000</td><td class="colsep0 rowsep0" align="left">>30,000</td><td class="colsep0 rowsep0" align="left">not available</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>14</b></td><td class="colsep0 rowsep0" align="left">3-Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">39.8 ± 5.3</td><td class="colsep0 rowsep0" align="left">1540 ± 170</td><td class="colsep0 rowsep0" align="left">39</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>15</b></td><td class="colsep0 rowsep0" align="left">4-Cl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">45.9 ± 7.3</td><td class="colsep0 rowsep0" align="left">1090 ± 140</td><td class="colsep0 rowsep0" align="left">24</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>16</b></td><td class="colsep0 rowsep0" align="left">3-MeO</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">57.8 ± 3.4</td><td class="colsep0 rowsep0" align="left">2710 ± 150</td><td class="colsep0 rowsep0" align="left">47</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">62.1 ± 5.2</td><td class="colsep0 rowsep0" align="left">541 ± 43</td><td class="colsep0 rowsep0" align="left">8.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>18</b></td><td class="colsep0 rowsep0" align="left">3-CF<sub>3</sub>O</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">12.9 ± 1.1</td><td class="colsep0 rowsep0" align="left">819 ± 36</td><td class="colsep0 rowsep0" align="left">63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>19</b></td><td class="colsep0 rowsep0" align="left">3-cyclopropyl</td><td class="colsep0 rowsep0" align="left">H</td><td class="colsep0 rowsep0" align="left">29.0 ± 1.7</td><td class="colsep0 rowsep0" align="left">1630 ± 45</td><td class="colsep0 rowsep0" align="left">56</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>20</b></td><td class="colsep0 rowsep0" align="left">3-phenyl</td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">9.19 ± 0.94</td><td class="colsep0 rowsep0" align="left">237 ± 21</td><td class="colsep0 rowsep0" align="left">26</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">3-phenyl</td><td class="colsep0 rowsep0" align="left">Et</td><td class="colsep0 rowsep0" align="left">3.91 ± 0.61</td><td class="colsep0 rowsep0" align="left">200 ± 16</td><td class="colsep0 rowsep0" align="left">51</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Average of at least three independent replicates ± SEM.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Selectivity index (SI) is the hDHFR IC<sub>50</sub>/<i>Tg</i>DHFR IC<sub>50</sub>.</p></div></div></div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Structure–Activity Relationships for Heteroaryl Analogs of Meta-Biphenyl <b>2</b></h3><div class="NLM_p">We then turned our focus toward improving the solubility and metabolic stability issues observed with early lead <b>2</b> by preparing a variety of heteroaryl analogs (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). We hypothesized that the distal phenyl ring of <b>2</b> was the likely site of metabolism and that introducing nitrogen molecules into this ring would block metabolism and increase solubility. The 2-, 3- and 4-pyridine analogs <b>22</b>, <b>23</b>, and <b>24</b> maintained or slightly improved potency and selectivity but without much improvement in solubility. The potency of 3-pyridine analog <b>23</b> is noteworthy at 2.7 nM, about 3.3-fold more potent than <b>2</b>, and with a selectivity index of 112-fold. Addition of a second nitrogen into this ring to give pyrimidines, pyridazines, and pyrazines provided analogs with variable improvements in potency, selectivity, solubility, and HLM metabolic stability. 5-Pyrimidine analog <b>26</b> stood out with a 307-fold <i>Tg</i>DHFR selectivity index and a <i>Tg</i>DHFR IC<sub>50</sub> of 5.2 nM, as well as markedly improved solubility (>200 uM) and metabolic stability (Cl<sub>int</sub> < 8.6 mL min<sup>–1</sup> kg<sup>–1</sup>). The improvement in selectivity observed for <b>26</b> is nearly 4 times that of early lead <b>2</b> and 25-fold better than <b>1</b>. 2-Pyrazine <b>27</b> and 4-pyridazine <b>28</b> had promising potency with IC<sub>50</sub> values of 10 and 6.0 nM, respectively, and selectivity indexes of 129 and 185-fold, respectively, but both were hampered with low kinetic solubility, precluding additional investigation with these chemotypes. In general, heteroaryl substitutions increase <i>Tg</i>DHFR selectivity and maintain or slightly improve potency relative to <b>2</b>. The 2-fold improvement in selectivity observed for 5-pyrimidine analog <b>26</b> compared to the 3-pyridyl analog <b>23</b> may result from one of the nitrogen atoms on the distal pyrimidine ring being forced to make an unfavorable interaction in hDHFR. The 3-pyridyl analog <b>23</b>, which can rotate the nitrogen away from such an unfavorable interaction, is about 5-fold more potent at hDHFR than pyrimidine <b>26 (</b> hDHFR IC<sub>50</sub> = 1430 nM<b>)</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Evaluation of Heteroaryl Replacements of the Distal Phenyl of <b>2</b> on DHFR Inhibition, Selectivity, Solubility, Human Liver Microsomal Clearance, and MDCK-MDR1 Permeability</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0011.gif" alt="" id="GRAPHIC-d7e1583-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>2</sup></th><th class="colsep0 rowsep0" align="center"><i>Tg</i>DHFR<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>h</i>DHFR<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a> IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">selectivity<a class="ref internalNav" href="#t4fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">solubility<a class="ref internalNav" href="#t4fn3" aria-label="c">c</a> (μM)</th><th class="colsep0 rowsep0" align="center">HLM<a class="ref internalNav" href="#t4fn4" aria-label="d">d</a> (CL<sub>int</sub>)</th><th class="colsep0 rowsep0" align="center">MDR1-MDCK<a class="ref internalNav" href="#t4fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>22</b></td><td class="colsep0 rowsep0" align="left">2-pyridine</td><td class="colsep0 rowsep0" align="left">10.3 ± 1.6</td><td class="colsep0 rowsep0" align="left">1360 ± 210</td><td class="colsep0 rowsep0" align="left">132</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">17.7</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="left">3-pyridine</td><td class="colsep0 rowsep0" align="left">2.68 ± 0.12</td><td class="colsep0 rowsep0" align="left">300 ± 55</td><td class="colsep0 rowsep0" align="left">112</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>24</b></td><td class="colsep0 rowsep0" align="left">4-pyridine</td><td class="colsep0 rowsep0" align="left">4.34 ± 0.43</td><td class="colsep0 rowsep0" align="left">468 ± 32</td><td class="colsep0 rowsep0" align="left">108</td><td class="colsep0 rowsep0" align="left">2.2</td><td class="colsep0 rowsep0" align="left">18.7</td><td class="colsep0 rowsep0" align="left">17.4 (0.86)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>25</b></td><td class="colsep0 rowsep0" align="left">2-pyrimidine</td><td class="colsep0 rowsep0" align="left">27.3 ± 2.3</td><td class="colsep0 rowsep0" align="left">1300 ± 51</td><td class="colsep0 rowsep0" align="left">47.6</td><td class="colsep0 rowsep0" align="left">180</td><td class="colsep0 rowsep0" align="left"><8.6</td><td class="colsep0 rowsep0" align="left">31.7 (0.80)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">5-pyrimidine</td><td class="colsep0 rowsep0" align="left">4.75 ± 0.34</td><td class="colsep0 rowsep0" align="left">1430 ± 100</td><td class="colsep0 rowsep0" align="left">301</td><td class="colsep0 rowsep0" align="left">>200</td><td class="colsep0 rowsep0" align="left"><8.6</td><td class="colsep0 rowsep0" align="left">20.2 (1.2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>27</b></td><td class="colsep0 rowsep0" align="left">2-pyrazine</td><td class="colsep0 rowsep0" align="left">10.3 ± 0.39</td><td class="colsep0 rowsep0" align="left">1330 ± 50</td><td class="colsep0 rowsep0" align="left">129</td><td class="colsep0 rowsep0" align="left">1.6</td><td class="colsep0 rowsep0" align="left"><8.6</td><td class="colsep0 rowsep0" align="left">19.3 (0.77)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>28</b></td><td class="colsep0 rowsep0" align="left">4-pyridazine</td><td class="colsep0 rowsep0" align="left">6.00 ± 0.70</td><td class="colsep0 rowsep0" align="left">1100 ± 130</td><td class="colsep0 rowsep0" align="left">185</td><td class="colsep0 rowsep0" align="left">5.7</td><td class="colsep0 rowsep0" align="left"><8.6</td><td class="colsep0 rowsep0" align="left">6.40 (3.8)</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Average of at least three independent replicates ± SEM.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Selectivity index (SI) is the <i>h</i>DHFR IC<sub>50</sub>/<i>Tg</i>DHFR IC<sub>50</sub>, determined within the same experiment.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">Kinetic solubility.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">HLM, human liver microsome; CL<sub>int</sub>, intrinsic clearance (mL min<sup>–1</sup> kg<sup>–1</sup>).</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">A:B permeability (<i>P</i><sub>app</sub> 10<sup>–6</sup> cm/s), where ER is efflux ratio defined as permeability in B:A/A:B directions.</p></div></div></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> SAR for the Distal 5-Pyrimidine Ring of <b>26</b></h3><div class="NLM_p">Next, we evaluated if selectivity could be further improved by adding substitutions onto the 2-position of the distal 5-pyrimidine ring of <b>26</b> (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). On the basis of the crystal structure and modeling (see <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>), it appeared that substitutions at this position were not likely to have steric effects as they pointed into solvent space. However, if the pyrimidine nitrogen atoms were making a favorable hydrogen bond interaction with <i>Tg</i>DHFR His-27 and an unfavorable interaction with hDHFR Pro-26, then electron donating substituents would be predicted to enhance potency and selectivity. Methyl analog <b>29</b> maintained <i>Tg</i>DHFR potency (IC<sub>50</sub> = 3.95 nM) with only a slight reduction in selectivity (237-fold) relative to unsubstituted 5-pyrimidine <b>26</b>. Methyl analog <b>29</b> had good solubility, HLM stability, and MDCK-MDR1 permeability. An electron donating 2-methoxy substituent gave <b>3</b>, with excellent <i>Tg</i>DHFR potency with an IC<sub>50</sub> of 1.57 nM but a slightly reduced selectivity index of 196. Trifluoromethyl <b>30</b> and cyclopropyl <b>31</b> were significantly less potent against <i>Tg</i>DHFR, less selective and had low kinetic solubility. The loss in selectivity with these analogs is principally driven more by loss of activity against <i>Tg</i>DHFR rather than by gaining potency at hDHFR.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Evaluation of Substitutions on the Distal Pyrimidine Ring of <b>26</b> on DHFR Inhibition, Selectivity, Solubility, Human Liver Microsomal Clearance, and MDCK-MDR-1 Permeability</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0012.gif" alt="" id="GRAPHIC-d7e1910-autogenerated" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center">R<sup>3</sup></th><th class="colsep0 rowsep0" align="center"><i>Tg</i>DHFR<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>h</i>DHFR<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a>IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center">selectivity index<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">solubility (μM)<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">HLM<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a>(CL<sub>int</sub>)</th><th class="colsep0 rowsep0" align="center">MDR1-MDCK<a class="ref internalNav" href="#t5fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">Me</td><td class="colsep0 rowsep0" align="left">3.95 ± 0.26</td><td class="colsep0 rowsep0" align="left">935 ± 46</td><td class="colsep0 rowsep0" align="left">237</td><td class="colsep0 rowsep0" align="left">150</td><td class="colsep0 rowsep0" align="left"><8.6</td><td class="colsep0 rowsep0" align="left">19.3 (1.2)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">MeO</td><td class="colsep0 rowsep0" align="left">1.57 ± 0.42</td><td class="colsep0 rowsep0" align="left">308 ± 71</td><td class="colsep0 rowsep0" align="left">196</td><td class="colsep0 rowsep0" align="left">186</td><td class="colsep0 rowsep0" align="left"><8.6</td><td class="colsep0 rowsep0" align="left">20.1 (1.1)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>30</b></td><td class="colsep0 rowsep0" align="left">CF<sub>3</sub></td><td class="colsep0 rowsep0" align="left">32.7 ± 3.3</td><td class="colsep0 rowsep0" align="left">2800 ± 470</td><td class="colsep0 rowsep0" align="left">85.6</td><td class="colsep0 rowsep0" align="left">17</td><td class="colsep0 rowsep0" align="left">10.5</td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">cyclopropyl</td><td class="colsep0 rowsep0" align="left">9.92 ± 0.83</td><td class="colsep0 rowsep0" align="left">973 ± 120</td><td class="colsep0 rowsep0" align="left">98</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">17.4</td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Average of at least three independent replicates ± SEM.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Selectivity index (SI) is the <i>h</i>DHFR IC<sub>50</sub>/<i>Tg</i>DHFR IC<sub>50</sub>, determined within the same experiment.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">Kinetic solubility.</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">HLM, human liver microsome; CL<sub>int</sub>, intrinsic clearance (mL min<sup>–1</sup> kg<sup>–1</sup>).</p></div><div class="footnote" id="t5fn5"><sup><sup>e</sup></sup><p class="last">A:B permeability (P<sub>app</sub> 10<sup>–6</sup> cm/s), where ER is efflux ratio defined as permeability in B:A/A:B directions.</p></div></div></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structure of <i>Tg</i>DHFR with pyrimidine <b>29</b> bound. Crystal structure data were visualized and modeled using MOE software from Chemical Consulting Group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01754&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structure of <i>Tg</i>DHFR with pyrimidine <b>3</b> bound. Crystal structure data were visualized and modeled using MOE software from Chemical Consulting Group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01754&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Further characterization of <b>3</b> demonstrated good kinetic solubility of 186 μM at pH 7.4, low human microsomal clearance (<8.6 mL min<sup>–1</sup> kg<sup>–1</sup>), and high permeability in MDR1-MDCK cells (20.1 × 10<sup>–6</sup> cm/s) with a low efflux ratio of 1.1 (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). In the CEREP 44 safety screen at a 10 μM dose level, <b>3</b> demonstrated good selectivity against all 44 targets tested except for hERG where [<sup>3</sup>H]dofetilide binding was inhibited by 60%.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Chemistry</h3><div class="NLM_p">The compounds presented here were synthesized as shown in <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. In <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, substituted piperazines (<b>36a</b>–<b>n</b>) were condensed with 5-bromouracil <b>33</b> in the presence of KF and heating in DMSO to give the corresponding uracil derivatives <b>37a</b>–<b>n</b>. Chlorination using POCl<sub>3</sub> and DIPEA provided intermediates <b>38a</b>–<b>n</b>, followed by amination reaction using NH<sub>3</sub>/EtOH at 145 °C to give final products <b>2</b>, <b>7</b>–<b>18</b>, <b>20</b>, <b>21</b>, and <b>32</b>. 6-Methyl and 6-ethyl diaminopyrimidine targets <b>20</b> and <b>21</b> were synthesized as described above but starting with the corresponding 6-alkyl-5-bromouracils <b>34</b> and <b>35</b> and condensing with biphenylpiperazine <b>36a</b>. Piperazine intermediates <b>36a</b>–<b>n</b> are generally commercially available or can be prepared by various literature methods.<a onclick="showRef(event, 'ref34 ref35'); return false;" href="javascript:void(0);" class="ref ref34 ref35">(34,35)</a></div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0008.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>2</b>, <b>7</b>–<b>18</b>, <b>20</b>, <b>21</b>, and <b>32</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01754&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>R<sup>2</sup> = (a) 3-phenyl, (b) hydrogen, (c) 2-phenyl, (d) 4-phenyl, (e) 2-methyl, (f) 3-methyl, (g) 4-methyl, (h) 2-chloro, (i) 3-chloro, (j) 4-chloro, (k) 3-methoxy, (l) 3-trifluoromethyl, (m) 3-trifluoromethoxy, (n) 3-bromo. Reagents and conditions: (a) KF, DMSO, 110 °C, 12 h; (b) POCl<sub>3</sub>, DIPEA, 110 °C, 5 h; (c) NH<sub>3</sub>, EtOH, 145 °C, 24 h.</p></p></figure><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0009.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>3</b>, <b>19</b>, <b>22</b>–<b>31</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01754&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>R<sup>2</sup> = (o) 5-(2-methoxypyrimidine), (p) cyclopropyl, (q) 3-pyridine, (r) 4-pyridine, (s) 5-pyrimidine, (t) 4-pyridazine, (u) 5-(2-methylpyrimidine), (v) 5-(2-trifluoromethylpyrimidine), (w) 5-(2-cyclopropylpyrimidine), (x) 2-pyridine, (y) 2-pyrimidine and (z) 2-pyrazine. Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, R<sup>2</sup>-B(OH)<sub>2</sub> (<b>39o</b>–<b>w</b>), Cs<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, 110 °C; or (b) Pd<sub>2</sub>(dba)<sub>3</sub>, Sn(nBu)<sub>3</sub>-R<sup>2</sup> (<b>40x</b>–<b>z</b>), XPhos, dioxane, 100 °C.</p></p></figure><div class="NLM_p last">Analogs in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a> were prepared by either Suzuki coupling of 3-bromophenyl <b>32</b> with the corresponding boronic acids <b>39o</b>–<b>w</b> to give targets <b>3</b>, <b>19</b>, <b>23</b>, <b>24</b>, <b>26</b>, and <b>28</b>–<b>31</b> or Stille coupling of 3-bromophenyl <b>32</b> with Sn(Bu)<sub>3</sub>R<sup>2</sup><b>40x</b>–<b>z</b> to generate compounds <b>22</b>, <b>25</b>, and <b>27</b>.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Crystal Structure of <i>Tg</i>DHFR</h3><div class="NLM_p last">To aide in the understanding of the observed selectivity and guide future lead optimization efforts, several X-ray crystal structures with lead compounds bound to <i>Tg</i>DHFR were solved, including the complex of 5-pyrimidines <b>3</b> and <b>29</b> with <i>Tg</i>DHFR (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a> and <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). Although at a high-level these data are consistent with modeling predictions, the crystal structure provides more subtle clues into why the distal pyrimidine moiety enhances selectivity. The phenyl groups of <b>3</b> and <b>29</b> occupy the <i>Tg</i>DHFR cavity created near F91 and G22 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), while the residues present in <i>h</i>DHFR at these positions appear to be less accommodating. These <i>Tg</i>DHFR phenylalanine residues (F32 and F91) create a more enclosed hydrophobic area around the phenyl ring connected to the piperazine. This configuration also positions the distal heteroaromatic ring into the glycine site, possibly enabling a hydrogen bonding interaction with His27 in the <i>T. gondii</i> enzyme (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). The presence of a proline residue (Pro26) in <i>h</i>DHFR, at the analogous position of His 27 in <i>Tg</i>DHFR, provides a hypothesis for the observed subtle improvement in selectivity with the 5-pyrimidines. The <i>Tg</i>DHFR His27 may enable a favorable H-bond with a pyrimidine N, whereas this would not be feasible in the human enzyme. In addition, there could be an unfavorable interaction in the <i>h</i>DHFR between the pyrimidine nitrogen atoms of <b>3</b> and Pro 26. This interaction might help explain why 3-pyridine <b>23</b> is less selective than pyrimidine <b>3</b>, as the pyridine N could rotate away from the proposed unfavorable interaction with Pro26 in the human enzyme. We hypothesize these are the likely reasons for the observed <i>Tg</i>DHFR selectivity. However, it is also noted that N64 in <i>h</i>DHFR blocks π–π interactions. Interactions at these residues are well supported by the literature and may also contribute to the observed <i>Tg</i>DHFR selectivity.<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> A search of UniProt shows that there are no reported human polymorphisms related to these amino acids that would alter selectivity.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Parasiticidal and Antiproliferative Effects of 5-Methoxypyrimidine <b>3</b> in Cell-Based Models</h3><div class="NLM_p">Optimized pyrimidine <b>3</b> and comparator drug <b>1</b> were evaluated in cell-based models to investigate translation of the respective DHFR inhibitory activities into parasiticidal and antiproliferative host cell effects. Lead <b>3</b> had a parasiticidal EC<sub>50</sub> of 13 nM and <b>1</b> had an EC<sub>50</sub> of 680 nM against the type I RH strain of <i>T. gondii</i>. The 52-fold improvement in potency of <b>3</b> over <b>1</b> in this assay is consistent with its 89-fold potency advantage for inhibiting <i>Tg</i>DHFR. Antiproliferative effects of these compounds in human MCF-7 cells, measured using the MTT assay, were consistent with the human DHFR data, wherein <b>1</b> and <b>3</b> had EC<sub>50</sub> values of 11 600 nM and 7300 nM, respectively. The selectivity of both <b>1</b> (17-fold) and <b>3</b> (560-fold) in the cell-based assays (<a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>) is in line with their DHFR selectivity profiles of 12- and 200-fold, respectively. These data are important as they demonstrate that <b>3</b> has antiparasiticidal activity with similar efficacy as <b>1</b>, but with substantially better potency and selectivity (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>).</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Parasiticidal Activity for <b>1</b> and <b>3</b> in <i>T. gondii</i> Infected Human Foreskin Fibroblast Cells As Compared to the Antiproliferative Effects of <b>1</b> and <b>3</b> in MCF-7 Cells</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center"><i>T. gondii</i> cell-based EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">MCF-7 EC<sub>50</sub> (nM)<a class="ref internalNav" href="#t6fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">selectivity index<a class="ref internalNav" href="#t6fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="left">13 ± 3.8</td><td class="colsep0 rowsep0" align="left">7300</td><td class="colsep0 rowsep0" align="left">560</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="left">680 ± 210</td><td class="colsep0 rowsep0" align="left">11700</td><td class="colsep0 rowsep0" align="left">17</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">EC<sub>50</sub> = half maximal response concentration, average of at least three experiments (±SD).</p></div><div class="footnote" id="t6fn2"><sup><sup>b</sup></sup><p class="last">MCF-7 cell viability determined using the MTT assay in triplicate (<i>n</i> = 1).</p></div><div class="footnote" id="t6fn3"><sup><sup>c</sup></sup><p class="last">Selectivity index calculated as the MCF-7 EC<sub>50</sub>/<i>Tg</i> cell-based EC<sub>50</sub>.</p></div></div></div><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Parasiticidal dose–response curves of <b>1</b> and <b>3</b> in <i>T. gondii</i> infected human foreskin fibroblast cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01754&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Comparison of Potency against Additional Strains of <i>Toxoplasma</i></h3><div class="NLM_p">Given the enhanced potency of <b>3</b>, we wanted to test it against different lineages of <i>T. gondii</i>. Consequently, we chose a series of low passage isolates that are representative of the major genotypes of <i>T. gondii</i> seen in human infection from different regions of the world. As we have previously described, the population structure of <i>T. gondii</i> comprises six major clades, each of which contains several related lineages.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The majority of human cases of toxoplasmosis in Europe and North America are due to type 2 strains,<a onclick="showRef(event, 'ref39 ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref39 ref40 ref41">(39−41)</a> and we typically use a laboratory strain called ME49 as representative for such strains. The ME49 strain was originally isolated from a sheep in the United States,<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> and it reflects the genotype of many strains found in food animals and which cause human toxoplasmosis. The CTG strain was originally isolated from a cat in the United States, and it represents a common genotype found in animals, although it is relatively rare in humans.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> Type 1 strains are also reasonably abundant in North America, and they are of interest as they are more pathogenic in many hosts including immunocompromised humans.<a onclick="showRef(event, 'ref41 ref44'); return false;" href="javascript:void(0);" class="ref ref41 ref44">(41,44)</a> Although most lab studies use the type 1 RH strain, use of the GT1 strain is preferable as it preserves the entire lifecycle.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> The GT1 strain was originally isolated from a goat in North America,<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> although it is genetically similar to a number of human isolates including the RH strain. In contrast to North America and Europe, strains in South America are dominated by highly pathogenic lines such as types 5 (reference strain RUB) and 10 (reference strain VAND).<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> The VAND and RUB strains were isolated from severe human cases of toxoplasmosis that are characteristic of the Amazon region.<a onclick="showRef(event, 'ref47 ref48'); return false;" href="javascript:void(0);" class="ref ref47 ref48">(47,48)</a> These strains have also been used as reference strains for the <i>Toxoplasma</i> comparative genomes paper.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><div class="NLM_p">To monitor the effects of new antiparasitic compounds on different strains of <i>T. gondii</i>, we generated fire fly luciferase (FLUC) expressing lines so that we could use a common luciferase-based growth assay to monitor growth inhibition. We compared the potency of <b>3</b> for its ability to inhibit the growth of <i>T. gondii</i> strains in vitro. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a></a>, the potency of <b>3</b> was highly similar across these different lineages, with only 2- to 4-fold differences being observed in potency. The FLUC lines used here also carry a pyrimethamine resistance allele of DHFR that was used to generate the transgenic lines. This resistant DHFR allele confers highly level resistance to pyrimethamine as described previously,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a> but interestingly this did not lead to cross-resistance to <b>3</b>.</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Growth Effects of <b>3</b> on Different Strains of <i>T. gondii</i><a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">strain</th><th class="colsep0 rowsep0" align="center">host of origin</th><th class="colsep0 rowsep0" align="center">geographic distribution</th><th class="colsep0 rowsep0" align="center">type</th><th class="colsep0 rowsep0" align="center">EC<sub>50</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">GT1</td><td class="colsep0 rowsep0" align="left">goat</td><td class="colsep0 rowsep0" align="left">North America</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">18.0 ± 9.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">ME49</td><td class="colsep0 rowsep0" align="left">sheep</td><td class="colsep0 rowsep0" align="left">North America, Europe</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">8.3 ± 2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CTG</td><td class="colsep0 rowsep0" align="left">cat</td><td class="colsep0 rowsep0" align="left">North America</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">29.8 ± 15.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">RUB</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">South America</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">7.6 ± 3.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">VAND</td><td class="colsep0 rowsep0" align="left">human</td><td class="colsep0 rowsep0" align="left">South America</td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">11.2 ± 0.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup><sup>a</sup></sup><p class="last">Average of at least three independent replicates ± SEM.</p></div></div></div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Mouse Pharmacokinetic and Brain to Plasma Exposure Studies</h3><div class="NLM_p">2-Methoxypyrimidine <b>3</b> was selected over 2-methylpyrimidine <b>29</b> and unsubstituted pyrimidine <b>26</b> for further in vivo characterization owing to its substantially improved stability in mouse liver microsomes (MLMs). Preclinical models of toxoplasmosis are primarily performed in mice, and therefore a compound with sufficient oral bioavailability and plasma and CNS exposure to support murine efficacy testing was desired. Fortunately, <b>3</b> had moderate mouse liver microsome (MLM) intrinsic clearance (Cl<sub>int</sub>) of 56.3 mL min<sup>–1</sup> kg<sup>–1</sup>, which is 63% of mouse liver blood flow (LBF), whereas <b>29</b> and <b>26</b> both had high predicted clearance with MLM Cl<sub>int</sub> values of 431 and 2700 mL min<sup>–1</sup> kg<sup>–1</sup>, respectively, multiples above mouse LBF. The oral and iv PK parameters in mouse are summarized in <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">Table <a class="ref showTableEvent internalNav" data-ID="tbl8" href="#tbl8">8</a></a>. Compound <b>3</b> has low to moderate clearance of 10.6 mL min<sup>–1</sup> kg<sup>–1</sup>, a volume of distribution of 1.14 L/kg, and a half-life of 3.9 h after a 1.0 mg/kg, iv dose. Oral bioavailability after a 0.83 mg/kg po dose was 47.3% with a <i>C</i><sub>max</sub> of 178 ng/mL 30 min after dosing. The unbound fraction (%) in mouse plasma is 8.7 ± 0.2 and in brain homogenate 2.4 ± 0.3, determined using an equilibrium dialysis method. Compound <b>3</b> was freely permeable into the mouse CNS at 0.5 h after a 10 mg/kg oral dose; the concentration in brain was 2560 ± 240 ng/g and in blood 1610 ± 580 ng/mL, giving a brain to blood ratio of 1.7 ± 0.6.</div><div class="NLM_table-wrap" id="tbl8"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 8. Pharmacokinetics of Compound <b>3</b> in Mouse<a class="ref internalNav" href="#t8fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">route</th><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center"><i>F</i> (%)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>max,po</sub> (ng/mL)</th><th class="colsep0 rowsep0" align="center"><i>T</i><sub>max,po</sub> (h)</th><th class="colsep0 rowsep0" align="center">AUC<sub>0–last,po</sub> (ng·h/mL)</th><th class="colsep0 rowsep0" align="center">CL<sub>iv</sub> (mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center">Vd<sub>iv</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center"><i>t</i><sub>1/2,iv</sub> (h)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">iv</td><td class="colsep0 rowsep0" align="left">1.0</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">10.6</td><td class="colsep0 rowsep0" align="left">1.14</td><td class="colsep0 rowsep0" align="left">3.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">po</td><td class="colsep0 rowsep0" align="left">0.83</td><td class="colsep0 rowsep0" align="left">47.3</td><td class="colsep0 rowsep0" align="left">178</td><td class="colsep0 rowsep0" align="left">0.05</td><td class="colsep0 rowsep0" align="left">750</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t8fn1"><div class="footnote" id="t8fn1"><sup><sup>a</sup></sup><p class="last">Oral bioavailability (<i>F</i>), area under the concentration–time curve from time zero to the last measurable concentration (AUC<sub>0–last</sub>), clearance (CL), maximum observed plasma concentration (<i>C</i><sub>max</sub>), intravenous (iv), per os (po), elimination half-life (<i>t</i><sub>1/2</sub>), time to <i>C</i><sub>max</sub> (<i>T</i><sub>max</sub>), volume of distribution (Vd).</p></div></div></div></div><div id="sec2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> In Vivo Efficacy of <b>1</b> and <b>3</b> in a Murine Model of Acute Toxoplasmosis</h3><div class="NLM_p">Compounds <b>1</b> and <b>3</b> were tested independently in a murine model of acute toxoplasmosis and observed to improve survival in a dose-dependent manner (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>a and <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>b). Female CD-1 mice were inoculated intraperitoneally (ip) with 3000 tachyzoites of the highly virulent RH strain of <i>T. gondii</i> on day 0. In parallel, three negative control mice were inoculated with vehicle, lacking the parasite. The parasite strain used in this study was genetically modified to constitutively express the enzyme luciferase and enable infection monitoring via an in vivo imaging system (IVIS).<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Mice were monitored for survival for 30 days with intermittent IVIS monitoring (data not shown). On day 4 of dosing, compound exposure was assessed by microsampling from tail vein from three mice per group at 1, 4, and 12 h postdose and three mice per group at 2, 8, and 24 h postdose (data shown in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>a and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>b).</div><figure id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0006.jpeg" id="GRAPHIC-d7e3175-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) Kaplan–Meier survival curves of compound <b>1</b> in CD-1 female mice (<i>n</i> = 12 for drug treated groups, <i>n</i> = 9 for vehicle group) infected with 3000 RH type 1 <i>T. gondii</i> tachyzoites on day 0 followed by oral administration of <b>1</b> beginning on day 1 through day 7. Mice were carefully monitored for signs of infection, including by intermittent imaging (data not shown). (b) Kaplan–Meier survival curves of compound <b>3</b> in CD-1 female mice (<i>n</i> = 12 for drug treated groups, <i>n</i> = 9 for vehicle group) infected with 3000 RH type 1 <i>T. gondii</i> tachyzoites on day 0 followed by oral administration of <b>3</b> beginning on day 1 through day 7. Mice were carefully monitored for signs of infection, including by intermittent imaging (data not shown).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01754&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0007.jpeg" id="GRAPHIC-d7e3194-autogenerated" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (a) Day 4 [plasma]<sub>free</sub> exposure of <b>1</b> from the acute murine model of toxoplasmosis plotted as free plasma (nM) levels versus time. (b) Day 4 [plasma]<sub>free</sub> exposure of <b>3</b> from the acute murine model of toxoplasmosis plotted as free plasma (nM) levels versus time.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01754&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>3</b> at doses of 10 mg/kg, q.d. or b.i.d. for 7 days, yielded 100% survival for 30 days (end of study), while doses of 1 and 3 mg/kg produced similar results on survival as comparator compound <b>1</b> did at 18 mg/kg b.i.d. and 54 mg/kg q.d., respectively. Survival data for <b>1</b> in this study were consistent with published literature.<a onclick="showRef(event, 'ref52 ref53 ref54'); return false;" href="javascript:void(0);" class="ref ref52 ref53 ref54">(52−54)</a> All mice treated with vehicle died within 6–7 days. It should be noted that the single animals that were lost in the 3 mg/kg compound <b>3</b> group and 54 mg/kg compound <b>1</b> group were believed to be due to handling errors during imaging rather than active <i>T. gondii</i> infection as no signs of infection or bioluminescence (data not shown) were observed for these animals during the study. Consistent with the improved in vitro potency of <b>3</b> relative to <b>1</b>, it was also more potent in vivo producing similar efficacy at doses about 18-fold lower.</div><div class="NLM_p">Cure rates were assessed by subinfection of naive mice with combined homogenized brain and lung tissue from mice that survived 30 days. The tissues from two surviving mice of the same dosing group were injected into one donor mouse. Infection with a single <i>T. gondii</i> parasite of the type I RH strain is believed to be 100% lethal in naive mice;<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> therefore, subinoculated naive mice that survived for 15 days and were without signs of infection was indicative of a cure (i.e., the donor mice were devoid of parasite). It should be noted that the RH strain of <i>T. gondii</i> does not typically form tissue cysts. Therefore, a cure in this model may not translate to a cure with clinically relevant strains that form tissue cysts. Nonetheless, it is clear both <b>1</b> and <b>3</b> are strongly efficacious in eradicating the tissue damaging and life threatening tachyzoite form of the parasite.</div><div class="NLM_p">Compound <b>3</b> had a cure rate of 50% in the 1 and 3 mg/kg groups and 100% in the 10 mg/kg groups. Pyrimethamine <b>1</b> was 100% curative at the 54 mg/kg dose and 33–67% curative at the 18 mg/kg b.i.d. dose. These data suggest that inhibition of <i>Tg</i>DHFR is sufficient for maximal efficacy as a stand-alone therapy (e.g., without coadministration of a DHPS inhibitor). Regarding the results for pyrimethamine <b>1</b>, the human equivalent dose of 54 mg/kg in mouse (approximately 300 mg/day in a 70 kg individual) cannot be administered in patients owing to dose-limiting, mechanism-based safety issues.</div><div class="NLM_p last">For both compounds, the onset of effect on survival time occurred at exposures near or slightly above the <i>T. gondii</i> cell-based EC<sub>50</sub> values (1.0 mg/kg for <b>3</b> and 18 mg/kg for <b>1</b>), with maximal effects occurring at dose levels of 3 mg/kg and 10 mg/kg for <b>3</b> and 54 mg/kg for <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>a and <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>b), which exceed the cell-based EC<sub>50</sub> values.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12028" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12028" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Rational drug design led to the identification of several highly selective and potent arylpiperazine-based <i>Tg</i>DHFR inhibitors. The structure–activity relationship for these compounds provides proof-of-concept for the feasibility of discovering a next generation toxoplasmosis treatment with improved potency, selectivity, and safety. 2-Methoxypyrimidine <b>3</b>, with 16-fold better selectivity for <i>Tg</i>DHFR and 89-fold better potency as compared to pyrimethamine <b>1</b> and with desirable DMPK and safety properties, was selected for exploration in preclinical models of toxoplasmosis. Compound <b>3</b> was effective in radical cure of acute infection with the highly virulent type I RH strain in the murine model and showed similar potency across multiple parasite lineages in cell-based parasite growth assays. On the basis of the efficacy observed, we hypothesize it will be feasible to achieve parasiticidal levels of <b>3</b> in patients that are below concentrations that would inhibit <i>h</i>DHFR, thus providing a safer and more efficacious therapy than is currently available and possibly obviating the need for sulfonamide combination therapy.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23365" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23365" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Materials and Methods. General</h3><div class="NLM_p">All synthetic chemistry, DMPK, <i>T. gondii</i> DHFR crystal structures with <b>3</b> and <b>29</b>, and DHFR in vitro pharmacology were performed at WuXi App Tec at the China facilities in Tianjin and Shanghai. Work with <i>Toxoplasma gondii</i> was performed at Evotec in Manchester, U.K., and in Prof. Sibley’s lab at Washington University, St. Louis, MO. Proton NMR spectra were recorded on a Varian 400 MHz NMR. LC/MS data were taken on a quadrupole mass spectrometer on Shimadzu LC/MS 2010 (column Sepax ODS 50 mm × 2.0 mm, 5 μm) or Agilent 1200 HPLC, 1956 MSD (column Shim-pack XR-ODS 30 mm × 3.0 mm, 2.2 μm) operating in ES (+) ionization mode. All final compounds were greater than 95% pure based on HPLC UV% AUC. Structures were determined by <sup>1</sup>H NMR and LC/MS. Final compounds in this manuscript are not known to interfere with the assays herein (i.e., they are not PAINS).</div><div class="NLM_p last">All animal studies were conducted at WuXi App Tec in China and Evotec in Manchester, U.K., and were performed in accordance with the institutional guidelines for these countries and laboratories.</div></div><div id="sec4_1_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> LC/MS methods. Method A</h3><div class="NLM_p last">Method A was run on a Shimadzu LC-20AB with a MS 2010 detector using a Luna-C18(1) column (2.0 mm × 30 mm, 3 μm) at 40 °C. Mobile phase A was 0.037% (v/v) aqueous TFA, and mobile phase B was 0.018% (v/v) TFA in acetonitrile. The flow rate was 0.8 mL/min from 0.01 to 1.51 min, then 1.2 mL/min from 1.52 to 2.00 min. The gradient ran from 90% mobile phase A to 10% mobile phase A over 1.15 min, then remained at 10% mobile phase A through 1.65 min, then back to 90% mobile phase A at 1.66 min and was maintained at 90% mobile phase A through 2.0 min. The UV detection was 220 nm, and the MS was measured in positive ion mode.</div></div><div id="sec4_1_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Method B</h3><div class="NLM_p last">Method B was run on an Agilent 1200 with a MS 6120 detector using an Xbridge Shield RP18 column (2.1 mm × 50 mm, 5 μm) at 40 °C. Mobile phase A was 10 mM aqueous NH<sub>4</sub>HCO<sub>3</sub>, and mobile phase B was acetonitrile. The flow rate was 1.0 mL/min from 0.01 to 2.48 min, then 1.2 mL/min from 2.50 to 3.00 min. The gradient ran from 90% mobile phase A to 20% mobile phase A over 2.00 min, then remained at 20% mobile phase A through 2.48 min, then back to 90% mobile phase A at 2.50 min and maintained at 90% mobile phase A through 3.0 min. The UV detection was 220 nm, and the MS was measured in positive ion mode.</div></div><div id="sec4_1_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Method C</h3><div class="NLM_p last">Method C was run on an Agilent 1200 with a MS 6120 detector using an Xbridge Shield RP18 column (2.1 mm × 50 mm, 5um) at 40 °C. Mobile phase A was 10 mM aqueous NH<sub>4</sub>HCO<sub>3</sub>, and mobile phase B was acetonitrile. The flow rate was 1.0 mL/min from 0.01 to 2.50 min, then 1.2 mL/min from 2.51 to 3.00 min. The gradient ran from 70% mobile phase A to 10% mobile phase A over 1.50 min, then remained at 10% mobile phase A through 2.50 min, then back to 70% mobile phase A at 2.51 min and maintained at 70% mobile phase A through 3.0 min. The UV detection was 220 nm, and the MS was measured in positive ion mode.</div></div><div id="sec4_1_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Method D</h3><div class="NLM_p last">Method D was run on an Agilent 1200 with a MS 6120 detector using a Venusil XBP-C18 column (2.1 mm × 50 mm, 5 μm) at 40 °C. Mobile phase A was 0.0375% aqueous TFA and mobile phase B was 0.018% TFA in acetonitrile. The flow rate was 0.8 mL/min from 0.01 to 4.5 min. The gradient was maintained at 99% mobile phase A from 0.00 to 0.40 min, then the gradient ran from 99% mobile phase A to 10% mobile phase A over 3.00 min, then to 0% mobile phase A over 0.45 min, then back to 99% mobile phase A over 0.01 min and maintained here for 0.55 min. The UV detection was 220 nm, and the MS was measured in positive ion mode.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Chemistry</h3><div class="NLM_p">The compounds in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a> were sourced as follows. Compound <b>2</b> was prepared as described previously.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Pyrimethamine (<b>1</b>) was sourced from the drug manufacturer, and <sup>1</sup>H NMR and LC/MS data confirmed structure and purity of 99.9%. Trimethoprim (<b>4</b>) was purchased from a commercial supplier as the lactate salt, and <sup>1</sup>H NMR and LC/MS data confirmed structure with a purity of 98.7%. Methotrexate (<b>5</b>) was purchased from a commercial supplier, and <sup>1</sup>H NMR and LC/MS data confirmed structure with a purity near 100%. Trimetrexate (<b>6</b>) was purchased from a commercial supplier as the trihydrochloride salt, and <sup>1</sup>H NMR and LC/MS data confirmed structure with a purity of 95.2%.</div><div class="NLM_p">The compounds in <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Tables <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a> were prepared according to <a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a> and <a class="ref internalNav" href="#sch2" aria-label="2">2</a>.</div><div class="NLM_p last">Compounds <b>7</b>–<b>18</b>, <b>20</b>, and <b>21</b> were prepared in a similar fashion as described below for the synthesis of <b>32</b>.</div></div><div id="sec4_2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 5-(4-(3-Bromophenyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>32</b>)</h3><div class="NLM_p"><b>32</b> was prepared in 3 steps and 12.8% overall yield as follows.</div><div id="sec4_2_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Step 1. 5-(4-([3-Bromophenyl])piperazin-1-yl)pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione (<b>37n</b>)</h4><div class="NLM_p last">To a mixture of 5-bromo-1<i>H</i>-pyrimidine-2,4-dione <b>33</b> (7.92 g, 42 mmol, 1.0 equiv) and 1-(3-bromophenyl)piperazine <b>36n</b> (10.0 g, 42 mmol, 1.0 equiv) in DMSO (200 mL) was added potassium fluoride (5.0 g, 94 mmol, 2.0 equiv). The resulting mixture was stirred at 130 °C for 12 h, cooled to room temperature, and poured into 300 mL of water. The precipitate was collected by suction filtration, washed with 200 mL of EtOH, and dried in vacuo leaving 5-(4-([3-bromophenyl])piperazin-1-yl)pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione <b>37n</b> as a brown solid (10.6 g, 30.2 mmol, 73.5% yield) used as such in the next step. LC/MS method B (ESI+): expected <i>m</i>/<i>z</i> 351 (M + 1)<sup>+</sup>; found <i>m</i>/<i>z</i> 351 (M + 1)<sup>+</sup>, <i>t</i><sub>R</sub> = 1.07 min.</div></div><div id="sec4_2_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> Step 2. 5-(4-(3-Bromophenyl)piperazin-1-yl)-2,4-dichloropyrimidine (<b>38n</b>)</h4><div class="NLM_p last">A mixture of 5-(4-(3-bromophenyl)piperazin-1-yl)pyrimidine-2,4(1<i>H</i>,3<i>H</i>)-dione <b>37n</b> (10 g, 28.5 mmol, 1.0 equiv) and DIPEA (14.4 g, 111 mmol, 3.9 equiv) in 70 mL of toluene was cooled to 10 °C, and POCl<sub>3</sub> (15.8 g, 103 mmol) was added over 1 h, keeping the reaction temperature 20 °C. The mixture was stirred at 20 °C for 1 h, heated to 95 °C, and held at 95 °C for 12 h. LC/MS was consistent with the desired product MS. The reaction mixture was concentrated under reduced pressure to give a black residue, which was diluted with cold water (200 mL) and extracted with DCM (3 × 100 mL). The combined organic layers were washed with brine (2 × 100 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give 5-(4-(3-bromophenyl)piperazin-1-yl)-2,4-dichloropyrimidine (<b>38n</b>) (6.4 g, 58% yield, 90.8% HPLC purity) as a yellow solid used as such in the next step. LC/MS method C (ESI+): expected <i>m</i>/<i>z</i> 389.1 (M + 1)<sup>+</sup>; found <i>m</i>/<i>z</i> 389.0 (M + 1)<sup>+</sup>, <i>t</i><sub>R</sub> = 2.18 min.</div></div><div id="sec4_2_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> Step 3. 5-(4-(3-Bromophenyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>32</b>)</h4><div class="NLM_p last">A mixture of 5-(4-(bromophenyl)piperazin-1-yl)-2,4-dichloropyrimidine <b>38n</b> (100.0 mg, 0.26 mmol, 1.0 equiv) in NH<sub>3</sub>/EtOH (10 mL) was added to a steel bomb. The mixture was stirred at 145 °C for 12 h. The suspension was cooled to room temperature and concentrated under reduced pressure to give a brown residue. The residue was purified by prep-HPLC (TFA condition) to give 5-(4-(3-bromophenyl)piperazin-1-yl)pyrimidine-2,4-diamine <b>32</b> (86.5 mg, 249.6 μmol, 30.0% yield) as a white solid. LC/MS method D (ESI+): expected <i>m</i>/<i>z</i> (349.0 and 351.1 M + 1)<sup>+</sup>; found <i>m</i>/<i>z</i> 349.0 and 351.1 (M + 1)<sup>+</sup>, <i>t</i><sub>R</sub> = 2.18 min. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz) δ = 7.57 (s, 1H), 7.19–7.12 (m, 1H), 7.09 (br s, 1H), 6.94 (br dd, <i>J</i> = 7.9, 18.4 Hz, 2H), 5.65 (s, 2H), 3.29 (br s, 4H), 2.85 (br s, 4H).</div></div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 5-(4-Phenylpiperazin-1-yl)pyrimidine-2,4-diamine (<b>7</b>)</h3><div class="NLM_p last"><b>7</b> was prepared in an analogous 3 step manner as described for <b>32</b> starting with 1-phenylpiperazine (<b>36b</b>) to give a light yellow solid (26.6% yield). <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ = 7.59 (s, 1H), 7.22 (br t, <i>J</i> = 7.8 Hz, 2H), 6.96 (br d, <i>J</i> = 8.2 Hz, 2H), 6.78 (t, <i>J</i> = 7.0 Hz, 1H), 6.07 (br s, 2H), 5.61 (br s, 2H), 3.25 (br s, 4H), 2.88 (br t, <i>J</i> = 4.5 Hz, 4H). LC/MS (M + 1) expected MW 271.1, observed MW 271.1,% UV purity 99.9%.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 5-(4-([1,1′-Biphenyl]-2-yl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>8</b>)</h3><div class="NLM_p last"><b>8</b> was prepared in an analogous 3 step manner as described for <b>32</b> above starting with 1-([1,1′-biphenyl]-2-yl)piperazine (<b>36c</b>) to give <b>8</b> in 7.0% yield as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ = 7.65 (br d, <i>J</i> = 7.6 Hz, 2H), 7.48 (s, 1H), 7.44 (br t, <i>J</i> = 7.2 Hz, 2H), 7.31 (br t, <i>J</i> = 7.2 Hz, 2H), 7.21 (br d, <i>J</i> = 7.2 Hz, 1H), 7.12–7.05 (m, 2H), 5.99 (br s, 1H), 5.60 (s, 2H), 2.88 (br s, 4H), 2.64 (br s, 4H). LC/MS (M + 1) expected MW 347.2, observed MW 347.2, UV purity 97.8%.</div></div><div id="sec4_2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 5-(4-([1,1′-Biphenyl]-4-yl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>9</b>)</h3><div class="NLM_p last"><b>9</b> was prepared in an analogous 3 step manner as described for <b>32</b> starting with 1-([1,1′-biphenyl]-4-yl)piperazine (<b>36d</b>) to give <b>9</b> in 10.6% yield as a white solid. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ = 7.60–7.50 (m, 5H), 7.39 (br t, <i>J</i> = 7.4 Hz, 2H), 7.30–7.23 (m, 1H), 7.10 (br d, <i>J</i> = 8.6 Hz, 2H), 3.48–3.36 (m, 4H), 3.03 (br d, <i>J</i> = 4.3 Hz, 4H). LC/MS (M + 1) expected MW 347.2, observed MW 347.2, UV purity 96.7%.</div></div><div id="sec4_2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 5-(4-(<i>o</i>-Tolyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>10</b>)</h3><div class="NLM_p last"><b>10</b> was prepared in an analogous 3 step manner as described for <b>32</b> starting with 1-(<i>o</i>-tolyl)piperazine (<b>36e</b>) to give <b>10</b> in 32.8% yield as a white solid. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ = 7.53 (s, 1H), 7.21–7.11 (m, 3H), 7.03–6.97 (m, 1H), 3.10 (br s, 4H), 3.03 (br d, <i>J</i> = 4.0 Hz, 4H), 2.34 (s, 3H). LC/MS (M + 1) expected MW 285.2, observed MW 285.1, UV purity 99.4%.</div></div><div id="sec4_2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 5-(4-(<i>m</i>-Tolyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>11</b>)</h3><div class="NLM_p last"><b>11</b> was prepared in an analogous 3 step manner as described for <b>32</b> starting with 1-(<i>m</i>-tolyl)piperazine (<b>36f</b>) to give <b>11</b> in 7.2% yield as a yellow solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ = 7.59 (s, 1H), 7.10 (t, <i>J</i> = 7.8 Hz, 1H), 6.83–6.70 (m, 2H), 6.60 (br d, <i>J</i> = 7.4 Hz, 1H), 6.08 (br s, 2H), 5.62 (s, 2H), 3.23 (br s, 4H), 2.86 (br t, <i>J</i> = 4.3 Hz, 4H), 2.25 (s, 3H). LC/MS (M + 1) expected MW 285.1, observed MW 285.1, UV purity 99.5%.</div></div><div id="sec4_2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 5-(4-(<i>p</i>-Tolyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>12</b>)</h3><div class="NLM_p last"><b>12</b> was prepared in an analogous 3 step manner as described for <b>32</b> starting with 1-(<i>p</i>-tolyl)piperazine (<b>36g</b>) to give <b>12</b> in 2.3% yield as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ = 7.58 (s, 1H), 7.03 (d, <i>J</i> = 8.4 Hz, 2H), 6.86 (d, <i>J</i> = 8.4 Hz, 2H), 6.06 (br. s., 1H), 5.60 (s, 2H), 3.19 (br. s., 4H), 2.87 (d, <i>J</i> = 4.0 Hz, 4H), 2.20 (s, 3H). LC/MS (M + 1) expected MW 285.1, observed MW 285.1, UV purity 98.1%.</div></div><div id="sec4_2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 5-(4-(2-Chlorophenyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>13</b>)</h3><div class="NLM_p last"><b>13</b> was prepared in an analogous 3 step manner as described for <b>32</b> starting with 1-(2-chlorophenyl)piperazine (<b>36h</b>) to give <b>13</b> in 19.4% yield as a light yellow solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ = 7.62 (s, 1H), 7.42 (br d, <i>J</i> = 7.8 Hz, 1H), 7.35–7.28 (m, 1H), 7.18 (br d, <i>J</i> = 7.8 Hz, 1H), 7.05 (br t, <i>J</i> = 7.4 Hz, 1H), 6.09 (br s, 2H), 5.63 (s, 2H), 3.11 (br s, 4H), 2.91 (br d, <i>J</i> = 3.9 Hz, 4H). LC/MS (M + 1) expected MW 305.1, observed MW 305.1, UV purity 99.1%.</div></div><div id="sec4_2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 5-(4-(3-Chlorophenyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>14</b>)</h3><div class="NLM_p last"><b>14</b> was prepared in an analogous 3 step manner as described for <b>32</b> starting with 1-(3-chlorophenyl)piperazine (<b>36i</b>) to give <b>14</b> in 6.6% yield as a solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ = 11.76 (br, 1H), 8.43 (br s, 1H), 7.65 (br s, 1H), 7.56 (br s, 1H), 7.43 (br s, 2H), 7.23 (br t, <i>J</i> = 8.4 Hz, 1H), 6.98 (br s, 1H), 6.93 (br d, <i>J</i> = 8.4 Hz, 1H), 6.80 (br d, <i>J</i> = 7.6 Hz, 1H), 3.36 (br s, 4H), 2.86 (br s, 4H). LC/MS (M + 1) expected MW 305.1, observed MW 305.1, UV purity 98.1%.</div></div><div id="sec4_2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 5-(4-(4-Chlorophenyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>15</b>)</h3><div class="NLM_p last"><b>15</b> was prepared in an analogous 3 step manner as described for <b>32</b> starting with 1-(4-chlorophenyl)piperazine (<b>36j</b>) to give <b>15</b> in 71.9% yield as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ = 7.58 (s, 1H), 7.24 (br d, <i>J</i> = 9.0 Hz, 2H), 6.97 (br d, <i>J</i> = 9.0 Hz, 2H), 6.08 (br s, 1H), 5.61 (s, 2H), 3.26 (br s, 4H), 2.86 (br t, <i>J</i> = 4.3 Hz, 4H). LC/MS (M + 1) expected MW 305.1, observed MW 305.1, UV purity 96.3%.</div></div><div id="sec4_2_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 5-(4-(3-Methoxyphenyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>16</b>)</h3><div class="NLM_p last"><b>16</b> was prepared in an analogous 3 step manner as described for <b>32</b> starting with 1-(3-methoxyphenyl)piperazine (<b>36k</b>) to give <b>16</b> in 24.2% yield as a white solid. <sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>) δ = 7.58 (s, 1H), 7.11 (t, <i>J</i> = 8.4 Hz, 1H), 6.54 (br d, <i>J</i> = 8.0 Hz, 1H), 6.47 (s, 1H), 6.37 (br d, <i>J</i> = 8.0 Hz, 1H), 6.08 (br s, 1H), 5.61 (s, 2H), 3.72 (s, 3H), 3.25 (br s, 4H), 2.86 (br d, <i>J</i> = 4.0 Hz, 4H). LC/MS (M + 1) expected MW 301.1, observed MW 301.1, UV purity 98.7%.</div></div><div id="sec4_2_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 5-(4-(3-(Trifluoromethyl)phenyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>17</b>)</h3><div class="NLM_p last"><b>17</b> was prepared in an analogous 3 step manner as described for <b>32</b> starting with 1-(3-trifluoromethylphenyl)piperazine (<b>36l</b>) to give <b>17</b> in 18.8% yield as a yellow solid. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ = 7.50 (s, 1H), 7.44–7.39 (m, 1H), 7.23 (br d, <i>J</i> = 8.8 Hz, 1H), 7.20 (br s, 1H), 7.10 (br d, <i>J</i> = 7.5 Hz, 1H), 3.40 (br s, 4H), 3.01 (br d, <i>J</i> = 4.4 Hz, 4H). LC/MS (M + 1) expected MW 339.1, observed MW 339.1, UV purity 99.5%.</div></div><div id="sec4_2_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 5-(4-(3-(Trifluoromethoxy)phenyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>18</b>)</h3><div class="NLM_p last"><b>18</b> was prepared in an analogous 3 step manner as described for <b>32</b> starting with 1-(3-trifluoromethoxyphenyl)piperazine (<b>36m</b>) to give <b>18</b> in 22.7% yield as a yellow solid. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ = 7.49 (s, 1H), 7.31 (t, <i>J</i> = 8.2 Hz, 1H), 6.98 (d, <i>J</i> = 7.9 Hz, 1H), 6.84 (s, 1H), 6.72 (d, <i>J</i> = 7.9 Hz, 1H), 3.38 (s, 4H), 2.99 (s, 4H). LC/MS (M + 1) expected MW 355.1, observed MW 355.1, UV purity 100%.</div></div><div id="sec4_2_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 5-(4-([1,1′-Biphenyl]-3-yl)piperazin-1-yl)-6-methylpyrimidine-2,4-diamine (<b>20</b>)</h3><div class="NLM_p last"><b>20</b> was prepared in an analogous 3 step manner as described for <b>32</b> starting with 1-([1,1′-biphenyl]-3-yl)piperazine (<b>36a</b>) and 5-bromo-6-methyluracil (<b>34</b>) to give <b>20</b> in 31.8% yield as a yellow solid. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ = 7.64–7.57 (m, 2H), 7.51–7.28 (m, 5H), 7.20 (br d, <i>J</i> = 7.5 Hz, 1H), 7.09 (br d, <i>J</i> = 7.9 Hz, 1H), 3.66 (br d, <i>J</i> = 11.5 Hz, 2H), 3.45–3.35 (m, 2H), 3.26–3.16 (m, 2H), 3.03 (br d, <i>J</i> = 11.5 Hz, 2H), 2.38 (s, 3H). LC/MS (M + 1) expected MW 361.2, observed MW 361.1, UV purity 95.9%.</div></div><div id="sec4_2_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> 5-(4-([1,1′-Biphenyl]-3-yl)piperazin-1-yl)-6-ethylpyrimidine-2,4-diamine (<b>21</b>)</h3><div class="NLM_p"><b>21</b> was prepared in an analogous 3 step manner as described for <b>32</b> starting with 1-([1,1′-biphenyl]-3-yl)piperazine (<b>36a</b>) and 5-bromo-6-ethyluracil (<b>35</b>) to give <b>21</b> in 71.4% yield as a yellow solid. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ = 7.61 (d, <i>J</i> = 7.2 Hz, 2H), 7.43 (d, <i>J</i> = 8.0 Hz, 4H), 7.36 (d, <i>J</i> = 6.4 Hz, 1H), 7.30 (d, <i>J</i> = 7.2 Hz, 1H), 7.18 (d, <i>J</i> = 7.2 Hz, 1H), 3.65 (d, <i>J</i> = 9.2 Hz, 2H), 3.44–3.31 (m, 4H), 3.12 (d, <i>J</i> = 8.8 Hz, 2H), 2.73 (d, <i>J</i> = 7.6 Hz, 2H), 1.33 (t, <i>J</i> = 6.8 Hz, 3H). LC/MS (M + 1) expected MW 375.2, observed MW 375.1, UV purity 98.7%.</div><div class="NLM_p last">Compounds <b>3</b>, <b>19</b>, <b>23</b>, <b>24</b>, <b>26</b>, <b>28</b>, <b>30</b>, and <b>31</b> were prepared in a similar fashion as described below for the synthesis of <b>29</b>.</div></div><div id="sec4_2_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> 5-(4-(3-(2-Methylpyrimidin-5-yl)phenyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>29</b>)</h3><div class="NLM_p last">A mixture of 5-(4-(3-bromophenyl)piperazin-1-yl)pyrimidine-2,4-diamine <b>32</b> (1.0 g, 2.8 mmol, 1.0 equiv), (2-methylpyrimidin-5-yl)boronic acid <b>39u</b> (395 mg, 2.8 mmol, 1.0 equiv), Cs<sub>2</sub>CO<sub>3</sub> (1.4 g, 4.3 mmol, 1.5 equiv), Pd(PPh<sub>3</sub>)<sub>4</sub> (165 mg, 143 μmol, 0.05 equiv) in dioxane (32 mL), and H<sub>2</sub>O (8.0 mL) was degassed and purged with N<sub>2</sub> 3 times and then stirred at 100 °C for 12 h under N<sub>2</sub> atmosphere. Then it was stirred with silica S thiol Met at 20 °C, filtered, and concentrated to give a residue. The residue was purified by prep-HPLC (TFA condition) to give 5-(4-(3-(2-methylpyrimidin-5-yl)phenyl)piperazin-1-yl)pyrimidine-2,4-diamine <b>29</b> (1.2 g, 2.5 mmol, 88.0% yield) as a white solid. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ = 8.93 (s, 2H), 7.51 (s, 1H), 7.41 (t, <i>J</i> = 7.8 Hz, 1H), 7.26–7.24 (m, 1H), 7.16–7.09 (m, 2H), 3.44 (br s, 4H), 3.02 (br t, <i>J</i> = 4.8 Hz, 4H), 2.73 (s, 3H). LC/MS expected <i>m</i>/<i>z</i> 363.2 (M + 1)<sup>+</sup>; found <i>m</i>/<i>z</i> 363.1 (M + 1)<sup>+</sup>. UV purity 99.0%.</div></div><div id="sec4_2_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> 5-(4-(3-(2-Methoxypyrimidin-5-yl)phenyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>3</b>)</h3><div class="NLM_p last"><b>3</b> was prepared in an analogous manner as described for <b>29</b> starting with <b>32</b> and 5-(2-methoxypyrimidinyl)boronic acid (<b>39o</b>) to give <b>3</b> in 92.8% yield as a light yellow solid. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ = 8.81 (s, 2H), 7.51 (s, 1H), 7.39 (br t, <i>J</i> = 7.6 Hz, 1H), 7.22 (br s, 1H), 7.14–7.07 (m, 2H), 4.06 (s, 3H), 3.44 (br s, 4H), 3.03 (br s, 4H). Elemental analysis for C<sub>19</sub>H<sub>22</sub>N<sub>8</sub>O + 0.15 H<sub>2</sub>O: theoretical C 59.83%, H 5.90%, N 29.39%. Found C 59.56%, H 5.83%, N 29.05%. LC/MS (M + 1) expected MW 379.2, observed MW 379.1, UV purity 96.4%.</div></div><div id="sec4_2_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> 5-(4-(3-Cyclopropylphenyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>19</b>)</h3><div class="NLM_p last"><b>19</b> was prepared in an analogous manner as described for <b>29</b> starting with <b>32</b> and cyclopropyl boronic acid (<b>39p</b>) to give <b>19</b> in 59.2% yield as solid. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ = 7.52 (br s, 1H), 7.20 (br d, <i>J</i> = 7.2 Hz, 1H), 6.97–6.83 (m, 2H), 6.73 (br s, 1H), 3.43 (br s, 4H), 3.06 (br s, 4H), 1.91 (br s, 1H), 0.96 (br d, <i>J</i> = 6.0 Hz, 2H), 0.68 (br s, 2H). LC/MS (M + 1) expected MW 311.2, observed MW 311.1, UV purity 98.9%.</div></div><div id="sec4_2_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> 5-(4-(3-(Pyridin-3-yl)phenyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>23</b>)</h3><div class="NLM_p last"><b>23</b> was prepared in an analogous manner as described for <b>29</b> starting with <b>32</b> and 3-pyridylboronic acid (<b>39q</b>) to give <b>23</b> in 28.2% yield as a light yellow oil. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ = 9.08 (br s, 1H), 8.79–8.69 (m, 2H), 8.01 (br s, 1H), 7.52 (s, 1H), 7.49–7.44 (m, 1H), 7.36 (s, 1H), 7.24 (d, <i>J</i> = 7.6 Hz, 1H), 7.19 (dd, <i>J</i> = 2.0, 8.4 Hz, 1H), 3.48 (br s, 4H), 3.04 (br s, 4H). LC/MS (M + 1) expected MW 348.2, observed MW 348.2, UV purity 98.2%.</div></div><div id="sec4_2_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> 5-(4-(3-(Pyridin-4-yl)phenyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>24</b>)</h3><div class="NLM_p last"><b>24</b> was prepared in an analogous manner as described for <b>29</b> starting with <b>32</b> and 4-pyridylboronic acid (<b>39r</b>) to give <b>24</b> in 11.5% yield. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ = 8.56 (br s, 2H), 7.73–7.62 (m, 3H), 7.39 (br d, <i>J</i> = 8.8 Hz, 1H), 7.33 (br s, 1H), 7.22 (br d, <i>J</i> = 7.2 Hz, 1H), 7.13 (br d, <i>J</i> = 7.6 Hz, 1H), 3.50–3.35 (m, 4H), 3.03 (br s, 4H). LC/MS (M + 1) expected MW 348.2, observed MW 348.2, UV purity 95.3%.</div></div><div id="sec4_2_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> 5-(4-(3-(Pyrimidin-5-yl)phenyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>26</b>)</h3><div class="NLM_p last"><b>26</b> was prepared in an analogous manner as described for <b>29</b> starting with <b>32</b> and 5-pyrimidinylboronic acid (<b>39s</b>) to give <b>26</b> in 34.9% yield as a light yellow oil. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ = 9.14 (br s, 1H), 9.07 (br s, 2H), 7.52 (s, 1H), 7.49–7.42 (m, 1H), 7.34 (br s, 1H), 7.21 (br dd, <i>J</i> = 7.7, 18.7 Hz, 2H), 3.48 (br s, 4H), 3.05 (br s, 4H). LC/MS (M + 1) expected MW 349.1, observed MW 349.1, UV purity 95.8%.</div></div><div id="sec4_2_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> 5-(4-(3-(Pyridazin-4-yl)phenyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>28</b>)</h3><div class="NLM_p last"><b>28</b> was prepared in an analogous manner as described for <b>29</b> starting with <b>32</b> and 4-pyridazineboronic acid pinacol ester (<b>39t</b>) to give <b>28</b> in 9.2% yield as a yellow solid. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ = 9.59 (s, 1H), 9.25 (d, <i>J</i> = 5.3 Hz, 1H), 8.10 (dd, <i>J</i> = 2.4, 5.5 Hz, 1H), 7.55–7.41 (m, 3H), 7.34 (br d, <i>J</i> = 7.9 Hz, 1H), 7.22 (br d, <i>J</i> = 8.4 Hz, 1H), 3.48 (br s, 4H), 3.04 (br d, <i>J</i> = 4.4 Hz, 4H). LC/MS (M + 1) expected MW 349.2, observed MW 349.1, UV purity 100%.</div></div><div id="sec4_2_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> 5-(4-(3-(2-(Trifluoromethyl)pyrimidin-5-yl)phenyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>30</b>)</h3><div class="NLM_p last"><b>30</b> was prepared in an analogous manner as described for <b>29</b> starting with <b>32</b> and 5-(2-trifluoromethylpyrimidine)boronic acid (<b>39v</b>) to give <b>30</b> in 27.3% yield as a yellow solid. <sup>1</sup>H NMR (methanol-d4) δ = 9.23 (s, 2H), 7.51 (s, 1H), 7.46–7.44 (m, 1H), 7.36 (s, 1H), 7.25 (d, <i>J</i> = 8.0 Hz, 1H), 7.18 (d, <i>J</i> = 6.4 Hz, 1H), 3.47 (br s, 4H), 3.03 (br s, 4H). LC/MS (M + 1) expected MW 417.2, observed MW 417.1, UV purity 98.2%.</div></div><div id="sec4_2_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> 5-(4-(3-(2-Cyclopropylpyrimidin-5-yl)phenyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>31</b>)</h3><div class="NLM_p"><b>31</b> was prepared in an analogous manner as described for <b>29</b> starting with <b>32</b> and 5-(2-cyclopropylpyrimidine)boronic acid (<b>39w</b>) to give <b>31</b> in 42.9% yield as a light yellow solid. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ = 8.89 (s, 2H), 7.52 (s, 1H), 7.43–7.41 (m, 1H), 7.28 (s, 1H), 7.19–7.13 (m, 2H), 3.46 (br s, 4H), 3.04 (br s, 4H), 2.30–2.25 (m, 1H), 1.17–1.15 (m, 4H). Expected MW 389.2, observed MW 389.1, UV purity 100%.</div><div class="NLM_p last">Compounds <b>25</b> and <b>27</b> were prepared in a fashion as described below for the synthesis of <b>22</b>.</div></div><div id="sec4_2_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> 5-(4-(3-(Pyridin-2-yl)phenyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>22</b>)</h3><div class="NLM_p last">A mixture of 5-(4-(3-bromophenyl)piperazin-1-yl)pyrimidine-2,4-diamine <b>32</b> (100.0 mg, 286.3 μmol, 1.0 equiv), tributyl(pyridin-2-yl)stannane <b>40x</b> (106 mg, 286 μmol, 1 equiv), Pd<sub>2</sub>(dba)<sub>3</sub> (7.8 mg, 8.6 μmol, 0.03 equiv), XPhos (23 mg, 49 μmol, 0.17 equiv) in dioxane (8.0 mL) was degassed and purged with N<sub>2</sub> 3 times. The mixture was stirred at 100 °C for 12 h under N<sub>2</sub> atmosphere, concentrated under reduced pressure and the residue was purified by prep-HPLC (TFA condition) to give 5-(4-(3-(pyridin-2-yl)phenyl)piperazin-1-yl)pyrimidine-2,4-diamine <b>22</b> (4.5 mg, 4.5% yield) as a yellow solid. LC/MS method D (ESI+): expected <i>m</i>/<i>z</i> (348.2 M + 1)<sup>+</sup>; found <i>m</i>/<i>z</i> 348.1 (M + 1)<sup>+</sup>. <sup>1</sup>H NMR (CD<sub>3</sub>OD-<i>d</i><sub>6</sub>) δ = 8.60 (br d, <i>J</i> = 4.9 Hz, 1H), 7.94–7.88 (m, 1H), 7.87–7.82 (m, 1H), 7.63 (s, 1H), 7.58 (s, 1H), 7.42–7.34 (m, 3H), 7.12 (br s, 1H), 3.39 (br d, <i>J</i> = 11.0 Hz, 4H), 3.03 (br t, <i>J</i> = 4.6 Hz, 4H).</div></div><div id="sec4_2_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 5-(4-(3-(Pyrimidin-2-yl)phenyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>25</b>)</h3><div class="NLM_p last"><b>25</b> was prepared in an analogous manner as described for <b>22</b> starting with <b>32</b> and tributyl(pyrimidin-2-yl)stannane (<b>40y</b>) to give <b>25</b> in 23.5% yield as a white solid. <sup>1</sup>H NMR ((methanol-<i>d</i><sub>4</sub>) δ = 8.85 (br s, 2H), 8.07 (br s, 1H), 7.92 (br d, <i>J</i> = 6.6 Hz, 1H), 7.52 (br s, 1H), 7.40 (br d, <i>J</i> = 13.7 Hz, 2H), 7.21 (br s, 1H), 3.46 (br s, 4H), 3.05 (br s, 4H). expected MW 349.2, observed MW 349.2, UV purity 97.1%.</div></div><div id="sec4_2_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 5-(4-(3-(Pyrazin-2-yl)phenyl)piperazin-1-yl)pyrimidine-2,4-diamine (<b>27</b>)</h3><div class="NLM_p last"><b>27</b> was prepared in an analogous manner as described for <b>22</b> starting with <b>32</b> and tributyl(pyrazin-2-yl)stannane (<b>40z</b>) to give <b>27</b> in 50.1% yield as a light yellow solid. <sup>1</sup>H NMR (methanol-<i>d</i><sub>4</sub>) δ = 9.19 (s, 1H), 8.73 (s, 1H), 8.60 (br d, <i>J</i> = 2.0 Hz, 1H), 8.30 (s, 1H), 8.11 (br d, <i>J</i> = 7.6 Hz, 1H), 7.73–7.65 (m, 2H), 7.62 (s, 1H), 3.85 (br s, 4H), 3.30–3.26 (m, 4H). expected MW 349.2, observed MW 349.2, UV purity 99.1%.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> DHFR Assay for Human and <i>T. gondii</i></h3><div class="NLM_p">All compounds were tested in duplicate and replicated in at least 3 independent experiments. Human and <i>T. gondii</i> DHFR assays were run in parallel using the same stocks to optimize selectivity data. Key comparator compounds <b>1</b> (<i>n</i> = 12 for human and <i>T. gondii</i>) and <b>3</b> (<i>n</i> = 16 for human and <i>T. gondii</i>) were tested in free base form on the same days for optimal comparison. The protein expression and purification protocol were adapted from a previously published procedure.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a><i>T. gondii</i> TS-DHFR was subcloned into a PET15b plasmid and transformed into <i>Escherichia coli</i> BL21 competent cells. Overnight cultured bacteria were inoculated into a 1 L of LB culture media at a ratio of 1:100 at 37 °C. Upon reaching a q.d. 600 nm of 0.7, protein expression was induced with 0.5 mM isopropyl β-<span class="smallcaps smallerCapital">d</span>-thiogalactoside at 16 °C overnight. Cells were then pelleted (∼4.6 g) and resuspended in buffer A (25 mM Tris-HCl, pH 7.3, 100 mM NaCl, 1 mM EDTA) before lysis by sonication. MTX agarose beads (∼1 mL) were added to the lysate, and the beads were subsequently washed 2× with buffer A (∼10 mL) and 1× with buffer B (∼10 mL, 25 mM Tris-HCl, pH 7.3, 1 M KCl, 1 mM EDTA) prior to elution with buffer C (∼6 mL, 25 mM Tris-HCl, 10 mM DTT, 10% glycerol, 2 mM H<sub>2</sub>F). The eluent containing the purified enzyme was then concentrated and the protein was transferred, using a PD-MiniTrap G-25 column, to the final storage buffer (25 mM Tris-HCl, 10 mM DTT, 10% glycerol). Purified hDHFR was obtained commercially from Sigma-Aldrich, dihydrofolate reductase human (Sigma D6566). The protein was confirmed by sequencing.</div><div class="NLM_p last">The diaphorase-coupled assay for DHFR activity was adapted from a previously published procedure.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> Compounds were added as solutions of DMSO at 100× the desired concentration to purified enzyme (1 μg/mL) suspended in assay buffer (150 mM KCl, 8.9 mM β-mercaptoethanol in 40.0 mM sodium phosphate at pH 7.4) in 384-well format (Corning 3573). Following a 15 min incubation at 25 °C, solutions of NADPH (1.6 μM, Sigma N7505) and DHF (10 μM, Sigma D7006) in assay buffer were added sequentially. The plate was then incubated at 25 °C for an additional 60 min prior to the addition of diaphorase (10 U/mL) and resazurin (5 μM, Sigma R7017). After a final 10 min incubation at 25 °C, fluorescence was measured using an EnVision plate reader (531 nm Ex/590 nm Em). IC<sub>50</sub> values were determined from the raw fluorometric data by nonlinear regression using GraphPad Prism.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Parasite Strains and Cell Lines</h3><div class="NLM_p last">Tachyzoites of <i>T. gondii</i> strains were grown in monolayers of human foreskin fibroblasts (HFF) (ATCC SCRC 1041) maintained in complete medium (DMEM containing 10% FBS, 2 mM <span class="smallcaps smallerCapital">l</span>-glutamine, 10 mM HEPES, and 10 μg/mL gentamicin in 35 mM NaHCO<sub>3</sub> solution), 37 °C in 5% CO<sub>2</sub>. Following natural egress, tachyzoites were purified in HBSS containing 10 mM HEPES, 0.1 mM EGTA and separated from host debris using 3.0 micro polycarbonate membrane filters, followed by centrifugation at 400<i>g</i>.</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> Cell-Based Parasite Growth Assays Using β-Galactosidase</h3><div class="NLM_p last">This work was performed at Evotec in Manchester, U.K. Parasite growth inhibition assays were conducted using the type I RH strain, 2F clone that expresses bacterial β-galactosidase (β-gal), as described previously.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Compounds dissolved in DMSO at 10 mM stocks were diluted in medium to 2 times final concentrations and added to an equal volume of medium containing 5 × 10<sup>2</sup> parasites and incubated for 20 min. Mixtures of compounds (ranging from 10 μM to 0.01 nM) containing 0.1% (v/v) DMSO or DMSO alone was added to monolayers of HFF cells grown in 96-well plates, centrifuged at 300<i>g</i> for 5 min, and returned to culture at 37 °C, 5% CO<sub>2</sub>. The cells were preincubated for 2 h in the presence of parasites. Varying concentrations of drugs were added to each well (100 μL volumes containing 0.2% DMSO in D10 media) to give a final concentration range of 0.02–10 μM in 0.1% DMSO. The plates were centrifuged at 300<i>g</i> for 5 min at room temperature and then incubated at 37 °C in 5% CO<sub>2</sub> for 72 h. At the end of the incubation period, the monolayer was lysed in 1% Triton X-100 and β-gal activity monitored using 1 mM chlorophenol red β-<span class="smallcaps smallerCapital">d</span>-galactopyranoside by absorption at 570 nm, as described previously.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> Individual EC<sub>50</sub> values were determined from three or more independent biological replicates and are reported as mean values.</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> Generation of Firefly Luciferase (FLUC) Tagged Strains</h3><div class="NLM_p last">This work was performed at Washington University of St. Louis, MO. Experiments were conducted with the ME49Δ<i>h</i>x::FLUC strain of <i>T. gondii</i>, a transgenic line that expresses firefly luciferase (FLUC).<a onclick="showRef(event, 'ref57'); return false;" href="javascript:void(0);" class="ref ref57">(57)</a> To tag additional strains with FLUC, a reporter plasmid was created using a two-step Gibson assembly approach. Fragment 1 was generated from PCR linearized pUPRT::Floxed DHFR-TS* plasmid (Addgene no. 100606) that includes both 5′ and 3′ uracil phosphoribosyltransferase (UPRT) flanking regions to drive locus specific integration at the <i>UPRT</i> gene and a floxed <i>T. gondii</i> DHFR selectable marker. Fragment 2 was synthesized using a gBlock (IDT DNA) containing the constitutive <i>T. gondii</i> α-tubulin promoter (608-bp) driving expression of the firefly luciferase reporter (1641-bp). The expression construct was targeted to the <i>UPRT</i> gene in <i>T. gondii</i> by co-transfection with the CRISPR plasmid pSAG1:CAS9, U6:sgUPRT. Parasites were sequentially selected in pyrimethamine (1.0 μM) followed by 5-fluorodeoxyracil (FUDR, 10 μM) and independent clones isolated by limiting dilution. All clones contain the floxed <i>T.gondii</i> DHFR selectable marker that can be excised using a plasmid expressing CRE recombinase.</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> In Vitro Growth Assays Using Luciferase</h3><div class="NLM_p last">To assess potency of compounds on different strains of <i>T. gondii</i>, values were determined from a 10-point dose–response curve. Briefly, 5 × 10<sup>3</sup> of luciferase expressing parasites (100 μL/well) were added to a 96-well plate that contained 100 μL of 2× compound concentration (to achieve 1× final compound concentration in 200 μL total well volume containing 0.1% DMSO) and allowed to replicate for 72 h prior to preparation for luciferase assay. All experimental steps, growth conditions, and luciferase assay protocols were completed as described above. Compounds were tested using a 3-fold dilution series from 10 μM to 0.001 μM with all wells containing a final concentration of 0.1% DMSO. The EC<sub>50</sub> data are presented as the average of three or more biological replicates (i.e., separate EC<sub>50</sub> titrations) each with two technical replicates (i.e., separate wells).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> Antiproliferative Assay in MCF7 Cells</h3><div class="NLM_p last">This work was performed at Cyprotex in Watertown, MA. MCF-7 cells were plated on 96-well tissue culture treated polystyrene plates at 0.75 × 10<sup>4</sup> cells in 100 μL of MEM/EBSS (supplemented with 10% fetal bovine serum, sodium pyruvate, and antibiotics) per well. After an overnight incubation at 37 °C, the cells were dosed with test compounds and controls at a range of concentrations and incubated for 72 h at 37 °C. Pyrimethamine <b>1</b> was tested from 0.156 to 20 μM, and compound <b>3</b> was evaluated from 0.313 to 40 μM with an 8-point dose curve in triplicate on three separate plates. Cell viability was measured using the Promega CellTiter 96 nonradioactive cell proliferation assay (MTT) kit by adding 15 μL of the dye solution to each well and incubating for 3 h at 37 °C. After incubation, 100 μL of the solubilization solution/stop mix was added to each well. Plates were incubated at 37 °C for 1 h, mixed on a plate shaker for 10 min, and then absorbance was read at 570 nm. The EC<sub>50</sub> was then calculated.</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> Pharmacokinetics (Mouse)</h3><div class="NLM_p last">Fasted female CD-1 mice (<i>n</i> = 3), 6–8 weeks old (supplied from Beijing Vital River Laboratory Animal Technology Co., Ltd.) were administered a 0.5 mg/kg intravenous dose of compound <b>3</b>, formulated as a clear 0.1 mg/mL solution in saline at pH 5. A second group (<i>n</i> = 3) was administered a 0.83 mg/kg oral dose of compound <b>3</b> (targeted dose was 1.0 mg/kg), formulated as a 0.1 mg/mL homogeneous opaque suspension with fine particles in 0.5% CMC. Plasma (EDTA-K<sub>2</sub>) from the iv dose was collected at 0.083, 0.50, 1.0, 2.0, 4.0, 8.0, and 24 h. Plasma (EDTA-K<sub>2</sub>) from the po dose was collected at 0.50, 1.0, 2.0, 4.0, 8.0, 12, and 24 h. Plasma preparation: An aliquot of 10 μL plasma was protein precipitated with 100 μL of IS, and the mixture was vortexed and centrifuged at 13 000 rpm for 10 min, 4 °C. The supernatant (25 μL) was then mixed with 25 μL of water/ACN (v:v, 95:5) containing 0.1% formic acid, vortexed, and centrifuged at 4 °C. 3 μL of supernatant was injected for LC–MS/MS analysis. Concentration of compound <b>3</b> was determined using an LC–MS/MS-AG (API 4000) instrument in ESI positive mode with SRM detection monitoring for [M + H]<sup>+</sup><i>m</i>/<i>z</i> transition 379.3/152.2 and using an internal standard 100 ng/mL tolbutamide [M + H]<sup>+</sup><i>m</i>/<i>z</i> transition 271.1/155.1. The UPLC method mobile phase Aof 0.025% formic acid, 1 mM NH<sub>4</sub>OAc in water/ACN (v:v, 95:5) and mobile phase B of 0.025% formic acid, 1 mM NH<sub>4</sub>OAc in ACN/water (v:v, 95:5) used a gradient starting with 15% mobile phase B and going to 90% over 1.40 min, on a Acquity UPLC BEH C18 1.7 μm, 2.1 mm × 50 mm column at 60 °C at a flow rate of 0.7 mL/min. The retention time of compound <b>3</b> was 0.55 min and tolbutamide 0.88 min. A calibration curve from 1.00 to 3000 ng/mL of compound <b>3</b> in male CD-1 mouse plasma (EDTA-K<sub>2</sub>) was made, and the data were analyzed using Phoenix WinNonlin 6.3 with a linear/log trapezoidal calculation method.</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> Brain to Blood Ratio (Mouse)</h3><div class="NLM_p last">This work was performed at Evotec, Manchester, U.K. Fed female CD1 mice (<i>n</i> = 3) were orally administered 10 mg/kg of the TFA-salt form of compound <b>3</b>, formulated as a clear solution in 0.25% carboxymethyl cellulose (CMC). Blood (EDTA-K<sub>2</sub>) 20 μL was collected by tail prick of the lateral tail vein 0.5 h postdose and diluted 2× with water for LC–MS/MS injection. Animals were then euthanized, and brain was collected and homogenized. The brain homogenates (40 μL) were run within the blood calibration curve and utilized the homogenization dilution factors for final quantitation but also incorporated a 2-fold adjustment for sample volume versus blood.</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> In Vivo Murine Model of Toxoplasmosis</h3><div class="NLM_p last">This work was performed at Evotec in Manchester, U.K. Fed female CD-1 mice (60 mice per study; 12 mice per drug treatment group, 9 mice for vehicle and 3 mice as negative controls) were inoculated intraperitoneally with 3000 tachyzoites of the highly virulent RH strain of <i>T. gondii</i> on day 0. The <i>T. gondii</i> strain used in this study had been genetically modified to constitutively express the enzyme fire fly luciferase (FLUC) and enable infection monitoring via an in vivo bioluminescence imaging system.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> Beginning 24 h after inoculation, mice were dosed with either compound <b>1</b> formulated at 0.6, 1.8, and 5.4 mg/mL in 0.25% CMC or the TFA salt form of compound <b>3</b> formulated in 0.25% CMC at 0.1 mg/mL, 0.3 mg/mL, or 1.0 mg/mL as a clear solution and dosed at a volume of 10 mL/kg. On day 4 microsampling of blood from the tail vein was collected into K2EDTA tubes and evaluated by LC/MS–MS as described above for the mouse brain to blood experiment.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i72"><a href="/doi/suppl/10.1021/acs.jmedchem.8b01754" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_37441" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_37441" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a href="/" class="ext-link">ACS Publications website</a> at DOI: <a href="/doi/abs/10.1021/acs.jmedchem.8b01754" class="ext-link">10.1021/acs.jmedchem.8b01754</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Molecular formula strings and some data (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01754/suppl_file/jm8b01754_si_001.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Methods for TgDHFR-TS protein purification and crystallization with <b>3</b> and <b>29</b> with diffraction and refinement statistics data; methods for kinetic solubility, log <i>P</i>, human and mouse liver microsome clearance, and MDCK-MDR1 permeability determinations; CEREP 44 cross-reactivity safety assessment data; molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.8b01754/suppl_file/jm8b01754_si_002.pdf" class="ext-link">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01754/suppl_file/jm8b01754_si_001.csv">jm8b01754_si_001.csv (2.31 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01754/suppl_file/jm8b01754_si_002.pdf">jm8b01754_si_002.pdf (504.32 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Crystal structures of the TgDHFR-TS protein with bound compounds <b>3</b> and <b>29</b> have PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6n1t">6n1t</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6n1s">6n1s</a>, respectively. Authors will release the atomic coordinates and experimental data upon article publication.</p><div class="testing" data-doi="10.1021/acs.jmedchem.8b01754" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_46470" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_46470" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Allen T. Hopper</span> - <span class="hlFld-Affiliation affiliation">Vyera
Pharmaceuticals, LLC, 600 Third Avenue, 10th Floor, New York, New York 10016, United States</span>; 
    <span>Present Address:
                        A.T.H.: Sage Therapeutics, 215 First Street, Cambridge, MA 02142</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-8797-7882" title="Orcid link">http://orcid.org/0000-0001-8797-7882</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#492825252c2767212639392c3b093a282e2c3b31672a2624"><span class="__cf_email__" data-cfemail="a7c6cbcbc2c989cfc8d7d7c2d5e7d4c6c0c2d5df89c4c8ca">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adam Brockman</span> - <span class="hlFld-Affiliation affiliation">Vyera
Pharmaceuticals, LLC, 600 Third Avenue, 10th Floor, New York, New York 10016, United States</span>; 
    <span>Present Address:
                        A.B.: Cyprotex, 313 Pleasant Street, Watertown, MA 02472</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Andy Wise</span> - <span class="hlFld-Affiliation affiliation">Evotec
(UK) LTD., Alderley Park, Cheshire SK104TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Julie Gould</span> - <span class="hlFld-Affiliation affiliation">Evotec
(UK) LTD., Alderley Park, Cheshire SK104TG, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jennifer Barks</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Microbiology, Washington University
School of Medicine, 660 S. Euclid Avenue, St. Louis, Missouri 63130, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joshua B. Radke</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Microbiology, Washington University
School of Medicine, 660 S. Euclid Avenue, St. Louis, Missouri 63130, United
States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">L. David Sibley</span> - <span class="hlFld-Affiliation affiliation">Department
of Molecular Microbiology, Washington University
School of Medicine, 660 S. Euclid Avenue, St. Louis, Missouri 63130, United
States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-7110-0285" title="Orcid link">http://orcid.org/0000-0001-7110-0285</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yongmao Zou</span> - <span class="hlFld-Affiliation affiliation">WuXi
AppTec (Tianjin) Co., Ltd., 168 NanHai Road, 10th Avenue, TEDA, Tianjin 300457, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephen Thomas</span> - <span class="hlFld-Affiliation affiliation">Vyera
Pharmaceuticals, LLC, 600 Third Avenue, 10th Floor, New York, New York 10016, United States</span>; 
    <span>Present Address:
                        S.T.: Cerecor, 400 E. Pratt Street, No. 606, Baltimore, MD 21202</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>A.T.H., A.B., and S.T. formulated lead optimization strategy. A.T.H., A.B., A.W., L.D.S., and S.T. designed experimental strategies. A.T.H., S.T., Y.Z. supported chemistry. A.W., J.B., J.B.R., and J.G. conducted biological assays. A.T.H., A.B., A.W., J.B., J.B.R., L.D.S., J.G., and S.T. analyzed data. A.T.H. wrote the manuscript with input from all authors.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): A.T.H., S.T., and A.B. are former employees of Vyera Pharmaceuticals. This study was funded by Vyera Pharmaceuticals. Contributions on this project from Dr. Sibley's laboratory were supported by a research agreement between Vyera Pharmaceuticals and Washington University.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i78">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55563" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55563" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors are grateful to Rubin Ben-Harari and Nick Pelliccione for their contributions to the writing of this manuscript and support. The authors are also grateful to the chemists, in vitro pharmacologists, and ADME/DMPK personnel at WuXi for generating much of lead optimization data summarized in this paper. This study was funded by Vyera Pharmaceuticals. Contributions on this project from Dr. Sibley’s laboratory were supported by a research Agreement between Vyera Pharmaceuticals and Washington University.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">FLUC</td><td class="NLM_def"><p class="first last">fire fly luciferase</p></td></tr><tr><td class="NLM_term">CMC</td><td class="NLM_def"><p class="first last">carboxymethyl cellulose</p></td></tr><tr><td class="NLM_term">UPRT</td><td class="NLM_def"><p class="first last">uracil phosphoribosyltransferase</p></td></tr><tr><td class="NLM_term">DHFR</td><td class="NLM_def"><p class="first last">dihydrofolate reductase</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">MTX</td><td class="NLM_def"><p class="first last">methotrexate</p></td></tr><tr><td class="NLM_term">HFF</td><td class="NLM_def"><p class="first last">human foreskin fibroblasts</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i80">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_13382" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_13382" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 57 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsay, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speer, C. A.</span></span> <span> </span><span class="NLM_article-title">Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts</span>. <i>Clin. Microbiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1128/CMR.11.2.267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1128%2FCMR.11.2.267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=9564564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADyaK1c3isFOmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1998&pages=267-299&issue=2&author=J.+P.+Dubeyauthor=D.+S.+Lindsayauthor=C.+A.+Speer&title=Structures+of+Toxoplasma+gondii+tachyzoites%2C+bradyzoites%2C+and+sporozoites+and+biology+and+development+of+tissue+cysts&doi=10.1128%2FCMR.11.2.267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts</span></div><div class="casAuthors">Dubey J P; Lindsay D S; Speer C A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology reviews</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-99</span>
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    </div><div class="casAbstract">Infections by the protozoan parasite Toxoplasma gondii are widely prevalent world-wide in animals and humans.  This paper reviews the life cycle; the structure of tachyzoites, bradyzoites, oocysts, sporocysts, sporozoites and enteroepithelial stages of T. gondii; and the mode of penetration of T. gondii.  The review provides a detailed account of the biology of tissue cysts and bradyzoites including in vivo and in vitro development, methods of separation from host tissue, tissue cyst rupture, and relapse.  The mechanism of in vivo and in vitro stage conversion from sporozoites to tachyzoites to bradyzoites and from bradyzoites to tachyzoites to bradyzoites is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJgUNM2kcJ3X6HPRus0rAafW6udTcc2eaQcJIJ9h1Hfbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c3isFOmsw%253D%253D&md5=136e44676463d503570e684570bfb0ee</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1128%2FCMR.11.2.267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.11.2.267%26sid%3Dliteratum%253Aachs%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26aulast%3DLindsay%26aufirst%3DD.%2BS.%26aulast%3DSpeer%26aufirst%3DC.%2BA.%26atitle%3DStructures%2520of%2520Toxoplasma%2520gondii%2520tachyzoites%252C%2520bradyzoites%252C%2520and%2520sporozoites%2520and%2520biology%2520and%2520development%2520of%2520tissue%2520cysts%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D1998%26volume%3D11%26issue%3D2%26spage%3D267%26epage%3D299%26doi%3D10.1128%2FCMR.11.2.267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tenter, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckeroth, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, L. M.</span></span> <span> </span><span class="NLM_article-title">Toxoplasma gondii: from animals to humans</span>. <i>Int. J. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">12–13</span>),  <span class="NLM_fpage">1217</span>– <span class="NLM_lpage">1258</span>, <span class="refDoi"> DOI: 10.1016/S0020-7519(00)00124-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1016%2FS0020-7519%2800%2900124-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=11113252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADC%252BD3MzgsVSqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2000&pages=1217-1258&issue=12%E2%80%9313&author=A.+M.+Tenterauthor=A.+R.+Heckerothauthor=L.+M.+Weiss&title=Toxoplasma+gondii%3A+from+animals+to+humans&doi=10.1016%2FS0020-7519%2800%2900124-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasma gondii: from animals to humans</span></div><div class="casAuthors">Tenter A M; Heckeroth A R; Weiss L M</div><div class="citationInfo"><span class="NLM_cas:title">International journal for parasitology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">12-13</span>),
    <span class="NLM_cas:pages">1217-58</span>
        ISSN:<span class="NLM_cas:issn">0020-7519</span>.
    </div><div class="casAbstract">Toxoplasmosis is one of the more common parasitic zoonoses world-wide.  Its causative agent, Toxoplasma gondii, is a facultatively heteroxenous, polyxenous protozoon that has developed several potential routes of transmission within and between different host species.  If first contracted during pregnancy, T. gondii may be transmitted vertically by tachyzoites that are passed to the foetus via the placenta.  Horizontal transmission of T. gondii may involve three life-cycle stages, i.e. ingesting infectious oocysts from the environment or ingesting tissue cysts or tachyzoites which are contained in meat or primary offal (viscera) of many different animals.  Transmission may also occur via tachyzoites contained in blood products, tissue transplants, or unpasteurised milk.  However, it is not known which of these routes is more important epidemiologically.  In the past, the consumption of raw or undercooked meat, in particular of pigs and sheep, has been regarded as a major route of transmission to humans.  However, recent studies showed that the prevalence of T. gondii in meat-producing animals decreased considerably over the past 20 years in areas with intensive farm management.  For example, in several countries of the European Union prevalences of T. gondii in fattening pigs are now <1%.  Considering these data it is unlikely that pork is still a major source of infection for humans in these countries.  However, it is likely that the major routes of transmission are different in human populations with differences in culture and eating habits.  In the Americas, recent outbreaks of acute toxoplasmosis in humans have been associated with oocyst contamination of the environment.  Therefore, future epidemiological studies on T. gondii infections should consider the role of oocysts as potential sources of infection for humans, and methods to monitor these are currently being developed.  This review presents recent epidemiological data on T. gondii, hypotheses on the major routes of transmission to humans in different populations, and preventive measures that may reduce the risk of contracting a primary infection during pregnancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQjKocxHWsOAsULxIEhxUjPfW6udTcc2eaQcJIJ9h1Hfbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MzgsVSqsA%253D%253D&md5=63a3c204a5335071b2a723d25126fae9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0020-7519%2800%2900124-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0020-7519%252800%252900124-7%26sid%3Dliteratum%253Aachs%26aulast%3DTenter%26aufirst%3DA.%2BM.%26aulast%3DHeckeroth%26aufirst%3DA.%2BR.%26aulast%3DWeiss%26aufirst%3DL.%2BM.%26atitle%3DToxoplasma%2520gondii%253A%2520from%2520animals%2520to%2520humans%26jtitle%3DInt.%2520J.%2520Parasitol.%26date%3D2000%26volume%3D30%26issue%3D12%25E2%2580%259313%26spage%3D1217%26epage%3D1258%26doi%3D10.1016%2FS0020-7519%2800%2900124-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prusa, A.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasper, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayde, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stillwaggon, E.</span></span> <span> </span><span class="NLM_article-title">Congenital toxoplasmosis in Austria: Prenatal screening for prevention is cost-saving</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">7</span>), <span class="NLM_elocation-id">e0005648</span> <span class="refDoi"> DOI: 10.1371/journal.pntd.0005648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1371%2Fjournal.pntd.0005648" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2017&issue=7&author=A.-R.+Prusaauthor=D.+C.+Kasperauthor=L.+Sawersauthor=E.+Walterauthor=M.+Haydeauthor=E.+Stillwaggon&title=Congenital+toxoplasmosis+in+Austria%3A+Prenatal+screening+for+prevention+is+cost-saving&doi=10.1371%2Fjournal.pntd.0005648"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0005648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0005648%26sid%3Dliteratum%253Aachs%26aulast%3DPrusa%26aufirst%3DA.-R.%26aulast%3DKasper%26aufirst%3DD.%2BC.%26aulast%3DSawers%26aufirst%3DL.%26aulast%3DWalter%26aufirst%3DE.%26aulast%3DHayde%26aufirst%3DM.%26aulast%3DStillwaggon%26aufirst%3DE.%26atitle%3DCongenital%2520toxoplasmosis%2520in%2520Austria%253A%2520Prenatal%2520screening%2520for%2520prevention%2520is%2520cost-saving%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2017%26volume%3D11%26issue%3D7%26doi%3D10.1371%2Fjournal.pntd.0005648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalimi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdoli, A.</span></span> <span> </span><span class="NLM_article-title">Latent toxoplasmosis and human</span>. <i>Iran J. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGgsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1-17&issue=1&author=A.+Dalimiauthor=A.+Abdoli&title=Latent+toxoplasmosis+and+human"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning and expression of EG95 gene of Iranian isolates of Echinococcus granulosus</span></div><div class="casAuthors">Sarvi, S.; Dalimi, A.; Ghafarifar, F.</div><div class="citationInfo"><span class="NLM_cas:title">Iranian Journal of Parasitology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">IJPRHE</span>;
        ISSN:<span class="NLM_cas:issn">1735-7020</span>.
    
            (<span class="NLM_cas:orgname">Iranian Society of Parasitology</span>)
        </div><div class="casAbstract">Background: Echinococcosis or hydatidosis is a chronic, zoonotic worldwide infection that occurs by the larval stages of taeniid cestodes of the genus Echinococcus.  Iran is known as endemic region for this infection in the world.  Vaccination has been considered as a good prevention method for this disease.  Recombinant vaccines contg. EG95 protein, against E. granulosus, has shown a high degree of protection against E. granulosus infection.  In this study EG95 gene was extd. from Iranian isolates of E. granulosus and then cloned and expressed in expression vector.  Methods: Protoscoleces were collected from sheep hydatid cysts.  Then DNA and RNA were extd. from protoscoleces, and amplified by PCR and RT-PCR with specific primer.  Afterward the purified RT-PCR products were successfully ligated into pTZ57R/T plasmid vector.  The pcDNA3 plasmid was used as expression vector and Eg95 fragment sub cloned into this plasmid.  The pcEG95 plasmid was digested by restriction enzymes to confirm cloning of this gene in pcDNA3 plasmid.  In last step, the subcloned gene was expressed in CHO as eukaryotic cell.  Results: EG95 fragment successfully was subcloned in pcDNA3 and EG95 protein was expressed by eukaryotic cell.  The recombinant EG95 protein was confirmed by SDS-PAGE and Western blot.  Conclusion: Recombinant plasmid of pcEG95 was constructed successfully and express of recombinant EG95 protein was confirmed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIhV3qrQ-KjrVg90H21EOLACvtfcHk0lhpFA9H1H19yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGgsrzJ&md5=870a60481e556f39729bf7b9d9865341</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDalimi%26aufirst%3DA.%26aulast%3DAbdoli%26aufirst%3DA.%26atitle%3DLatent%2520toxoplasmosis%2520and%2520human%26jtitle%3DIran%2520J.%2520Parasitol.%26date%3D2012%26volume%3D7%26issue%3D1%26spage%3D1%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montoya, A.</span>; <span class="NLM_string-name">Boothroyd, J. C.</span>; <span class="NLM_string-name">Kovacs, J.</span></span>, <span> </span><span class="NLM_article-title"><i>Toxoplasma gondii</i></span>. In  <i>Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases</i>, <span class="NLM_edition">8</span>th ed.; <span class="NLM_publisher-name">Elsevier Saunders</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>, <span class="NLM_year">2015</span>; pp  <span class="NLM_fpage">3122</span>– <span class="NLM_lpage">3153</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=3122-3153&author=A.+Montoya&author=J.+C.+Boothroyd&author=J.+Kovacs&title=Mandell%2C+Douglas%2C+and+Bennett%E2%80%99s+Principles+and+Practice+of+Infectious+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMontoya%26aufirst%3DA.%26atitle%3DToxoplasma%2520gondii%26btitle%3DMandell%252C%2520Douglas%252C%2520and%2520Bennett%25E2%2580%2599s%2520Principles%2520and%2520Practice%2520of%2520Infectious%2520Diseases%26pub%3DElsevier%2520Saunders%26date%3D2015%26spage%3D3122%26epage%3D3153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halonen, S. K.</span>; <span class="NLM_string-name">Weiss, L. M.</span></span>, <span> </span><span class="NLM_article-title">Toxoplasmosis</span>. In  <i>Handbook of Clinical Neurology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hector, H.</span>, <span class="NLM_string-name">Garcia, H. B. T.</span>, <span class="NLM_string-name">Oscar, H. D. B.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2013</span>; Vol.  <span class="NLM_volume">114</span>, Chapter 8, pp  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">145</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=125-145&author=S.+K.+Halonen&author=L.+M.+Weissauthor=H.+Hector&author=H.+B.+T.+Garcia&author=H.+D.+B.+Oscar&title=Handbook+of+Clinical+Neurology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHalonen%26aufirst%3DS.%2BK.%26atitle%3DToxoplasmosis%26btitle%3DHandbook%2520of%2520Clinical%2520Neurology%26aulast%3DHector%26aufirst%3DH.%26pub%3DElsevier%26date%3D2013%26volume%3D114%26spage%3D125%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabaud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amiel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katlama, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leport, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambroise-Thomas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canton, P.</span></span> <span> </span><span class="NLM_article-title">Extracerebral toxoplasmosis in patients infected with HIV. A French national survey</span>. <i>Medicine (Philadelphia, PA, U. S.)</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>73</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">306</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1097/00005792-199411000-00004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1097%2F00005792-199411000-00004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1994&pages=306-314&issue=6&author=C.+Rabaudauthor=T.+Mayauthor=C.+Amielauthor=C.+Katlamaauthor=C.+Leportauthor=P.+Ambroise-Thomasauthor=P.+Canton&title=Extracerebral+toxoplasmosis+in+patients+infected+with+HIV.+A+French+national+survey&doi=10.1097%2F00005792-199411000-00004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1097%2F00005792-199411000-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00005792-199411000-00004%26sid%3Dliteratum%253Aachs%26aulast%3DRabaud%26aufirst%3DC.%26aulast%3DMay%26aufirst%3DT.%26aulast%3DAmiel%26aufirst%3DC.%26aulast%3DKatlama%26aufirst%3DC.%26aulast%3DLeport%26aufirst%3DC.%26aulast%3DAmbroise-Thomas%26aufirst%3DP.%26aulast%3DCanton%26aufirst%3DP.%26atitle%3DExtracerebral%2520toxoplasmosis%2520in%2520patients%2520infected%2520with%2520HIV.%2520A%2520French%2520national%2520survey%26jtitle%3DMedicine%2520%2528Philadelphia%252C%2520PA%252C%2520U.%2520S.%2529%26date%3D1994%26volume%3D73%26issue%3D6%26spage%3D306%26epage%3D314%26doi%3D10.1097%2F00005792-199411000-00004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span> <span> </span><span class="NLM_article-title">The role of IL-18 in innate immunity</span>. <i>Curr. Opin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1016/S0952-7915(99)00051-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1016%2FS0952-7915%2899%2900051-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10679398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsVOkurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2000&pages=59-63&author=S.+Akira&title=The+role+of+IL-18+in+innate+immunity&doi=10.1016%2FS0952-7915%2899%2900051-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The role of IL-18 in innate immunity</span></div><div class="casAuthors">Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-63</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 35 refs.  Interleukin 18 (IL-18), a novel cytokine with potent interferon γ-inducing activities, plays an important role in the Th1-mediated immune response in collaboration with IL-12.  IL-18 is a member of the IL-1 family.  The IL-18 receptor system and its signal transduction pathway are analogous to those of the IL-1 receptor.  Mice deficient in IL-18 have demonstrated its crit. role in natural killer cell activity and in vivo Th1 response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQk7Am7QuQrVg90H21EOLACvtfcHk0lhpFA9H1H19yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsVOkurw%253D&md5=1588e3a5c93bc0b4b7d7c234dcd2f9b9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2899%2900051-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252899%252900051-5%26sid%3Dliteratum%253Aachs%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DThe%2520role%2520of%2520IL-18%2520in%2520innate%2520immunity%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2000%26volume%3D12%26spage%3D59%26epage%3D63%26doi%3D10.1016%2FS0952-7915%2899%2900051-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuervo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonetti, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alegre, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Salado, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podzamczer, D.</span></span> <span> </span><span class="NLM_article-title">Toxoplasma myocarditis: a rare but serious complication in an HIV-infected late presenter</span>. <i>AIDS</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">2253</span>– <span class="NLM_lpage">2254</span>, <span class="refDoi"> DOI: 10.1097/QAD.0000000000001174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1097%2FQAD.0000000000001174" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=2253-2254&issue=14&author=G.+Cuervoauthor=A.+F.+Simonettiauthor=O.+Alegreauthor=J.+C.+Sanchez-Saladoauthor=D.+Podzamczer&title=Toxoplasma+myocarditis%3A+a+rare+but+serious+complication+in+an+HIV-infected+late+presenter&doi=10.1097%2FQAD.0000000000001174"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1097%2FQAD.0000000000001174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQAD.0000000000001174%26sid%3Dliteratum%253Aachs%26aulast%3DCuervo%26aufirst%3DG.%26aulast%3DSimonetti%26aufirst%3DA.%2BF.%26aulast%3DAlegre%26aufirst%3DO.%26aulast%3DSanchez-Salado%26aufirst%3DJ.%2BC.%26aulast%3DPodzamczer%26aufirst%3DD.%26atitle%3DToxoplasma%2520myocarditis%253A%2520a%2520rare%2520but%2520serious%2520complication%2520in%2520an%2520HIV-infected%2520late%2520presenter%26jtitle%3DAIDS%26date%3D2016%26volume%3D30%26issue%3D14%26spage%3D2253%26epage%3D2254%26doi%3D10.1097%2FQAD.0000000000001174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montoya, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liesenfeld, O.</span></span> <span> </span><span class="NLM_article-title">Toxoplasmosis</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>363</i></span> (<span class="NLM_issue">9425</span>),  <span class="NLM_fpage">1965</span>– <span class="NLM_lpage">1976</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(04)16412-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1016%2FS0140-6736%2804%2916412-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=15194258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvVemuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2004&pages=1965-1976&issue=9425&author=J.+G.+Montoyaauthor=O.+Liesenfeld&title=Toxoplasmosis&doi=10.1016%2FS0140-6736%2804%2916412-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasmosis</span></div><div class="casAuthors">Montoya, J. G.; Liesenfeld, O.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">9425</span>),
    <span class="NLM_cas:pages">1965-1976</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Toxoplasma gondii is a protozoan parasite that infects up to a third of the world's population.  Infection is mainly acquired by ingestion of food or water that is contaminated with oocysts shed by cats or by eating undercooked or raw meat contg. tissue cysts.  Primary infection is usually subclin. but in some patients cervical lymphadenopathy or ocular disease can be present.  Infection acquired during pregnancy may cause severe damage to the fetus.  In immunocompromised patients, reactivation of latent disease can cause life-threatening encephalitis.  Diagnosis of toxoplasmosis can be established by direct detection of the parasite or by serol. techniques.  The most commonly used therapeutic regimen, and probably the most effective, is the combination of pyrimethamine with sulfadiazine and folinic acid.  This Seminar provides an overview and update on management of patients with acute infection, pregnant women who acquire infection during gestation, fetuses or infants who are congenitally infected, those with ocular disease, and immunocompromised individuals.  Controversy about the effectiveness of primary and secondary prevention in pregnant women is discussed.  Important topics of current and future research are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjtqSI8fuY4rVg90H21EOLACvtfcHk0ljE_IJ3lDzzXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvVemuro%253D&md5=7fe37d0af87e4bbff2e087b416dcf5c0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2804%2916412-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252804%252916412-X%26sid%3Dliteratum%253Aachs%26aulast%3DMontoya%26aufirst%3DJ.%2BG.%26aulast%3DLiesenfeld%26aufirst%3DO.%26atitle%3DToxoplasmosis%26jtitle%3DLancet%26date%3D2004%26volume%3D363%26issue%3D9425%26spage%3D1965%26epage%3D1976%26doi%3D10.1016%2FS0140-6736%2804%2916412-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olliaro, P.</span></span> <span> </span><span class="NLM_article-title">Drug resistance hampers our capacity to roll back malaria</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">Suppl. 4</span>),  <span class="NLM_fpage">S247</span>– <span class="NLM_lpage">S257</span>, <span class="refDoi"> DOI: 10.1086/430785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1086%2F430785" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=16032560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADC%252BD2Mznt1ShsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=S247-S257&issue=Suppl.+4&author=P.+Olliaro&title=Drug+resistance+hampers+our+capacity+to+roll+back+malaria&doi=10.1086%2F430785"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Drug resistance hampers our capacity to roll back malaria</span></div><div class="casAuthors">Olliaro Piero</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">41 Suppl 4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">S247-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Widespread drug resistance in parasites aggravates the burden of malaria.  The extent of the problem is due mainly to the limited armamentarium of drugs used thus far to treat malaria and to policies and practices constrained by limited resources.  All drugs in use are affected except, thus far, artemisinin derivatives.  The scale and impact of resistance has been underestimated, leading to the continued use of failing drugs, which contributes to the rise in resistance and increased morbidity and mortality due to malaria.  Pharmacological, epidemiological, and operational aspects factor the development and spread of resistance.  Although the problem is complex, much can be done to reverse the course of events: adopt adequate tests to assess resistance, encourage and sustain development of new drugs, protect drugs against resistance through use of combinations, expand access to prompt and effective treatment, and promote evidence-based policies and sensible practices.  The current situation favors the development of sensible strategies to restrain resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7l6KFKSfqfOR_TJajKxJDfW6udTcc2eaT-fwnNeFJBrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mznt1ShsA%253D%253D&md5=65fef7390e9fd91431ac5f051afefe7a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1086%2F430785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F430785%26sid%3Dliteratum%253Aachs%26aulast%3DOlliaro%26aufirst%3DP.%26atitle%3DDrug%2520resistance%2520hampers%2520our%2520capacity%2520to%2520roll%2520back%2520malaria%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2005%26volume%3D41%26issue%3DSuppl.%25204%26spage%3DS247%26epage%3DS257%26doi%3D10.1086%2F430785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCabe, R. E.</span></span> <span> </span><span class="NLM_article-title">Antitoxoplasma Chemotherapy</span>. In  <i>Toxoplasmosis: A Comprehensive Clinical Guide</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joynson, D. H. M.</span>, <span class="NLM_string-name">Wreghitt, T. G.</span></span>, Eds.; <span class="NLM_publisher-name">Cambridge University Press</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>, <span class="NLM_year">2001</span>; pp  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">359</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1017%2FCBO9780511527005.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=319-359&author=R.+E.+McCabeauthor=D.+H.+M.+Joynson&author=T.+G.+Wreghitt&title=Toxoplasmosis%3A+A+Comprehensive+Clinical+Guide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1017%2FCBO9780511527005.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1017%252FCBO9780511527005.015%26sid%3Dliteratum%253Aachs%26aulast%3DMcCabe%26aufirst%3DR.%2BE.%26atitle%3DAntitoxoplasma%2520Chemotherapy%26btitle%3DToxoplasmosis%253A%2520A%2520Comprehensive%2520Clinical%2520Guide%26aulast%3DJoynson%26aufirst%3DD.%2BH.%2BM.%26pub%3DCambridge%2520University%2520Press%26date%3D2001%26spage%3D319%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Harari, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casoy, J.</span></span> <span> </span><span class="NLM_article-title">Adverse event profile of pyrimethamine-based therapy in toxoplasmosis: A systematic review</span>. <i>Drugs R&D</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">523</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1007/s40268-017-0206-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1007%2Fs40268-017-0206-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=28879584" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=523-544&issue=4&author=R.+R.+Ben-Harariauthor=E.+Goodwinauthor=J.+Casoy&title=Adverse+event+profile+of+pyrimethamine-based+therapy+in+toxoplasmosis%3A+A+systematic+review&doi=10.1007%2Fs40268-017-0206-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs40268-017-0206-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40268-017-0206-8%26sid%3Dliteratum%253Aachs%26aulast%3DBen-Harari%26aufirst%3DR.%2BR.%26aulast%3DGoodwin%26aufirst%3DE.%26aulast%3DCasoy%26aufirst%3DJ.%26atitle%3DAdverse%2520event%2520profile%2520of%2520pyrimethamine-based%2520therapy%2520in%2520toxoplasmosis%253A%2520A%2520systematic%2520review%26jtitle%3DDrugs%2520R%2526D%26date%3D2017%26volume%3D17%26issue%3D4%26spage%3D523%26epage%3D544%26doi%3D10.1007%2Fs40268-017-0206-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan
Assir, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akram, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yusuf, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamran, U.</span></span> <span> </span><span class="NLM_article-title">An outbreak of pyrimethamine toxicity in patients with ischaemic heart disease in pakistan</span>. <i>Basic Clin. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>115</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1111/bcpt.12206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1111%2Fbcpt.12206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=24490639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKjtr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2014&pages=291-296&issue=3&author=M.+Z.+Khan%0AAssirauthor=H.+I.+Ahmadauthor=J.+Akramauthor=N.+W.+Yusufauthor=U.+Kamran&title=An+outbreak+of+pyrimethamine+toxicity+in+patients+with+ischaemic+heart+disease+in+pakistan&doi=10.1111%2Fbcpt.12206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">An Outbreak of Pyrimethamine Toxicity in Patients with Ischaemic Heart Disease in Pakistan</span></div><div class="casAuthors">Khan Assir, Muhammad Zaman; Ahmad, Hafiz Ijaz; Akram, Javed; Yusuf, Noshin Wasim; Kamran, Umair</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-296</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">We investigated an outbreak of darkening of skin, bleeding from multiple sites, leucopenia and thrombocytopenia in ischemic heart disease patients.  Case patients were defined as patients who had received medicines from the pharmacy of Punjab Institute of Cardiol. between 1 Dec. 2011 and 12 Jan. 2012 and who developed any one of the following: darkening of skin, bleeding from any site, thrombocytopenia and leucopenia.  Clin. and drug-related data were abstracted.  All 664 case patients had received iso-sorbide-mono-nitrate contaminated with about 50 mg of pyrimethamine, and 151 (23%) died.  The median age of 117 patients admitted at Jinnah Hospital Lahore was 57 years (range, 37-100) and 92 (79%) were male.  The median time from intake of medicine to presentation was 37 days (range 13-72).  Symptoms and signs included bleeding (in 95% of the patients), skin hyperpigmentation (in 61%), diarrhoea (in 53%) and abdominal pain (in 48%).  At presentation, the median white cell count was 2.3 × 109/L (range, 0.1 × 109-16.0 × 109), the median Hb concn. was 109 g/L (range 58-169) and the median platelet count was 18 × 109/L (range, 0 × 109-318 × 109).  Bone marrow examn. revealed trileneage dysplasia and severe megaloblastosis.  The predictors of mortality included presentation prior to 15 Jan. 2012, age more than 57 years, hypotension and leukocyte count less than 1.5 × 109/L.  None of the patients who died received Calcium folinate because all deaths occurred prior to contaminant identification.  We describe an outbreak of pyrimethamine toxicity in ischemic heart disease patients receiving medicines from a single pharmacy due to accidental contamination of iso-sorbide mono-nitrate tablets at industrial level.  Late recognition of illness resulted in high mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2G7GidNN4h7Vg90H21EOLACvtfcHk0lgD0coTpO0lAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKjtr%252FE&md5=9c0c75b8af4f5c668440697e6744a081</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fbcpt.12206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcpt.12206%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%2BAssir%26aufirst%3DM.%2BZ.%26aulast%3DAhmad%26aufirst%3DH.%2BI.%26aulast%3DAkram%26aufirst%3DJ.%26aulast%3DYusuf%26aufirst%3DN.%2BW.%26aulast%3DKamran%26aufirst%3DU.%26atitle%3DAn%2520outbreak%2520of%2520pyrimethamine%2520toxicity%2520in%2520patients%2520with%2520ischaemic%2520heart%2520disease%2520in%2520pakistan%26jtitle%3DBasic%2520Clin.%2520Pharmacol.%2520Toxicol.%26date%3D2014%26volume%3D115%26issue%3D3%26spage%3D291%26epage%3D296%26doi%3D10.1111%2Fbcpt.12206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eyles, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, N.</span></span> <span> </span><span class="NLM_article-title">Tests of 2,4-diaminopyrimidines on toxoplasmosis</span>. <i>Public Health Rep.</i> <span class="NLM_year" style="font-weight: bold;">1952</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.2307/4588050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.2307%2F4588050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=14900360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADyaG38XjtlClsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1952&pages=249-252&author=D.+E.+Eylesauthor=N.+Coleman&title=Tests+of+2%2C4-diaminopyrimidines+on+toxoplasmosis&doi=10.2307%2F4588050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Tests of 2,4-diaminopyrimidines on toxoplasmosis</span></div><div class="casAuthors">Eyles, Don E.; Coleman, Nell</div><div class="citationInfo"><span class="NLM_cas:title">Public Health Reports</span>
        (<span class="NLM_cas:date">1952</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">249-52</span>CODEN:
                <span class="NLM_cas:coden">PHRPA6</span>;
        ISSN:<span class="NLM_cas:issn">0033-3549</span>.
    </div><div class="casAbstract">Screening of compds. for antitoxoplasmic activity showed 2 members of the 2,4-diaminopyrimidine group to have effect.  The most active compd. was 2,4-diamino-5-(4-chlorophenyl)-6-ethylpyrimidine.  Defining the effective dose as the dose permitting 10-day survival, this compd. had a median effective dose of 9 mg. % in the diet as compared with 40 mg. % for sulfadiazine under identical conditions.  The efficiency of the drug was low, as the (max. tolerated dose)/(median effective dose) ratio was about 3 or less.  The cure rate following 14-day treatment was also low, since only 9 of 33 mice (27%) given doses higher than the median effective dose survived for 42 days.  6 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwBNJFVEjMxbVg90H21EOLACvtfcHk0lgD0coTpO0lAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG38XjtlClsw%253D%253D&md5=ec411c411fee24423c3d3b2a0c454f62</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2307%2F4588050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2307%252F4588050%26sid%3Dliteratum%253Aachs%26aulast%3DEyles%26aufirst%3DD.%2BE.%26aulast%3DColeman%26aufirst%3DN.%26atitle%3DTests%2520of%25202%252C4-diaminopyrimidines%2520on%2520toxoplasmosis%26jtitle%3DPublic%2520Health%2520Rep.%26date%3D1952%26volume%3D67%26spage%3D249%26epage%3D252%26doi%3D10.2307%2F4588050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Felix, J. P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, R. P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zacchia, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toribio, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nascimento, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arieta, C. E. L.</span></span> <span> </span><span class="NLM_article-title">Trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrences of Toxoplasma gondii retinochoroiditis: Randomized controlled clinical trial</span>. <i>Am. J. Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>157</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">762</span>– <span class="NLM_lpage">766</span>, <span class="refDoi"> DOI: 10.1016/j.ajo.2013.12.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1016%2Fj.ajo.2013.12.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=24388839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktlWhtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2014&pages=762-766&issue=4&author=J.+P.+F.+Felixauthor=R.+P.+C.+Liraauthor=R.+S.+Zacchiaauthor=J.+M.+Toribioauthor=M.+A.+Nascimentoauthor=C.+E.+L.+Arieta&title=Trimethoprim-sulfamethoxazole+versus+placebo+to+reduce+the+risk+of+recurrences+of+Toxoplasma+gondii+retinochoroiditis%3A+Randomized+controlled+clinical+trial&doi=10.1016%2Fj.ajo.2013.12.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Trimethoprim-Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrences of Toxoplasma Gondii Retinochoroiditis: Randomized Controlled Clinical Trial</span></div><div class="casAuthors">Felix, Joao Paulo Fernandes; Lira, Rodrigo Pessoa Cavalcanti; Zacchia, Rafael Santos; Toribio, Jaqueline Machado; Nascimento, Mauricio Abujamra; Arieta, Carlos Eduardo Leite</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Ophthalmology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">762-766.e1</span>CODEN:
                <span class="NLM_cas:coden">AJOPAA</span>;
        ISSN:<span class="NLM_cas:issn">0002-9394</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">To compare the effects of trimethoprim-sulfamethoxazole vs placebo in reducing the risk of recurrences of Toxoplasma gondii retinochoroiditis.  Single-center, prospective randomized double-masked clin. trial.  A total of 95 patients from Campinas, Brazil, with active recurrent Toxoplasma gondii retinochoroiditis were included.  The initially active toxoplasmosis lesions were successfully treated in all cases using trimethoprim-sulfamethoxazole (800 mg/160 mg) twice daily for 45 days.  Subsequently, 5 patients dropped out of the study.  The remaining patients were randomized to Group 1 (trimethoprim/sulfamethoxazole tablet every 2 days) or Group 2 (identical placebo tablet every 2 days).  Randomization was 1:1, was stratified by sex, and used block sizes of 4.  The primary outcome was recurrent toxoplasmosis retinochoroiditis within 1 yr, and the secondary outcome was a 1-yr change in best-cor. visual acuity (BCVA) (ETDRS chart).  The incidence of recurrent toxoplasmosis retinochoroiditis within 12 mo was 0 of 46 (0%) and 6 of 47 (12.80%) in the trimethoprim-sulfamethoxazole and placebo groups, resp. (P = .026).  Visual acuity improvements in the 2 groups were similar.  No treatment-limiting toxicity was obsd.  Trimethoprim/sulfamethoxazole therapy resulted in a 100% redn. in the recurrence of Toxoplasma gondii retinochoroiditis over 1 yr of treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_4yzfwpFQorVg90H21EOLACvtfcHk0lgB5jFfwaCSPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktlWhtb0%253D&md5=42f595249ced30f5791fc9bb4762d3bc</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ajo.2013.12.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajo.2013.12.022%26sid%3Dliteratum%253Aachs%26aulast%3DFelix%26aufirst%3DJ.%2BP.%2BF.%26aulast%3DLira%26aufirst%3DR.%2BP.%2BC.%26aulast%3DZacchia%26aufirst%3DR.%2BS.%26aulast%3DToribio%26aufirst%3DJ.%2BM.%26aulast%3DNascimento%26aufirst%3DM.%2BA.%26aulast%3DArieta%26aufirst%3DC.%2BE.%2BL.%26atitle%3DTrimethoprim-sulfamethoxazole%2520versus%2520placebo%2520to%2520reduce%2520the%2520risk%2520of%2520recurrences%2520of%2520Toxoplasma%2520gondii%2520retinochoroiditis%253A%2520Randomized%2520controlled%2520clinical%2520trial%26jtitle%3DAm.%2520J.%2520Ophthalmol.%26date%3D2014%26volume%3D157%26issue%3D4%26spage%3D762%26epage%3D766%26doi%3D10.1016%2Fj.ajo.2013.12.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanford, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">See, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, R. E.</span></span> <span> </span><span class="NLM_article-title">Antibiotics for toxoplasmic retinochoroiditis: An evidence-based systematic review</span>. <i>Ophthalmology</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">926</span>– <span class="NLM_lpage">31</span>, (quiz 931–932) <span class="refDoi"> DOI: 10.1016/S0161-6420(03)00083-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1016%2FS0161-6420%2803%2900083-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=12750091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADC%252BD3s3ivVylsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2003&pages=926-31&issue=5&author=M.+R.+Stanfordauthor=S.+E.+Seeauthor=L.+V.+Jonesauthor=R.+E.+Gilbert&title=Antibiotics+for+toxoplasmic+retinochoroiditis%3A+An+evidence-based+systematic+review&doi=10.1016%2FS0161-6420%2803%2900083-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review</span></div><div class="casAuthors">Stanford Miles R; See Sarah E; Jones Leanne V; Gilbert Ruth E</div><div class="citationInfo"><span class="NLM_cas:title">Ophthalmology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">926-31; quiz 931-2</span>
        ISSN:<span class="NLM_cas:issn">0161-6420</span>.
    </div><div class="casAbstract">PURPOSE:  To determine the effectiveness of systemic antibiotic treatment for toxoplasmic retinochoroiditis.  CLINICAL RELEVANCE:  Toxoplasma retinochoroiditis is a significant cause of visual morbidity.  Multiple different antibiotic regimens are used, but controversy about treatment effectiveness remains.  LITERATURE REVIEWED:  Searches were conducted of Cochrane Controlled Trials Register, Medline (1966 onward), Embase (1980 onward), Dissertation Abstracts (1861 onward), Lilacs (1982 onward), and Pascal (1984 onward).  Pharmaceutical companies were contacted for unpublished data.  Any randomized controlled trials that compared antibiotics versus placebo in immunocompetent patients with toxoplasmic retinochoroiditis were retrieved.  Primary outcome measures were long-term visual acuity and risk of recurrent retinochoroiditis.  Secondary outcomes included duration and severity of acute symptoms, size of the lesion at end of follow-up, and adverse effects of treatment.  RESULTS:  Only 3 studies (total of 173 participants) were randomized controlled trials and hence met the inclusion criteria (level II).  All 3 were methodologically poor, and 2 were carried out more than 35 years ago.  None reported the effect on long-term visual outcome.  We found no evidence for a beneficial effect on the duration and severity of signs of acute toxoplasmic retinochoroiditis (A,II).  There was weak evidence for an effect of long-term treatment for chronic recurrent toxoplasmic retinochoroiditis on lesion recurrence.  Treatment was associated with adverse effects.  CONCLUSIONS:  There is a lack of evidence to support routine antibiotic treatment for acute toxoplasmic retinochoroiditis.  Placebo-controlled randomized trials of antibiotic treatment in patients presenting with acute or chronic toxoplasmic retinochoroiditis arising in any part of the retina are required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSsQP9xAl_XtLBItaL1WaVAfW6udTcc2eaVzuLSib8xGrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3ivVylsg%253D%253D&md5=27b6b7e3f40f8dffe513befba811ac8d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0161-6420%2803%2900083-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0161-6420%252803%252900083-6%26sid%3Dliteratum%253Aachs%26aulast%3DStanford%26aufirst%3DM.%2BR.%26aulast%3DSee%26aufirst%3DS.%2BE.%26aulast%3DJones%26aufirst%3DL.%2BV.%26aulast%3DGilbert%26aufirst%3DR.%2BE.%26atitle%3DAntibiotics%2520for%2520toxoplasmic%2520retinochoroiditis%253A%2520An%2520evidence-based%2520systematic%2520review%26jtitle%3DOphthalmology%26date%3D2003%26volume%3D110%26issue%3D5%26spage%3D926%26epage%3D31%26doi%3D10.1016%2FS0161-6420%2803%2900083-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taques, I. I. G.G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, A. d. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitchenin, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braga, Í.A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Melo, A. L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakazato, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Aguiar, D. M.</span></span> <span> </span><span class="NLM_article-title">Molecular assessment of the transplacental transmission of Toxoplasma gondii, Neospora caninum, Brucella canis and Ehrlichia canis in dogs</span>. <i>Comparative immunology, microbiology and infectious diseases</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.cimid.2016.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1016%2Fj.cimid.2016.09.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2016&pages=47-50&author=I.+I.+G.G.+Taquesauthor=T.+R.+Barbosaauthor=A.+d.+C.+Martiniauthor=L.+C.+Pitcheninauthor=%C3%8D.A.+Bragaauthor=A.+L.+T.+de+Meloauthor=L.+Nakazatoauthor=V.+Dutraauthor=D.+M.+de+Aguiar&title=Molecular+assessment+of+the+transplacental+transmission+of+Toxoplasma+gondii%2C+Neospora+caninum%2C+Brucella+canis+and+Ehrlichia+canis+in+dogs&doi=10.1016%2Fj.cimid.2016.09.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.cimid.2016.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cimid.2016.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DTaques%26aufirst%3DI.%2BI.%2BG.G.%26aulast%3DBarbosa%26aufirst%3DT.%2BR.%26aulast%3DMartini%26aufirst%3DA.%2Bd.%2BC.%26aulast%3DPitchenin%26aufirst%3DL.%2BC.%26aulast%3DBraga%26aufirst%3D%25C3%258D.A.%26aulast%3Dde%2BMelo%26aufirst%3DA.%2BL.%2BT.%26aulast%3DNakazato%26aufirst%3DL.%26aulast%3DDutra%26aufirst%3DV.%26aulast%3Dde%2BAguiar%26aufirst%3DD.%2BM.%26atitle%3DMolecular%2520assessment%2520of%2520the%2520transplacental%2520transmission%2520of%2520Toxoplasma%2520gondii%252C%2520Neospora%2520caninum%252C%2520Brucella%2520canis%2520and%2520Ehrlichia%2520canis%2520in%2520dogs%26jtitle%3DComparative%2520immunology%252C%2520microbiology%2520and%2520infectious%2520diseases%26date%3D2016%26volume%3D49%26spage%3D47%26epage%3D50%26doi%3D10.1016%2Fj.cimid.2016.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peters, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thigpen, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parise, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, R. D.</span></span> <span> </span><span class="NLM_article-title">Safety and toxicity of sulfadoxine/pyrimethamine implications for malaria prevention in pregnancy using intermittent preventive treatment</span>. <i>Drug Saf.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.2165/00002018-200730060-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.2165%2F00002018-200730060-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=17536875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1Wjtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=481-501&issue=6&author=P.+J.+Petersauthor=M.+C.+Thigpenauthor=M.+E.+Pariseauthor=R.+D.+Newman&title=Safety+and+toxicity+of+sulfadoxine%2Fpyrimethamine+implications+for+malaria+prevention+in+pregnancy+using+intermittent+preventive+treatment&doi=10.2165%2F00002018-200730060-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and toxicity of sulfadoxine/pyrimethamine implications for malaria prevention in pregnancy using intermittent preventive treatment</span></div><div class="casAuthors">Peters, Philip J.; Thigpen, Michael C.; Parise, Monica E.; Newman, Robert D.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Safety</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">481-501</span>CODEN:
                <span class="NLM_cas:coden">DRSAEA</span>;
        ISSN:<span class="NLM_cas:issn">0114-5916</span>.
    
            (<span class="NLM_cas:orgname">Wolters Kluwer Health</span>)
        </div><div class="casAbstract">A review.  Plasmodium falciparum infection during pregnancy is strongly assocd. with maternal anemia and low birth wt., contributing to substantial morbidity and mortality in sub-Saharan Africa.  Intermittent preventive treatment in pregnancy with sulfadoxine/pyrimethamine (IPTp-SP) has been one of the most effective approaches to reduce the burden of malaria during pregnancy in Africa.  IPTp-SP is based on administering ≥2 treatment doses of sulfadoxine/pyrimethamine to pregnant women at predefined intervals after quickening (around 18-20 wk).  Randomised, controlled trials have demonstrated decreased rates of maternal anemia and low birth wt. with this approach.  The WHO currently recommends IPTp-SP in malaria-endemic areas of sub-Saharan Africa.  However, implementation has been suboptimal in part because of concerns of potential drug toxicities.  This review evaluates the toxicity data of sulfadoxine/pyrimethamine, including severe cutaneous adverse reactions, teratogenicity and alterations in bilirubin metab.  Weekly sulfadoxine/pyrimethamine prophylaxis is assocd. with rare but potentially fatal cutaneous reactions.  Fortunately, sulfadoxine/pyrimethamine use in IPTp programs in Africa, with 2-4 treatment doses over 6 mo, has been well tolerated in multiple IPTp trials.  However, sulfadoxine/pyrimethamine should not be administered concurrently with cotrimoxazole given their redundant mechanisms of action and synergistic worsening of adverse drug reactions.  Therefore, HIV-infected pregnant women in malaria endemic areas who are already receiving cotrimoxazole prophylaxis should not also receive IPTp-SP.  Although folate antagonist use in the first trimester is assocd. with neural tube defects, large case-control studies have demonstrated that sulfadoxine/pyrimethamine administered as IPTp (exclusively in the second and third trimesters and after organogenesis) does not result in an increased risk of teratogenesis.  Folic acid supplementation is recommended for all pregnant women to reduce the rate of congenital anomalies but high doses of folic acid (5 mg/day) may interfere with the antimalarial efficacy of sulfadoxine/pyrimethamine.  However, the recommended std. dose of folic acid supplementation (0.4 mg/day) does not affect antimalarial efficacy and may provide the optimal balance to prevent neural tube defects and maintain the effectiveness of IPTp-SP.  No clin. assocn. between sulfadoxine/pyrimethamine use and kernicterus has been reported despite the extensive use of sulfadoxine/pyrimethamine and related compds. to treat maternal malaria and congenital toxoplasmosis in near-term pregnant women and newborns.  Although few drugs in pregnancy can be considered completely safe, sulfadoxine/pyrimethamine - when delivered as IPTp - has a favorable safety profile.  Improved pharmacovigilance programs throughout Africa are now needed to confirm its safety as access to IPTp-SP increases.  Given the documented benefits of IPTp-SP in malaria endemic areas of Africa, access to this treatment for pregnant women should continue to expand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSzOkmKuhWYLVg90H21EOLACvtfcHk0lgsCe6JouOqmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1Wjtrk%253D&md5=bac55f32364572ba565f1739821d3f31</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2165%2F00002018-200730060-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002018-200730060-00003%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DP.%2BJ.%26aulast%3DThigpen%26aufirst%3DM.%2BC.%26aulast%3DParise%26aufirst%3DM.%2BE.%26aulast%3DNewman%26aufirst%3DR.%2BD.%26atitle%3DSafety%2520and%2520toxicity%2520of%2520sulfadoxine%252Fpyrimethamine%2520implications%2520for%2520malaria%2520prevention%2520in%2520pregnancy%2520using%2520intermittent%2520preventive%2520treatment%26jtitle%3DDrug%2520Saf.%26date%3D2007%26volume%3D30%26issue%3D6%26spage%3D481%26epage%3D501%26doi%3D10.2165%2F00002018-200730060-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carr, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penny, R.</span></span> <span> </span><span class="NLM_article-title">Allergic manifestations of human immunodeficiency virus (HIV) infection</span>. <i>J. Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1007/BF00917741</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1007%2FBF00917741" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1676034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADyaK3M3nslWhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1991&pages=55-64&issue=2&author=A.+Carrauthor=D.+A.+Cooperauthor=R.+Penny&title=Allergic+manifestations+of+human+immunodeficiency+virus+%28HIV%29+infection&doi=10.1007%2FBF00917741"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Allergic manifestations of human immunodeficiency virus (HIV) infection</span></div><div class="casAuthors">Carr A; Cooper D A; Penny R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical immunology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">55-64</span>
        ISSN:<span class="NLM_cas:issn">0271-9142</span>.
    </div><div class="casAbstract">Drug allergy is the most common and significant allergic manifestation of HIV3 infection.  Initially described in patients treated with SMX-TMP for PCP, allergy is now known to involve a multitude of drugs.  The pathogenesis of, and risk factors for, allergy in HIV infection are poorly understood, although there is evidence suggesting that allergy is more common with advancing immunodeficiency.  HIV-negative subjects with sulfonamide allergy may have drug-specific antibodies and drug metabolite-induced lymphocyte cytotoxicity, abnormalities that could partly explain the allergic mechanisms and which may have future diagnostic potential; these abnormalities have not been described in HIV-infected subjects.  Therapy includes avoidance, suppressive agents such as corticosteroids, and desensitization, although the appropriate role for each is not entirely clear.  Serum IgE levels have been shown to rise with progressive disease; those patients with higher levels may have a worse prognosis.  The mechanisms of this rise are multifactorial, probably a combination of altered T-lymphocyte regulation of IgE synthesis and of production of specific IgE directed against microbial antigens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSo8wrtVpq2lRKDYG3bNImrfW6udTcc2eaK45_-KLEn_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M3nslWhtQ%253D%253D&md5=ee8b3ef9dda6ee8447510a6ca983ed03</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2FBF00917741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00917741%26sid%3Dliteratum%253Aachs%26aulast%3DCarr%26aufirst%3DA.%26aulast%3DCooper%26aufirst%3DD.%2BA.%26aulast%3DPenny%26aufirst%3DR.%26atitle%3DAllergic%2520manifestations%2520of%2520human%2520immunodeficiency%2520virus%2520%2528HIV%2529%2520infection%26jtitle%3DJ.%2520Clin.%2520Immunol.%26date%3D1991%26volume%3D11%26issue%3D2%26spage%3D55%26epage%3D64%26doi%3D10.1007%2FBF00917741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallal, S.</span></span> <span> </span><span class="NLM_article-title">Drug hypersensitivity in HIV</span>. <i>Curr. Opin Allergy Clin Immunol</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">324</span>– <span class="NLM_lpage">330</span>, <span class="refDoi"> DOI: 10.1097/ACI.0b013e32825ea68a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1097%2FACI.0b013e32825ea68a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=17620824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADC%252BD2svgt1yqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=324-330&issue=4&author=E.+Phillipsauthor=S.+Mallal&title=Drug+hypersensitivity+in+HIV&doi=10.1097%2FACI.0b013e32825ea68a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Drug hypersensitivity in HIV</span></div><div class="casAuthors">Phillips Elizabeth; Mallal Simon</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in allergy and clinical immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">324-30</span>
        ISSN:<span class="NLM_cas:issn">1528-4050</span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  Drug hypersensitivity has been reported to occur 100 times more commonly in those living with HIV.  In the first decade of HIV treatment, this mainly involved drugs used to treat HIV-related infections but now primarily includes drugs used to treat HIV.  This review focuses on the current knowledge of the epidemiology, pathophysiology and clinical features of drug hypersensitivity reactions of drugs used in the management of the HIV-infected patient.  RECENT FINDINGS:  Our understanding of the immunogenetics and host predisposition to drug hypersensitivity has been advanced considerably by the antiretroviral drugs abacavir and nevirapine.  The association of abacavir hypersensitivity reaction with HLA-B*5701 has been particularly important and provides a basis for genetic screening in the clinic setting.  SUMMARY:  The increased predisposition of drug hypersensitivity disease in HIV will continue to provide a fertile ground for study of the diverse and complex processes that drive its pathophysiology.  Our knowledge of drug hypersensitivity will also increase as the expanding armentarium of antiretroviral therapy is applied to more diverse populations in the developing world.  The potential for widespread implementation of HLA-B*5701 screening for abacavir hypersensitivity will set an important precedent for bringing individualized medicine to the clinic and the use of genetic testing to improve drug safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCWItGk7-CmAMthz5_Rx5rfW6udTcc2eaK45_-KLEn_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svgt1yqtQ%253D%253D&md5=5409bb4a52c76ea16b2669e0e4d1dbdf</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1097%2FACI.0b013e32825ea68a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FACI.0b013e32825ea68a%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DE.%26aulast%3DMallal%26aufirst%3DS.%26atitle%3DDrug%2520hypersensitivity%2520in%2520HIV%26jtitle%3DCurr.%2520Opin%2520Allergy%2520Clin%2520Immunol%26date%3D2007%26volume%3D7%26issue%3D4%26spage%3D324%26epage%3D330%26doi%3D10.1097%2FACI.0b013e32825ea68a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slatore, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilles, S. A.</span></span> <span> </span><span class="NLM_article-title">Sulfonamide hypersensitivity</span>. <i>Immunol. Allergy Clin. North Am.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">490</span>, <span class="refDoi"> DOI: 10.1016/j.iac.2004.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1016%2Fj.iac.2004.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=15242722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADC%252BD2czktVOmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=477-490&issue=3&author=C.+G.+Slatoreauthor=S.+A.+Tilles&title=Sulfonamide+hypersensitivity&doi=10.1016%2Fj.iac.2004.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamide hypersensitivity</span></div><div class="casAuthors">Slatore Christopher G; Tilles Stephen A</div><div class="citationInfo"><span class="NLM_cas:title">Immunology and allergy clinics of North America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">477-90, vii</span>
        ISSN:<span class="NLM_cas:issn">0889-8561</span>.
    </div><div class="casAbstract">Sulfonamide antibiotics can result in a wide variety of hypersensitivity reactions.  No validated diagnostic tests are available for sulfonamide reactions; therefore, clinicians must rely on the combination of a careful patient history, review of medical records, and a sound knowledge base regarding the common clinical manifestations of sulfonamide hypersensitivity reactions.  Although HIV-infected individuals have a high risk for hypersensitivity reactions to sulfamethoxazole, readministering the drug can usually be performed safely by using a desensitization protocol.  Sulfonamide-containing medications that are not antibiotics also have the capacity for causing hypersensitivity reactions.  Whether the sulfa moiety confers a risk of cross-reaction is controversial.  The preponderance of available evidence suggests that sulfonamide antibiotics probably do not cross-react with sulfonamide nonantibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcROy-82oedYtRjv2lLSLOxFfW6udTcc2eaK45_-KLEn_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czktVOmtA%253D%253D&md5=de2494eb20056455dbc84704cc056317</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.iac.2004.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.iac.2004.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DSlatore%26aufirst%3DC.%2BG.%26aulast%3DTilles%26aufirst%3DS.%2BA.%26atitle%3DSulfonamide%2520hypersensitivity%26jtitle%3DImmunol.%2520Allergy%2520Clin.%2520North%2520Am.%26date%3D2004%26volume%3D24%26issue%3D3%26spage%3D477%26epage%3D490%26doi%3D10.1016%2Fj.iac.2004.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amabeoku, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chikuni, O.</span></span> <span> </span><span class="NLM_article-title">GABAergic and dopaminergic systems may be involved in seizures induced by pyrimethamine in mice</span>. <i>Gen. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1269</span>– <span class="NLM_lpage">1277</span>, <span class="refDoi"> DOI: 10.1016/0306-3623(94)90149-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1016%2F0306-3623%2894%2990149-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=7875556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADyaK2MXitVKntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1994&pages=1269-1277&issue=6&author=G.+Amabeokuauthor=O.+Chikuni&title=GABAergic+and+dopaminergic+systems+may+be+involved+in+seizures+induced+by+pyrimethamine+in+mice&doi=10.1016%2F0306-3623%2894%2990149-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">GABAergic and dopaminergic systems may be involved in seizures induced by pyrimethamine in mice</span></div><div class="casAuthors">Amabeoku, George; Chikuni, Ordias</div><div class="citationInfo"><span class="NLM_cas:title">General Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1269-77</span>CODEN:
                <span class="NLM_cas:coden">GEPHDP</span>;
        ISSN:<span class="NLM_cas:issn">0306-3623</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The effects of some GABAergic and dopaminergic agents on pyrimethamine-induced tonic seizures were investigated in mice.  Pyrimethamine dose dependently induced seizures in mice.  Muscimol, AOAA and DABA significantly protected mice against pyrimethamine-induced seizures.  Bicuculline and picrotoxin effectively potentiated seizures elicited by pyrimethamine and significantly antagonized the protective effect of muscimol against the seizures.  Diazepam and phenobarbitone effectively protected mice against seizures elicited by pyrimethamine.  L-Dopa significantly potentiated pyrimethamine-induced seizures.  Apomorphine and pargyline significantly reduced the latency of seizures induced by pyrimethamine.  Haloperidol and pimozide effectively protected mice against pyrimethamine-elicited seizures and also significantly antagonized the potentiating effects of apomorphine and L-dopa on the seizures.  Disulfiram significantly potentiated seizures induced by pyrimethamine and also significantly enhanced the seizure-potentiating effect of L-dopa.  α-Methyl-p-tyrosine effectively protected against seizures induced by pyrimethamine.  However, L-dopa significantly potentiated the seizures in α-methyl-p-tyrosine-pretreated animals.  Muscimol significantly attenuated the potentiating effect of L-dopa on pyrimethamine-induced seizures while bicuculline significantly enhanced the effect of L-dopa.  Furthermore, haloperidol significantly potentiated the protective effect of muscimol against pyrimethamine-induced seizures.  These results suggest that both GABA and dopamine might be involved in the mechanism(s) of pyrimethamine seizures in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqykqaVs_eIK7Vg90H21EOLACvtfcHk0lhy5H1XcnmRQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXitVKntrc%253D&md5=19ad17df1c10316ecfbfadab36a3bfbe</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2F0306-3623%2894%2990149-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0306-3623%252894%252990149-X%26sid%3Dliteratum%253Aachs%26aulast%3DAmabeoku%26aufirst%3DG.%26aulast%3DChikuni%26aufirst%3DO.%26atitle%3DGABAergic%2520and%2520dopaminergic%2520systems%2520may%2520be%2520involved%2520in%2520seizures%2520induced%2520by%2520pyrimethamine%2520in%2520mice%26jtitle%3DGen.%2520Pharmacol.%26date%3D1994%26volume%3D25%26issue%3D6%26spage%3D1269%26epage%3D1277%26doi%3D10.1016%2F0306-3623%2894%2990149-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bolstad, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolstad, E. S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frey, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, A. C.</span></span> <span> </span><span class="NLM_article-title">Structure-based approach to the development of potent and selective inhibitors of dihydrofolate reductase from Cryptosporidium</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6839</span>– <span class="NLM_lpage">6852</span>, <span class="refDoi"> DOI: 10.1021/jm8009124</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8009124" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6839-6852&issue=21&author=D.+B.+Bolstadauthor=E.+S.+D.+Bolstadauthor=K.+M.+Freyauthor=D.+L.+Wrightauthor=A.+C.+Anderson&title=Structure-based+approach+to+the+development+of+potent+and+selective+inhibitors+of+dihydrofolate+reductase+from+Cryptosporidium&doi=10.1021%2Fjm8009124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm8009124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8009124%26sid%3Dliteratum%253Aachs%26aulast%3DBolstad%26aufirst%3DD.%2BB.%26aulast%3DBolstad%26aufirst%3DE.%2BS.%2BD.%26aulast%3DFrey%26aufirst%3DK.%2BM.%26aulast%3DWright%26aufirst%3DD.%2BL.%26aulast%3DAnderson%26aufirst%3DA.%2BC.%26atitle%3DStructure-based%2520approach%2520to%2520the%2520development%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520dihydrofolate%2520reductase%2520from%2520Cryptosporidium%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D21%26spage%3D6839%26epage%3D6852%26doi%3D10.1021%2Fjm8009124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsch, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Queener, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosowsky, A.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and antifolate activity of new analogues of piritrexim and other diaminopyrimidine dihydrofolate reductase inhibitors with ω-carboxyalkoxy or ω-carboxy-1-alkynyl substitution in the side chain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">4420</span>– <span class="NLM_lpage">4431</span>, <span class="refDoi"> DOI: 10.1021/jm0581718</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0581718" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4420-4431&issue=13&author=D.+C.+M.+Chanauthor=H.+Fuauthor=R.+A.+Forschauthor=S.+F.+Queenerauthor=A.+Rosowsky&title=Design%2C+synthesis%2C+and+antifolate+activity+of+new+analogues+of+piritrexim+and+other+diaminopyrimidine+dihydrofolate+reductase+inhibitors+with+%CF%89-carboxyalkoxy+or+%CF%89-carboxy-1-alkynyl+substitution+in+the+side+chain&doi=10.1021%2Fjm0581718"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm0581718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0581718%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DD.%2BC.%2BM.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DForsch%26aufirst%3DR.%2BA.%26aulast%3DQueener%26aufirst%3DS.%2BF.%26aulast%3DRosowsky%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520antifolate%2520activity%2520of%2520new%2520analogues%2520of%2520piritrexim%2520and%2520other%2520diaminopyrimidine%2520dihydrofolate%2520reductase%2520inhibitors%2520with%2520%25CF%2589-carboxyalkoxy%2520or%2520%25CF%2589-carboxy-1-alkynyl%2520substitution%2520in%2520the%2520side%2520chain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D13%26spage%3D4420%26epage%3D4431%26doi%3D10.1021%2Fjm0581718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, H.
C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggadike, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKilligin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinsman, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Queener, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span> <span> </span><span class="NLM_article-title">6,7-Disubstituted 2,4-diaminopteridines: Novel inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1371</span>– <span class="NLM_lpage">1375</span>, <span class="refDoi"> DOI: 10.1128/AAC.40.6.1371</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1128%2FAAC.40.6.1371" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1996&pages=1371-1375&issue=6&author=H.%0AC.+Jacksonauthor=K.+Biggadikeauthor=E.+McKilliginauthor=O.+S.+Kinsmanauthor=S.+F.+Queenerauthor=A.+Laneauthor=J.+Smith&title=6%2C7-Disubstituted+2%2C4-diaminopteridines%3A+Novel+inhibitors+of+Pneumocystis+carinii+and+Toxoplasma+gondii+dihydrofolate+reductase&doi=10.1128%2FAAC.40.6.1371"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1128%2FAAC.40.6.1371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.40.6.1371%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DH.%2BC.%26aulast%3DBiggadike%26aufirst%3DK.%26aulast%3DMcKilligin%26aufirst%3DE.%26aulast%3DKinsman%26aufirst%3DO.%2BS.%26aulast%3DQueener%26aufirst%3DS.%2BF.%26aulast%3DLane%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DJ.%26atitle%3D6%252C7-Disubstituted%25202%252C4-diaminopteridines%253A%2520Novel%2520inhibitors%2520of%2520Pneumocystis%2520carinii%2520and%2520Toxoplasma%2520gondii%2520dihydrofolate%2520reductase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1996%26volume%3D40%26issue%3D6%26spage%3D1371%26epage%3D1375%26doi%3D10.1128%2FAAC.40.6.1371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelphrey, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popov, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joska, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beierlein, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolstad, E. S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillingham, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, A. C.</span></span> <span> </span><span class="NLM_article-title">Highly efficient ligands for dihydrofolate reductase from Cryptosporidium hominis and Toxoplasma gondii inspired by structural analysis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">940</span>– <span class="NLM_lpage">950</span>, <span class="refDoi"> DOI: 10.1021/jm061027h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061027h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=940-950&issue=5&author=P.+M.+Pelphreyauthor=V.+M.+Popovauthor=T.+M.+Joskaauthor=J.+M.+Beierleinauthor=E.+S.+D.+Bolstadauthor=Y.+A.+Fillinghamauthor=D.+L.+Wrightauthor=A.+C.+Anderson&title=Highly+efficient+ligands+for+dihydrofolate+reductase+from+Cryptosporidium+hominis+and+Toxoplasma+gondii+inspired+by+structural+analysis&doi=10.1021%2Fjm061027h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm061027h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061027h%26sid%3Dliteratum%253Aachs%26aulast%3DPelphrey%26aufirst%3DP.%2BM.%26aulast%3DPopov%26aufirst%3DV.%2BM.%26aulast%3DJoska%26aufirst%3DT.%2BM.%26aulast%3DBeierlein%26aufirst%3DJ.%2BM.%26aulast%3DBolstad%26aufirst%3DE.%2BS.%2BD.%26aulast%3DFillingham%26aufirst%3DY.%2BA.%26aulast%3DWright%26aufirst%3DD.%2BL.%26aulast%3DAnderson%26aufirst%3DA.%2BC.%26atitle%3DHighly%2520efficient%2520ligands%2520for%2520dihydrofolate%2520reductase%2520from%2520Cryptosporidium%2520hominis%2520and%2520Toxoplasma%2520gondii%2520inspired%2520by%2520structural%2520analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D5%26spage%3D940%26epage%3D950%26doi%3D10.1021%2Fjm061027h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosowsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hynes, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Queener, S. F.</span></span> <span> </span><span class="NLM_article-title">Structure-activity and structure-selectivity studies on diaminoquinazolines and other inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1128/AAC.39.1.79</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1128%2FAAC.39.1.79" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1995&pages=79-86&issue=1&author=A.+Rosowskyauthor=J.+B.+Hynesauthor=S.+F.+Queener&title=Structure-activity+and+structure-selectivity+studies+on+diaminoquinazolines+and+other+inhibitors+of+Pneumocystis+carinii+and+Toxoplasma+gondii+dihydrofolate+reductase&doi=10.1128%2FAAC.39.1.79"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1128%2FAAC.39.1.79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.39.1.79%26sid%3Dliteratum%253Aachs%26aulast%3DRosowsky%26aufirst%3DA.%26aulast%3DHynes%26aufirst%3DJ.%2BB.%26aulast%3DQueener%26aufirst%3DS.%2BF.%26atitle%3DStructure-activity%2520and%2520structure-selectivity%2520studies%2520on%2520diaminoquinazolines%2520and%2520other%2520inhibitors%2520of%2520Pneumocystis%2520carinii%2520and%2520Toxoplasma%2520gondii%2520dihydrofolate%2520reductase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1995%26volume%3D39%26issue%3D1%26spage%3D79%26epage%3D86%26doi%3D10.1128%2FAAC.39.1.79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landau, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargo, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spasov, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. S.</span></span> <span> </span><span class="NLM_article-title">First three-dimensional structure of Toxoplasma gondii thymidylate synthase-dihydrofolate reductase: Insights for catalysis, interdomain interactions, and substrate channeling</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">41</span>),  <span class="NLM_fpage">7305</span>– <span class="NLM_lpage">7317</span>, <span class="refDoi"> DOI: 10.1021/bi400576t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi400576t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVynsr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=7305-7317&issue=41&author=H.+Sharmaauthor=M.+J.+Landauauthor=M.+A.+Vargoauthor=K.+A.+Spasovauthor=K.+S.+Anderson&title=First+three-dimensional+structure+of+Toxoplasma+gondii+thymidylate+synthase-dihydrofolate+reductase%3A+Insights+for+catalysis%2C+interdomain+interactions%2C+and+substrate+channeling&doi=10.1021%2Fbi400576t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">First Three-Dimensional Structure of Toxoplasma gondii Thymidylate Synthase-Dihydrofolate Reductase: Insights for Catalysis, Interdomain Interactions, and Substrate Channeling</span></div><div class="casAuthors">Sharma, Hitesh; Landau, Mark J.; Vargo, Melissa A.; Spasov, Krasimir A.; Anderson, Karen S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">7305-7317</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Most species, such as humans, have monofunctional forms of thymidylate synthase (TS) and dihydrofolate reductase (DHFR) that are key folate metab. enzymes making crit. folate components required for DNA synthesis.  In contrast, several parasitic protozoa, including Toxoplasma gondii, contain a unique bifunctional thymidylate synthase-dihydrofolate reductase (TS-DHFR) having the catalytic activities contained on a single polypeptide chain.  The prevalence of T. gondii infections across the world, esp. for those immunocompromised, underscores the need to understand TS-DHFR enzyme function and to find new avenues to exploit for the design of novel antiparasitic drugs.  As a first step, we have solved the first three-dimensional structures of T. gondii TS-DHFR at 3.7 Å and of a loop truncated TS-DHFR, removing several flexible surface loops in the DHFR domain, improving resoln. to 2.2 Å.  Distinct structural features of the TS-DHFR homodimer include a junctional region contg. a kinked crossover helix between the DHFR domains of the two adjacent monomers, a long linker connecting the TS and DHFR domains, and a DHFR domain that is pos. charged.  The roles of these unique structural features were probed by site-directed mutagenesis coupled with presteady state and steady state kinetics.  Mutational anal. of the crossover helix region combined with kinetic characterization established the importance of this region not only in DHFR catalysis but also in modulating the distal TS activity, suggesting a role for TS-DHFR interdomain interactions.  Addnl. kinetic studies revealed that substrate channeling occurs in which dihydrofolate is directly transferred from the TS to DHFR active site without entering bulk soln.  The crystal structure suggests that the pos. charged DHFR domain governs this electrostatically mediated movement of dihydrofolate, preventing release from the enzyme.  Taken together, these structural and kinetic studies reveal unique, functional regions on the T. gondii TS-DHFR enzyme that may be targeted for inhibition, thus paving the way for designing species specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqgJc1yVXlfrVg90H21EOLACvtfcHk0lgAZ-RyFlQLhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVynsr3K&md5=cd220cd54e8474cbd47925aa4b5c6d58</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fbi400576t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi400576t%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DH.%26aulast%3DLandau%26aufirst%3DM.%2BJ.%26aulast%3DVargo%26aufirst%3DM.%2BA.%26aulast%3DSpasov%26aufirst%3DK.%2BA.%26aulast%3DAnderson%26aufirst%3DK.%2BS.%26atitle%3DFirst%2520three-dimensional%2520structure%2520of%2520Toxoplasma%2520gondii%2520thymidylate%2520synthase-dihydrofolate%2520reductase%253A%2520Insights%2520for%2520catalysis%252C%2520interdomain%2520interactions%252C%2520and%2520substrate%2520channeling%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D52%26issue%3D41%26spage%3D7305%26epage%3D7317%26doi%3D10.1021%2Fbi400576t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Welsch, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agnihotri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, S. B.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective leads against Toxoplasma gondii dihydrofolate reductase via structure-based design</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1124</span>– <span class="NLM_lpage">1129</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00328</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00328" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFanu7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1124-1129&issue=12&author=M.+E.+Welschauthor=J.+Zhouauthor=Y.+Gaoauthor=Y.+Yanauthor=G.+Porterauthor=G.+Agnihotriauthor=Y.+Liauthor=H.+Luauthor=Z.+Chenauthor=S.+B.+Thomas&title=Discovery+of+potent+and+selective+leads+against+Toxoplasma+gondii+dihydrofolate+reductase+via+structure-based+design&doi=10.1021%2Facsmedchemlett.6b00328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Leads against Toxoplasma gondii Dihydrofolate Reductase via Structure-Based Design</span></div><div class="casAuthors">Welsch, Matthew E.; Zhou, Jian; Gao, Yueqiang; Yan, Yunqing; Porter, Gene; Agnihotri, Gautam; Li, Yingjie; Lu, Henry; Chen, Zhongguo; Thomas, Stephen B.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1124-1129</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Current treatment of toxoplasmosis targets the parasite's folate metab. through inhibition of dihydrofolate reductase (DHFR).  The most widely used DHFR antagonist, pyrimethamine, was introduced over 60 years ago and is assocd. with toxicity that can be largely attributed to a similar affinity for parasite and human DHFR.  Computational anal. of biochem. differences between Toxoplasma gondii and human DHFR enabled the design of inhibitors with both improved potency and selectivity.  The approach described herein yielded I, a promising lead with an IC50 of 9 nM and 89-fold selectivity in favor of Toxoplasma gondii DHFR, as well as crystallog. data to substantiate in silico methodol.  Overall, 50% of synthesized in silico designs met hit threshold criteria of IC50 < 10 μM and >2-fold selectivity favoring Toxoplasma gondii, further demonstrating the efficiency of the structure-based drug design approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdfV8Zx0CTnrVg90H21EOLACvtfcHk0lgAZ-RyFlQLhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFanu7nJ&md5=bc9310b6e5f9e976d13f89e9d1f9fe74</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00328%26sid%3Dliteratum%253Aachs%26aulast%3DWelsch%26aufirst%3DM.%2BE.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DPorter%26aufirst%3DG.%26aulast%3DAgnihotri%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DThomas%26aufirst%3DS.%2BB.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520leads%2520against%2520Toxoplasma%2520gondii%2520dihydrofolate%2520reductase%2520via%2520structure-based%2520design%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D12%26spage%3D1124%26epage%3D1129%26doi%3D10.1021%2Facsmedchemlett.6b00328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allegra, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovacs, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drake, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swan, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabner, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masur, H.</span></span> <span> </span><span class="NLM_article-title">Potent in vitro and in vivo antitoxoplasma activity of the lipid-soluble antifolate trimetrexate</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>79</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">478</span>– <span class="NLM_lpage">482</span>, <span class="refDoi"> DOI: 10.1172/JCI112837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1172%2FJCI112837" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1987&pages=478-482&issue=2&author=C.+J.+Allegraauthor=J.+A.+Kovacsauthor=J.+C.+Drakeauthor=J.+C.+Swanauthor=B.+A.+Chabnerauthor=H.+Masur&title=Potent+in+vitro+and+in+vivo+antitoxoplasma+activity+of+the+lipid-soluble+antifolate+trimetrexate&doi=10.1172%2FJCI112837"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1172%2FJCI112837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI112837%26sid%3Dliteratum%253Aachs%26aulast%3DAllegra%26aufirst%3DC.%2BJ.%26aulast%3DKovacs%26aufirst%3DJ.%2BA.%26aulast%3DDrake%26aufirst%3DJ.%2BC.%26aulast%3DSwan%26aufirst%3DJ.%2BC.%26aulast%3DChabner%26aufirst%3DB.%2BA.%26aulast%3DMasur%26aufirst%3DH.%26atitle%3DPotent%2520in%2520vitro%2520and%2520in%2520vivo%2520antitoxoplasma%2520activity%2520of%2520the%2520lipid-soluble%2520antifolate%2520trimetrexate%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1987%26volume%3D79%26issue%3D2%26spage%3D478%26epage%3D482%26doi%3D10.1172%2FJCI112837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tonelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naesens, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazzarrini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santucci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cichero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasso, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moroni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loddo, R.</span></span> <span> </span><span class="NLM_article-title">Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">467</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.04.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1016%2Fj.ejmech.2017.04.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=28477572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFWrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2017&pages=467-478&author=M.+Tonelliauthor=L.+Naesensauthor=S.+Gazzarriniauthor=M.+Santucciauthor=E.+Cicheroauthor=B.+Tassoauthor=A.+Moroniauthor=M.+P.+Costiauthor=R.+Loddo&title=Host+dihydrofolate+reductase+%28DHFR%29-directed+cycloguanil+analogues+endowed+with+activity+against+influenza+virus+and+respiratory+syncytial+virus&doi=10.1016%2Fj.ejmech.2017.04.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus</span></div><div class="casAuthors">Tonelli, Michele; Naesens, Lieve; Gazzarrini, Sabrina; Santucci, Matteo; Cichero, Elena; Tasso, Bruno; Moroni, Anna; Costi, Maria Paola; Loddo, Roberta</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">467-478</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">We have identified a series of 1-aryl-4,6-diamino-1,2-dihydrotriazines, structurally related to the antimalarial drug cycloguanil, as new inhibitors of influenza A and B virus and respiratory syncytial virus (RSV) via targeting of the host dihydrofolate reductase (DHFR) enzyme.  Most analogs proved active against influenza B virus in the low micromolar range, and the best compds. (11, 13, 14 and 16) even reached the sub-micromolar potency of zanamivir (EC50 = 0.060 μM), and markedly exceeded (up to 327 times) the antiviral efficacy of ribavirin.  Activity was also obsd. for two influenza A strains, including a virus with the S31N mutant form of M2 proton channel, which is the most prevalent resistance mutation for amantadine.  Importantly, the compds. displayed nanomolar activity against RSV and a superior selectivity index, since the ratio of cytotoxic to antiviral concn. was >10,000 for the three most active compds. 11, 14 and 16 (EC50 ∼0.008 μM), far surpassing the potency and safety profile of the licensed drug ribavirin (EC50 = 5.8 μM, SI > 43).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqftRmKNGZDgLVg90H21EOLACvtfcHk0lg5Wd1PihT87g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFWrtbc%253D&md5=3e39d991a7aad659a1f4a5c8230a01fe</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.04.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.04.070%26sid%3Dliteratum%253Aachs%26aulast%3DTonelli%26aufirst%3DM.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DGazzarrini%26aufirst%3DS.%26aulast%3DSantucci%26aufirst%3DM.%26aulast%3DCichero%26aufirst%3DE.%26aulast%3DTasso%26aufirst%3DB.%26aulast%3DMoroni%26aufirst%3DA.%26aulast%3DCosti%26aufirst%3DM.%2BP.%26aulast%3DLoddo%26aufirst%3DR.%26atitle%3DHost%2520dihydrofolate%2520reductase%2520%2528DHFR%2529-directed%2520cycloguanil%2520analogues%2520endowed%2520with%2520activity%2520against%2520influenza%2520virus%2520and%2520respiratory%2520syncytial%2520virus%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D135%26spage%3D467%26epage%3D478%26doi%3D10.1016%2Fj.ejmech.2017.04.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Andrade Junior, H.
F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lescano, S. A. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amato-Neto, V.</span></span> <span> </span><span class="NLM_article-title">In vitro action of antiparasitic drugs, especially artesunate, against Toxoplasma gondii</span>. <i>Rev. Soc. Bras Med. Trop</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">485</span>– <span class="NLM_lpage">490</span>, <span class="refDoi"> DOI: 10.1590/S0037-86822012000400014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1590%2FS0037-86822012000400014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=22930046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADC%252BC38bitVKrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2012&pages=485-490&issue=4&author=T.+C.+Gomesauthor=H.%0AF.+de+Andrade+Juniorauthor=S.+A.+Z.+Lescanoauthor=V.+Amato-Neto&title=In+vitro+action+of+antiparasitic+drugs%2C+especially+artesunate%2C+against+Toxoplasma+gondii&doi=10.1590%2FS0037-86822012000400014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro action of antiparasitic drugs, especially artesunate, against Toxoplasma gondii</span></div><div class="casAuthors">Gomes Thais Cobellis; de Andrade Junior Heitor Franco; Lescano Susana Angelica Zevallos; Amato-Neto Vicente</div><div class="citationInfo"><span class="NLM_cas:title">Revista da Sociedade Brasileira de Medicina Tropical</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">485-90</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  Toxoplasmosis is usually a benign infection, except in the event of ocular, central nervous system (CNS), or congenital disease and particularly when the patient is immunocompromised.  Treatment consists of drugs that frequently cause adverse effects; thus, newer, more effective drugs are needed.  In this study, the possible activity of artesunate, a drug successfully being used for the treatment of malaria, on Toxoplasma gondii growth in cell culture is evaluated and compared with the action of drugs that are already being used against this parasite.  METHODS:  LLC-MK2 cells were cultivated in RPMI medium, kept in disposable plastic bottles, and incubated at 36oC with 5% CO2.  Tachyzoites of the RH strain were used.  The following drugs were tested: artesunate, cotrimoxazole, pentamidine, pyrimethamine, quinine, and trimethoprim.  The effects of these drugs on tachyzoites and LLC-MK2 cells were analyzed using nonlinear regression analysis with Prism 3.0 software.  RESULTS:  Artesunate showed a mean tachyzoite inhibitory concentration (IC50) of 0.075μM and an LLC MK2 toxicity of 2.003μM.  Pyrimethamine was effective at an IC50 of 0.482μM and a toxicity of 11.178μM.  Trimethoprim alone was effective against the in vitro parasite.  Cotrimoxazole also was effective against the parasite but at higher concentrations than those observed for artesunate and pyrimethamine.  Pentamidine and quinine had no inhibitory effect over tachyzoites.  CONCLUSIONS:  Artesunate is proven in vitro to be a useful alternative for the treatment of toxoplasmosis, implying a subsequent in vivo effect and suggesting the mechanism of this drug against the parasite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVBppxeusH2YqdXsLcGTEUfW6udTcc2eabu09C1t5XYrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bitVKrtA%253D%253D&md5=7ef6c9c3b6f79fcc0d7bbbef8f2d1208</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1590%2FS0037-86822012000400014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252FS0037-86822012000400014%26sid%3Dliteratum%253Aachs%26aulast%3DGomes%26aufirst%3DT.%2BC.%26aulast%3Dde%2BAndrade%2BJunior%26aufirst%3DH.%2BF.%26aulast%3DLescano%26aufirst%3DS.%2BA.%2BZ.%26aulast%3DAmato-Neto%26aufirst%3DV.%26atitle%3DIn%2520vitro%2520action%2520of%2520antiparasitic%2520drugs%252C%2520especially%2520artesunate%252C%2520against%2520Toxoplasma%2520gondii%26jtitle%3DRev.%2520Soc.%2520Bras%2520Med.%2520Trop%26date%3D2012%26volume%3D45%26issue%3D4%26spage%3D485%26epage%3D490%26doi%3D10.1590%2FS0037-86822012000400014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canney, D. J.</span></span> <span> </span><span class="NLM_article-title">A versatile and practical microwave-assisted synthesis of sterically hindered N-arylpiperazines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>75</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">7451</span>– <span class="NLM_lpage">7453</span>, <span class="refDoi"> DOI: 10.1021/jo101478c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo101478c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2010&pages=7451-7453&issue=21&author=R.+Gaoauthor=D.+J.+Canney&title=A+versatile+and+practical+microwave-assisted+synthesis+of+sterically+hindered+N-arylpiperazines&doi=10.1021%2Fjo101478c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo101478c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo101478c%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DR.%26aulast%3DCanney%26aufirst%3DD.%2BJ.%26atitle%3DA%2520versatile%2520and%2520practical%2520microwave-assisted%2520synthesis%2520of%2520sterically%2520hindered%2520N-arylpiperazines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2010%26volume%3D75%26issue%3D21%26spage%3D7451%26epage%3D7453%26doi%3D10.1021%2Fjo101478c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ravilla, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkata Subba Naidu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagarajan, K.</span></span> <span> </span><span class="NLM_article-title">An efficient scale up process for synthesis of N-arylpiperazines</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">30</span>),  <span class="NLM_fpage">4541</span>– <span class="NLM_lpage">4544</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2015.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1016%2Fj.tetlet.2015.06.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=4541-4544&issue=30&author=L.+Ravillaauthor=N.+Venkata+Subba+Naiduauthor=K.+Nagarajan&title=An+efficient+scale+up+process+for+synthesis+of+N-arylpiperazines&doi=10.1016%2Fj.tetlet.2015.06.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2015.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2015.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DRavilla%26aufirst%3DL.%26aulast%3DVenkata%2BSubba%2BNaidu%26aufirst%3DN.%26aulast%3DNagarajan%26aufirst%3DK.%26atitle%3DAn%2520efficient%2520scale%2520up%2520process%2520for%2520synthesis%2520of%2520N-arylpiperazines%26jtitle%3DTetrahedron%2520Lett.%26date%3D2015%26volume%3D56%26issue%3D30%26spage%3D4541%26epage%3D4544%26doi%3D10.1016%2Fj.tetlet.2015.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">G-Dayanandan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, A. C.</span></span> <span> </span><span class="NLM_article-title">Elucidating features that drive the design of selective antifolates using crystal structures of human dihydrofolate reductase</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">41</span>),  <span class="NLM_fpage">7318</span>– <span class="NLM_lpage">7326</span>, <span class="refDoi"> DOI: 10.1021/bi400852h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi400852h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVynsrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=7318-7326&issue=41&author=K.+M.+Lambauthor=N.+G-Dayanandanauthor=D.+L.+Wrightauthor=A.+C.+Anderson&title=Elucidating+features+that+drive+the+design+of+selective+antifolates+using+crystal+structures+of+human+dihydrofolate+reductase&doi=10.1021%2Fbi400852h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidating Features That Drive the Design of Selective Antifolates Using Crystal Structures of Human Dihydrofolate Reductase</span></div><div class="casAuthors">Lamb, Kristen M.; G-Dayanandan, Narendran; Wright, Dennis L.; Anderson, Amy C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">7318-7326</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The pursuit of antimicrobial drugs that target dihydrofolate reductase (DHFR) exploits differences in sequence and dynamics between the pathogenic and human enzymes.  Here, we present five crystal structures of human DHFR bound to a new class of antimicrobial agents, the propargyl-linked antifolates (PLAs), with a range of potency (IC50 values of 0.045-1.07 μM) for human DHFR.  These structures reveal that interactions between the ligands and Asn 64, Phe 31, and Phe 34 are important for increased affinity for human DHFR and that loop residues 58-64 undergo ligand-induced conformational changes.  The utility of these structural studies was demonstrated through the design of three new ligands that reduce the no. of contacts with Asn 64, Phe 31, and Phe 34.  Synthesis and evaluation show that one of the designed inhibitors exhibits the lowest affinity for human DHFR of any of the PLAs (2.64 μM).  Comparisons of structures of human and Staphylococcus aureus DHFR bound to the same PLA reveal a conformational change in the ligand that enhances interactions with residues Phe 92 (Val 115 in huDHFR) and Ile 50 (Ile 60 in huDHFR) in S. aureus DHFR, yielding selectivity.  Likewise, comparisons of human and Candida glabrata DHFR bound to the same ligand show that hydrophobic interactions with residues Ile 121 and Phe 66 (Val 115 and Asn 64 in human DHFR) yield selective inhibitors.  The identification of residue substitutions that are important for selectivity and the observation of active site flexibility will help guide antimicrobial antifolate development for the inhibition of pathogenic species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogP92W2vZAIbVg90H21EOLACvtfcHk0liutFiJryaBzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVynsrbP&md5=fa3efc551faf88f452cfcf2c481a1ee9</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fbi400852h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi400852h%26sid%3Dliteratum%253Aachs%26aulast%3DLamb%26aufirst%3DK.%2BM.%26aulast%3DG-Dayanandan%26aufirst%3DN.%26aulast%3DWright%26aufirst%3DD.%2BL.%26aulast%3DAnderson%26aufirst%3DA.%2BC.%26atitle%3DElucidating%2520features%2520that%2520drive%2520the%2520design%2520of%2520selective%2520antifolates%2520using%2520crystal%2520structures%2520of%2520human%2520dihydrofolate%2520reductase%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D52%26issue%3D41%26spage%3D7318%26epage%3D7326%26doi%3D10.1021%2Fbi400852h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span>UniProtKB, U. UniProtKB-P00374
(DYR_HUMAN) [database entry for human DHFR] (accessed November 2,
2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=UniProtKB%2C+U.+UniProtKB-P00374%0A%28DYR_HUMAN%29+%5Bdatabase+entry+for+human+DHFR%5D+%28accessed+November+2%2C%0A2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajzenberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dardé, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajioka, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Globally diverse <i>Toxoplasma gondii</i> isolates comprise six major clades originating from a small number of distinct ancestral lineages</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">5844</span>– <span class="NLM_lpage">5849</span>, <span class="refDoi"> DOI: 10.1073/pnas.1203190109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1073%2Fpnas.1203190109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=5844-5849&author=C.+L.+Suauthor=A.+Khanauthor=P.+Zhouauthor=D.+Majumdarauthor=D.+Ajzenbergauthor=M.+L.+Dard%C3%A9author=X.+Q.+Zhuauthor=J.+W.+Ajiokaauthor=B.+Rosenthalauthor=J.+P.+Dubeyauthor=L.+D.+Sibley&title=Globally+diverse+Toxoplasma+gondii+isolates+comprise+six+major+clades+originating+from+a+small+number+of+distinct+ancestral+lineages&doi=10.1073%2Fpnas.1203190109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1203190109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1203190109%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DC.%2BL.%26aulast%3DKhan%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DAjzenberg%26aufirst%3DD.%26aulast%3DDard%25C3%25A9%26aufirst%3DM.%2BL.%26aulast%3DZhu%26aufirst%3DX.%2BQ.%26aulast%3DAjioka%26aufirst%3DJ.%2BW.%26aulast%3DRosenthal%26aufirst%3DB.%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DGlobally%2520diverse%2520Toxoplasma%2520gondii%2520isolates%2520comprise%2520six%2520major%2520clades%2520originating%2520from%2520a%2520small%2520number%2520of%2520distinct%2520ancestral%2520lineages%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D5844%26epage%3D5849%26doi%3D10.1073%2Fpnas.1203190109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ajzenberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cogné, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paris, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessieres, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thulliez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filisetti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelloux, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marty, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dardé, M. L.</span></span> <span> </span><span class="NLM_article-title">Genotype of 86 <i>Toxoplasma gondii</i> isolates associated with human congenital toxoplasmosis and correlation with clinical findings</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>186</i></span>,  <span class="NLM_fpage">684</span>– <span class="NLM_lpage">689</span>, <span class="refDoi"> DOI: 10.1086/342663</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1086%2F342663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=12195356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVSlur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2002&pages=684-689&author=D.+Ajzenbergauthor=N.+Cogn%C3%A9author=L.+Parisauthor=M.+H.+Bessieresauthor=P.+Thulliezauthor=D.+Filisettiauthor=H.+Pellouxauthor=P.+Martyauthor=M.+L.+Dard%C3%A9&title=Genotype+of+86+Toxoplasma+gondii+isolates+associated+with+human+congenital+toxoplasmosis+and+correlation+with+clinical+findings&doi=10.1086%2F342663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings</span></div><div class="casAuthors">Ajzenberg, Daniel; Cogne, Nadine; Paris, Luc; Bessieres, Marie-Helene; Thulliez, Philippe; Filisetti, Denis; Pelloux, Herve; Marty, Pierre; Darde, Marie-Laure</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">186</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">684-689</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">To study the influence of Toxoplasma gondii genotypes on the severity of human congenital toxoplasmosis (asymptomatic, benign, or severe infection or newborn or fetal death), 8 microsatellite markers were used to analyze 86 T. gondii isolates collected from patients with congenital toxoplasmosis.  Seventy-four different genotypes were detected, some identical genotypes originating probably from the same source of contamination.  The 3 less polymorphic microsatellite markers assocd. with 6 isoenzymic markers allowed a classification of isolates into the 3 classical types and detected atypical genotypes.  Whatever the clin. findings, type II isolates were largely predominant (84.88% in the whole collection and 96.49% in 57 consecutive cases).  Type I and atypical isolates were not found in asymptomatic or benign congenital toxoplasmosis.  However, in 4 cases in which children were not infected despite isolation of T. gondii from placenta, only type I isolates were found.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZsrDGd7wi77Vg90H21EOLACvtfcHk0ligq1iyY2g8qw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVSlur0%253D&md5=c1e3ecf11423f3c0d46a4b1343c36f38</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1086%2F342663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F342663%26sid%3Dliteratum%253Aachs%26aulast%3DAjzenberg%26aufirst%3DD.%26aulast%3DCogn%25C3%25A9%26aufirst%3DN.%26aulast%3DParis%26aufirst%3DL.%26aulast%3DBessieres%26aufirst%3DM.%2BH.%26aulast%3DThulliez%26aufirst%3DP.%26aulast%3DFilisetti%26aufirst%3DD.%26aulast%3DPelloux%26aufirst%3DH.%26aulast%3DMarty%26aufirst%3DP.%26aulast%3DDard%25C3%25A9%26aufirst%3DM.%2BL.%26atitle%3DGenotype%2520of%252086%2520Toxoplasma%2520gondii%2520isolates%2520associated%2520with%2520human%2520congenital%2520toxoplasmosis%2520and%2520correlation%2520with%2520clinical%2520findings%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2002%26volume%3D186%26spage%3D684%26epage%3D689%26doi%3D10.1086%2F342663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ajzenberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yera, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marty, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paris, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalle, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menotti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubert, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessieres, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelloux, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delhaes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desbois, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thulliez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert-Gangneux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffmann-Lacroix, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujol, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabodonirina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bougnoux, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuisenier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duhamel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filisetti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flori, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gay-Andrieu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratlong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carme, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnabau, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darde, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villena, I.</span></span> <span> </span><span class="NLM_article-title">Genotype of 88 <i>Toxoplasma gondii</i> isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>199</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1155</span>– <span class="NLM_lpage">1167</span>, <span class="refDoi"> DOI: 10.1086/597477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1086%2F597477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=19265484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADC%252BD1MzhtFyhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=199&publication_year=2009&pages=1155-1167&issue=8&author=D.+Ajzenbergauthor=H.+Yeraauthor=P.+Martyauthor=L.+Parisauthor=F.+Dalleauthor=J.+Menottiauthor=D.+Aubertauthor=J.+Franckauthor=M.+H.+Bessieresauthor=D.+Quinioauthor=H.+Pellouxauthor=L.+Delhaesauthor=N.+Desboisauthor=P.+Thulliezauthor=F.+Robert-Gangneuxauthor=C.+Kauffmann-Lacroixauthor=S.+Pujolauthor=M.+Rabodonirinaauthor=M.+E.+Bougnouxauthor=B.+Cuisenierauthor=C.+Duhamelauthor=T.+H.+Duongauthor=D.+Filisettiauthor=P.+Floriauthor=F.+Gay-Andrieuauthor=F.+Pratlongauthor=G.+Nevezauthor=A.+Totetauthor=B.+Carmeauthor=H.+Bonnabauauthor=M.+L.+Dardeauthor=I.+Villena&title=Genotype+of+88+Toxoplasma+gondii+isolates+associated+with+toxoplasmosis+in+immunocompromised+patients+and+correlation+with+clinical+findings&doi=10.1086%2F597477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings</span></div><div class="casAuthors">Ajzenberg Daniel; Yera Helene; Marty Pierre; Paris Luc; Dalle Frederic; Menotti Jean; Aubert Dominique; Franck Jacqueline; Bessieres Marie-Helene; Quinio Dorothee; Pelloux Herve; Delhaes Laurence; Desbois Nicole; Thulliez Philippe; Robert-Gangneux Florence; Kauffmann-Lacroix Catherine; Pujol Sophie; Rabodonirina Meja; Bougnoux Marie-Elisabeth; Cuisenier Bernadette; Duhamel Chantal; Duong Thanh Hai; Filisetti Denis; Flori Pierre; Gay-Andrieu Francoise; Pratlong Francine; Nevez Gilles; Totet Anne; Carme Bernard; Bonnabau Henri; Darde Marie-Laure; Villena Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infectious diseases</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">199</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1155-67</span>
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    </div><div class="casAbstract">We report the genotyping analysis of Toxoplasma gondii isolates in samples collected from 88 immunocompromised patients, along with clinical and epidemiological data.  Most of these samples were collected in France during the current decade by the Toxoplasma Biological Resource Center.  Lack of specific anti-Toxoplasma treatment, pulmonary toxoplasmosis, and involvement of multiple organs were the 3 main risk factors associated with death for this patient group.  Genotyping results with 6 microsatellite markers showed that type II isolates were predominant among patients who acquired toxoplasmic infection in Europe.  Non-type II isolates included 13 different genotypes and were mainly collected from patients who acquired toxoplasmosis outside Europe.  Type III was the second most common genotype recovered from patients, whereas type I was rare in our population.  Three nonarchetypal genotypes were repeatedly recovered from different patients who acquired the infection in sub-Saharan Africa (genotypes Africa 1 and Africa 2) and in the French West Indies (genotype Caribbean 1).  The distribution of genotypes (type II vs. non-type II) was not significantly different when patients were stratified by underlying cause of immunosuppression, site of infection, or outcome.  We conclude that in immunocompromised patients, host factors are much more involved than parasite factors in patients' resistance or susceptibility to toxoplasmosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQx3qNeinzn-jQLBVDQn4bCfW6udTcc2eaEqNjlJqBFtbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MzhtFyhug%253D%253D&md5=a37b8c1ca627e6a35aedc353a4ba9130</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1086%2F597477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F597477%26sid%3Dliteratum%253Aachs%26aulast%3DAjzenberg%26aufirst%3DD.%26aulast%3DYera%26aufirst%3DH.%26aulast%3DMarty%26aufirst%3DP.%26aulast%3DParis%26aufirst%3DL.%26aulast%3DDalle%26aufirst%3DF.%26aulast%3DMenotti%26aufirst%3DJ.%26aulast%3DAubert%26aufirst%3DD.%26aulast%3DFranck%26aufirst%3DJ.%26aulast%3DBessieres%26aufirst%3DM.%2BH.%26aulast%3DQuinio%26aufirst%3DD.%26aulast%3DPelloux%26aufirst%3DH.%26aulast%3DDelhaes%26aufirst%3DL.%26aulast%3DDesbois%26aufirst%3DN.%26aulast%3DThulliez%26aufirst%3DP.%26aulast%3DRobert-Gangneux%26aufirst%3DF.%26aulast%3DKauffmann-Lacroix%26aufirst%3DC.%26aulast%3DPujol%26aufirst%3DS.%26aulast%3DRabodonirina%26aufirst%3DM.%26aulast%3DBougnoux%26aufirst%3DM.%2BE.%26aulast%3DCuisenier%26aufirst%3DB.%26aulast%3DDuhamel%26aufirst%3DC.%26aulast%3DDuong%26aufirst%3DT.%2BH.%26aulast%3DFilisetti%26aufirst%3DD.%26aulast%3DFlori%26aufirst%3DP.%26aulast%3DGay-Andrieu%26aufirst%3DF.%26aulast%3DPratlong%26aufirst%3DF.%26aulast%3DNevez%26aufirst%3DG.%26aulast%3DTotet%26aufirst%3DA.%26aulast%3DCarme%26aufirst%3DB.%26aulast%3DBonnabau%26aufirst%3DH.%26aulast%3DDarde%26aufirst%3DM.%2BL.%26aulast%3DVillena%26aufirst%3DI.%26atitle%3DGenotype%2520of%252088%2520Toxoplasma%2520gondii%2520isolates%2520associated%2520with%2520toxoplasmosis%2520in%2520immunocompromised%2520patients%2520and%2520correlation%2520with%2520clinical%2520findings%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2009%26volume%3D199%26issue%3D8%26spage%3D1155%26epage%3D1167%26doi%3D10.1086%2F597477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howe, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title"><i>Toxoplasma gondii</i> comprises three clonal lineages: correlation of parasite genotype with human disease</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">1561</span>– <span class="NLM_lpage">1566</span>, <span class="refDoi"> DOI: 10.1093/infdis/172.6.1561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1093%2Finfdis%2F172.6.1561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=7594717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADyaK28%252FotlGjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=1995&pages=1561-1566&author=D.+K.+Howeauthor=L.+D.+Sibley&title=Toxoplasma+gondii+comprises+three+clonal+lineages%3A+correlation+of+parasite+genotype+with+human+disease&doi=10.1093%2Finfdis%2F172.6.1561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease</span></div><div class="casAuthors">Howe D K; Sibley L D</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infectious diseases</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1561-6</span>
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    </div><div class="casAbstract">The population genetic structure of Toxoplasma gondii was determined by multilocus restriction fragment length polymorphism analysis at 6 loci in 106 independent isolates from humans and animals.  Phylogenetic and statistical analyses indicated a highly unusual population structure consisting of 3 widespread clonal lineages.  Extensively mixed genotypes were only apparent in 4 strains, which indicated that, while not separate species, sexual recombination between the 3 lineages is exceedingly rare in natural populations.  T. gondii is a major cause of subclinical human infection and an important opportunistic pathogen that causes severe disease in immunocompromised patients.  While strains from all 3 lineages were isolated from humans, the majority of human toxoplasmosis cases were associated with strains of a type II genotype.  The correlation of specific clonal lineages with human toxoplasmosis has important implications for development of vaccines, drug treatments, and diagnostic protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTdtB05sEuTX-_Q9URG6Dx8fW6udTcc2eaEqNjlJqBFtbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28%252FotlGjsA%253D%253D&md5=fe655a0dbdc9e106a2bce542500ce0e3</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2F172.6.1561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252F172.6.1561%26sid%3Dliteratum%253Aachs%26aulast%3DHowe%26aufirst%3DD.%2BK.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DToxoplasma%2520gondii%2520comprises%2520three%2520clonal%2520lineages%253A%2520correlation%2520of%2520parasite%2520genotype%2520with%2520human%2520disease%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D1995%26volume%3D172%26spage%3D1561%26epage%3D1566%26doi%3D10.1093%2Finfdis%2F172.6.1561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lunde, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, L.</span></span> <span> </span><span class="NLM_article-title">Antigenic differences between endozoites and cystozoites of <i>Toxoplasma gondii</i></span>. <i>J. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">806</span>– <span class="NLM_lpage">808</span>, <span class="refDoi"> DOI: 10.2307/3281034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.2307%2F3281034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=6200590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADyaL2c7msVarsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1983&pages=806-808&author=M.+N.+Lundeauthor=L.+Jacobs&title=Antigenic+differences+between+endozoites+and+cystozoites+of+Toxoplasma+gondii&doi=10.2307%2F3281034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Antigenic differences between endozoites and cystozoites of Toxoplasma gondii</span></div><div class="casAuthors">Lunde M N; Jacobs L</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of parasitology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">806-8</span>
        ISSN:<span class="NLM_cas:issn">0022-3395</span>.
    </div><div class="casAbstract">Antigenic differences between the cystozoite and endozoite of Toxoplasma gondii were found using fluorescent antibody staining.  Antisera against the cystozoite reacted against only the cystozoite, whereas antisera against the endozoite reacted against both endozoite and cystozoite.  Absorption of sera with endozoites removed only positive reactions with endozoites.  These findings are the first to suggest antigenic differences between these two forms of Toxoplasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkJyg42hFwwRfKb6ELK8t0fW6udTcc2eZmt2z9flmdDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c7msVarsQ%253D%253D&md5=1bc470913334c054345ae8ef48f4b683</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.2307%2F3281034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2307%252F3281034%26sid%3Dliteratum%253Aachs%26aulast%3DLunde%26aufirst%3DM.%2BN.%26aulast%3DJacobs%26aufirst%3DL.%26atitle%3DAntigenic%2520differences%2520between%2520endozoites%2520and%2520cystozoites%2520of%2520Toxoplasma%2520gondii%26jtitle%3DJ.%2520Parasitol.%26date%3D1983%26volume%3D69%26spage%3D806%26epage%3D808%26doi%3D10.2307%2F3281034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howe, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>172</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1561</span>– <span class="NLM_lpage">1566</span>, <span class="refDoi"> DOI: 10.1093/infdis/172.6.1561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1093%2Finfdis%2F172.6.1561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=7594717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADyaK28%252FotlGjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=1995&pages=1561-1566&issue=6&author=D.+K.+Howeauthor=L.+D.+Sibley&title=Toxoplasma+gondii+comprises+three+clonal+lineages%3A+correlation+of+parasite+genotype+with+human+disease&doi=10.1093%2Finfdis%2F172.6.1561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease</span></div><div class="casAuthors">Howe D K; Sibley L D</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infectious diseases</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1561-6</span>
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    </div><div class="casAbstract">The population genetic structure of Toxoplasma gondii was determined by multilocus restriction fragment length polymorphism analysis at 6 loci in 106 independent isolates from humans and animals.  Phylogenetic and statistical analyses indicated a highly unusual population structure consisting of 3 widespread clonal lineages.  Extensively mixed genotypes were only apparent in 4 strains, which indicated that, while not separate species, sexual recombination between the 3 lineages is exceedingly rare in natural populations.  T. gondii is a major cause of subclinical human infection and an important opportunistic pathogen that causes severe disease in immunocompromised patients.  While strains from all 3 lineages were isolated from humans, the majority of human toxoplasmosis cases were associated with strains of a type II genotype.  The correlation of specific clonal lineages with human toxoplasmosis has important implications for development of vaccines, drug treatments, and diagnostic protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTdtB05sEuTX-_Q9URG6Dx8fW6udTcc2eZmt2z9flmdDbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28%252FotlGjsA%253D%253D&md5=fe655a0dbdc9e106a2bce542500ce0e3</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2F172.6.1561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252F172.6.1561%26sid%3Dliteratum%253Aachs%26aulast%3DHowe%26aufirst%3DD.%2BK.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DToxoplasma%2520gondii%2520comprises%2520three%2520clonal%2520lineages%253A%2520correlation%2520of%2520parasite%2520genotype%2520with%2520human%2520disease%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D1995%26volume%3D172%26issue%3D6%26spage%3D1561%26epage%3D1566%26doi%3D10.1093%2Finfdis%2F172.6.1561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">German, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storch, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifford, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Genotyping of <i>Toxoplasma gondii</i> strains from immunocompromised patients reveals high prevalence of type I strains</span>. <i>J. Clin. Micro.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">5881</span>– <span class="NLM_lpage">5887</span>, <span class="refDoi"> DOI: 10.1128/JCM.43.12.5881-5887.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1128%2FJCM.43.12.5881-5887.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=16333071" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2005&pages=5881-5887&author=A.+Khanauthor=C.+Suauthor=M.+Germanauthor=G.+A.+Storchauthor=D.+Cliffordauthor=L.+D.+Sibley&title=Genotyping+of+Toxoplasma+gondii+strains+from+immunocompromised+patients+reveals+high+prevalence+of+type+I+strains&doi=10.1128%2FJCM.43.12.5881-5887.2005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1128%2FJCM.43.12.5881-5887.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJCM.43.12.5881-5887.2005%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DC.%26aulast%3DGerman%26aufirst%3DM.%26aulast%3DStorch%26aufirst%3DG.%2BA.%26aulast%3DClifford%26aufirst%3DD.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DGenotyping%2520of%2520Toxoplasma%2520gondii%2520strains%2520from%2520immunocompromised%2520patients%2520reveals%2520high%2520prevalence%2520of%2520type%2520I%2520strains%26jtitle%3DJ.%2520Clin.%2520Micro.%26date%3D2005%26volume%3D43%26spage%3D5881%26epage%3D5887%26doi%3D10.1128%2FJCM.43.12.5881-5887.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajioka, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Identification of quantitative trait loci controlling acute virulence in <i>Toxoplasma gondii</i></span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">10753</span>– <span class="NLM_lpage">10758</span>, <span class="refDoi"> DOI: 10.1073/pnas.172117099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1073%2Fpnas.172117099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=12149482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmt1Cht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=10753-10758&author=C.+Suauthor=D.+K.+Howeauthor=J.+P.+Dubeyauthor=J.+W.+Ajiokaauthor=L.+D.+Sibley&title=Identification+of+quantitative+trait+loci+controlling+acute+virulence+in+Toxoplasma+gondii&doi=10.1073%2Fpnas.172117099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of quantitative trait loci controlling acute virulence in Toxoplasma gondii</span></div><div class="casAuthors">Su, Chunlei; Howe, Daniel K.; Dubey, J. P.; Ajioka, James W.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">10753-10758</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Strains of Toxoplasma gondii can be grouped into three predominant clonal lineages with members of the type I group being uniformly lethal in mice.  To elucidate the basis of this extreme virulence, a genetic cross was performed between a highly virulent type I strain (GT-1) and a less-virulent type III strain (CTG), and the phenotypes of resulting progeny were analyzed by genetic linkage mapping.  Anal. of independent recombinant progeny identified several quant. trait loci that contributed to acute virulence.  A major quant. trait locus located on chromosome VII accounted for ≈50% of the virulence phenotype, whereas a minor locus on chromosome IV, linked to the ROP1 gene, accounted for ≈10%.  These loci are conserved in other type I strains, indicating that acute virulence is controlled by discrete genes common to the type I lineage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaGd1mv6I_YbVg90H21EOLACvtfcHk0lh091AmEIFbtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmt1Cht7o%253D&md5=7677a36353d5f0e37eab2cb01a8fee1a</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1073%2Fpnas.172117099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.172117099%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DC.%26aulast%3DHowe%26aufirst%3DD.%2BK.%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26aulast%3DAjioka%26aufirst%3DJ.%2BW.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DIdentification%2520of%2520quantitative%2520trait%2520loci%2520controlling%2520acute%2520virulence%2520in%2520Toxoplasma%2520gondii%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D10753%26epage%3D10758%26doi%3D10.1073%2Fpnas.172117099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J.</span></span> <span> </span><span class="NLM_article-title">Mouse pathogenicity of <i>Toxoplasma gondii</i> isolated from a goat</span>. <i>Am. J. Vet. Res.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">427</span>– <span class="NLM_lpage">429</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=7369619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADyaL3c7ntlGhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1980&pages=427-429&author=J.+Dubey&title=Mouse+pathogenicity+of+Toxoplasma+gondii+isolated+from+a+goat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse pathogenicity of Toxoplasma gondii isolated from a goat</span></div><div class="casAuthors">Dubey J P</div><div class="citationInfo"><span class="NLM_cas:title">American journal of veterinary research</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">427-9</span>
        ISSN:<span class="NLM_cas:issn">0002-9645</span>.
    </div><div class="casAbstract">Characteristics of Toxoplasma gondii (strain GT-1) isolated from skeletal muscle of a goat are described.  One oocyst, bradyzoite, or tachyzoite of GT-1 strain was lethal to mice.  Toxoplasma tachyzoites were found in the peritoneal exudates and in the lungs 9 to 34 days after infection in mice inoculated intraperitoneally with tissues infected with strain GT-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRLrZmF67bwaOWhZTslLrfffW6udTcc2eaoVPHPWUNn2Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3c7ntlGhug%253D%253D&md5=ec23263931c938fe8e560c677d5ff357</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDubey%26aufirst%3DJ.%26atitle%3DMouse%2520pathogenicity%2520of%2520Toxoplasma%2520gondii%2520isolated%2520from%2520a%2520goat%26jtitle%3DAm.%2520J.%2520Vet.%2520Res.%26date%3D1980%26volume%3D41%26spage%3D427%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carme, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bissuel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajzenberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouyne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aznar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bichat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louvel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourbigot, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peneau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neron, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dardé, M. L.</span></span> <span> </span><span class="NLM_article-title">Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana</span>. <i>J. Clin. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">4037</span>– <span class="NLM_lpage">4044</span>, <span class="refDoi"> DOI: 10.1128/JCM.40.11.4037-4044.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1128%2FJCM.40.11.4037-4044.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=12409371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADC%252BD38nmsFKlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2002&pages=4037-4044&author=B.+Carmeauthor=F.+Bissuelauthor=D.+Ajzenbergauthor=R.+Bouyneauthor=C.+Aznarauthor=M.+Demarauthor=S.+Bichatauthor=D.+Louvelauthor=A.+M.+Bourbigotauthor=C.+Peneauauthor=P.+Neronauthor=M.+L.+Dard%C3%A9&title=Severe+acquired+toxoplasmosis+in+immunocompetent+adult+patients+in+French+Guiana&doi=10.1128%2FJCM.40.11.4037-4044.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana</span></div><div class="casAuthors">Carme B; Bissuel F; Ajzenberg D; Bouyne R; Aznar C; Demar M; Bichat S; Louvel D; Bourbigot A M; Peneau C; Neron P; Darde M L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical microbiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4037-44</span>
        ISSN:<span class="NLM_cas:issn">0095-1137</span>.
    </div><div class="casAbstract">The most common presentation of symptomatic postnatally acquired toxoplasmosis in immunocompetent patients is painless cervical adenopathy.  Acute visceral manifestations are associated in rare cases.  We report 16 cases of severe primary toxoplasmosis diagnosed in French Guiana during a 6.5-year period.  All of the subjects were immunocompetent adults hospitalized with clinical presentations consisting of a marked, nonspecific infectious syndrome accompanied by an altered general status with at least one visceral localization, mainly pulmonary involvement (14 cases).  Acute toxoplasmosis was diagnosed according to the results of serological tests suggestive of recent primary infection and the absence of an alternative etiology.  Recovery was rapid following specific antitoxoplasmosis treatment.  Thirteen of the 16 patients had consumed game in the 2 weeks before the onset of the symptoms, and in eight cases the game was considered to have been undercooked.  Toxoplasma strains, which were virulent in mice, were isolated from three patients.  Microsatellite analysis showed that all of these isolates exhibited an atypical multilocus genotype, with one allele found only for isolates of this region.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTK0ykmjz3kRLBItaL1WaVAfW6udTcc2eax45BwRNE6kbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38nmsFKlsg%253D%253D&md5=c7c291e85f4f80e296f30e5c9de762fc</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1128%2FJCM.40.11.4037-4044.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJCM.40.11.4037-4044.2002%26sid%3Dliteratum%253Aachs%26aulast%3DCarme%26aufirst%3DB.%26aulast%3DBissuel%26aufirst%3DF.%26aulast%3DAjzenberg%26aufirst%3DD.%26aulast%3DBouyne%26aufirst%3DR.%26aulast%3DAznar%26aufirst%3DC.%26aulast%3DDemar%26aufirst%3DM.%26aulast%3DBichat%26aufirst%3DS.%26aulast%3DLouvel%26aufirst%3DD.%26aulast%3DBourbigot%26aufirst%3DA.%2BM.%26aulast%3DPeneau%26aufirst%3DC.%26aulast%3DNeron%26aufirst%3DP.%26aulast%3DDard%25C3%25A9%26aufirst%3DM.%2BL.%26atitle%3DSevere%2520acquired%2520toxoplasmosis%2520in%2520immunocompetent%2520adult%2520patients%2520in%2520French%2520Guiana%26jtitle%3DJ.%2520Clin.%2520Microbiol.%26date%3D2002%26volume%3D40%26spage%3D4037%26epage%3D4044%26doi%3D10.1128%2FJCM.40.11.4037-4044.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Demar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djossou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peneau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boukhari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louvel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourbigot, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasser, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajzenberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darde, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carme, B.</span></span> <span> </span><span class="NLM_article-title">Acute toxoplasmoses in immunocompetent patients hospitalized in an intensive care unit in French Guiana</span>. <i>Clin. Microbiol. Infect.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">E221</span>– <span class="NLM_lpage">E231</span>, <span class="refDoi"> DOI: 10.1111/j.1469-0691.2011.03648.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1111%2Fj.1469-0691.2011.03648.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=21958195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOhtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=E221-E231&issue=7&author=M.+Demarauthor=D.+Hommelauthor=F.+Djossouauthor=C.+Peneauauthor=R.+Boukhariauthor=D.+Louvelauthor=A.+M.+Bourbigotauthor=V.+Nasserauthor=D.+Ajzenbergauthor=M.+L.+Dardeauthor=B.+Carme&title=Acute+toxoplasmoses+in+immunocompetent+patients+hospitalized+in+an+intensive+care+unit+in+French+Guiana&doi=10.1111%2Fj.1469-0691.2011.03648.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Acute toxoplasmoses in immunocompetent patients hospitalized in an intensive care unit in French Guiana</span></div><div class="casAuthors">Demar, M.; Hommel, D.; Djossou, F.; Peneau, C.; Boukhari, R.; Louvel, D.; Bourbigot, A.-M.; Nasser, V.; Ajzenberg, D.; Darde, M.-L.; Carme, B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology and Infection</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">E221-E231</span>CODEN:
                <span class="NLM_cas:coden">CMINFM</span>;
        ISSN:<span class="NLM_cas:issn">1198-743X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Atypical Toxoplasma gondii strains, unrelated to archetypal clonal lineages (I, II, III), have been reported more frequently over the last decade in areas other than Europe and North America.  A newly described form of toxoplasmosis, 'Amazonian toxoplasmosis' (AT), has been reported since 2002 in French Guiana.  It is characterized by severe cases and atypical strains linked to a neotropical forest-based cycle.  We report on the cases of AT that required intensive care management.  We performed a prospective observational study on hospitalized adults in the Intensive Care Unit (ICU) from 2002 to 2008.  Clin. and lab. data, microbiol. findings and outcomes were recorded.  Data, including the ICU simplified acute physiol. score and the pneumonia severity index, were calcd.  Epidemiol. risk factors for AT were assessed through questionnaires.  Eleven non-immunodeficient patients were admitted to the ICU in Cayenne for life-threatening pneumonia assocd. with disseminated toxoplasmosis.  Mech. ventilation was necessary in seven patients, four of whom required immediate orotracheal intubation.  Cardiac and ophthalmol. abnormalities were found in five and four patients, resp.  One patient died from multiple organ failure.  The genetic characterization of Toxoplasma DNA using six microsatellite markers revealed unique and atypical genotypes in eight patients.  All patients presented epidemiol. risk factors for AT.  In French Guiana, significant T. gondii-related infectious syndrome assocd. with the lungs, a high level of LDH activity and the reported risk factors for AT was strongly suggestive of disseminated toxoplasmosis with a possible trend toward life-threatening pneumonia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplzR3IgTJ7GrVg90H21EOLACvtfcHk0lj4k24lSzl-qA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOhtrvP&md5=70cb03dd2f6ddc9900ef5b1833d4224e</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1111%2Fj.1469-0691.2011.03648.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1469-0691.2011.03648.x%26sid%3Dliteratum%253Aachs%26aulast%3DDemar%26aufirst%3DM.%26aulast%3DHommel%26aufirst%3DD.%26aulast%3DDjossou%26aufirst%3DF.%26aulast%3DPeneau%26aufirst%3DC.%26aulast%3DBoukhari%26aufirst%3DR.%26aulast%3DLouvel%26aufirst%3DD.%26aulast%3DBourbigot%26aufirst%3DA.%2BM.%26aulast%3DNasser%26aufirst%3DV.%26aulast%3DAjzenberg%26aufirst%3DD.%26aulast%3DDarde%26aufirst%3DM.%2BL.%26aulast%3DCarme%26aufirst%3DB.%26atitle%3DAcute%2520toxoplasmoses%2520in%2520immunocompetent%2520patients%2520hospitalized%2520in%2520an%2520intensive%2520care%2520unit%2520in%2520French%2520Guiana%26jtitle%3DClin.%2520Microbiol.%2520Infect.%26date%3D2012%26volume%3D18%26issue%3D7%26spage%3DE221%26epage%3DE231%26doi%3D10.1111%2Fj.1469-0691.2011.03648.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behnke, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namasivayam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swapna, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadjithomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karamycheva, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunk, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajioka, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajzenberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothroyd, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darde, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Miranda, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gennari, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeij, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grigg, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kissinger, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roos, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Local admixture of amplified and diversified secreted pathogenesis determinants shapes mosaic Toxoplasma gondii genomes</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">10147</span>, <span class="refDoi"> DOI: 10.1038/ncomms10147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1038%2Fncomms10147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=26738725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC28XltFOrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=10147&author=H.+Lorenziauthor=A.+Khanauthor=M.+S.+Behnkeauthor=S.+Namasivayamauthor=L.+S.+Swapnaauthor=M.+Hadjithomasauthor=S.+Karamychevaauthor=D.+Pinneyauthor=B.+P.+Brunkauthor=J.+W.+Ajiokaauthor=D.+Ajzenbergauthor=J.+C.+Boothroydauthor=J.+P.+Boyleauthor=M.+L.+Dardeauthor=M.+A.+Diaz-Mirandaauthor=J.+P.+Dubeyauthor=H.+M.+Fritzauthor=S.+M.+Gennariauthor=B.+D.+Gregoryauthor=K.+Kimauthor=J.+P.+Saeijauthor=C.+Suauthor=M.+W.+Whiteauthor=X.+Q.+Zhuauthor=D.+K.+Howeauthor=B.+M.+Rosenthalauthor=M.+E.+Griggauthor=J.+Parkinsonauthor=L.+Liuauthor=J.+C.+Kissingerauthor=D.+S.+Roosauthor=L.+D.+Sibley&title=Local+admixture+of+amplified+and+diversified+secreted+pathogenesis+determinants+shapes+mosaic+Toxoplasma+gondii+genomes&doi=10.1038%2Fncomms10147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Local admixture of amplified and diversified secreted pathogenesis determinants shapes mosaic Toxoplasma gondii genomes</span></div><div class="casAuthors">Lorenzi, Hernan; Khan, Asis; Behnke, Michael S.; Namasivayam, Sivaranjani; Swapna, Lakshmipuram S.; Hadjithomas, Michalis; Karamycheva, Svetlana; Pinney, Deborah; Brunk, Brian P.; Ajioka, James W.; Ajzenberg, Daniel; Boothroyd, John C.; Boyle, Jon P.; Darde, Marie L.; Diaz-Miranda, Maria A.; Dubey, Jitender P.; Fritz, Heather M.; Gennari, Solange M.; Gregory, Brian D.; Kim, Kami; Saeij, Jeroen P. J.; Su, Chunlei; White, Michael W.; Zhu, Xing-Quan; Howe, Daniel K.; Rosenthal, Benjamin M.; Grigg, Michael E.; Parkinson, John; Liu, Liang; Kissinger, Jessica C.; Roos, David S.; David Sibley, L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10147</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Toxoplasma gondii is among the most prevalent parasites worldwide, infecting many wild and domestic animals and causing zoonotic infections in humans.  T. gondii differs substantially in its broad distribution from closely related parasites that typically have narrow, specialized host ranges.  To elucidate the genetic basis for these differences, we compared the genomes of 62 globally distributed T. gondii isolates to several closely related coccidian parasites.  Our findings reveal that tandem amplification and diversification of secretory pathogenesis determinants is the primary feature that distinguishes the closely related genomes of these biol. diverse parasites.  We further show that the unusual population structure of T. gondii is characterized by clade-specific inheritance of large conserved haploblocks that are significantly enriched in tandemly clustered secretory pathogenesis determinants.  The shared inheritance of these conserved haploblocks, which show a different ancestry than the genome as a whole, may thus influence transmission, host range, and pathogenicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdDKqaMZXy87Vg90H21EOLACvtfcHk0liPF74V4IHWtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltFOrsw%253D%253D&md5=1952e8e223c43abfde12aa2f61a64cf3</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fncomms10147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms10147%26sid%3Dliteratum%253Aachs%26aulast%3DLorenzi%26aufirst%3DH.%26aulast%3DKhan%26aufirst%3DA.%26aulast%3DBehnke%26aufirst%3DM.%2BS.%26aulast%3DNamasivayam%26aufirst%3DS.%26aulast%3DSwapna%26aufirst%3DL.%2BS.%26aulast%3DHadjithomas%26aufirst%3DM.%26aulast%3DKaramycheva%26aufirst%3DS.%26aulast%3DPinney%26aufirst%3DD.%26aulast%3DBrunk%26aufirst%3DB.%2BP.%26aulast%3DAjioka%26aufirst%3DJ.%2BW.%26aulast%3DAjzenberg%26aufirst%3DD.%26aulast%3DBoothroyd%26aufirst%3DJ.%2BC.%26aulast%3DBoyle%26aufirst%3DJ.%2BP.%26aulast%3DDarde%26aufirst%3DM.%2BL.%26aulast%3DDiaz-Miranda%26aufirst%3DM.%2BA.%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26aulast%3DFritz%26aufirst%3DH.%2BM.%26aulast%3DGennari%26aufirst%3DS.%2BM.%26aulast%3DGregory%26aufirst%3DB.%2BD.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DSaeij%26aufirst%3DJ.%2BP.%26aulast%3DSu%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DM.%2BW.%26aulast%3DZhu%26aufirst%3DX.%2BQ.%26aulast%3DHowe%26aufirst%3DD.%2BK.%26aulast%3DRosenthal%26aufirst%3DB.%2BM.%26aulast%3DGrigg%26aufirst%3DM.%2BE.%26aulast%3DParkinson%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DKissinger%26aufirst%3DJ.%2BC.%26aulast%3DRoos%26aufirst%3DD.%2BS.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DLocal%2520admixture%2520of%2520amplified%2520and%2520diversified%2520secreted%2520pathogenesis%2520determinants%2520shapes%2520mosaic%2520Toxoplasma%2520gondii%2520genomes%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D10147%26doi%3D10.1038%2Fncomms10147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roos, D. S.</span></span> <span> </span><span class="NLM_article-title">A biochemical and genetic model for parasite resistance to antifolates. Toxoplasma gondii provides insights into pyrimethamine and cycloguanil resistance in Plasmodium falciparum</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>273</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">3461</span>– <span class="NLM_lpage">3469</span>, <span class="refDoi"> DOI: 10.1074/jbc.273.6.3461</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1074%2Fjbc.273.6.3461" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=3461-3469&issue=6&author=M.+G.+Reynoldsauthor=D.+S.+Roos&title=A+biochemical+and+genetic+model+for+parasite+resistance+to+antifolates.+Toxoplasma+gondii+provides+insights+into+pyrimethamine+and+cycloguanil+resistance+in+Plasmodium+falciparum&doi=10.1074%2Fjbc.273.6.3461"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.6.3461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.6.3461%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DM.%2BG.%26aulast%3DRoos%26aufirst%3DD.%2BS.%26atitle%3DA%2520biochemical%2520and%2520genetic%2520model%2520for%2520parasite%2520resistance%2520to%2520antifolates.%2520Toxoplasma%2520gondii%2520provides%2520insights%2520into%2520pyrimethamine%2520and%2520cycloguanil%2520resistance%2520in%2520Plasmodium%2520falciparum%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26issue%3D6%26spage%3D3461%26epage%3D3469%26doi%3D10.1074%2Fjbc.273.6.3461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Behnke, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fentress, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mashayekhi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">The polymorphic pseudokinase ROP5 controls virulence in <i>Toxoplasma gondii</i> by regulating the active kinase ROP18</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e1002992</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1002992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1371%2Fjournal.ppat.1002992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=23144612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCis7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&author=M.+S.+Behnkeauthor=S.+J.+Fentressauthor=M.+Mashayekhiauthor=L.+L.+Liauthor=G.+A.+Taylorauthor=L.+D.+Sibley&title=The+polymorphic+pseudokinase+ROP5+controls+virulence+in+Toxoplasma+gondii+by+regulating+the+active+kinase+ROP18&doi=10.1371%2Fjournal.ppat.1002992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The polymorphic pseudokinase ROP5 controls virulence in Toxoplasma gondii by regulating the active kinase ROP18</span></div><div class="casAuthors">Behnke, Michael S.; Fentress, Sarah J.; Mashayekhi, Mona; Li, Lucy X.; Taylor, Gregory A.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e1002992</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Secretory polymorphic serine/threonine kinases control pathogenesis of Toxoplasma gondii in the mouse.  Genetic studies show that the pseudokinase ROP5 is essential for acute virulence, but do not reveal its mechanism of action.  Here we demonstrate that ROP5 controls virulence by blocking IFN-γ mediated clearance in activated macrophages.  ROP5 was required for the catalytic activity of the active S/T kinase ROP18, which phosphorylates host immunity related GTPases (IRGs) and protects the parasite from clearance.  ROP5 directly regulated activity of ROP18 in vitro, and both proteins were necessary to avoid IRG recruitment and clearance in macrophages.  Clearance of both the Δrop5 and Δrop18 mutants was reversed in macrophages lacking Irgm3, which is required for IRG function, and the virulence defect was fully restored in Irgm3-/- mice.  Our findings establish that the pseudokinase ROP5 controls the activity of ROP18, thereby blocking IRG mediated clearance in macrophages.  Addnl., ROP5 has other functions that are also Irgm3 and IFN-γ dependent, indicting it plays a general role in governing virulence factors that block immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovOrvMpFAA67Vg90H21EOLACvtfcHk0lhhcXT4smqmTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCis7vP&md5=4600462dbd8bc9d56720b8af2a92354b</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1002992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1002992%26sid%3Dliteratum%253Aachs%26aulast%3DBehnke%26aufirst%3DM.%2BS.%26aulast%3DFentress%26aufirst%3DS.%2BJ.%26aulast%3DMashayekhi%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DL.%2BL.%26aulast%3DTaylor%26aufirst%3DG.%2BA.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DThe%2520polymorphic%2520pseudokinase%2520ROP5%2520controls%2520virulence%2520in%2520Toxoplasma%2520gondii%2520by%2520regulating%2520the%2520active%2520kinase%2520ROP18%26jtitle%3DPLoS%2520Pathog.%26date%3D2012%26volume%3D8%26doi%3D10.1371%2Fjournal.ppat.1002992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arribas, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Diego, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamallo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, J. J.</span></span> <span> </span><span class="NLM_article-title">A new murine model of severe acute toxoplasma encephalitis</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">503</span>– <span class="NLM_lpage">513</span>, <span class="refDoi"> DOI: 10.1093/jac/36.3.503</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1093%2Fjac%2F36.3.503" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=8830014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADyaK2MXosFyit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=503-513&issue=3&author=J.+R.+Arribasauthor=J.+A.+de+Diegoauthor=C.+Gamalloauthor=J.+J.+Vazquez&title=A+new+murine+model+of+severe+acute+toxoplasma+encephalitis&doi=10.1093%2Fjac%2F36.3.503"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">A new murine model of severe acute toxoplasma encephalitis</span></div><div class="casAuthors">Arribas, Jose Ramon; de Diego, Jose Antonio; Gamallo, Carlos; Vazquez, Juan Jose</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">503-12</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Saunders</span>)
        </div><div class="casAbstract">The authors have developed a new murine model of toxoplasmic encephalitis based on the intracerebral inoculation of tachyzoites of the highly virulent RH strain of Toxoplasma gondii.  Intracerebral infection resulted in a mortality of 100% on day five.  Large inflammatory abscessed infiltrates developed by the second day after inoculation and expanded throughout the remaining period of observation.  Numerous tachyzoites were detectable in brain parenchyma by the second day of infection.  The marked and precocious histopathol. brain lesions produced by the RH strain are useful to detect therapeutic rather than prophylactic effects of drugs against toxoplasmic encephalitis.  In this model pyrimethamine, sulfadiazine and its combination were useful in terms of mortality, histopathol. and spread of infection whereas clindamycin showed no activity.  This murine model of toxoplasmic encephalitis is useful to evaluate antitoxoplasma agents with high therapeutic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgJiBB1skBSbVg90H21EOLACvtfcHk0lhhcXT4smqmTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXosFyit7s%253D&md5=0228d2d6edfca9548a4afdf36c69af93</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F36.3.503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F36.3.503%26sid%3Dliteratum%253Aachs%26aulast%3DArribas%26aufirst%3DJ.%2BR.%26aulast%3Dde%2BDiego%26aufirst%3DJ.%2BA.%26aulast%3DGamallo%26aufirst%3DC.%26aulast%3DVazquez%26aufirst%3DJ.%2BJ.%26atitle%3DA%2520new%2520murine%2520model%2520of%2520severe%2520acute%2520toxoplasma%2520encephalitis%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D1995%26volume%3D36%26issue%3D3%26spage%3D503%26epage%3D513%26doi%3D10.1093%2Fjac%2F36.3.503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martins-Duarte, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Souza, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vommaro, R. C.</span></span> <span> </span><span class="NLM_article-title">Toxoplasma gondii: The effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model</span>. <i>Exp. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>133</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">294</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1016/j.exppara.2012.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1016%2Fj.exppara.2012.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=23270807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC3sXislynuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2013&pages=294-299&issue=3&author=E.+S.+Martins-Duarteauthor=W.+de+Souzaauthor=R.+C.+Vommaro&title=Toxoplasma+gondii%3A+The+effect+of+fluconazole+combined+with+sulfadiazine+and+pyrimethamine+against+acute+toxoplasmosis+in+murine+model&doi=10.1016%2Fj.exppara.2012.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasma gondii: The effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model</span></div><div class="casAuthors">Martins-Duarte, Erica S.; de Souza, Wanderley; Vommaro, Rossiane C.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Parasitology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">294-299</span>CODEN:
                <span class="NLM_cas:coden">EXPAAA</span>;
        ISSN:<span class="NLM_cas:issn">0014-4894</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Toxoplasma gondii is an important opportunistic pathogen for immunocompromised patients and responsible for toxoplasmic encephalitis, which is often lethal.  Treatment for this infection is limited to a restricted therapeutic arsenal.  In this work we tested the combination of fluconazole with the current treatment for acute toxoplasmosis on the murine model in vivo.  Different exptl. groups were treated with combinations of sulfadiazine plus pyrimethamine with fluconazole and pyrimethamine with fluconazole.  Fluconazole is an important antifungal triazole used against others CNS related opportunistic pathogens such as Cryptococcus neoformans and Candida spp.  The combinations of fluconazole plus sulfadiazine and pyrimethamine or fluconazole plus pyrimethamine were remarkably effective against T. gondii in vivo.  The 10-day treatment with 10 mg/kg/day of fluconazole combined with 40/1 mg/kg/day sulfadiazine and pyrimethamine resulted in 93% survival of CF1 mice acutely infected with the highly virulent T. gondii RH strain, vs. 36% of mice treated with just sulfadiazine and pyrimethamine.  Combinations of fluconazole with lower doses of sulfadiazine and pyrimethamine or with just pyrimethamine were also efficient in reducing the mortality of mice compared with the treatment without fluconazole.  The results obtained are promising for the treatment of human toxoplasmosis and point to the need to extend these studies to other murine models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5uXjaEjQY_LVg90H21EOLACvtfcHk0lhhcXT4smqmTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXislynuro%253D&md5=49ecf69325804cef4da7fb4d10680e57</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.exppara.2012.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exppara.2012.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DMartins-Duarte%26aufirst%3DE.%2BS.%26aulast%3Dde%2BSouza%26aufirst%3DW.%26aulast%3DVommaro%26aufirst%3DR.%2BC.%26atitle%3DToxoplasma%2520gondii%253A%2520The%2520effect%2520of%2520fluconazole%2520combined%2520with%2520sulfadiazine%2520and%2520pyrimethamine%2520against%2520acute%2520toxoplasmosis%2520in%2520murine%2520model%26jtitle%3DExp.%2520Parasitol.%26date%3D2013%26volume%3D133%26issue%3D3%26spage%3D294%26epage%3D299%26doi%3D10.1016%2Fj.exppara.2012.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piketty, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derouin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouveix, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pocidalo, J. J.</span></span> <span> </span><span class="NLM_article-title">In vivo assessment of antimicrobial agents against toxoplasma gondii by quantification of parasites in the blood, lungs, and brain of infected mice</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1467</span>– <span class="NLM_lpage">1472</span>, <span class="refDoi"> DOI: 10.1128/AAC.34.8.1467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1128%2FAAC.34.8.1467" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1990&pages=1467-1472&issue=8&author=C.+Pikettyauthor=F.+Derouinauthor=B.+Rouveixauthor=J.+J.+Pocidalo&title=In+vivo+assessment+of+antimicrobial+agents+against+toxoplasma+gondii+by+quantification+of+parasites+in+the+blood%2C+lungs%2C+and+brain+of+infected+mice&doi=10.1128%2FAAC.34.8.1467"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1128%2FAAC.34.8.1467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.34.8.1467%26sid%3Dliteratum%253Aachs%26aulast%3DPiketty%26aufirst%3DC.%26aulast%3DDerouin%26aufirst%3DF.%26aulast%3DRouveix%26aufirst%3DB.%26aulast%3DPocidalo%26aufirst%3DJ.%2BJ.%26atitle%3DIn%2520vivo%2520assessment%2520of%2520antimicrobial%2520agents%2520against%2520toxoplasma%2520gondii%2520by%2520quantification%2520of%2520parasites%2520in%2520the%2520blood%252C%2520lungs%252C%2520and%2520brain%2520of%2520infected%2520mice%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1990%26volume%3D34%26issue%3D8%26spage%3D1467%26epage%3D1472%26doi%3D10.1128%2FAAC.34.8.1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafsat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.-W.</span></span> <span> </span><span class="NLM_article-title">High-throughput screening and sensitized bacteria identify an M. tuberculosis dihydrofolate reductase inhibitor with whole cell activity</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">6</span>), <span class="NLM_elocation-id">e39961</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0039961</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1371%2Fjournal.pone.0039961" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=22768185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVSks7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&issue=6&author=A.+Kumarauthor=M.+Zhangauthor=L.+Zhuauthor=R.+P.+Liaoauthor=C.+Mutaiauthor=S.+Hafsatauthor=D.+R.+Shermanauthor=M.-W.+Wang&title=High-throughput+screening+and+sensitized+bacteria+identify+an+M.+tuberculosis+dihydrofolate+reductase+inhibitor+with+whole+cell+activity&doi=10.1371%2Fjournal.pone.0039961"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput screening and sensitized bacteria identify an M. tuberculosis dihydrofolate reductase inhibitor with whole cell activity</span></div><div class="casAuthors">Kumar, Anuradha; Zhang, Meng; Zhu, Linyun; Liao, Reiling P.; Mutai, Charles; Hafsat, Shittu; Sherman, David R.; Wang, Ming-Wei</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e39961</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, is a bacterial pathogen that claims roughly 1.4 million lives every year.  Current drug regimens are inefficient at clearing infection, requiring at least 6 mo of chemotherapy, and resistance to existing agents is rising.  There is an urgent need for new drugs that are more effective and faster acting.  The folate pathway has been successfully targeted in other pathogens and diseases, but has not yielded a lead drug against tuberculosis.  We developed a high-throughput screening assay against Mtb dihydrofolate reductase (DHFR), a crit. enzyme in the folate pathway, and screened a library consisting of 32,000 synthetic and natural product-derived compds.  One potent inhibitor contg. a quinazoline ring was identified.  This compd. was active against the wild-type lab. strain H37Rv (MIC99 = 207 μM).  In addn., an Mtb strain with artificially lowered DHFR levels showed increased sensitivity to this compd. (MIC99 = 70.7 μM), supporting that the inhibition was target-specific.  Our results demonstrate the potential to identify Mtb DHFR inhibitors with activity against whole cells, and indicate the power of using a recombinant strain of Mtb expressing lower levels of DHFR to facilitate the discovery of antimycobacterial agents.  With these new tools, we highlight the folate pathway as a potential target for new drugs to combat the tuberculosis epidemic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-F4lNfuNzN7Vg90H21EOLACvtfcHk0lgyeA9Al-wSRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVSks7rF&md5=dba80990d912522046fb14b6ec98dd93</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0039961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0039961%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DLiao%26aufirst%3DR.%2BP.%26aulast%3DMutai%26aufirst%3DC.%26aulast%3DHafsat%26aufirst%3DS.%26aulast%3DSherman%26aufirst%3DD.%2BR.%26aulast%3DWang%26aufirst%3DM.-W.%26atitle%3DHigh-throughput%2520screening%2520and%2520sensitized%2520bacteria%2520identify%2520an%2520M.%2520tuberculosis%2520dihydrofolate%2520reductase%2520inhibitor%2520with%2520whole%2520cell%2520activity%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26issue%3D6%26doi%3D10.1371%2Fjournal.pone.0039961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lourido, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wildman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Optimizing small molecule inhibitors of calcium-dependent protein kinase 1 to prevent infection by <i>Toxoplasma gondii</i></span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3068</span>– <span class="NLM_lpage">3077</span>, <span class="refDoi"> DOI: 10.1021/jm4001314</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4001314" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslSgt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3068-3077&author=S.+Louridoauthor=C.+Zhangauthor=M.+S.+Lopezauthor=K.+Tangauthor=J.+Barksauthor=Q.+Wangauthor=S.+A.+Wildmanauthor=K.+M.+Shokatauthor=L.+D.+Sibley&title=Optimizing+small+molecule+inhibitors+of+calcium-dependent+protein+kinase+1+to+prevent+infection+by+Toxoplasma+gondii&doi=10.1021%2Fjm4001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing Small Molecule Inhibitors of Calcium-Dependent Protein Kinase 1 to Prevent Infection by Toxoplasma gondii</span></div><div class="casAuthors">Lourido, Sebastian; Zhang, Chao; Lopez, Michael S.; Tang, Keliang; Barks, Jennifer; Wang, Qiuling; Wildman, Scott A.; Shokat, Kevan M.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3068-3077</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Toxoplasma gondii is sensitive to bulky pyrazolo [3,4-d] pyrimidine (PP) inhibitors due to the presence of a Gly gatekeeper in the essential calcium dependent protein kinase 1 (CDPK1).  Here we synthesized a no. of new derivs. of 3-methyl-benzyl-PP (3-MB-PP, or 1).  The potency of PP analogs in inhibiting CDPK1 enzyme activity in vitro (low nM IC50 values) and blocking parasite growth in host cell monolayers in vivo (low μM EC50 values) were highly correlated and occurred in a CDPK1-specific manner.  Chem. modification of the PP scaffold to increase half-life in the presence of microsomes in vitro led to identification of compds. with enhanced stability while retaining activity.  Several of these more potent compds. were able to prevent lethal infection with T. gondii in the mouse model.  Collectively, the strategies outlined here provide a route for development of more effective compds. for treatment of toxoplasmosis and perhaps related parasitic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBcv37M-6fobVg90H21EOLACvtfcHk0ljoxNk-ZbFzJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslSgt78%253D&md5=352bb9e5b5304656aab52da763202b68</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm4001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4001314%26sid%3Dliteratum%253Aachs%26aulast%3DLourido%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLopez%26aufirst%3DM.%2BS.%26aulast%3DTang%26aufirst%3DK.%26aulast%3DBarks%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWildman%26aufirst%3DS.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DOptimizing%2520small%2520molecule%2520inhibitors%2520of%2520calcium-dependent%2520protein%2520kinase%25201%2520to%2520prevent%2520infection%2520by%2520Toxoplasma%2520gondii%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3068%26epage%3D3077%26doi%3D10.1021%2Fjm4001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tobin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoll, L. J.</span></span> <span> </span><span class="NLM_article-title">A patatin-like protein protects Toxoplasma gondii from degradation in a nitric oxide-dependent manner</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1128/IAI.05543-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1128%2FIAI.05543-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=22006568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC38XktlGitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=55-61&issue=1&author=C.+M.+Tobinauthor=L.+J.+Knoll&title=A+patatin-like+protein+protects+Toxoplasma+gondii+from+degradation+in+a+nitric+oxide-dependent+manner&doi=10.1128%2FIAI.05543-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">A patatin-like protein protects Toxoplasma gondii from degradation in a nitric oxide-dependent manner</span></div><div class="casAuthors">Tobin, Crystal M.; Knoll, Laura J.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-61</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Toxoplasma gondii is an obligate intracellular parasite that uses immune cells to disseminate throughout its host.  T. gondii can persist and even slowly replicate in activated host macrophages by reducing the antimicrobial effects of mols. such as nitric oxide (NO).  A T. gondii patatin-like protein called TgPL1 was previously shown to be important for survival in activated macrophages.  Here we show that a T. gondii mutant with a deletion of the TgPL1 gene (ΔTgPL1) is degraded in activated macrophages.  This degrdn. phenotype is abolished by the removal of NO by the use of an inducible NO synthase (iNOS) inhibitor or iNOS-deficient macrophages.  The exogenous addn. of NO to macrophages results in reduced parasite growth but not the degrdn. of ΔTgPL1 parasites.  These results suggest that NO is necessary but not sufficient for the degrdn. of ΔTgPL1 parasites in activated macrophages.  While some patatin-like proteins have phospholipase A2 (PLA2) activity, recombinant TgPL1 purified from Escherichia coli does not have phospholipase activity.  This result was not surprising, as TgPL1 contains a G-to-S change at the predicted catalytic serine residue.  An epitope-tagged version of TgPL1 partially colocalized with a dense granule protein in the parasitophorous vacuole space.  These results may suggest that TgPL1 moves to the parasitophorous vacuole to protect parasites from nitric oxide by an undetd. mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU1uPDCKZvk7Vg90H21EOLACvtfcHk0ljoxNk-ZbFzJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktlGitw%253D%253D&md5=4adbe39d3ed61bdd9d57a539cbe58e5f</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1128%2FIAI.05543-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.05543-11%26sid%3Dliteratum%253Aachs%26aulast%3DTobin%26aufirst%3DC.%2BM.%26aulast%3DKnoll%26aufirst%3DL.%2BJ.%26atitle%3DA%2520patatin-like%2520protein%2520protects%2520Toxoplasma%2520gondii%2520from%2520degradation%2520in%2520a%2520nitric%2520oxide-dependent%2520manner%26jtitle%3DInfect.%2520Immun.%26date%3D2012%26volume%3D80%26issue%3D1%26spage%3D55%26epage%3D61%26doi%3D10.1128%2FIAI.05543-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 11 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">João A. Baptista, Ricardo A. E. Castro, Mário T. S. Rosado, Teresa M. R. Maria, M. Ramos Silva, João Canotilho, <span class="NLM_string-name hlFld-ContribAuthor">M. Ermelinda S. Eusébio</span>. </span><span class="cited-content_cbyCitation_article-title">Polymorphic Cocrystals of the Antimalarial Drug Pyrimethamine: Two Case Studies. </span><span class="cited-content_cbyCitation_journal-name">Crystal Growth & Design</span><span> <strong>2021,</strong> <em>21 </em>
                                    (7)
                                     , 3699-3713. <a href="https://doi.org/10.1021/acs.cgd.1c00005" title="DOI URL">https://doi.org/10.1021/acs.cgd.1c00005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.cgd.1c00005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.cgd.1c00005%26sid%3Dliteratum%253Aachs%26jtitle%3DCrystal%2520Growth%2520%2526%2520Design%26atitle%3DPolymorphic%252BCocrystals%252Bof%252Bthe%252BAntimalarial%252BDrug%252BPyrimethamine%25253A%252BTwo%252BCase%252BStudies%26aulast%3DBaptista%26aufirst%3DJo%25C3%25A3o%2BA.%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D04012021%26date%3D14052021%26date%3D28052021%26volume%3D21%26issue%3D7%26spage%3D3699%26epage%3D3713" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yanmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Sourav  Chowdhury</span>, <span class="hlFld-ContribAuthor ">João V  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Eugene  Shakhnovich</span>. </span><span class="cited-content_cbyCitation_article-title">Development of antibacterial compounds that constrain evolutionary pathways to resistance. </span><span class="cited-content_cbyCitation_journal-name">eLife</span><span> <strong>2021,</strong> <em>10 </em><a href="https://doi.org/10.7554/eLife.64518" title="DOI URL">https://doi.org/10.7554/eLife.64518</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.7554/eLife.64518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.7554%2FeLife.64518%26sid%3Dliteratum%253Aachs%26jtitle%3DeLife%26atitle%3DDevelopment%252Bof%252Bantibacterial%252Bcompounds%252Bthat%252Bconstrain%252Bevolutionary%252Bpathways%252Bto%252Bresistance%26aulast%3DZhang%26aufirst%3DYanmin%26date%3D2021%26date%3D2021%26volume%3D10" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Carlla Assis  Araujo-Silva</span>, <span class="hlFld-ContribAuthor ">Wanderley  De Souza</span>, <span class="hlFld-ContribAuthor ">Erica S.  Martins-Duarte</span>, <span class="hlFld-ContribAuthor ">Rossiane C.  Vommaro</span>. </span><span class="cited-content_cbyCitation_article-title">HDAC inhibitors Tubastatin A and SAHA affect parasite cell division and are potential anti-Toxoplasma gondii chemotherapeutics. </span><span class="cited-content_cbyCitation_journal-name">International Journal for Parasitology: Drugs and Drug Resistance</span><span> <strong>2021,</strong> <em>15 </em>, 25-35. <a href="https://doi.org/10.1016/j.ijpddr.2020.12.003" title="DOI URL">https://doi.org/10.1016/j.ijpddr.2020.12.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijpddr.2020.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijpddr.2020.12.003%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520for%2520Parasitology%253A%2520Drugs%2520and%2520Drug%2520Resistance%26atitle%3DHDAC%252Binhibitors%252BTubastatin%252BA%252Band%252BSAHA%252Baffect%252Bparasite%252Bcell%252Bdivision%252Band%252Bare%252Bpotential%252Banti-Toxoplasma%252Bgondii%252Bchemotherapeutics%26aulast%3DAraujo-Silva%26aufirst%3DCarlla%2BAssis%26date%3D2021%26volume%3D15%26spage%3D25%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas C.  Smith</span>, <span class="hlFld-ContribAuthor ">Cibelly  Goulart</span>, <span class="hlFld-ContribAuthor ">Jenni A.  Hayward</span>, <span class="hlFld-ContribAuthor ">Andreas  Kupz</span>, <span class="hlFld-ContribAuthor ">Catherine M.  Miller</span>, <span class="hlFld-ContribAuthor ">Giel G.  van Dooren</span>. </span><span class="cited-content_cbyCitation_article-title">Control of human toxoplasmosis. </span><span class="cited-content_cbyCitation_journal-name">International Journal for Parasitology</span><span> <strong>2021,</strong> <em>51 </em>
                                    (2-3)
                                     , 95-121. <a href="https://doi.org/10.1016/j.ijpara.2020.11.001" title="DOI URL">https://doi.org/10.1016/j.ijpara.2020.11.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijpara.2020.11.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijpara.2020.11.001%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520for%2520Parasitology%26atitle%3DControl%252Bof%252Bhuman%252Btoxoplasmosis%26aulast%3DSmith%26aufirst%3DNicholas%2BC.%26date%3D2021%26volume%3D51%26issue%3D2-3%26spage%3D95%26epage%3D121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shabnam  Shahzad</span>, <span class="hlFld-ContribAuthor ">Muhammad Abdul  Qadir</span>, <span class="hlFld-ContribAuthor ">Mahmood  Ahmed</span>, <span class="hlFld-ContribAuthor ">Saghir  Ahmad</span>, <span class="hlFld-ContribAuthor ">Muhammad Jadoon  Khan</span>, <span class="hlFld-ContribAuthor ">Asad  Gulzar</span>, <span class="hlFld-ContribAuthor ">Muhammad  Muddassar</span>. </span><span class="cited-content_cbyCitation_article-title">Folic acid-sulfonamide conjugates as antibacterial agents: design, synthesis and molecular docking studies. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2020,</strong> <em>10 </em>
                                    (70)
                                     , 42983-42992. <a href="https://doi.org/10.1039/D0RA09051D" title="DOI URL">https://doi.org/10.1039/D0RA09051D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0RA09051D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0RA09051D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DFolic%252Bacid-sulfonamide%252Bconjugates%252Bas%252Bantibacterial%252Bagents%25253A%252Bdesign%25252C%252Bsynthesis%252Band%252Bmolecular%252Bdocking%252Bstudies%26aulast%3DShahzad%26aufirst%3DShabnam%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D70%26spage%3D42983%26epage%3D42992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rahman  Abdizadeh</span>, <span class="hlFld-ContribAuthor ">Farzin  Hadizadeh</span>, <span class="hlFld-ContribAuthor ">Tooba  Abdizadeh</span>. </span><span class="cited-content_cbyCitation_article-title">In silico studies of novel scaffold of thiazolidin-4-one derivatives as anti-Toxoplasma gondii agents by 2D/3D-QSAR, molecular docking, and molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Structural Chemistry</span><span> <strong>2020,</strong> <em>31 </em>
                                    (3)
                                     , 1149-1182. <a href="https://doi.org/10.1007/s11224-019-01458-y" title="DOI URL">https://doi.org/10.1007/s11224-019-01458-y</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11224-019-01458-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11224-019-01458-y%26sid%3Dliteratum%253Aachs%26jtitle%3DStructural%2520Chemistry%26atitle%3DIn%252Bsilico%252Bstudies%252Bof%252Bnovel%252Bscaffold%252Bof%252Bthiazolidin-4-one%252Bderivatives%252Bas%252Banti-Toxoplasma%252Bgondii%252Bagents%252Bby%252B2D%25252F3D-QSAR%25252C%252Bmolecular%252Bdocking%25252C%252Band%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DAbdizadeh%26aufirst%3DRahman%26date%3D2020%26date%3D2020%26volume%3D31%26issue%3D3%26spage%3D1149%26epage%3D1182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dae Gyu  Kim</span>, <span class="hlFld-ContribAuthor ">Chul Min  Park</span>, <span class="hlFld-ContribAuthor ">Srigouri  Huddar</span>, <span class="hlFld-ContribAuthor ">Semi  Lim</span>, <span class="hlFld-ContribAuthor ">Sunghoon  Kim</span>, <span class="hlFld-ContribAuthor ">Sunkyung  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Anticancer Activity of Pyrimethamine via Ubiquitin Mediated Degradation of AIMP2-DX2. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2020,</strong> <em>25 </em>
                                    (12)
                                     , 2763. <a href="https://doi.org/10.3390/molecules25122763" title="DOI URL">https://doi.org/10.3390/molecules25122763</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules25122763&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules25122763%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAnticancer%252BActivity%252Bof%252BPyrimethamine%252Bvia%252BUbiquitin%252BMediated%252BDegradation%252Bof%252BAIMP2-DX2%26aulast%3DKim%26aufirst%3DDae%2BGyu%26date%3D2020%26date%3D2020%26volume%3D25%26issue%3D12%26spage%3D2763" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara A.  Fox</span>, <span class="hlFld-ContribAuthor ">David J.  Bzik</span>. </span><span class="cited-content_cbyCitation_article-title">Biochemistry and metabolism of Toxoplasma gondii: purine and pyrimidine acquisition in Toxoplasma gondii and other Apicomplexa. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 397-449. <a href="https://doi.org/10.1016/B978-0-12-815041-2.00009-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-815041-2.00009-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-815041-2.00009-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-815041-2.00009-8%26sid%3Dliteratum%253Aachs%26atitle%3DBiochemistry%252Band%252Bmetabolism%252Bof%252BToxoplasma%252Bgondii%25253A%252Bpurine%252Band%252Bpyrimidine%252Bacquisition%252Bin%252BToxoplasma%252Bgondii%252Band%252Bother%252BApicomplexa%26aulast%3DFox%26aufirst%3DBarbara%2BA.%26date%3D2020%26spage%3D397%26epage%3D449%26pub%3DElsevier%26atitle%3DToxoplasma%252Bgondii%26date%3D2020%26volume%3D304" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Agnieszka  Wróbel</span>, <span class="hlFld-ContribAuthor ">Karolina  Arciszewska</span>, <span class="hlFld-ContribAuthor ">Dawid  Maliszewski</span>, <span class="hlFld-ContribAuthor ">Danuta  Drozdowska</span>. </span><span class="cited-content_cbyCitation_article-title">Trimethoprim and other nonclassical antifolates an excellent template for searching modifications of dihydrofolate reductase enzyme inhibitors. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Antibiotics</span><span> <strong>2020,</strong> <em>73 </em>
                                    (1)
                                     , 5-27. <a href="https://doi.org/10.1038/s41429-019-0240-6" title="DOI URL">https://doi.org/10.1038/s41429-019-0240-6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41429-019-0240-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41429-019-0240-6%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Antibiotics%26atitle%3DTrimethoprim%252Band%252Bother%252Bnonclassical%252Bantifolates%252Ban%252Bexcellent%252Btemplate%252Bfor%252Bsearching%252Bmodifications%252Bof%252Bdihydrofolate%252Breductase%252Benzyme%252Binhibitors%26aulast%3DWr%25C3%25B3bel%26aufirst%3DAgnieszka%26date%3D2020%26date%3D2019%26volume%3D73%26issue%3D1%26spage%3D5%26epage%3D27" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alex  Rosenberg</span>, <span class="hlFld-ContribAuthor ">Madeline R.  Luth</span>, <span class="hlFld-ContribAuthor ">Elizabeth A.  Winzeler</span>, <span class="hlFld-ContribAuthor ">Michael  Behnke</span>, <span class="hlFld-ContribAuthor ">L. David  Sibley</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of resistance in vitro reveals mechanisms of artemisinin activity in
              Toxoplasma gondii. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2019,</strong> <em>116 </em>
                                    (52)
                                     , 26881-26891. <a href="https://doi.org/10.1073/pnas.1914732116" title="DOI URL">https://doi.org/10.1073/pnas.1914732116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1914732116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1914732116%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DEvolution%252Bof%252Bresistance%252Bin%252Bvitro%252Breveals%252Bmechanisms%252Bof%252Bartemisinin%252Bactivity%252Bin%252BToxoplasma%252Bgondii%26aulast%3DRosenberg%26aufirst%3DAlex%26date%3D2019%26date%3D2019%26volume%3D116%26issue%3D52%26spage%3D26881%26epage%3D26891" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paula J.  Lapinskas</span>, <span class="hlFld-ContribAuthor ">Ruben R.  Ben-Harari</span>. </span><span class="cited-content_cbyCitation_article-title">Perspective on current and emerging drugs in the treatment of acute and chronic toxoplasmosis. </span><span class="cited-content_cbyCitation_journal-name">Postgraduate Medicine</span><span> <strong>2019,</strong> <em>131 </em>
                                    (8)
                                     , 589-596. <a href="https://doi.org/10.1080/00325481.2019.1655258" title="DOI URL">https://doi.org/10.1080/00325481.2019.1655258</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00325481.2019.1655258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00325481.2019.1655258%26sid%3Dliteratum%253Aachs%26jtitle%3DPostgraduate%2520Medicine%26atitle%3DPerspective%252Bon%252Bcurrent%252Band%252Bemerging%252Bdrugs%252Bin%252Bthe%252Btreatment%252Bof%252Bacute%252Band%252Bchronic%252Btoxoplasmosis%26aulast%3DLapinskas%26aufirst%3DPaula%2BJ.%26date%3D2019%26date%3D2019%26volume%3D131%26issue%3D8%26spage%3D589%26epage%3D596" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0013.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01754&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Dose–response curve of <b>1</b> for inhibition of <i>T. gondii</i> DHFR and human DHFR. The shaded blue area represents the concentration of <b>1</b> with >80% inhibition of <i>Tg</i>DHFR and 5–35% <i>h</i>DHFR.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01754&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Reference compounds pyrimethamine (<b>1</b>), trimethoprim (<b>4</b>), methotrexate (<b>5</b>), trimetrexate (<b>6</b>) and initial lead TRC-19 (<b>2</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01754&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Crystal structure of <i>Tg</i>DHFR with pyrimidine <b>29</b> bound. Crystal structure data were visualized and modeled using MOE software from Chemical Consulting Group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01754&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structure of <i>Tg</i>DHFR with pyrimidine <b>3</b> bound. Crystal structure data were visualized and modeled using MOE software from Chemical Consulting Group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01754&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0008.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Compounds <b>2</b>, <b>7</b>–<b>18</b>, <b>20</b>, <b>21</b>, and <b>32</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01754&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>R<sup>2</sup> = (a) 3-phenyl, (b) hydrogen, (c) 2-phenyl, (d) 4-phenyl, (e) 2-methyl, (f) 3-methyl, (g) 4-methyl, (h) 2-chloro, (i) 3-chloro, (j) 4-chloro, (k) 3-methoxy, (l) 3-trifluoromethyl, (m) 3-trifluoromethoxy, (n) 3-bromo. Reagents and conditions: (a) KF, DMSO, 110 °C, 12 h; (b) POCl<sub>3</sub>, DIPEA, 110 °C, 5 h; (c) NH<sub>3</sub>, EtOH, 145 °C, 24 h.</p></p></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0009.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Compounds <b>3</b>, <b>19</b>, <b>22</b>–<b>31</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01754&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>R<sup>2</sup> = (o) 5-(2-methoxypyrimidine), (p) cyclopropyl, (q) 3-pyridine, (r) 4-pyridine, (s) 5-pyrimidine, (t) 4-pyridazine, (u) 5-(2-methylpyrimidine), (v) 5-(2-trifluoromethylpyrimidine), (w) 5-(2-cyclopropylpyrimidine), (x) 2-pyridine, (y) 2-pyrimidine and (z) 2-pyrazine. Reagents and conditions: (a) Pd(PPh<sub>3</sub>)<sub>4</sub>, R<sup>2</sup>-B(OH)<sub>2</sub> (<b>39o</b>–<b>w</b>), Cs<sub>2</sub>CO<sub>3</sub>, dioxane/H<sub>2</sub>O, 110 °C; or (b) Pd<sub>2</sub>(dba)<sub>3</sub>, Sn(nBu)<sub>3</sub>-R<sup>2</sup> (<b>40x</b>–<b>z</b>), XPhos, dioxane, 100 °C.</p></p></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Parasiticidal dose–response curves of <b>1</b> and <b>3</b> in <i>T. gondii</i> infected human foreskin fibroblast cells.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01754&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0006.jpeg" id="rightTab-GRAPHIC-d7e3175-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) Kaplan–Meier survival curves of compound <b>1</b> in CD-1 female mice (<i>n</i> = 12 for drug treated groups, <i>n</i> = 9 for vehicle group) infected with 3000 RH type 1 <i>T. gondii</i> tachyzoites on day 0 followed by oral administration of <b>1</b> beginning on day 1 through day 7. Mice were carefully monitored for signs of infection, including by intermittent imaging (data not shown). (b) Kaplan–Meier survival curves of compound <b>3</b> in CD-1 female mice (<i>n</i> = 12 for drug treated groups, <i>n</i> = 9 for vehicle group) infected with 3000 RH type 1 <i>T. gondii</i> tachyzoites on day 0 followed by oral administration of <b>3</b> beginning on day 1 through day 7. Mice were carefully monitored for signs of infection, including by intermittent imaging (data not shown).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01754&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/medium/jm-2018-01754k_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0007.jpeg" id="rightTab-GRAPHIC-d7e3194-autogenerated" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. (a) Day 4 [plasma]<sub>free</sub> exposure of <b>1</b> from the acute murine model of toxoplasmosis plotted as free plasma (nM) levels versus time. (b) Day 4 [plasma]<sub>free</sub> exposure of <b>3</b> from the acute murine model of toxoplasmosis plotted as free plasma (nM) levels versus time.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-3/acs.jmedchem.8b01754/20190211/images/large/jm-2018-01754k_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b01754&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i80">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_82315" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_82315" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 57 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lindsay, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speer, C. A.</span></span> <span> </span><span class="NLM_article-title">Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts</span>. <i>Clin. Microbiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">267</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1128/CMR.11.2.267</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1128%2FCMR.11.2.267" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=9564564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADyaK1c3isFOmsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1998&pages=267-299&issue=2&author=J.+P.+Dubeyauthor=D.+S.+Lindsayauthor=C.+A.+Speer&title=Structures+of+Toxoplasma+gondii+tachyzoites%2C+bradyzoites%2C+and+sporozoites+and+biology+and+development+of+tissue+cysts&doi=10.1128%2FCMR.11.2.267"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts</span></div><div class="casAuthors">Dubey J P; Lindsay D S; Speer C A</div><div class="citationInfo"><span class="NLM_cas:title">Clinical microbiology reviews</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">267-99</span>
        ISSN:<span class="NLM_cas:issn">0893-8512</span>.
    </div><div class="casAbstract">Infections by the protozoan parasite Toxoplasma gondii are widely prevalent world-wide in animals and humans.  This paper reviews the life cycle; the structure of tachyzoites, bradyzoites, oocysts, sporocysts, sporozoites and enteroepithelial stages of T. gondii; and the mode of penetration of T. gondii.  The review provides a detailed account of the biology of tissue cysts and bradyzoites including in vivo and in vitro development, methods of separation from host tissue, tissue cyst rupture, and relapse.  The mechanism of in vivo and in vitro stage conversion from sporozoites to tachyzoites to bradyzoites and from bradyzoites to tachyzoites to bradyzoites is also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSJgUNM2kcJ3X6HPRus0rAafW6udTcc2ebJb7Zstajc67ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK1c3isFOmsw%253D%253D&md5=136e44676463d503570e684570bfb0ee</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1128%2FCMR.11.2.267&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FCMR.11.2.267%26sid%3Dliteratum%253Aachs%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26aulast%3DLindsay%26aufirst%3DD.%2BS.%26aulast%3DSpeer%26aufirst%3DC.%2BA.%26atitle%3DStructures%2520of%2520Toxoplasma%2520gondii%2520tachyzoites%252C%2520bradyzoites%252C%2520and%2520sporozoites%2520and%2520biology%2520and%2520development%2520of%2520tissue%2520cysts%26jtitle%3DClin.%2520Microbiol.%2520Rev.%26date%3D1998%26volume%3D11%26issue%3D2%26spage%3D267%26epage%3D299%26doi%3D10.1128%2FCMR.11.2.267" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tenter, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckeroth, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiss, L. M.</span></span> <span> </span><span class="NLM_article-title">Toxoplasma gondii: from animals to humans</span>. <i>Int. J. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">12–13</span>),  <span class="NLM_fpage">1217</span>– <span class="NLM_lpage">1258</span>, <span class="refDoi"> DOI: 10.1016/S0020-7519(00)00124-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1016%2FS0020-7519%2800%2900124-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=11113252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADC%252BD3MzgsVSqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2000&pages=1217-1258&issue=12%E2%80%9313&author=A.+M.+Tenterauthor=A.+R.+Heckerothauthor=L.+M.+Weiss&title=Toxoplasma+gondii%3A+from+animals+to+humans&doi=10.1016%2FS0020-7519%2800%2900124-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasma gondii: from animals to humans</span></div><div class="casAuthors">Tenter A M; Heckeroth A R; Weiss L M</div><div class="citationInfo"><span class="NLM_cas:title">International journal for parasitology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">12-13</span>),
    <span class="NLM_cas:pages">1217-58</span>
        ISSN:<span class="NLM_cas:issn">0020-7519</span>.
    </div><div class="casAbstract">Toxoplasmosis is one of the more common parasitic zoonoses world-wide.  Its causative agent, Toxoplasma gondii, is a facultatively heteroxenous, polyxenous protozoon that has developed several potential routes of transmission within and between different host species.  If first contracted during pregnancy, T. gondii may be transmitted vertically by tachyzoites that are passed to the foetus via the placenta.  Horizontal transmission of T. gondii may involve three life-cycle stages, i.e. ingesting infectious oocysts from the environment or ingesting tissue cysts or tachyzoites which are contained in meat or primary offal (viscera) of many different animals.  Transmission may also occur via tachyzoites contained in blood products, tissue transplants, or unpasteurised milk.  However, it is not known which of these routes is more important epidemiologically.  In the past, the consumption of raw or undercooked meat, in particular of pigs and sheep, has been regarded as a major route of transmission to humans.  However, recent studies showed that the prevalence of T. gondii in meat-producing animals decreased considerably over the past 20 years in areas with intensive farm management.  For example, in several countries of the European Union prevalences of T. gondii in fattening pigs are now <1%.  Considering these data it is unlikely that pork is still a major source of infection for humans in these countries.  However, it is likely that the major routes of transmission are different in human populations with differences in culture and eating habits.  In the Americas, recent outbreaks of acute toxoplasmosis in humans have been associated with oocyst contamination of the environment.  Therefore, future epidemiological studies on T. gondii infections should consider the role of oocysts as potential sources of infection for humans, and methods to monitor these are currently being developed.  This review presents recent epidemiological data on T. gondii, hypotheses on the major routes of transmission to humans in different populations, and preventive measures that may reduce the risk of contracting a primary infection during pregnancy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQjKocxHWsOAsULxIEhxUjPfW6udTcc2eYT9GDAc1n13Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MzgsVSqsA%253D%253D&md5=63a3c204a5335071b2a723d25126fae9</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2FS0020-7519%2800%2900124-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0020-7519%252800%252900124-7%26sid%3Dliteratum%253Aachs%26aulast%3DTenter%26aufirst%3DA.%2BM.%26aulast%3DHeckeroth%26aufirst%3DA.%2BR.%26aulast%3DWeiss%26aufirst%3DL.%2BM.%26atitle%3DToxoplasma%2520gondii%253A%2520from%2520animals%2520to%2520humans%26jtitle%3DInt.%2520J.%2520Parasitol.%26date%3D2000%26volume%3D30%26issue%3D12%25E2%2580%259313%26spage%3D1217%26epage%3D1258%26doi%3D10.1016%2FS0020-7519%2800%2900124-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prusa, A.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasper, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawers, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayde, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stillwaggon, E.</span></span> <span> </span><span class="NLM_article-title">Congenital toxoplasmosis in Austria: Prenatal screening for prevention is cost-saving</span>. <i>PLoS Neglected Trop. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">7</span>), <span class="NLM_elocation-id">e0005648</span> <span class="refDoi"> DOI: 10.1371/journal.pntd.0005648</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1371%2Fjournal.pntd.0005648" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2017&issue=7&author=A.-R.+Prusaauthor=D.+C.+Kasperauthor=L.+Sawersauthor=E.+Walterauthor=M.+Haydeauthor=E.+Stillwaggon&title=Congenital+toxoplasmosis+in+Austria%3A+Prenatal+screening+for+prevention+is+cost-saving&doi=10.1371%2Fjournal.pntd.0005648"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pntd.0005648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pntd.0005648%26sid%3Dliteratum%253Aachs%26aulast%3DPrusa%26aufirst%3DA.-R.%26aulast%3DKasper%26aufirst%3DD.%2BC.%26aulast%3DSawers%26aufirst%3DL.%26aulast%3DWalter%26aufirst%3DE.%26aulast%3DHayde%26aufirst%3DM.%26aulast%3DStillwaggon%26aufirst%3DE.%26atitle%3DCongenital%2520toxoplasmosis%2520in%2520Austria%253A%2520Prenatal%2520screening%2520for%2520prevention%2520is%2520cost-saving%26jtitle%3DPLoS%2520Neglected%2520Trop.%2520Dis.%26date%3D2017%26volume%3D11%26issue%3D7%26doi%3D10.1371%2Fjournal.pntd.0005648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dalimi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdoli, A.</span></span> <span> </span><span class="NLM_article-title">Latent toxoplasmosis and human</span>. <i>Iran J. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">17</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGgsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=1-17&issue=1&author=A.+Dalimiauthor=A.+Abdoli&title=Latent+toxoplasmosis+and+human"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning and expression of EG95 gene of Iranian isolates of Echinococcus granulosus</span></div><div class="casAuthors">Sarvi, S.; Dalimi, A.; Ghafarifar, F.</div><div class="citationInfo"><span class="NLM_cas:title">Iranian Journal of Parasitology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1-7</span>CODEN:
                <span class="NLM_cas:coden">IJPRHE</span>;
        ISSN:<span class="NLM_cas:issn">1735-7020</span>.
    
            (<span class="NLM_cas:orgname">Iranian Society of Parasitology</span>)
        </div><div class="casAbstract">Background: Echinococcosis or hydatidosis is a chronic, zoonotic worldwide infection that occurs by the larval stages of taeniid cestodes of the genus Echinococcus.  Iran is known as endemic region for this infection in the world.  Vaccination has been considered as a good prevention method for this disease.  Recombinant vaccines contg. EG95 protein, against E. granulosus, has shown a high degree of protection against E. granulosus infection.  In this study EG95 gene was extd. from Iranian isolates of E. granulosus and then cloned and expressed in expression vector.  Methods: Protoscoleces were collected from sheep hydatid cysts.  Then DNA and RNA were extd. from protoscoleces, and amplified by PCR and RT-PCR with specific primer.  Afterward the purified RT-PCR products were successfully ligated into pTZ57R/T plasmid vector.  The pcDNA3 plasmid was used as expression vector and Eg95 fragment sub cloned into this plasmid.  The pcEG95 plasmid was digested by restriction enzymes to confirm cloning of this gene in pcDNA3 plasmid.  In last step, the subcloned gene was expressed in CHO as eukaryotic cell.  Results: EG95 fragment successfully was subcloned in pcDNA3 and EG95 protein was expressed by eukaryotic cell.  The recombinant EG95 protein was confirmed by SDS-PAGE and Western blot.  Conclusion: Recombinant plasmid of pcEG95 was constructed successfully and express of recombinant EG95 protein was confirmed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIhV3qrQ-KjrVg90H21EOLACvtfcHk0lgn7C9RH3eppw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGgsrzJ&md5=870a60481e556f39729bf7b9d9865341</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDalimi%26aufirst%3DA.%26aulast%3DAbdoli%26aufirst%3DA.%26atitle%3DLatent%2520toxoplasmosis%2520and%2520human%26jtitle%3DIran%2520J.%2520Parasitol.%26date%3D2012%26volume%3D7%26issue%3D1%26spage%3D1%26epage%3D17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montoya, A.</span>; <span class="NLM_string-name">Boothroyd, J. C.</span>; <span class="NLM_string-name">Kovacs, J.</span></span>, <span> </span><span class="NLM_article-title"><i>Toxoplasma gondii</i></span>. In  <i>Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases</i>, <span class="NLM_edition">8</span>th ed.; <span class="NLM_publisher-name">Elsevier Saunders</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>, <span class="NLM_year">2015</span>; pp  <span class="NLM_fpage">3122</span>– <span class="NLM_lpage">3153</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&pages=3122-3153&author=A.+Montoya&author=J.+C.+Boothroyd&author=J.+Kovacs&title=Mandell%2C+Douglas%2C+and+Bennett%E2%80%99s+Principles+and+Practice+of+Infectious+Diseases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DMontoya%26aufirst%3DA.%26atitle%3DToxoplasma%2520gondii%26btitle%3DMandell%252C%2520Douglas%252C%2520and%2520Bennett%25E2%2580%2599s%2520Principles%2520and%2520Practice%2520of%2520Infectious%2520Diseases%26pub%3DElsevier%2520Saunders%26date%3D2015%26spage%3D3122%26epage%3D3153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halonen, S. K.</span>; <span class="NLM_string-name">Weiss, L. M.</span></span>, <span> </span><span class="NLM_article-title">Toxoplasmosis</span>. In  <i>Handbook of Clinical Neurology</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hector, H.</span>, <span class="NLM_string-name">Garcia, H. B. T.</span>, <span class="NLM_string-name">Oscar, H. D. B.</span></span>, Eds.; <span class="NLM_publisher-name">Elsevier</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2013</span>; Vol.  <span class="NLM_volume">114</span>, Chapter 8, pp  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">145</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=125-145&author=S.+K.+Halonen&author=L.+M.+Weissauthor=H.+Hector&author=H.+B.+T.+Garcia&author=H.+D.+B.+Oscar&title=Handbook+of+Clinical+Neurology"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DHalonen%26aufirst%3DS.%2BK.%26atitle%3DToxoplasmosis%26btitle%3DHandbook%2520of%2520Clinical%2520Neurology%26aulast%3DHector%26aufirst%3DH.%26pub%3DElsevier%26date%3D2013%26volume%3D114%26spage%3D125%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabaud, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amiel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katlama, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leport, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ambroise-Thomas, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canton, P.</span></span> <span> </span><span class="NLM_article-title">Extracerebral toxoplasmosis in patients infected with HIV. A French national survey</span>. <i>Medicine (Philadelphia, PA, U. S.)</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>73</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">306</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1097/00005792-199411000-00004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1097%2F00005792-199411000-00004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=1994&pages=306-314&issue=6&author=C.+Rabaudauthor=T.+Mayauthor=C.+Amielauthor=C.+Katlamaauthor=C.+Leportauthor=P.+Ambroise-Thomasauthor=P.+Canton&title=Extracerebral+toxoplasmosis+in+patients+infected+with+HIV.+A+French+national+survey&doi=10.1097%2F00005792-199411000-00004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1097%2F00005792-199411000-00004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F00005792-199411000-00004%26sid%3Dliteratum%253Aachs%26aulast%3DRabaud%26aufirst%3DC.%26aulast%3DMay%26aufirst%3DT.%26aulast%3DAmiel%26aufirst%3DC.%26aulast%3DKatlama%26aufirst%3DC.%26aulast%3DLeport%26aufirst%3DC.%26aulast%3DAmbroise-Thomas%26aufirst%3DP.%26aulast%3DCanton%26aufirst%3DP.%26atitle%3DExtracerebral%2520toxoplasmosis%2520in%2520patients%2520infected%2520with%2520HIV.%2520A%2520French%2520national%2520survey%26jtitle%3DMedicine%2520%2528Philadelphia%252C%2520PA%252C%2520U.%2520S.%2529%26date%3D1994%26volume%3D73%26issue%3D6%26spage%3D306%26epage%3D314%26doi%3D10.1097%2F00005792-199411000-00004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Akira, S.</span></span> <span> </span><span class="NLM_article-title">The role of IL-18 in innate immunity</span>. <i>Curr. Opin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">59</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1016/S0952-7915(99)00051-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1016%2FS0952-7915%2899%2900051-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10679398" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsVOkurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2000&pages=59-63&author=S.+Akira&title=The+role+of+IL-18+in+innate+immunity&doi=10.1016%2FS0952-7915%2899%2900051-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">The role of IL-18 in innate immunity</span></div><div class="casAuthors">Akira, Shizuo</div><div class="citationInfo"><span class="NLM_cas:title">Current Opinion in Immunology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">59-63</span>CODEN:
                <span class="NLM_cas:coden">COPIEL</span>;
        ISSN:<span class="NLM_cas:issn">0952-7915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review with 35 refs.  Interleukin 18 (IL-18), a novel cytokine with potent interferon γ-inducing activities, plays an important role in the Th1-mediated immune response in collaboration with IL-12.  IL-18 is a member of the IL-1 family.  The IL-18 receptor system and its signal transduction pathway are analogous to those of the IL-1 receptor.  Mice deficient in IL-18 have demonstrated its crit. role in natural killer cell activity and in vivo Th1 response.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQk7Am7QuQrVg90H21EOLACvtfcHk0ljFfq-jx4J6uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsVOkurw%253D&md5=1588e3a5c93bc0b4b7d7c234dcd2f9b9</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2FS0952-7915%2899%2900051-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0952-7915%252899%252900051-5%26sid%3Dliteratum%253Aachs%26aulast%3DAkira%26aufirst%3DS.%26atitle%3DThe%2520role%2520of%2520IL-18%2520in%2520innate%2520immunity%26jtitle%3DCurr.%2520Opin.%2520Immunol.%26date%3D2000%26volume%3D12%26spage%3D59%26epage%3D63%26doi%3D10.1016%2FS0952-7915%2899%2900051-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cuervo, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonetti, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alegre, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Salado, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Podzamczer, D.</span></span> <span> </span><span class="NLM_article-title">Toxoplasma myocarditis: a rare but serious complication in an HIV-infected late presenter</span>. <i>AIDS</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">14</span>),  <span class="NLM_fpage">2253</span>– <span class="NLM_lpage">2254</span>, <span class="refDoi"> DOI: 10.1097/QAD.0000000000001174</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1097%2FQAD.0000000000001174" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=2253-2254&issue=14&author=G.+Cuervoauthor=A.+F.+Simonettiauthor=O.+Alegreauthor=J.+C.+Sanchez-Saladoauthor=D.+Podzamczer&title=Toxoplasma+myocarditis%3A+a+rare+but+serious+complication+in+an+HIV-infected+late+presenter&doi=10.1097%2FQAD.0000000000001174"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1097%2FQAD.0000000000001174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FQAD.0000000000001174%26sid%3Dliteratum%253Aachs%26aulast%3DCuervo%26aufirst%3DG.%26aulast%3DSimonetti%26aufirst%3DA.%2BF.%26aulast%3DAlegre%26aufirst%3DO.%26aulast%3DSanchez-Salado%26aufirst%3DJ.%2BC.%26aulast%3DPodzamczer%26aufirst%3DD.%26atitle%3DToxoplasma%2520myocarditis%253A%2520a%2520rare%2520but%2520serious%2520complication%2520in%2520an%2520HIV-infected%2520late%2520presenter%26jtitle%3DAIDS%26date%3D2016%26volume%3D30%26issue%3D14%26spage%3D2253%26epage%3D2254%26doi%3D10.1097%2FQAD.0000000000001174" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Montoya, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liesenfeld, O.</span></span> <span> </span><span class="NLM_article-title">Toxoplasmosis</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>363</i></span> (<span class="NLM_issue">9425</span>),  <span class="NLM_fpage">1965</span>– <span class="NLM_lpage">1976</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(04)16412-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1016%2FS0140-6736%2804%2916412-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=15194258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvVemuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2004&pages=1965-1976&issue=9425&author=J.+G.+Montoyaauthor=O.+Liesenfeld&title=Toxoplasmosis&doi=10.1016%2FS0140-6736%2804%2916412-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasmosis</span></div><div class="casAuthors">Montoya, J. G.; Liesenfeld, O.</div><div class="citationInfo"><span class="NLM_cas:title">Lancet</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">9425</span>),
    <span class="NLM_cas:pages">1965-1976</span>CODEN:
                <span class="NLM_cas:coden">LANCAO</span>;
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A review.  Toxoplasma gondii is a protozoan parasite that infects up to a third of the world's population.  Infection is mainly acquired by ingestion of food or water that is contaminated with oocysts shed by cats or by eating undercooked or raw meat contg. tissue cysts.  Primary infection is usually subclin. but in some patients cervical lymphadenopathy or ocular disease can be present.  Infection acquired during pregnancy may cause severe damage to the fetus.  In immunocompromised patients, reactivation of latent disease can cause life-threatening encephalitis.  Diagnosis of toxoplasmosis can be established by direct detection of the parasite or by serol. techniques.  The most commonly used therapeutic regimen, and probably the most effective, is the combination of pyrimethamine with sulfadiazine and folinic acid.  This Seminar provides an overview and update on management of patients with acute infection, pregnant women who acquire infection during gestation, fetuses or infants who are congenitally infected, those with ocular disease, and immunocompromised individuals.  Controversy about the effectiveness of primary and secondary prevention in pregnant women is discussed.  Important topics of current and future research are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjtqSI8fuY4rVg90H21EOLACvtfcHk0ljFfq-jx4J6uQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvVemuro%253D&md5=7fe37d0af87e4bbff2e087b416dcf5c0</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2804%2916412-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252804%252916412-X%26sid%3Dliteratum%253Aachs%26aulast%3DMontoya%26aufirst%3DJ.%2BG.%26aulast%3DLiesenfeld%26aufirst%3DO.%26atitle%3DToxoplasmosis%26jtitle%3DLancet%26date%3D2004%26volume%3D363%26issue%3D9425%26spage%3D1965%26epage%3D1976%26doi%3D10.1016%2FS0140-6736%2804%2916412-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olliaro, P.</span></span> <span> </span><span class="NLM_article-title">Drug resistance hampers our capacity to roll back malaria</span>. <i>Clin. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>41</i></span> (<span class="NLM_issue">Suppl. 4</span>),  <span class="NLM_fpage">S247</span>– <span class="NLM_lpage">S257</span>, <span class="refDoi"> DOI: 10.1086/430785</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1086%2F430785" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=16032560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADC%252BD2Mznt1ShsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2005&pages=S247-S257&issue=Suppl.+4&author=P.+Olliaro&title=Drug+resistance+hampers+our+capacity+to+roll+back+malaria&doi=10.1086%2F430785"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Drug resistance hampers our capacity to roll back malaria</span></div><div class="casAuthors">Olliaro Piero</div><div class="citationInfo"><span class="NLM_cas:title">Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">41 Suppl 4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">S247-57</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Widespread drug resistance in parasites aggravates the burden of malaria.  The extent of the problem is due mainly to the limited armamentarium of drugs used thus far to treat malaria and to policies and practices constrained by limited resources.  All drugs in use are affected except, thus far, artemisinin derivatives.  The scale and impact of resistance has been underestimated, leading to the continued use of failing drugs, which contributes to the rise in resistance and increased morbidity and mortality due to malaria.  Pharmacological, epidemiological, and operational aspects factor the development and spread of resistance.  Although the problem is complex, much can be done to reverse the course of events: adopt adequate tests to assess resistance, encourage and sustain development of new drugs, protect drugs against resistance through use of combinations, expand access to prompt and effective treatment, and promote evidence-based policies and sensible practices.  The current situation favors the development of sensible strategies to restrain resistance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR7l6KFKSfqfOR_TJajKxJDfW6udTcc2eYuiO2eTz_jDLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2Mznt1ShsA%253D%253D&md5=65fef7390e9fd91431ac5f051afefe7a</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1086%2F430785&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F430785%26sid%3Dliteratum%253Aachs%26aulast%3DOlliaro%26aufirst%3DP.%26atitle%3DDrug%2520resistance%2520hampers%2520our%2520capacity%2520to%2520roll%2520back%2520malaria%26jtitle%3DClin.%2520Infect.%2520Dis.%26date%3D2005%26volume%3D41%26issue%3DSuppl.%25204%26spage%3DS247%26epage%3DS257%26doi%3D10.1086%2F430785" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCabe, R. E.</span></span> <span> </span><span class="NLM_article-title">Antitoxoplasma Chemotherapy</span>. In  <i>Toxoplasmosis: A Comprehensive Clinical Guide</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joynson, D. H. M.</span>, <span class="NLM_string-name">Wreghitt, T. G.</span></span>, Eds.; <span class="NLM_publisher-name">Cambridge University Press</span>: <span class="NLM_publisher-loc">Cambridge, U.K.</span>, <span class="NLM_year">2001</span>; pp  <span class="NLM_fpage">319</span>– <span class="NLM_lpage">359</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1017%2FCBO9780511527005.015" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2001&pages=319-359&author=R.+E.+McCabeauthor=D.+H.+M.+Joynson&author=T.+G.+Wreghitt&title=Toxoplasmosis%3A+A+Comprehensive+Clinical+Guide"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1017%2FCBO9780511527005.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1017%252FCBO9780511527005.015%26sid%3Dliteratum%253Aachs%26aulast%3DMcCabe%26aufirst%3DR.%2BE.%26atitle%3DAntitoxoplasma%2520Chemotherapy%26btitle%3DToxoplasmosis%253A%2520A%2520Comprehensive%2520Clinical%2520Guide%26aulast%3DJoynson%26aufirst%3DD.%2BH.%2BM.%26pub%3DCambridge%2520University%2520Press%26date%3D2001%26spage%3D319%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ben-Harari, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casoy, J.</span></span> <span> </span><span class="NLM_article-title">Adverse event profile of pyrimethamine-based therapy in toxoplasmosis: A systematic review</span>. <i>Drugs R&D</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">523</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1007/s40268-017-0206-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1007%2Fs40268-017-0206-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=28879584" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=523-544&issue=4&author=R.+R.+Ben-Harariauthor=E.+Goodwinauthor=J.+Casoy&title=Adverse+event+profile+of+pyrimethamine-based+therapy+in+toxoplasmosis%3A+A+systematic+review&doi=10.1007%2Fs40268-017-0206-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1007%2Fs40268-017-0206-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40268-017-0206-8%26sid%3Dliteratum%253Aachs%26aulast%3DBen-Harari%26aufirst%3DR.%2BR.%26aulast%3DGoodwin%26aufirst%3DE.%26aulast%3DCasoy%26aufirst%3DJ.%26atitle%3DAdverse%2520event%2520profile%2520of%2520pyrimethamine-based%2520therapy%2520in%2520toxoplasmosis%253A%2520A%2520systematic%2520review%26jtitle%3DDrugs%2520R%2526D%26date%3D2017%26volume%3D17%26issue%3D4%26spage%3D523%26epage%3D544%26doi%3D10.1007%2Fs40268-017-0206-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan
Assir, M. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akram, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yusuf, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamran, U.</span></span> <span> </span><span class="NLM_article-title">An outbreak of pyrimethamine toxicity in patients with ischaemic heart disease in pakistan</span>. <i>Basic Clin. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>115</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">291</span>– <span class="NLM_lpage">296</span>, <span class="refDoi"> DOI: 10.1111/bcpt.12206</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1111%2Fbcpt.12206" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=24490639" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtlKjtr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2014&pages=291-296&issue=3&author=M.+Z.+Khan%0AAssirauthor=H.+I.+Ahmadauthor=J.+Akramauthor=N.+W.+Yusufauthor=U.+Kamran&title=An+outbreak+of+pyrimethamine+toxicity+in+patients+with+ischaemic+heart+disease+in+pakistan&doi=10.1111%2Fbcpt.12206"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">An Outbreak of Pyrimethamine Toxicity in Patients with Ischaemic Heart Disease in Pakistan</span></div><div class="casAuthors">Khan Assir, Muhammad Zaman; Ahmad, Hafiz Ijaz; Akram, Javed; Yusuf, Noshin Wasim; Kamran, Umair</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">291-296</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">We investigated an outbreak of darkening of skin, bleeding from multiple sites, leucopenia and thrombocytopenia in ischemic heart disease patients.  Case patients were defined as patients who had received medicines from the pharmacy of Punjab Institute of Cardiol. between 1 Dec. 2011 and 12 Jan. 2012 and who developed any one of the following: darkening of skin, bleeding from any site, thrombocytopenia and leucopenia.  Clin. and drug-related data were abstracted.  All 664 case patients had received iso-sorbide-mono-nitrate contaminated with about 50 mg of pyrimethamine, and 151 (23%) died.  The median age of 117 patients admitted at Jinnah Hospital Lahore was 57 years (range, 37-100) and 92 (79%) were male.  The median time from intake of medicine to presentation was 37 days (range 13-72).  Symptoms and signs included bleeding (in 95% of the patients), skin hyperpigmentation (in 61%), diarrhoea (in 53%) and abdominal pain (in 48%).  At presentation, the median white cell count was 2.3 × 109/L (range, 0.1 × 109-16.0 × 109), the median Hb concn. was 109 g/L (range 58-169) and the median platelet count was 18 × 109/L (range, 0 × 109-318 × 109).  Bone marrow examn. revealed trileneage dysplasia and severe megaloblastosis.  The predictors of mortality included presentation prior to 15 Jan. 2012, age more than 57 years, hypotension and leukocyte count less than 1.5 × 109/L.  None of the patients who died received Calcium folinate because all deaths occurred prior to contaminant identification.  We describe an outbreak of pyrimethamine toxicity in ischemic heart disease patients receiving medicines from a single pharmacy due to accidental contamination of iso-sorbide mono-nitrate tablets at industrial level.  Late recognition of illness resulted in high mortality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2G7GidNN4h7Vg90H21EOLACvtfcHk0lgrmDnhzR6pYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtlKjtr%252FE&md5=9c0c75b8af4f5c668440697e6744a081</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1111%2Fbcpt.12206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcpt.12206%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%2BAssir%26aufirst%3DM.%2BZ.%26aulast%3DAhmad%26aufirst%3DH.%2BI.%26aulast%3DAkram%26aufirst%3DJ.%26aulast%3DYusuf%26aufirst%3DN.%2BW.%26aulast%3DKamran%26aufirst%3DU.%26atitle%3DAn%2520outbreak%2520of%2520pyrimethamine%2520toxicity%2520in%2520patients%2520with%2520ischaemic%2520heart%2520disease%2520in%2520pakistan%26jtitle%3DBasic%2520Clin.%2520Pharmacol.%2520Toxicol.%26date%3D2014%26volume%3D115%26issue%3D3%26spage%3D291%26epage%3D296%26doi%3D10.1111%2Fbcpt.12206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eyles, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, N.</span></span> <span> </span><span class="NLM_article-title">Tests of 2,4-diaminopyrimidines on toxoplasmosis</span>. <i>Public Health Rep.</i> <span class="NLM_year" style="font-weight: bold;">1952</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.2307/4588050</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.2307%2F4588050" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=14900360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADyaG38XjtlClsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=1952&pages=249-252&author=D.+E.+Eylesauthor=N.+Coleman&title=Tests+of+2%2C4-diaminopyrimidines+on+toxoplasmosis&doi=10.2307%2F4588050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Tests of 2,4-diaminopyrimidines on toxoplasmosis</span></div><div class="casAuthors">Eyles, Don E.; Coleman, Nell</div><div class="citationInfo"><span class="NLM_cas:title">Public Health Reports</span>
        (<span class="NLM_cas:date">1952</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">249-52</span>CODEN:
                <span class="NLM_cas:coden">PHRPA6</span>;
        ISSN:<span class="NLM_cas:issn">0033-3549</span>.
    </div><div class="casAbstract">Screening of compds. for antitoxoplasmic activity showed 2 members of the 2,4-diaminopyrimidine group to have effect.  The most active compd. was 2,4-diamino-5-(4-chlorophenyl)-6-ethylpyrimidine.  Defining the effective dose as the dose permitting 10-day survival, this compd. had a median effective dose of 9 mg. % in the diet as compared with 40 mg. % for sulfadiazine under identical conditions.  The efficiency of the drug was low, as the (max. tolerated dose)/(median effective dose) ratio was about 3 or less.  The cure rate following 14-day treatment was also low, since only 9 of 33 mice (27%) given doses higher than the median effective dose survived for 42 days.  6 references.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwBNJFVEjMxbVg90H21EOLACvtfcHk0lgrmDnhzR6pYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaG38XjtlClsw%253D%253D&md5=ec411c411fee24423c3d3b2a0c454f62</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.2307%2F4588050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2307%252F4588050%26sid%3Dliteratum%253Aachs%26aulast%3DEyles%26aufirst%3DD.%2BE.%26aulast%3DColeman%26aufirst%3DN.%26atitle%3DTests%2520of%25202%252C4-diaminopyrimidines%2520on%2520toxoplasmosis%26jtitle%3DPublic%2520Health%2520Rep.%26date%3D1952%26volume%3D67%26spage%3D249%26epage%3D252%26doi%3D10.2307%2F4588050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Felix, J. P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, R. P. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zacchia, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toribio, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nascimento, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arieta, C. E. L.</span></span> <span> </span><span class="NLM_article-title">Trimethoprim-sulfamethoxazole versus placebo to reduce the risk of recurrences of Toxoplasma gondii retinochoroiditis: Randomized controlled clinical trial</span>. <i>Am. J. Ophthalmol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>157</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">762</span>– <span class="NLM_lpage">766</span>, <span class="refDoi"> DOI: 10.1016/j.ajo.2013.12.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1016%2Fj.ajo.2013.12.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=24388839" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC2cXktlWhtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2014&pages=762-766&issue=4&author=J.+P.+F.+Felixauthor=R.+P.+C.+Liraauthor=R.+S.+Zacchiaauthor=J.+M.+Toribioauthor=M.+A.+Nascimentoauthor=C.+E.+L.+Arieta&title=Trimethoprim-sulfamethoxazole+versus+placebo+to+reduce+the+risk+of+recurrences+of+Toxoplasma+gondii+retinochoroiditis%3A+Randomized+controlled+clinical+trial&doi=10.1016%2Fj.ajo.2013.12.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Trimethoprim-Sulfamethoxazole Versus Placebo to Reduce the Risk of Recurrences of Toxoplasma Gondii Retinochoroiditis: Randomized Controlled Clinical Trial</span></div><div class="casAuthors">Felix, Joao Paulo Fernandes; Lira, Rodrigo Pessoa Cavalcanti; Zacchia, Rafael Santos; Toribio, Jaqueline Machado; Nascimento, Mauricio Abujamra; Arieta, Carlos Eduardo Leite</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Ophthalmology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">762-766.e1</span>CODEN:
                <span class="NLM_cas:coden">AJOPAA</span>;
        ISSN:<span class="NLM_cas:issn">0002-9394</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">To compare the effects of trimethoprim-sulfamethoxazole vs placebo in reducing the risk of recurrences of Toxoplasma gondii retinochoroiditis.  Single-center, prospective randomized double-masked clin. trial.  A total of 95 patients from Campinas, Brazil, with active recurrent Toxoplasma gondii retinochoroiditis were included.  The initially active toxoplasmosis lesions were successfully treated in all cases using trimethoprim-sulfamethoxazole (800 mg/160 mg) twice daily for 45 days.  Subsequently, 5 patients dropped out of the study.  The remaining patients were randomized to Group 1 (trimethoprim/sulfamethoxazole tablet every 2 days) or Group 2 (identical placebo tablet every 2 days).  Randomization was 1:1, was stratified by sex, and used block sizes of 4.  The primary outcome was recurrent toxoplasmosis retinochoroiditis within 1 yr, and the secondary outcome was a 1-yr change in best-cor. visual acuity (BCVA) (ETDRS chart).  The incidence of recurrent toxoplasmosis retinochoroiditis within 12 mo was 0 of 46 (0%) and 6 of 47 (12.80%) in the trimethoprim-sulfamethoxazole and placebo groups, resp. (P = .026).  Visual acuity improvements in the 2 groups were similar.  No treatment-limiting toxicity was obsd.  Trimethoprim/sulfamethoxazole therapy resulted in a 100% redn. in the recurrence of Toxoplasma gondii retinochoroiditis over 1 yr of treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_4yzfwpFQorVg90H21EOLACvtfcHk0lgEJNS0s7mG6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXktlWhtb0%253D&md5=42f595249ced30f5791fc9bb4762d3bc</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.ajo.2013.12.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajo.2013.12.022%26sid%3Dliteratum%253Aachs%26aulast%3DFelix%26aufirst%3DJ.%2BP.%2BF.%26aulast%3DLira%26aufirst%3DR.%2BP.%2BC.%26aulast%3DZacchia%26aufirst%3DR.%2BS.%26aulast%3DToribio%26aufirst%3DJ.%2BM.%26aulast%3DNascimento%26aufirst%3DM.%2BA.%26aulast%3DArieta%26aufirst%3DC.%2BE.%2BL.%26atitle%3DTrimethoprim-sulfamethoxazole%2520versus%2520placebo%2520to%2520reduce%2520the%2520risk%2520of%2520recurrences%2520of%2520Toxoplasma%2520gondii%2520retinochoroiditis%253A%2520Randomized%2520controlled%2520clinical%2520trial%26jtitle%3DAm.%2520J.%2520Ophthalmol.%26date%3D2014%26volume%3D157%26issue%3D4%26spage%3D762%26epage%3D766%26doi%3D10.1016%2Fj.ajo.2013.12.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stanford, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">See, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gilbert, R. E.</span></span> <span> </span><span class="NLM_article-title">Antibiotics for toxoplasmic retinochoroiditis: An evidence-based systematic review</span>. <i>Ophthalmology</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>110</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">926</span>– <span class="NLM_lpage">31</span>, (quiz 931–932) <span class="refDoi"> DOI: 10.1016/S0161-6420(03)00083-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1016%2FS0161-6420%2803%2900083-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=12750091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADC%252BD3s3ivVylsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=110&publication_year=2003&pages=926-31&issue=5&author=M.+R.+Stanfordauthor=S.+E.+Seeauthor=L.+V.+Jonesauthor=R.+E.+Gilbert&title=Antibiotics+for+toxoplasmic+retinochoroiditis%3A+An+evidence-based+systematic+review&doi=10.1016%2FS0161-6420%2803%2900083-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systematic review</span></div><div class="casAuthors">Stanford Miles R; See Sarah E; Jones Leanne V; Gilbert Ruth E</div><div class="citationInfo"><span class="NLM_cas:title">Ophthalmology</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">110</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">926-31; quiz 931-2</span>
        ISSN:<span class="NLM_cas:issn">0161-6420</span>.
    </div><div class="casAbstract">PURPOSE:  To determine the effectiveness of systemic antibiotic treatment for toxoplasmic retinochoroiditis.  CLINICAL RELEVANCE:  Toxoplasma retinochoroiditis is a significant cause of visual morbidity.  Multiple different antibiotic regimens are used, but controversy about treatment effectiveness remains.  LITERATURE REVIEWED:  Searches were conducted of Cochrane Controlled Trials Register, Medline (1966 onward), Embase (1980 onward), Dissertation Abstracts (1861 onward), Lilacs (1982 onward), and Pascal (1984 onward).  Pharmaceutical companies were contacted for unpublished data.  Any randomized controlled trials that compared antibiotics versus placebo in immunocompetent patients with toxoplasmic retinochoroiditis were retrieved.  Primary outcome measures were long-term visual acuity and risk of recurrent retinochoroiditis.  Secondary outcomes included duration and severity of acute symptoms, size of the lesion at end of follow-up, and adverse effects of treatment.  RESULTS:  Only 3 studies (total of 173 participants) were randomized controlled trials and hence met the inclusion criteria (level II).  All 3 were methodologically poor, and 2 were carried out more than 35 years ago.  None reported the effect on long-term visual outcome.  We found no evidence for a beneficial effect on the duration and severity of signs of acute toxoplasmic retinochoroiditis (A,II).  There was weak evidence for an effect of long-term treatment for chronic recurrent toxoplasmic retinochoroiditis on lesion recurrence.  Treatment was associated with adverse effects.  CONCLUSIONS:  There is a lack of evidence to support routine antibiotic treatment for acute toxoplasmic retinochoroiditis.  Placebo-controlled randomized trials of antibiotic treatment in patients presenting with acute or chronic toxoplasmic retinochoroiditis arising in any part of the retina are required.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSsQP9xAl_XtLBItaL1WaVAfW6udTcc2eZfMNY37AOlU7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3s3ivVylsg%253D%253D&md5=27b6b7e3f40f8dffe513befba811ac8d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0161-6420%2803%2900083-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0161-6420%252803%252900083-6%26sid%3Dliteratum%253Aachs%26aulast%3DStanford%26aufirst%3DM.%2BR.%26aulast%3DSee%26aufirst%3DS.%2BE.%26aulast%3DJones%26aufirst%3DL.%2BV.%26aulast%3DGilbert%26aufirst%3DR.%2BE.%26atitle%3DAntibiotics%2520for%2520toxoplasmic%2520retinochoroiditis%253A%2520An%2520evidence-based%2520systematic%2520review%26jtitle%3DOphthalmology%26date%3D2003%26volume%3D110%26issue%3D5%26spage%3D926%26epage%3D31%26doi%3D10.1016%2FS0161-6420%2803%2900083-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taques, I. I. G.G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martini, A. d. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitchenin, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braga, Í.A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Melo, A. L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakazato, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Aguiar, D. M.</span></span> <span> </span><span class="NLM_article-title">Molecular assessment of the transplacental transmission of Toxoplasma gondii, Neospora caninum, Brucella canis and Ehrlichia canis in dogs</span>. <i>Comparative immunology, microbiology and infectious diseases</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">47</span>– <span class="NLM_lpage">50</span>, <span class="refDoi"> DOI: 10.1016/j.cimid.2016.09.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1016%2Fj.cimid.2016.09.002" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2016&pages=47-50&author=I.+I.+G.G.+Taquesauthor=T.+R.+Barbosaauthor=A.+d.+C.+Martiniauthor=L.+C.+Pitcheninauthor=%C3%8D.A.+Bragaauthor=A.+L.+T.+de+Meloauthor=L.+Nakazatoauthor=V.+Dutraauthor=D.+M.+de+Aguiar&title=Molecular+assessment+of+the+transplacental+transmission+of+Toxoplasma+gondii%2C+Neospora+caninum%2C+Brucella+canis+and+Ehrlichia+canis+in+dogs&doi=10.1016%2Fj.cimid.2016.09.002"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.cimid.2016.09.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cimid.2016.09.002%26sid%3Dliteratum%253Aachs%26aulast%3DTaques%26aufirst%3DI.%2BI.%2BG.G.%26aulast%3DBarbosa%26aufirst%3DT.%2BR.%26aulast%3DMartini%26aufirst%3DA.%2Bd.%2BC.%26aulast%3DPitchenin%26aufirst%3DL.%2BC.%26aulast%3DBraga%26aufirst%3D%25C3%258D.A.%26aulast%3Dde%2BMelo%26aufirst%3DA.%2BL.%2BT.%26aulast%3DNakazato%26aufirst%3DL.%26aulast%3DDutra%26aufirst%3DV.%26aulast%3Dde%2BAguiar%26aufirst%3DD.%2BM.%26atitle%3DMolecular%2520assessment%2520of%2520the%2520transplacental%2520transmission%2520of%2520Toxoplasma%2520gondii%252C%2520Neospora%2520caninum%252C%2520Brucella%2520canis%2520and%2520Ehrlichia%2520canis%2520in%2520dogs%26jtitle%3DComparative%2520immunology%252C%2520microbiology%2520and%2520infectious%2520diseases%26date%3D2016%26volume%3D49%26spage%3D47%26epage%3D50%26doi%3D10.1016%2Fj.cimid.2016.09.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peters, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thigpen, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parise, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, R. D.</span></span> <span> </span><span class="NLM_article-title">Safety and toxicity of sulfadoxine/pyrimethamine implications for malaria prevention in pregnancy using intermittent preventive treatment</span>. <i>Drug Saf.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>30</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">481</span>– <span class="NLM_lpage">501</span>, <span class="refDoi"> DOI: 10.2165/00002018-200730060-00003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.2165%2F00002018-200730060-00003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=17536875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BD2sXot1Wjtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2007&pages=481-501&issue=6&author=P.+J.+Petersauthor=M.+C.+Thigpenauthor=M.+E.+Pariseauthor=R.+D.+Newman&title=Safety+and+toxicity+of+sulfadoxine%2Fpyrimethamine+implications+for+malaria+prevention+in+pregnancy+using+intermittent+preventive+treatment&doi=10.2165%2F00002018-200730060-00003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Safety and toxicity of sulfadoxine/pyrimethamine implications for malaria prevention in pregnancy using intermittent preventive treatment</span></div><div class="casAuthors">Peters, Philip J.; Thigpen, Michael C.; Parise, Monica E.; Newman, Robert D.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Safety</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">481-501</span>CODEN:
                <span class="NLM_cas:coden">DRSAEA</span>;
        ISSN:<span class="NLM_cas:issn">0114-5916</span>.
    
            (<span class="NLM_cas:orgname">Wolters Kluwer Health</span>)
        </div><div class="casAbstract">A review.  Plasmodium falciparum infection during pregnancy is strongly assocd. with maternal anemia and low birth wt., contributing to substantial morbidity and mortality in sub-Saharan Africa.  Intermittent preventive treatment in pregnancy with sulfadoxine/pyrimethamine (IPTp-SP) has been one of the most effective approaches to reduce the burden of malaria during pregnancy in Africa.  IPTp-SP is based on administering ≥2 treatment doses of sulfadoxine/pyrimethamine to pregnant women at predefined intervals after quickening (around 18-20 wk).  Randomised, controlled trials have demonstrated decreased rates of maternal anemia and low birth wt. with this approach.  The WHO currently recommends IPTp-SP in malaria-endemic areas of sub-Saharan Africa.  However, implementation has been suboptimal in part because of concerns of potential drug toxicities.  This review evaluates the toxicity data of sulfadoxine/pyrimethamine, including severe cutaneous adverse reactions, teratogenicity and alterations in bilirubin metab.  Weekly sulfadoxine/pyrimethamine prophylaxis is assocd. with rare but potentially fatal cutaneous reactions.  Fortunately, sulfadoxine/pyrimethamine use in IPTp programs in Africa, with 2-4 treatment doses over 6 mo, has been well tolerated in multiple IPTp trials.  However, sulfadoxine/pyrimethamine should not be administered concurrently with cotrimoxazole given their redundant mechanisms of action and synergistic worsening of adverse drug reactions.  Therefore, HIV-infected pregnant women in malaria endemic areas who are already receiving cotrimoxazole prophylaxis should not also receive IPTp-SP.  Although folate antagonist use in the first trimester is assocd. with neural tube defects, large case-control studies have demonstrated that sulfadoxine/pyrimethamine administered as IPTp (exclusively in the second and third trimesters and after organogenesis) does not result in an increased risk of teratogenesis.  Folic acid supplementation is recommended for all pregnant women to reduce the rate of congenital anomalies but high doses of folic acid (5 mg/day) may interfere with the antimalarial efficacy of sulfadoxine/pyrimethamine.  However, the recommended std. dose of folic acid supplementation (0.4 mg/day) does not affect antimalarial efficacy and may provide the optimal balance to prevent neural tube defects and maintain the effectiveness of IPTp-SP.  No clin. assocn. between sulfadoxine/pyrimethamine use and kernicterus has been reported despite the extensive use of sulfadoxine/pyrimethamine and related compds. to treat maternal malaria and congenital toxoplasmosis in near-term pregnant women and newborns.  Although few drugs in pregnancy can be considered completely safe, sulfadoxine/pyrimethamine - when delivered as IPTp - has a favorable safety profile.  Improved pharmacovigilance programs throughout Africa are now needed to confirm its safety as access to IPTp-SP increases.  Given the documented benefits of IPTp-SP in malaria endemic areas of Africa, access to this treatment for pregnant women should continue to expand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSzOkmKuhWYLVg90H21EOLACvtfcHk0li9xK1344QHSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXot1Wjtrk%253D&md5=bac55f32364572ba565f1739821d3f31</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.2165%2F00002018-200730060-00003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F00002018-200730060-00003%26sid%3Dliteratum%253Aachs%26aulast%3DPeters%26aufirst%3DP.%2BJ.%26aulast%3DThigpen%26aufirst%3DM.%2BC.%26aulast%3DParise%26aufirst%3DM.%2BE.%26aulast%3DNewman%26aufirst%3DR.%2BD.%26atitle%3DSafety%2520and%2520toxicity%2520of%2520sulfadoxine%252Fpyrimethamine%2520implications%2520for%2520malaria%2520prevention%2520in%2520pregnancy%2520using%2520intermittent%2520preventive%2520treatment%26jtitle%3DDrug%2520Saf.%26date%3D2007%26volume%3D30%26issue%3D6%26spage%3D481%26epage%3D501%26doi%3D10.2165%2F00002018-200730060-00003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carr, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooper, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penny, R.</span></span> <span> </span><span class="NLM_article-title">Allergic manifestations of human immunodeficiency virus (HIV) infection</span>. <i>J. Clin. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">1991</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1007/BF00917741</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1007%2FBF00917741" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1676034" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADyaK3M3nslWhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1991&pages=55-64&issue=2&author=A.+Carrauthor=D.+A.+Cooperauthor=R.+Penny&title=Allergic+manifestations+of+human+immunodeficiency+virus+%28HIV%29+infection&doi=10.1007%2FBF00917741"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Allergic manifestations of human immunodeficiency virus (HIV) infection</span></div><div class="casAuthors">Carr A; Cooper D A; Penny R</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical immunology</span>
        (<span class="NLM_cas:date">1991</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">55-64</span>
        ISSN:<span class="NLM_cas:issn">0271-9142</span>.
    </div><div class="casAbstract">Drug allergy is the most common and significant allergic manifestation of HIV3 infection.  Initially described in patients treated with SMX-TMP for PCP, allergy is now known to involve a multitude of drugs.  The pathogenesis of, and risk factors for, allergy in HIV infection are poorly understood, although there is evidence suggesting that allergy is more common with advancing immunodeficiency.  HIV-negative subjects with sulfonamide allergy may have drug-specific antibodies and drug metabolite-induced lymphocyte cytotoxicity, abnormalities that could partly explain the allergic mechanisms and which may have future diagnostic potential; these abnormalities have not been described in HIV-infected subjects.  Therapy includes avoidance, suppressive agents such as corticosteroids, and desensitization, although the appropriate role for each is not entirely clear.  Serum IgE levels have been shown to rise with progressive disease; those patients with higher levels may have a worse prognosis.  The mechanisms of this rise are multifactorial, probably a combination of altered T-lymphocyte regulation of IgE synthesis and of production of specific IgE directed against microbial antigens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSo8wrtVpq2lRKDYG3bNImrfW6udTcc2eZ86U3Rdwjv1rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK3M3nslWhtQ%253D%253D&md5=ee8b3ef9dda6ee8447510a6ca983ed03</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1007%2FBF00917741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00917741%26sid%3Dliteratum%253Aachs%26aulast%3DCarr%26aufirst%3DA.%26aulast%3DCooper%26aufirst%3DD.%2BA.%26aulast%3DPenny%26aufirst%3DR.%26atitle%3DAllergic%2520manifestations%2520of%2520human%2520immunodeficiency%2520virus%2520%2528HIV%2529%2520infection%26jtitle%3DJ.%2520Clin.%2520Immunol.%26date%3D1991%26volume%3D11%26issue%3D2%26spage%3D55%26epage%3D64%26doi%3D10.1007%2FBF00917741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallal, S.</span></span> <span> </span><span class="NLM_article-title">Drug hypersensitivity in HIV</span>. <i>Curr. Opin Allergy Clin Immunol</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">324</span>– <span class="NLM_lpage">330</span>, <span class="refDoi"> DOI: 10.1097/ACI.0b013e32825ea68a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1097%2FACI.0b013e32825ea68a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=17620824" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADC%252BD2svgt1yqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2007&pages=324-330&issue=4&author=E.+Phillipsauthor=S.+Mallal&title=Drug+hypersensitivity+in+HIV&doi=10.1097%2FACI.0b013e32825ea68a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Drug hypersensitivity in HIV</span></div><div class="casAuthors">Phillips Elizabeth; Mallal Simon</div><div class="citationInfo"><span class="NLM_cas:title">Current opinion in allergy and clinical immunology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">324-30</span>
        ISSN:<span class="NLM_cas:issn">1528-4050</span>.
    </div><div class="casAbstract">PURPOSE OF REVIEW:  Drug hypersensitivity has been reported to occur 100 times more commonly in those living with HIV.  In the first decade of HIV treatment, this mainly involved drugs used to treat HIV-related infections but now primarily includes drugs used to treat HIV.  This review focuses on the current knowledge of the epidemiology, pathophysiology and clinical features of drug hypersensitivity reactions of drugs used in the management of the HIV-infected patient.  RECENT FINDINGS:  Our understanding of the immunogenetics and host predisposition to drug hypersensitivity has been advanced considerably by the antiretroviral drugs abacavir and nevirapine.  The association of abacavir hypersensitivity reaction with HLA-B*5701 has been particularly important and provides a basis for genetic screening in the clinic setting.  SUMMARY:  The increased predisposition of drug hypersensitivity disease in HIV will continue to provide a fertile ground for study of the diverse and complex processes that drive its pathophysiology.  Our knowledge of drug hypersensitivity will also increase as the expanding armentarium of antiretroviral therapy is applied to more diverse populations in the developing world.  The potential for widespread implementation of HLA-B*5701 screening for abacavir hypersensitivity will set an important precedent for bringing individualized medicine to the clinic and the use of genetic testing to improve drug safety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCWItGk7-CmAMthz5_Rx5rfW6udTcc2eZtipV59aMKOLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2svgt1yqtQ%253D%253D&md5=5409bb4a52c76ea16b2669e0e4d1dbdf</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1097%2FACI.0b013e32825ea68a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FACI.0b013e32825ea68a%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DE.%26aulast%3DMallal%26aufirst%3DS.%26atitle%3DDrug%2520hypersensitivity%2520in%2520HIV%26jtitle%3DCurr.%2520Opin%2520Allergy%2520Clin%2520Immunol%26date%3D2007%26volume%3D7%26issue%3D4%26spage%3D324%26epage%3D330%26doi%3D10.1097%2FACI.0b013e32825ea68a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Slatore, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilles, S. A.</span></span> <span> </span><span class="NLM_article-title">Sulfonamide hypersensitivity</span>. <i>Immunol. Allergy Clin. North Am.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>24</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">477</span>– <span class="NLM_lpage">490</span>, <span class="refDoi"> DOI: 10.1016/j.iac.2004.03.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1016%2Fj.iac.2004.03.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=15242722" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADC%252BD2czktVOmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=477-490&issue=3&author=C.+G.+Slatoreauthor=S.+A.+Tilles&title=Sulfonamide+hypersensitivity&doi=10.1016%2Fj.iac.2004.03.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Sulfonamide hypersensitivity</span></div><div class="casAuthors">Slatore Christopher G; Tilles Stephen A</div><div class="citationInfo"><span class="NLM_cas:title">Immunology and allergy clinics of North America</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">477-90, vii</span>
        ISSN:<span class="NLM_cas:issn">0889-8561</span>.
    </div><div class="casAbstract">Sulfonamide antibiotics can result in a wide variety of hypersensitivity reactions.  No validated diagnostic tests are available for sulfonamide reactions; therefore, clinicians must rely on the combination of a careful patient history, review of medical records, and a sound knowledge base regarding the common clinical manifestations of sulfonamide hypersensitivity reactions.  Although HIV-infected individuals have a high risk for hypersensitivity reactions to sulfamethoxazole, readministering the drug can usually be performed safely by using a desensitization protocol.  Sulfonamide-containing medications that are not antibiotics also have the capacity for causing hypersensitivity reactions.  Whether the sulfa moiety confers a risk of cross-reaction is controversial.  The preponderance of available evidence suggests that sulfonamide antibiotics probably do not cross-react with sulfonamide nonantibiotics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcROy-82oedYtRjv2lLSLOxFfW6udTcc2eYgNMQP98p4xrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czktVOmtA%253D%253D&md5=de2494eb20056455dbc84704cc056317</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.iac.2004.03.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.iac.2004.03.011%26sid%3Dliteratum%253Aachs%26aulast%3DSlatore%26aufirst%3DC.%2BG.%26aulast%3DTilles%26aufirst%3DS.%2BA.%26atitle%3DSulfonamide%2520hypersensitivity%26jtitle%3DImmunol.%2520Allergy%2520Clin.%2520North%2520Am.%26date%3D2004%26volume%3D24%26issue%3D3%26spage%3D477%26epage%3D490%26doi%3D10.1016%2Fj.iac.2004.03.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Amabeoku, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chikuni, O.</span></span> <span> </span><span class="NLM_article-title">GABAergic and dopaminergic systems may be involved in seizures induced by pyrimethamine in mice</span>. <i>Gen. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>25</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1269</span>– <span class="NLM_lpage">1277</span>, <span class="refDoi"> DOI: 10.1016/0306-3623(94)90149-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1016%2F0306-3623%2894%2990149-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=7875556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADyaK2MXitVKntrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1994&pages=1269-1277&issue=6&author=G.+Amabeokuauthor=O.+Chikuni&title=GABAergic+and+dopaminergic+systems+may+be+involved+in+seizures+induced+by+pyrimethamine+in+mice&doi=10.1016%2F0306-3623%2894%2990149-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">GABAergic and dopaminergic systems may be involved in seizures induced by pyrimethamine in mice</span></div><div class="casAuthors">Amabeoku, George; Chikuni, Ordias</div><div class="citationInfo"><span class="NLM_cas:title">General Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1269-77</span>CODEN:
                <span class="NLM_cas:coden">GEPHDP</span>;
        ISSN:<span class="NLM_cas:issn">0306-3623</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The effects of some GABAergic and dopaminergic agents on pyrimethamine-induced tonic seizures were investigated in mice.  Pyrimethamine dose dependently induced seizures in mice.  Muscimol, AOAA and DABA significantly protected mice against pyrimethamine-induced seizures.  Bicuculline and picrotoxin effectively potentiated seizures elicited by pyrimethamine and significantly antagonized the protective effect of muscimol against the seizures.  Diazepam and phenobarbitone effectively protected mice against seizures elicited by pyrimethamine.  L-Dopa significantly potentiated pyrimethamine-induced seizures.  Apomorphine and pargyline significantly reduced the latency of seizures induced by pyrimethamine.  Haloperidol and pimozide effectively protected mice against pyrimethamine-elicited seizures and also significantly antagonized the potentiating effects of apomorphine and L-dopa on the seizures.  Disulfiram significantly potentiated seizures induced by pyrimethamine and also significantly enhanced the seizure-potentiating effect of L-dopa.  α-Methyl-p-tyrosine effectively protected against seizures induced by pyrimethamine.  However, L-dopa significantly potentiated the seizures in α-methyl-p-tyrosine-pretreated animals.  Muscimol significantly attenuated the potentiating effect of L-dopa on pyrimethamine-induced seizures while bicuculline significantly enhanced the effect of L-dopa.  Furthermore, haloperidol significantly potentiated the protective effect of muscimol against pyrimethamine-induced seizures.  These results suggest that both GABA and dopamine might be involved in the mechanism(s) of pyrimethamine seizures in mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqykqaVs_eIK7Vg90H21EOLACvtfcHk0lgHgPZ866VM_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXitVKntrc%253D&md5=19ad17df1c10316ecfbfadab36a3bfbe</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2F0306-3623%2894%2990149-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0306-3623%252894%252990149-X%26sid%3Dliteratum%253Aachs%26aulast%3DAmabeoku%26aufirst%3DG.%26aulast%3DChikuni%26aufirst%3DO.%26atitle%3DGABAergic%2520and%2520dopaminergic%2520systems%2520may%2520be%2520involved%2520in%2520seizures%2520induced%2520by%2520pyrimethamine%2520in%2520mice%26jtitle%3DGen.%2520Pharmacol.%26date%3D1994%26volume%3D25%26issue%3D6%26spage%3D1269%26epage%3D1277%26doi%3D10.1016%2F0306-3623%2894%2990149-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bolstad, D. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolstad, E. S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frey, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, A. C.</span></span> <span> </span><span class="NLM_article-title">Structure-based approach to the development of potent and selective inhibitors of dihydrofolate reductase from Cryptosporidium</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">6839</span>– <span class="NLM_lpage">6852</span>, <span class="refDoi"> DOI: 10.1021/jm8009124</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm8009124" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=6839-6852&issue=21&author=D.+B.+Bolstadauthor=E.+S.+D.+Bolstadauthor=K.+M.+Freyauthor=D.+L.+Wrightauthor=A.+C.+Anderson&title=Structure-based+approach+to+the+development+of+potent+and+selective+inhibitors+of+dihydrofolate+reductase+from+Cryptosporidium&doi=10.1021%2Fjm8009124"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Fjm8009124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm8009124%26sid%3Dliteratum%253Aachs%26aulast%3DBolstad%26aufirst%3DD.%2BB.%26aulast%3DBolstad%26aufirst%3DE.%2BS.%2BD.%26aulast%3DFrey%26aufirst%3DK.%2BM.%26aulast%3DWright%26aufirst%3DD.%2BL.%26aulast%3DAnderson%26aufirst%3DA.%2BC.%26atitle%3DStructure-based%2520approach%2520to%2520the%2520development%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520dihydrofolate%2520reductase%2520from%2520Cryptosporidium%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26issue%3D21%26spage%3D6839%26epage%3D6852%26doi%3D10.1021%2Fjm8009124" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chan, D. C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forsch, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Queener, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosowsky, A.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and antifolate activity of new analogues of piritrexim and other diaminopyrimidine dihydrofolate reductase inhibitors with ω-carboxyalkoxy or ω-carboxy-1-alkynyl substitution in the side chain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">4420</span>– <span class="NLM_lpage">4431</span>, <span class="refDoi"> DOI: 10.1021/jm0581718</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0581718" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=4420-4431&issue=13&author=D.+C.+M.+Chanauthor=H.+Fuauthor=R.+A.+Forschauthor=S.+F.+Queenerauthor=A.+Rosowsky&title=Design%2C+synthesis%2C+and+antifolate+activity+of+new+analogues+of+piritrexim+and+other+diaminopyrimidine+dihydrofolate+reductase+inhibitors+with+%CF%89-carboxyalkoxy+or+%CF%89-carboxy-1-alkynyl+substitution+in+the+side+chain&doi=10.1021%2Fjm0581718"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fjm0581718&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0581718%26sid%3Dliteratum%253Aachs%26aulast%3DChan%26aufirst%3DD.%2BC.%2BM.%26aulast%3DFu%26aufirst%3DH.%26aulast%3DForsch%26aufirst%3DR.%2BA.%26aulast%3DQueener%26aufirst%3DS.%2BF.%26aulast%3DRosowsky%26aufirst%3DA.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520antifolate%2520activity%2520of%2520new%2520analogues%2520of%2520piritrexim%2520and%2520other%2520diaminopyrimidine%2520dihydrofolate%2520reductase%2520inhibitors%2520with%2520%25CF%2589-carboxyalkoxy%2520or%2520%25CF%2589-carboxy-1-alkynyl%2520substitution%2520in%2520the%2520side%2520chain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26issue%3D13%26spage%3D4420%26epage%3D4431%26doi%3D10.1021%2Fjm0581718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, H.
C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggadike, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKilligin, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kinsman, O. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Queener, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, J.</span></span> <span> </span><span class="NLM_article-title">6,7-Disubstituted 2,4-diaminopteridines: Novel inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>40</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1371</span>– <span class="NLM_lpage">1375</span>, <span class="refDoi"> DOI: 10.1128/AAC.40.6.1371</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1128%2FAAC.40.6.1371" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1996&pages=1371-1375&issue=6&author=H.%0AC.+Jacksonauthor=K.+Biggadikeauthor=E.+McKilliginauthor=O.+S.+Kinsmanauthor=S.+F.+Queenerauthor=A.+Laneauthor=J.+Smith&title=6%2C7-Disubstituted+2%2C4-diaminopteridines%3A+Novel+inhibitors+of+Pneumocystis+carinii+and+Toxoplasma+gondii+dihydrofolate+reductase&doi=10.1128%2FAAC.40.6.1371"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1128%2FAAC.40.6.1371&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.40.6.1371%26sid%3Dliteratum%253Aachs%26aulast%3DJackson%26aufirst%3DH.%2BC.%26aulast%3DBiggadike%26aufirst%3DK.%26aulast%3DMcKilligin%26aufirst%3DE.%26aulast%3DKinsman%26aufirst%3DO.%2BS.%26aulast%3DQueener%26aufirst%3DS.%2BF.%26aulast%3DLane%26aufirst%3DA.%26aulast%3DSmith%26aufirst%3DJ.%26atitle%3D6%252C7-Disubstituted%25202%252C4-diaminopteridines%253A%2520Novel%2520inhibitors%2520of%2520Pneumocystis%2520carinii%2520and%2520Toxoplasma%2520gondii%2520dihydrofolate%2520reductase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1996%26volume%3D40%26issue%3D6%26spage%3D1371%26epage%3D1375%26doi%3D10.1128%2FAAC.40.6.1371" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pelphrey, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popov, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joska, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beierlein, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolstad, E. S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fillingham, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, A. C.</span></span> <span> </span><span class="NLM_article-title">Highly efficient ligands for dihydrofolate reductase from Cryptosporidium hominis and Toxoplasma gondii inspired by structural analysis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span> (<span class="NLM_issue">5</span>),  <span class="NLM_fpage">940</span>– <span class="NLM_lpage">950</span>, <span class="refDoi"> DOI: 10.1021/jm061027h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm061027h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=940-950&issue=5&author=P.+M.+Pelphreyauthor=V.+M.+Popovauthor=T.+M.+Joskaauthor=J.+M.+Beierleinauthor=E.+S.+D.+Bolstadauthor=Y.+A.+Fillinghamauthor=D.+L.+Wrightauthor=A.+C.+Anderson&title=Highly+efficient+ligands+for+dihydrofolate+reductase+from+Cryptosporidium+hominis+and+Toxoplasma+gondii+inspired+by+structural+analysis&doi=10.1021%2Fjm061027h"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm061027h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm061027h%26sid%3Dliteratum%253Aachs%26aulast%3DPelphrey%26aufirst%3DP.%2BM.%26aulast%3DPopov%26aufirst%3DV.%2BM.%26aulast%3DJoska%26aufirst%3DT.%2BM.%26aulast%3DBeierlein%26aufirst%3DJ.%2BM.%26aulast%3DBolstad%26aufirst%3DE.%2BS.%2BD.%26aulast%3DFillingham%26aufirst%3DY.%2BA.%26aulast%3DWright%26aufirst%3DD.%2BL.%26aulast%3DAnderson%26aufirst%3DA.%2BC.%26atitle%3DHighly%2520efficient%2520ligands%2520for%2520dihydrofolate%2520reductase%2520from%2520Cryptosporidium%2520hominis%2520and%2520Toxoplasma%2520gondii%2520inspired%2520by%2520structural%2520analysis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26issue%3D5%26spage%3D940%26epage%3D950%26doi%3D10.1021%2Fjm061027h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosowsky, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hynes, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Queener, S. F.</span></span> <span> </span><span class="NLM_article-title">Structure-activity and structure-selectivity studies on diaminoquinazolines and other inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>39</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">86</span>, <span class="refDoi"> DOI: 10.1128/AAC.39.1.79</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1128%2FAAC.39.1.79" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1995&pages=79-86&issue=1&author=A.+Rosowskyauthor=J.+B.+Hynesauthor=S.+F.+Queener&title=Structure-activity+and+structure-selectivity+studies+on+diaminoquinazolines+and+other+inhibitors+of+Pneumocystis+carinii+and+Toxoplasma+gondii+dihydrofolate+reductase&doi=10.1128%2FAAC.39.1.79"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1128%2FAAC.39.1.79&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.39.1.79%26sid%3Dliteratum%253Aachs%26aulast%3DRosowsky%26aufirst%3DA.%26aulast%3DHynes%26aufirst%3DJ.%2BB.%26aulast%3DQueener%26aufirst%3DS.%2BF.%26atitle%3DStructure-activity%2520and%2520structure-selectivity%2520studies%2520on%2520diaminoquinazolines%2520and%2520other%2520inhibitors%2520of%2520Pneumocystis%2520carinii%2520and%2520Toxoplasma%2520gondii%2520dihydrofolate%2520reductase%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1995%26volume%3D39%26issue%3D1%26spage%3D79%26epage%3D86%26doi%3D10.1128%2FAAC.39.1.79" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landau, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vargo, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spasov, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, K. S.</span></span> <span> </span><span class="NLM_article-title">First three-dimensional structure of Toxoplasma gondii thymidylate synthase-dihydrofolate reductase: Insights for catalysis, interdomain interactions, and substrate channeling</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">41</span>),  <span class="NLM_fpage">7305</span>– <span class="NLM_lpage">7317</span>, <span class="refDoi"> DOI: 10.1021/bi400576t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi400576t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVynsr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=7305-7317&issue=41&author=H.+Sharmaauthor=M.+J.+Landauauthor=M.+A.+Vargoauthor=K.+A.+Spasovauthor=K.+S.+Anderson&title=First+three-dimensional+structure+of+Toxoplasma+gondii+thymidylate+synthase-dihydrofolate+reductase%3A+Insights+for+catalysis%2C+interdomain+interactions%2C+and+substrate+channeling&doi=10.1021%2Fbi400576t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">First Three-Dimensional Structure of Toxoplasma gondii Thymidylate Synthase-Dihydrofolate Reductase: Insights for Catalysis, Interdomain Interactions, and Substrate Channeling</span></div><div class="casAuthors">Sharma, Hitesh; Landau, Mark J.; Vargo, Melissa A.; Spasov, Krasimir A.; Anderson, Karen S.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">7305-7317</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Most species, such as humans, have monofunctional forms of thymidylate synthase (TS) and dihydrofolate reductase (DHFR) that are key folate metab. enzymes making crit. folate components required for DNA synthesis.  In contrast, several parasitic protozoa, including Toxoplasma gondii, contain a unique bifunctional thymidylate synthase-dihydrofolate reductase (TS-DHFR) having the catalytic activities contained on a single polypeptide chain.  The prevalence of T. gondii infections across the world, esp. for those immunocompromised, underscores the need to understand TS-DHFR enzyme function and to find new avenues to exploit for the design of novel antiparasitic drugs.  As a first step, we have solved the first three-dimensional structures of T. gondii TS-DHFR at 3.7 Å and of a loop truncated TS-DHFR, removing several flexible surface loops in the DHFR domain, improving resoln. to 2.2 Å.  Distinct structural features of the TS-DHFR homodimer include a junctional region contg. a kinked crossover helix between the DHFR domains of the two adjacent monomers, a long linker connecting the TS and DHFR domains, and a DHFR domain that is pos. charged.  The roles of these unique structural features were probed by site-directed mutagenesis coupled with presteady state and steady state kinetics.  Mutational anal. of the crossover helix region combined with kinetic characterization established the importance of this region not only in DHFR catalysis but also in modulating the distal TS activity, suggesting a role for TS-DHFR interdomain interactions.  Addnl. kinetic studies revealed that substrate channeling occurs in which dihydrofolate is directly transferred from the TS to DHFR active site without entering bulk soln.  The crystal structure suggests that the pos. charged DHFR domain governs this electrostatically mediated movement of dihydrofolate, preventing release from the enzyme.  Taken together, these structural and kinetic studies reveal unique, functional regions on the T. gondii TS-DHFR enzyme that may be targeted for inhibition, thus paving the way for designing species specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqgJc1yVXlfrVg90H21EOLACvtfcHk0lgOjV6Vyqt-uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVynsr3K&md5=cd220cd54e8474cbd47925aa4b5c6d58</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fbi400576t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi400576t%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DH.%26aulast%3DLandau%26aufirst%3DM.%2BJ.%26aulast%3DVargo%26aufirst%3DM.%2BA.%26aulast%3DSpasov%26aufirst%3DK.%2BA.%26aulast%3DAnderson%26aufirst%3DK.%2BS.%26atitle%3DFirst%2520three-dimensional%2520structure%2520of%2520Toxoplasma%2520gondii%2520thymidylate%2520synthase-dihydrofolate%2520reductase%253A%2520Insights%2520for%2520catalysis%252C%2520interdomain%2520interactions%252C%2520and%2520substrate%2520channeling%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D52%26issue%3D41%26spage%3D7305%26epage%3D7317%26doi%3D10.1021%2Fbi400576t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Welsch, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agnihotri, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, S. B.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective leads against Toxoplasma gondii dihydrofolate reductase via structure-based design</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1124</span>– <span class="NLM_lpage">1129</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00328</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00328" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFanu7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=1124-1129&issue=12&author=M.+E.+Welschauthor=J.+Zhouauthor=Y.+Gaoauthor=Y.+Yanauthor=G.+Porterauthor=G.+Agnihotriauthor=Y.+Liauthor=H.+Luauthor=Z.+Chenauthor=S.+B.+Thomas&title=Discovery+of+potent+and+selective+leads+against+Toxoplasma+gondii+dihydrofolate+reductase+via+structure-based+design&doi=10.1021%2Facsmedchemlett.6b00328"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Leads against Toxoplasma gondii Dihydrofolate Reductase via Structure-Based Design</span></div><div class="casAuthors">Welsch, Matthew E.; Zhou, Jian; Gao, Yueqiang; Yan, Yunqing; Porter, Gene; Agnihotri, Gautam; Li, Yingjie; Lu, Henry; Chen, Zhongguo; Thomas, Stephen B.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1124-1129</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Current treatment of toxoplasmosis targets the parasite's folate metab. through inhibition of dihydrofolate reductase (DHFR).  The most widely used DHFR antagonist, pyrimethamine, was introduced over 60 years ago and is assocd. with toxicity that can be largely attributed to a similar affinity for parasite and human DHFR.  Computational anal. of biochem. differences between Toxoplasma gondii and human DHFR enabled the design of inhibitors with both improved potency and selectivity.  The approach described herein yielded I, a promising lead with an IC50 of 9 nM and 89-fold selectivity in favor of Toxoplasma gondii DHFR, as well as crystallog. data to substantiate in silico methodol.  Overall, 50% of synthesized in silico designs met hit threshold criteria of IC50 < 10 μM and >2-fold selectivity favoring Toxoplasma gondii, further demonstrating the efficiency of the structure-based drug design approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdfV8Zx0CTnrVg90H21EOLACvtfcHk0ljwBsDsx3dqqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFanu7nJ&md5=bc9310b6e5f9e976d13f89e9d1f9fe74</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00328%26sid%3Dliteratum%253Aachs%26aulast%3DWelsch%26aufirst%3DM.%2BE.%26aulast%3DZhou%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DPorter%26aufirst%3DG.%26aulast%3DAgnihotri%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DLu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DThomas%26aufirst%3DS.%2BB.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520leads%2520against%2520Toxoplasma%2520gondii%2520dihydrofolate%2520reductase%2520via%2520structure-based%2520design%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26issue%3D12%26spage%3D1124%26epage%3D1129%26doi%3D10.1021%2Facsmedchemlett.6b00328" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allegra, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kovacs, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drake, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swan, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chabner, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masur, H.</span></span> <span> </span><span class="NLM_article-title">Potent in vitro and in vivo antitoxoplasma activity of the lipid-soluble antifolate trimetrexate</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>79</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">478</span>– <span class="NLM_lpage">482</span>, <span class="refDoi"> DOI: 10.1172/JCI112837</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1172%2FJCI112837" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=1987&pages=478-482&issue=2&author=C.+J.+Allegraauthor=J.+A.+Kovacsauthor=J.+C.+Drakeauthor=J.+C.+Swanauthor=B.+A.+Chabnerauthor=H.+Masur&title=Potent+in+vitro+and+in+vivo+antitoxoplasma+activity+of+the+lipid-soluble+antifolate+trimetrexate&doi=10.1172%2FJCI112837"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1172%2FJCI112837&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI112837%26sid%3Dliteratum%253Aachs%26aulast%3DAllegra%26aufirst%3DC.%2BJ.%26aulast%3DKovacs%26aufirst%3DJ.%2BA.%26aulast%3DDrake%26aufirst%3DJ.%2BC.%26aulast%3DSwan%26aufirst%3DJ.%2BC.%26aulast%3DChabner%26aufirst%3DB.%2BA.%26aulast%3DMasur%26aufirst%3DH.%26atitle%3DPotent%2520in%2520vitro%2520and%2520in%2520vivo%2520antitoxoplasma%2520activity%2520of%2520the%2520lipid-soluble%2520antifolate%2520trimetrexate%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D1987%26volume%3D79%26issue%3D2%26spage%3D478%26epage%3D482%26doi%3D10.1172%2FJCI112837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tonelli, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naesens, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gazzarrini, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santucci, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cichero, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasso, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moroni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costi, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loddo, R.</span></span> <span> </span><span class="NLM_article-title">Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">467</span>– <span class="NLM_lpage">478</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.04.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1016%2Fj.ejmech.2017.04.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=28477572" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC2sXntFWrtbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2017&pages=467-478&author=M.+Tonelliauthor=L.+Naesensauthor=S.+Gazzarriniauthor=M.+Santucciauthor=E.+Cicheroauthor=B.+Tassoauthor=A.+Moroniauthor=M.+P.+Costiauthor=R.+Loddo&title=Host+dihydrofolate+reductase+%28DHFR%29-directed+cycloguanil+analogues+endowed+with+activity+against+influenza+virus+and+respiratory+syncytial+virus&doi=10.1016%2Fj.ejmech.2017.04.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus</span></div><div class="casAuthors">Tonelli, Michele; Naesens, Lieve; Gazzarrini, Sabrina; Santucci, Matteo; Cichero, Elena; Tasso, Bruno; Moroni, Anna; Costi, Maria Paola; Loddo, Roberta</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">467-478</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">We have identified a series of 1-aryl-4,6-diamino-1,2-dihydrotriazines, structurally related to the antimalarial drug cycloguanil, as new inhibitors of influenza A and B virus and respiratory syncytial virus (RSV) via targeting of the host dihydrofolate reductase (DHFR) enzyme.  Most analogs proved active against influenza B virus in the low micromolar range, and the best compds. (11, 13, 14 and 16) even reached the sub-micromolar potency of zanamivir (EC50 = 0.060 μM), and markedly exceeded (up to 327 times) the antiviral efficacy of ribavirin.  Activity was also obsd. for two influenza A strains, including a virus with the S31N mutant form of M2 proton channel, which is the most prevalent resistance mutation for amantadine.  Importantly, the compds. displayed nanomolar activity against RSV and a superior selectivity index, since the ratio of cytotoxic to antiviral concn. was >10,000 for the three most active compds. 11, 14 and 16 (EC50 ∼0.008 μM), far surpassing the potency and safety profile of the licensed drug ribavirin (EC50 = 5.8 μM, SI > 43).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqftRmKNGZDgLVg90H21EOLACvtfcHk0lgLuYTTETFN0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXntFWrtbc%253D&md5=3e39d991a7aad659a1f4a5c8230a01fe</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.04.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.04.070%26sid%3Dliteratum%253Aachs%26aulast%3DTonelli%26aufirst%3DM.%26aulast%3DNaesens%26aufirst%3DL.%26aulast%3DGazzarrini%26aufirst%3DS.%26aulast%3DSantucci%26aufirst%3DM.%26aulast%3DCichero%26aufirst%3DE.%26aulast%3DTasso%26aufirst%3DB.%26aulast%3DMoroni%26aufirst%3DA.%26aulast%3DCosti%26aufirst%3DM.%2BP.%26aulast%3DLoddo%26aufirst%3DR.%26atitle%3DHost%2520dihydrofolate%2520reductase%2520%2528DHFR%2529-directed%2520cycloguanil%2520analogues%2520endowed%2520with%2520activity%2520against%2520influenza%2520virus%2520and%2520respiratory%2520syncytial%2520virus%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D135%26spage%3D467%26epage%3D478%26doi%3D10.1016%2Fj.ejmech.2017.04.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gomes, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Andrade Junior, H.
F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lescano, S. A. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amato-Neto, V.</span></span> <span> </span><span class="NLM_article-title">In vitro action of antiparasitic drugs, especially artesunate, against Toxoplasma gondii</span>. <i>Rev. Soc. Bras Med. Trop</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>45</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">485</span>– <span class="NLM_lpage">490</span>, <span class="refDoi"> DOI: 10.1590/S0037-86822012000400014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1590%2FS0037-86822012000400014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=22930046" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADC%252BC38bitVKrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2012&pages=485-490&issue=4&author=T.+C.+Gomesauthor=H.%0AF.+de+Andrade+Juniorauthor=S.+A.+Z.+Lescanoauthor=V.+Amato-Neto&title=In+vitro+action+of+antiparasitic+drugs%2C+especially+artesunate%2C+against+Toxoplasma+gondii&doi=10.1590%2FS0037-86822012000400014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro action of antiparasitic drugs, especially artesunate, against Toxoplasma gondii</span></div><div class="casAuthors">Gomes Thais Cobellis; de Andrade Junior Heitor Franco; Lescano Susana Angelica Zevallos; Amato-Neto Vicente</div><div class="citationInfo"><span class="NLM_cas:title">Revista da Sociedade Brasileira de Medicina Tropical</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">485-90</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  Toxoplasmosis is usually a benign infection, except in the event of ocular, central nervous system (CNS), or congenital disease and particularly when the patient is immunocompromised.  Treatment consists of drugs that frequently cause adverse effects; thus, newer, more effective drugs are needed.  In this study, the possible activity of artesunate, a drug successfully being used for the treatment of malaria, on Toxoplasma gondii growth in cell culture is evaluated and compared with the action of drugs that are already being used against this parasite.  METHODS:  LLC-MK2 cells were cultivated in RPMI medium, kept in disposable plastic bottles, and incubated at 36oC with 5% CO2.  Tachyzoites of the RH strain were used.  The following drugs were tested: artesunate, cotrimoxazole, pentamidine, pyrimethamine, quinine, and trimethoprim.  The effects of these drugs on tachyzoites and LLC-MK2 cells were analyzed using nonlinear regression analysis with Prism 3.0 software.  RESULTS:  Artesunate showed a mean tachyzoite inhibitory concentration (IC50) of 0.075μM and an LLC MK2 toxicity of 2.003μM.  Pyrimethamine was effective at an IC50 of 0.482μM and a toxicity of 11.178μM.  Trimethoprim alone was effective against the in vitro parasite.  Cotrimoxazole also was effective against the parasite but at higher concentrations than those observed for artesunate and pyrimethamine.  Pentamidine and quinine had no inhibitory effect over tachyzoites.  CONCLUSIONS:  Artesunate is proven in vitro to be a useful alternative for the treatment of toxoplasmosis, implying a subsequent in vivo effect and suggesting the mechanism of this drug against the parasite.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSVBppxeusH2YqdXsLcGTEUfW6udTcc2ebeLzbwy1s_iLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38bitVKrtA%253D%253D&md5=7ef6c9c3b6f79fcc0d7bbbef8f2d1208</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1590%2FS0037-86822012000400014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1590%252FS0037-86822012000400014%26sid%3Dliteratum%253Aachs%26aulast%3DGomes%26aufirst%3DT.%2BC.%26aulast%3Dde%2BAndrade%2BJunior%26aufirst%3DH.%2BF.%26aulast%3DLescano%26aufirst%3DS.%2BA.%2BZ.%26aulast%3DAmato-Neto%26aufirst%3DV.%26atitle%3DIn%2520vitro%2520action%2520of%2520antiparasitic%2520drugs%252C%2520especially%2520artesunate%252C%2520against%2520Toxoplasma%2520gondii%26jtitle%3DRev.%2520Soc.%2520Bras%2520Med.%2520Trop%26date%3D2012%26volume%3D45%26issue%3D4%26spage%3D485%26epage%3D490%26doi%3D10.1590%2FS0037-86822012000400014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canney, D. J.</span></span> <span> </span><span class="NLM_article-title">A versatile and practical microwave-assisted synthesis of sterically hindered N-arylpiperazines</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>75</i></span> (<span class="NLM_issue">21</span>),  <span class="NLM_fpage">7451</span>– <span class="NLM_lpage">7453</span>, <span class="refDoi"> DOI: 10.1021/jo101478c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo101478c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=75&publication_year=2010&pages=7451-7453&issue=21&author=R.+Gaoauthor=D.+J.+Canney&title=A+versatile+and+practical+microwave-assisted+synthesis+of+sterically+hindered+N-arylpiperazines&doi=10.1021%2Fjo101478c"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjo101478c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo101478c%26sid%3Dliteratum%253Aachs%26aulast%3DGao%26aufirst%3DR.%26aulast%3DCanney%26aufirst%3DD.%2BJ.%26atitle%3DA%2520versatile%2520and%2520practical%2520microwave-assisted%2520synthesis%2520of%2520sterically%2520hindered%2520N-arylpiperazines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2010%26volume%3D75%26issue%3D21%26spage%3D7451%26epage%3D7453%26doi%3D10.1021%2Fjo101478c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ravilla, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkata Subba Naidu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagarajan, K.</span></span> <span> </span><span class="NLM_article-title">An efficient scale up process for synthesis of N-arylpiperazines</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>56</i></span> (<span class="NLM_issue">30</span>),  <span class="NLM_fpage">4541</span>– <span class="NLM_lpage">4544</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2015.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1016%2Fj.tetlet.2015.06.003" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2015&pages=4541-4544&issue=30&author=L.+Ravillaauthor=N.+Venkata+Subba+Naiduauthor=K.+Nagarajan&title=An+efficient+scale+up+process+for+synthesis+of+N-arylpiperazines&doi=10.1016%2Fj.tetlet.2015.06.003"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2015.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2015.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DRavilla%26aufirst%3DL.%26aulast%3DVenkata%2BSubba%2BNaidu%26aufirst%3DN.%26aulast%3DNagarajan%26aufirst%3DK.%26atitle%3DAn%2520efficient%2520scale%2520up%2520process%2520for%2520synthesis%2520of%2520N-arylpiperazines%26jtitle%3DTetrahedron%2520Lett.%26date%3D2015%26volume%3D56%26issue%3D30%26spage%3D4541%26epage%3D4544%26doi%3D10.1016%2Fj.tetlet.2015.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamb, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">G-Dayanandan, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wright, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, A. C.</span></span> <span> </span><span class="NLM_article-title">Elucidating features that drive the design of selective antifolates using crystal structures of human dihydrofolate reductase</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>52</i></span> (<span class="NLM_issue">41</span>),  <span class="NLM_fpage">7318</span>– <span class="NLM_lpage">7326</span>, <span class="refDoi"> DOI: 10.1021/bi400852h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi400852h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVynsrbP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2013&pages=7318-7326&issue=41&author=K.+M.+Lambauthor=N.+G-Dayanandanauthor=D.+L.+Wrightauthor=A.+C.+Anderson&title=Elucidating+features+that+drive+the+design+of+selective+antifolates+using+crystal+structures+of+human+dihydrofolate+reductase&doi=10.1021%2Fbi400852h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Elucidating Features That Drive the Design of Selective Antifolates Using Crystal Structures of Human Dihydrofolate Reductase</span></div><div class="casAuthors">Lamb, Kristen M.; G-Dayanandan, Narendran; Wright, Dennis L.; Anderson, Amy C.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">41</span>),
    <span class="NLM_cas:pages">7318-7326</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The pursuit of antimicrobial drugs that target dihydrofolate reductase (DHFR) exploits differences in sequence and dynamics between the pathogenic and human enzymes.  Here, we present five crystal structures of human DHFR bound to a new class of antimicrobial agents, the propargyl-linked antifolates (PLAs), with a range of potency (IC50 values of 0.045-1.07 μM) for human DHFR.  These structures reveal that interactions between the ligands and Asn 64, Phe 31, and Phe 34 are important for increased affinity for human DHFR and that loop residues 58-64 undergo ligand-induced conformational changes.  The utility of these structural studies was demonstrated through the design of three new ligands that reduce the no. of contacts with Asn 64, Phe 31, and Phe 34.  Synthesis and evaluation show that one of the designed inhibitors exhibits the lowest affinity for human DHFR of any of the PLAs (2.64 μM).  Comparisons of structures of human and Staphylococcus aureus DHFR bound to the same PLA reveal a conformational change in the ligand that enhances interactions with residues Phe 92 (Val 115 in huDHFR) and Ile 50 (Ile 60 in huDHFR) in S. aureus DHFR, yielding selectivity.  Likewise, comparisons of human and Candida glabrata DHFR bound to the same ligand show that hydrophobic interactions with residues Ile 121 and Phe 66 (Val 115 and Asn 64 in human DHFR) yield selective inhibitors.  The identification of residue substitutions that are important for selectivity and the observation of active site flexibility will help guide antimicrobial antifolate development for the inhibition of pathogenic species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogP92W2vZAIbVg90H21EOLACvtfcHk0lhnxbeHIZie4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVynsrbP&md5=fa3efc551faf88f452cfcf2c481a1ee9</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fbi400852h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi400852h%26sid%3Dliteratum%253Aachs%26aulast%3DLamb%26aufirst%3DK.%2BM.%26aulast%3DG-Dayanandan%26aufirst%3DN.%26aulast%3DWright%26aufirst%3DD.%2BL.%26aulast%3DAnderson%26aufirst%3DA.%2BC.%26atitle%3DElucidating%2520features%2520that%2520drive%2520the%2520design%2520of%2520selective%2520antifolates%2520using%2520crystal%2520structures%2520of%2520human%2520dihydrofolate%2520reductase%26jtitle%3DBiochemistry%26date%3D2013%26volume%3D52%26issue%3D41%26spage%3D7318%26epage%3D7326%26doi%3D10.1021%2Fbi400852h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span>UniProtKB, U. UniProtKB-P00374
(DYR_HUMAN) [database entry for human DHFR] (accessed November 2,
2017).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=UniProtKB%2C+U.+UniProtKB-P00374%0A%28DYR_HUMAN%29+%5Bdatabase+entry+for+human+DHFR%5D+%28accessed+November+2%2C%0A2017%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumdar, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajzenberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dardé, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajioka, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Globally diverse <i>Toxoplasma gondii</i> isolates comprise six major clades originating from a small number of distinct ancestral lineages</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">5844</span>– <span class="NLM_lpage">5849</span>, <span class="refDoi"> DOI: 10.1073/pnas.1203190109</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1073%2Fpnas.1203190109" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2012&pages=5844-5849&author=C.+L.+Suauthor=A.+Khanauthor=P.+Zhouauthor=D.+Majumdarauthor=D.+Ajzenbergauthor=M.+L.+Dard%C3%A9author=X.+Q.+Zhuauthor=J.+W.+Ajiokaauthor=B.+Rosenthalauthor=J.+P.+Dubeyauthor=L.+D.+Sibley&title=Globally+diverse+Toxoplasma+gondii+isolates+comprise+six+major+clades+originating+from+a+small+number+of+distinct+ancestral+lineages&doi=10.1073%2Fpnas.1203190109"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1203190109&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1203190109%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DC.%2BL.%26aulast%3DKhan%26aufirst%3DA.%26aulast%3DZhou%26aufirst%3DP.%26aulast%3DMajumdar%26aufirst%3DD.%26aulast%3DAjzenberg%26aufirst%3DD.%26aulast%3DDard%25C3%25A9%26aufirst%3DM.%2BL.%26aulast%3DZhu%26aufirst%3DX.%2BQ.%26aulast%3DAjioka%26aufirst%3DJ.%2BW.%26aulast%3DRosenthal%26aufirst%3DB.%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DGlobally%2520diverse%2520Toxoplasma%2520gondii%2520isolates%2520comprise%2520six%2520major%2520clades%2520originating%2520from%2520a%2520small%2520number%2520of%2520distinct%2520ancestral%2520lineages%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2012%26volume%3D109%26spage%3D5844%26epage%3D5849%26doi%3D10.1073%2Fpnas.1203190109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ajzenberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cogné, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paris, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessieres, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thulliez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filisetti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelloux, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marty, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dardé, M. L.</span></span> <span> </span><span class="NLM_article-title">Genotype of 86 <i>Toxoplasma gondii</i> isolates associated with human congenital toxoplasmosis and correlation with clinical findings</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>186</i></span>,  <span class="NLM_fpage">684</span>– <span class="NLM_lpage">689</span>, <span class="refDoi"> DOI: 10.1086/342663</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1086%2F342663" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=12195356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BD38XnsVSlur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2002&pages=684-689&author=D.+Ajzenbergauthor=N.+Cogn%C3%A9author=L.+Parisauthor=M.+H.+Bessieresauthor=P.+Thulliezauthor=D.+Filisettiauthor=H.+Pellouxauthor=P.+Martyauthor=M.+L.+Dard%C3%A9&title=Genotype+of+86+Toxoplasma+gondii+isolates+associated+with+human+congenital+toxoplasmosis+and+correlation+with+clinical+findings&doi=10.1086%2F342663"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Genotype of 86 Toxoplasma gondii isolates associated with human congenital toxoplasmosis, and correlation with clinical findings</span></div><div class="casAuthors">Ajzenberg, Daniel; Cogne, Nadine; Paris, Luc; Bessieres, Marie-Helene; Thulliez, Philippe; Filisetti, Denis; Pelloux, Herve; Marty, Pierre; Darde, Marie-Laure</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Infectious Diseases</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">186</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">684-689</span>CODEN:
                <span class="NLM_cas:coden">JIDIAQ</span>;
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    
            (<span class="NLM_cas:orgname">University of Chicago Press</span>)
        </div><div class="casAbstract">To study the influence of Toxoplasma gondii genotypes on the severity of human congenital toxoplasmosis (asymptomatic, benign, or severe infection or newborn or fetal death), 8 microsatellite markers were used to analyze 86 T. gondii isolates collected from patients with congenital toxoplasmosis.  Seventy-four different genotypes were detected, some identical genotypes originating probably from the same source of contamination.  The 3 less polymorphic microsatellite markers assocd. with 6 isoenzymic markers allowed a classification of isolates into the 3 classical types and detected atypical genotypes.  Whatever the clin. findings, type II isolates were largely predominant (84.88% in the whole collection and 96.49% in 57 consecutive cases).  Type I and atypical isolates were not found in asymptomatic or benign congenital toxoplasmosis.  However, in 4 cases in which children were not infected despite isolation of T. gondii from placenta, only type I isolates were found.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrZsrDGd7wi77Vg90H21EOLACvtfcHk0lgvpXs4TUQenw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XnsVSlur0%253D&md5=c1e3ecf11423f3c0d46a4b1343c36f38</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1086%2F342663&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F342663%26sid%3Dliteratum%253Aachs%26aulast%3DAjzenberg%26aufirst%3DD.%26aulast%3DCogn%25C3%25A9%26aufirst%3DN.%26aulast%3DParis%26aufirst%3DL.%26aulast%3DBessieres%26aufirst%3DM.%2BH.%26aulast%3DThulliez%26aufirst%3DP.%26aulast%3DFilisetti%26aufirst%3DD.%26aulast%3DPelloux%26aufirst%3DH.%26aulast%3DMarty%26aufirst%3DP.%26aulast%3DDard%25C3%25A9%26aufirst%3DM.%2BL.%26atitle%3DGenotype%2520of%252086%2520Toxoplasma%2520gondii%2520isolates%2520associated%2520with%2520human%2520congenital%2520toxoplasmosis%2520and%2520correlation%2520with%2520clinical%2520findings%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2002%26volume%3D186%26spage%3D684%26epage%3D689%26doi%3D10.1086%2F342663" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ajzenberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yera, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marty, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paris, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalle, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menotti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aubert, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bessieres, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quinio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pelloux, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delhaes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desbois, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thulliez, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert-Gangneux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffmann-Lacroix, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pujol, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabodonirina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bougnoux, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuisenier, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duhamel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duong, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filisetti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flori, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gay-Andrieu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pratlong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nevez, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Totet, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carme, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnabau, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darde, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villena, I.</span></span> <span> </span><span class="NLM_article-title">Genotype of 88 <i>Toxoplasma gondii</i> isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>199</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1155</span>– <span class="NLM_lpage">1167</span>, <span class="refDoi"> DOI: 10.1086/597477</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1086%2F597477" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=19265484" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADC%252BD1MzhtFyhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=199&publication_year=2009&pages=1155-1167&issue=8&author=D.+Ajzenbergauthor=H.+Yeraauthor=P.+Martyauthor=L.+Parisauthor=F.+Dalleauthor=J.+Menottiauthor=D.+Aubertauthor=J.+Franckauthor=M.+H.+Bessieresauthor=D.+Quinioauthor=H.+Pellouxauthor=L.+Delhaesauthor=N.+Desboisauthor=P.+Thulliezauthor=F.+Robert-Gangneuxauthor=C.+Kauffmann-Lacroixauthor=S.+Pujolauthor=M.+Rabodonirinaauthor=M.+E.+Bougnouxauthor=B.+Cuisenierauthor=C.+Duhamelauthor=T.+H.+Duongauthor=D.+Filisettiauthor=P.+Floriauthor=F.+Gay-Andrieuauthor=F.+Pratlongauthor=G.+Nevezauthor=A.+Totetauthor=B.+Carmeauthor=H.+Bonnabauauthor=M.+L.+Dardeauthor=I.+Villena&title=Genotype+of+88+Toxoplasma+gondii+isolates+associated+with+toxoplasmosis+in+immunocompromised+patients+and+correlation+with+clinical+findings&doi=10.1086%2F597477"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Genotype of 88 Toxoplasma gondii isolates associated with toxoplasmosis in immunocompromised patients and correlation with clinical findings</span></div><div class="casAuthors">Ajzenberg Daniel; Yera Helene; Marty Pierre; Paris Luc; Dalle Frederic; Menotti Jean; Aubert Dominique; Franck Jacqueline; Bessieres Marie-Helene; Quinio Dorothee; Pelloux Herve; Delhaes Laurence; Desbois Nicole; Thulliez Philippe; Robert-Gangneux Florence; Kauffmann-Lacroix Catherine; Pujol Sophie; Rabodonirina Meja; Bougnoux Marie-Elisabeth; Cuisenier Bernadette; Duhamel Chantal; Duong Thanh Hai; Filisetti Denis; Flori Pierre; Gay-Andrieu Francoise; Pratlong Francine; Nevez Gilles; Totet Anne; Carme Bernard; Bonnabau Henri; Darde Marie-Laure; Villena Isabelle</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infectious diseases</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">199</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1155-67</span>
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    </div><div class="casAbstract">We report the genotyping analysis of Toxoplasma gondii isolates in samples collected from 88 immunocompromised patients, along with clinical and epidemiological data.  Most of these samples were collected in France during the current decade by the Toxoplasma Biological Resource Center.  Lack of specific anti-Toxoplasma treatment, pulmonary toxoplasmosis, and involvement of multiple organs were the 3 main risk factors associated with death for this patient group.  Genotyping results with 6 microsatellite markers showed that type II isolates were predominant among patients who acquired toxoplasmic infection in Europe.  Non-type II isolates included 13 different genotypes and were mainly collected from patients who acquired toxoplasmosis outside Europe.  Type III was the second most common genotype recovered from patients, whereas type I was rare in our population.  Three nonarchetypal genotypes were repeatedly recovered from different patients who acquired the infection in sub-Saharan Africa (genotypes Africa 1 and Africa 2) and in the French West Indies (genotype Caribbean 1).  The distribution of genotypes (type II vs. non-type II) was not significantly different when patients were stratified by underlying cause of immunosuppression, site of infection, or outcome.  We conclude that in immunocompromised patients, host factors are much more involved than parasite factors in patients' resistance or susceptibility to toxoplasmosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQx3qNeinzn-jQLBVDQn4bCfW6udTcc2eYKaI0NIKN47Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MzhtFyhug%253D%253D&md5=a37b8c1ca627e6a35aedc353a4ba9130</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1086%2F597477&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1086%252F597477%26sid%3Dliteratum%253Aachs%26aulast%3DAjzenberg%26aufirst%3DD.%26aulast%3DYera%26aufirst%3DH.%26aulast%3DMarty%26aufirst%3DP.%26aulast%3DParis%26aufirst%3DL.%26aulast%3DDalle%26aufirst%3DF.%26aulast%3DMenotti%26aufirst%3DJ.%26aulast%3DAubert%26aufirst%3DD.%26aulast%3DFranck%26aufirst%3DJ.%26aulast%3DBessieres%26aufirst%3DM.%2BH.%26aulast%3DQuinio%26aufirst%3DD.%26aulast%3DPelloux%26aufirst%3DH.%26aulast%3DDelhaes%26aufirst%3DL.%26aulast%3DDesbois%26aufirst%3DN.%26aulast%3DThulliez%26aufirst%3DP.%26aulast%3DRobert-Gangneux%26aufirst%3DF.%26aulast%3DKauffmann-Lacroix%26aufirst%3DC.%26aulast%3DPujol%26aufirst%3DS.%26aulast%3DRabodonirina%26aufirst%3DM.%26aulast%3DBougnoux%26aufirst%3DM.%2BE.%26aulast%3DCuisenier%26aufirst%3DB.%26aulast%3DDuhamel%26aufirst%3DC.%26aulast%3DDuong%26aufirst%3DT.%2BH.%26aulast%3DFilisetti%26aufirst%3DD.%26aulast%3DFlori%26aufirst%3DP.%26aulast%3DGay-Andrieu%26aufirst%3DF.%26aulast%3DPratlong%26aufirst%3DF.%26aulast%3DNevez%26aufirst%3DG.%26aulast%3DTotet%26aufirst%3DA.%26aulast%3DCarme%26aufirst%3DB.%26aulast%3DBonnabau%26aufirst%3DH.%26aulast%3DDarde%26aufirst%3DM.%2BL.%26aulast%3DVillena%26aufirst%3DI.%26atitle%3DGenotype%2520of%252088%2520Toxoplasma%2520gondii%2520isolates%2520associated%2520with%2520toxoplasmosis%2520in%2520immunocompromised%2520patients%2520and%2520correlation%2520with%2520clinical%2520findings%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D2009%26volume%3D199%26issue%3D8%26spage%3D1155%26epage%3D1167%26doi%3D10.1086%2F597477" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howe, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title"><i>Toxoplasma gondii</i> comprises three clonal lineages: correlation of parasite genotype with human disease</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>172</i></span>,  <span class="NLM_fpage">1561</span>– <span class="NLM_lpage">1566</span>, <span class="refDoi"> DOI: 10.1093/infdis/172.6.1561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1093%2Finfdis%2F172.6.1561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=7594717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADyaK28%252FotlGjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=1995&pages=1561-1566&author=D.+K.+Howeauthor=L.+D.+Sibley&title=Toxoplasma+gondii+comprises+three+clonal+lineages%3A+correlation+of+parasite+genotype+with+human+disease&doi=10.1093%2Finfdis%2F172.6.1561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease</span></div><div class="casAuthors">Howe D K; Sibley L D</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infectious diseases</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1561-6</span>
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    </div><div class="casAbstract">The population genetic structure of Toxoplasma gondii was determined by multilocus restriction fragment length polymorphism analysis at 6 loci in 106 independent isolates from humans and animals.  Phylogenetic and statistical analyses indicated a highly unusual population structure consisting of 3 widespread clonal lineages.  Extensively mixed genotypes were only apparent in 4 strains, which indicated that, while not separate species, sexual recombination between the 3 lineages is exceedingly rare in natural populations.  T. gondii is a major cause of subclinical human infection and an important opportunistic pathogen that causes severe disease in immunocompromised patients.  While strains from all 3 lineages were isolated from humans, the majority of human toxoplasmosis cases were associated with strains of a type II genotype.  The correlation of specific clonal lineages with human toxoplasmosis has important implications for development of vaccines, drug treatments, and diagnostic protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTdtB05sEuTX-_Q9URG6Dx8fW6udTcc2eYKaI0NIKN47Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28%252FotlGjsA%253D%253D&md5=fe655a0dbdc9e106a2bce542500ce0e3</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2F172.6.1561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252F172.6.1561%26sid%3Dliteratum%253Aachs%26aulast%3DHowe%26aufirst%3DD.%2BK.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DToxoplasma%2520gondii%2520comprises%2520three%2520clonal%2520lineages%253A%2520correlation%2520of%2520parasite%2520genotype%2520with%2520human%2520disease%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D1995%26volume%3D172%26spage%3D1561%26epage%3D1566%26doi%3D10.1093%2Finfdis%2F172.6.1561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lunde, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobs, L.</span></span> <span> </span><span class="NLM_article-title">Antigenic differences between endozoites and cystozoites of <i>Toxoplasma gondii</i></span>. <i>J. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">1983</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">806</span>– <span class="NLM_lpage">808</span>, <span class="refDoi"> DOI: 10.2307/3281034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.2307%2F3281034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=6200590" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADyaL2c7msVarsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=1983&pages=806-808&author=M.+N.+Lundeauthor=L.+Jacobs&title=Antigenic+differences+between+endozoites+and+cystozoites+of+Toxoplasma+gondii&doi=10.2307%2F3281034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Antigenic differences between endozoites and cystozoites of Toxoplasma gondii</span></div><div class="casAuthors">Lunde M N; Jacobs L</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of parasitology</span>
        (<span class="NLM_cas:date">1983</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">806-8</span>
        ISSN:<span class="NLM_cas:issn">0022-3395</span>.
    </div><div class="casAbstract">Antigenic differences between the cystozoite and endozoite of Toxoplasma gondii were found using fluorescent antibody staining.  Antisera against the cystozoite reacted against only the cystozoite, whereas antisera against the endozoite reacted against both endozoite and cystozoite.  Absorption of sera with endozoites removed only positive reactions with endozoites.  These findings are the first to suggest antigenic differences between these two forms of Toxoplasma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRkJyg42hFwwRfKb6ELK8t0fW6udTcc2eYq0batUOiJW7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL2c7msVarsQ%253D%253D&md5=1bc470913334c054345ae8ef48f4b683</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.2307%2F3281034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2307%252F3281034%26sid%3Dliteratum%253Aachs%26aulast%3DLunde%26aufirst%3DM.%2BN.%26aulast%3DJacobs%26aufirst%3DL.%26atitle%3DAntigenic%2520differences%2520between%2520endozoites%2520and%2520cystozoites%2520of%2520Toxoplasma%2520gondii%26jtitle%3DJ.%2520Parasitol.%26date%3D1983%26volume%3D69%26spage%3D806%26epage%3D808%26doi%3D10.2307%2F3281034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Howe, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease</span>. <i>J. Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>172</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">1561</span>– <span class="NLM_lpage">1566</span>, <span class="refDoi"> DOI: 10.1093/infdis/172.6.1561</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1093%2Finfdis%2F172.6.1561" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=7594717" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADyaK28%252FotlGjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=172&publication_year=1995&pages=1561-1566&issue=6&author=D.+K.+Howeauthor=L.+D.+Sibley&title=Toxoplasma+gondii+comprises+three+clonal+lineages%3A+correlation+of+parasite+genotype+with+human+disease&doi=10.1093%2Finfdis%2F172.6.1561"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease</span></div><div class="casAuthors">Howe D K; Sibley L D</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of infectious diseases</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">172</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1561-6</span>
        ISSN:<span class="NLM_cas:issn">0022-1899</span>.
    </div><div class="casAbstract">The population genetic structure of Toxoplasma gondii was determined by multilocus restriction fragment length polymorphism analysis at 6 loci in 106 independent isolates from humans and animals.  Phylogenetic and statistical analyses indicated a highly unusual population structure consisting of 3 widespread clonal lineages.  Extensively mixed genotypes were only apparent in 4 strains, which indicated that, while not separate species, sexual recombination between the 3 lineages is exceedingly rare in natural populations.  T. gondii is a major cause of subclinical human infection and an important opportunistic pathogen that causes severe disease in immunocompromised patients.  While strains from all 3 lineages were isolated from humans, the majority of human toxoplasmosis cases were associated with strains of a type II genotype.  The correlation of specific clonal lineages with human toxoplasmosis has important implications for development of vaccines, drug treatments, and diagnostic protocols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTdtB05sEuTX-_Q9URG6Dx8fW6udTcc2eYq0batUOiJW7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28%252FotlGjsA%253D%253D&md5=fe655a0dbdc9e106a2bce542500ce0e3</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1093%2Finfdis%2F172.6.1561&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Finfdis%252F172.6.1561%26sid%3Dliteratum%253Aachs%26aulast%3DHowe%26aufirst%3DD.%2BK.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DToxoplasma%2520gondii%2520comprises%2520three%2520clonal%2520lineages%253A%2520correlation%2520of%2520parasite%2520genotype%2520with%2520human%2520disease%26jtitle%3DJ.%2520Infect.%2520Dis.%26date%3D1995%26volume%3D172%26issue%3D6%26spage%3D1561%26epage%3D1566%26doi%3D10.1093%2Finfdis%2F172.6.1561" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">German, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Storch, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clifford, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Genotyping of <i>Toxoplasma gondii</i> strains from immunocompromised patients reveals high prevalence of type I strains</span>. <i>J. Clin. Micro.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">5881</span>– <span class="NLM_lpage">5887</span>, <span class="refDoi"> DOI: 10.1128/JCM.43.12.5881-5887.2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1128%2FJCM.43.12.5881-5887.2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=16333071" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2005&pages=5881-5887&author=A.+Khanauthor=C.+Suauthor=M.+Germanauthor=G.+A.+Storchauthor=D.+Cliffordauthor=L.+D.+Sibley&title=Genotyping+of+Toxoplasma+gondii+strains+from+immunocompromised+patients+reveals+high+prevalence+of+type+I+strains&doi=10.1128%2FJCM.43.12.5881-5887.2005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1128%2FJCM.43.12.5881-5887.2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJCM.43.12.5881-5887.2005%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DA.%26aulast%3DSu%26aufirst%3DC.%26aulast%3DGerman%26aufirst%3DM.%26aulast%3DStorch%26aufirst%3DG.%2BA.%26aulast%3DClifford%26aufirst%3DD.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DGenotyping%2520of%2520Toxoplasma%2520gondii%2520strains%2520from%2520immunocompromised%2520patients%2520reveals%2520high%2520prevalence%2520of%2520type%2520I%2520strains%26jtitle%3DJ.%2520Clin.%2520Micro.%26date%3D2005%26volume%3D43%26spage%3D5881%26epage%3D5887%26doi%3D10.1128%2FJCM.43.12.5881-5887.2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajioka, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Identification of quantitative trait loci controlling acute virulence in <i>Toxoplasma gondii</i></span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">10753</span>– <span class="NLM_lpage">10758</span>, <span class="refDoi"> DOI: 10.1073/pnas.172117099</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1073%2Fpnas.172117099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=12149482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BD38Xmt1Cht7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2002&pages=10753-10758&author=C.+Suauthor=D.+K.+Howeauthor=J.+P.+Dubeyauthor=J.+W.+Ajiokaauthor=L.+D.+Sibley&title=Identification+of+quantitative+trait+loci+controlling+acute+virulence+in+Toxoplasma+gondii&doi=10.1073%2Fpnas.172117099"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of quantitative trait loci controlling acute virulence in Toxoplasma gondii</span></div><div class="casAuthors">Su, Chunlei; Howe, Daniel K.; Dubey, J. P.; Ajioka, James W.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">10753-10758</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Strains of Toxoplasma gondii can be grouped into three predominant clonal lineages with members of the type I group being uniformly lethal in mice.  To elucidate the basis of this extreme virulence, a genetic cross was performed between a highly virulent type I strain (GT-1) and a less-virulent type III strain (CTG), and the phenotypes of resulting progeny were analyzed by genetic linkage mapping.  Anal. of independent recombinant progeny identified several quant. trait loci that contributed to acute virulence.  A major quant. trait locus located on chromosome VII accounted for ≈50% of the virulence phenotype, whereas a minor locus on chromosome IV, linked to the ROP1 gene, accounted for ≈10%.  These loci are conserved in other type I strains, indicating that acute virulence is controlled by discrete genes common to the type I lineage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaGd1mv6I_YbVg90H21EOLACvtfcHk0lizuN2MjDbkTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xmt1Cht7o%253D&md5=7677a36353d5f0e37eab2cb01a8fee1a</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1073%2Fpnas.172117099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.172117099%26sid%3Dliteratum%253Aachs%26aulast%3DSu%26aufirst%3DC.%26aulast%3DHowe%26aufirst%3DD.%2BK.%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26aulast%3DAjioka%26aufirst%3DJ.%2BW.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DIdentification%2520of%2520quantitative%2520trait%2520loci%2520controlling%2520acute%2520virulence%2520in%2520Toxoplasma%2520gondii%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2002%26volume%3D99%26spage%3D10753%26epage%3D10758%26doi%3D10.1073%2Fpnas.172117099" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J.</span></span> <span> </span><span class="NLM_article-title">Mouse pathogenicity of <i>Toxoplasma gondii</i> isolated from a goat</span>. <i>Am. J. Vet. Res.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">427</span>– <span class="NLM_lpage">429</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=7369619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADyaL3c7ntlGhug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1980&pages=427-429&author=J.+Dubey&title=Mouse+pathogenicity+of+Toxoplasma+gondii+isolated+from+a+goat"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Mouse pathogenicity of Toxoplasma gondii isolated from a goat</span></div><div class="casAuthors">Dubey J P</div><div class="citationInfo"><span class="NLM_cas:title">American journal of veterinary research</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">427-9</span>
        ISSN:<span class="NLM_cas:issn">0002-9645</span>.
    </div><div class="casAbstract">Characteristics of Toxoplasma gondii (strain GT-1) isolated from skeletal muscle of a goat are described.  One oocyst, bradyzoite, or tachyzoite of GT-1 strain was lethal to mice.  Toxoplasma tachyzoites were found in the peritoneal exudates and in the lungs 9 to 34 days after infection in mice inoculated intraperitoneally with tissues infected with strain GT-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRLrZmF67bwaOWhZTslLrfffW6udTcc2eYsRhPEoLLP7rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaL3c7ntlGhug%253D%253D&md5=ec23263931c938fe8e560c677d5ff357</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDubey%26aufirst%3DJ.%26atitle%3DMouse%2520pathogenicity%2520of%2520Toxoplasma%2520gondii%2520isolated%2520from%2520a%2520goat%26jtitle%3DAm.%2520J.%2520Vet.%2520Res.%26date%3D1980%26volume%3D41%26spage%3D427%26epage%3D429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carme, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bissuel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajzenberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouyne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aznar, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Demar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bichat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louvel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourbigot, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peneau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neron, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dardé, M. L.</span></span> <span> </span><span class="NLM_article-title">Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana</span>. <i>J. Clin. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">4037</span>– <span class="NLM_lpage">4044</span>, <span class="refDoi"> DOI: 10.1128/JCM.40.11.4037-4044.2002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1128%2FJCM.40.11.4037-4044.2002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=12409371" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A280%3ADC%252BD38nmsFKlsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2002&pages=4037-4044&author=B.+Carmeauthor=F.+Bissuelauthor=D.+Ajzenbergauthor=R.+Bouyneauthor=C.+Aznarauthor=M.+Demarauthor=S.+Bichatauthor=D.+Louvelauthor=A.+M.+Bourbigotauthor=C.+Peneauauthor=P.+Neronauthor=M.+L.+Dard%C3%A9&title=Severe+acquired+toxoplasmosis+in+immunocompetent+adult+patients+in+French+Guiana&doi=10.1128%2FJCM.40.11.4037-4044.2002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Severe acquired toxoplasmosis in immunocompetent adult patients in French Guiana</span></div><div class="casAuthors">Carme B; Bissuel F; Ajzenberg D; Bouyne R; Aznar C; Demar M; Bichat S; Louvel D; Bourbigot A M; Peneau C; Neron P; Darde M L</div><div class="citationInfo"><span class="NLM_cas:title">Journal of clinical microbiology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4037-44</span>
        ISSN:<span class="NLM_cas:issn">0095-1137</span>.
    </div><div class="casAbstract">The most common presentation of symptomatic postnatally acquired toxoplasmosis in immunocompetent patients is painless cervical adenopathy.  Acute visceral manifestations are associated in rare cases.  We report 16 cases of severe primary toxoplasmosis diagnosed in French Guiana during a 6.5-year period.  All of the subjects were immunocompetent adults hospitalized with clinical presentations consisting of a marked, nonspecific infectious syndrome accompanied by an altered general status with at least one visceral localization, mainly pulmonary involvement (14 cases).  Acute toxoplasmosis was diagnosed according to the results of serological tests suggestive of recent primary infection and the absence of an alternative etiology.  Recovery was rapid following specific antitoxoplasmosis treatment.  Thirteen of the 16 patients had consumed game in the 2 weeks before the onset of the symptoms, and in eight cases the game was considered to have been undercooked.  Toxoplasma strains, which were virulent in mice, were isolated from three patients.  Microsatellite analysis showed that all of these isolates exhibited an atypical multilocus genotype, with one allele found only for isolates of this region.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTK0ykmjz3kRLBItaL1WaVAfW6udTcc2eYPYMsnN8_DMbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38nmsFKlsg%253D%253D&md5=c7c291e85f4f80e296f30e5c9de762fc</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1128%2FJCM.40.11.4037-4044.2002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FJCM.40.11.4037-4044.2002%26sid%3Dliteratum%253Aachs%26aulast%3DCarme%26aufirst%3DB.%26aulast%3DBissuel%26aufirst%3DF.%26aulast%3DAjzenberg%26aufirst%3DD.%26aulast%3DBouyne%26aufirst%3DR.%26aulast%3DAznar%26aufirst%3DC.%26aulast%3DDemar%26aufirst%3DM.%26aulast%3DBichat%26aufirst%3DS.%26aulast%3DLouvel%26aufirst%3DD.%26aulast%3DBourbigot%26aufirst%3DA.%2BM.%26aulast%3DPeneau%26aufirst%3DC.%26aulast%3DNeron%26aufirst%3DP.%26aulast%3DDard%25C3%25A9%26aufirst%3DM.%2BL.%26atitle%3DSevere%2520acquired%2520toxoplasmosis%2520in%2520immunocompetent%2520adult%2520patients%2520in%2520French%2520Guiana%26jtitle%3DJ.%2520Clin.%2520Microbiol.%26date%3D2002%26volume%3D40%26spage%3D4037%26epage%3D4044%26doi%3D10.1128%2FJCM.40.11.4037-4044.2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Demar, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hommel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Djossou, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peneau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boukhari, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Louvel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourbigot, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nasser, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajzenberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darde, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carme, B.</span></span> <span> </span><span class="NLM_article-title">Acute toxoplasmoses in immunocompetent patients hospitalized in an intensive care unit in French Guiana</span>. <i>Clin. Microbiol. Infect.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>18</i></span> (<span class="NLM_issue">7</span>),  <span class="NLM_fpage">E221</span>– <span class="NLM_lpage">E231</span>, <span class="refDoi"> DOI: 10.1111/j.1469-0691.2011.03648.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1111%2Fj.1469-0691.2011.03648.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=21958195" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOhtrvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2012&pages=E221-E231&issue=7&author=M.+Demarauthor=D.+Hommelauthor=F.+Djossouauthor=C.+Peneauauthor=R.+Boukhariauthor=D.+Louvelauthor=A.+M.+Bourbigotauthor=V.+Nasserauthor=D.+Ajzenbergauthor=M.+L.+Dardeauthor=B.+Carme&title=Acute+toxoplasmoses+in+immunocompetent+patients+hospitalized+in+an+intensive+care+unit+in+French+Guiana&doi=10.1111%2Fj.1469-0691.2011.03648.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Acute toxoplasmoses in immunocompetent patients hospitalized in an intensive care unit in French Guiana</span></div><div class="casAuthors">Demar, M.; Hommel, D.; Djossou, F.; Peneau, C.; Boukhari, R.; Louvel, D.; Bourbigot, A.-M.; Nasser, V.; Ajzenberg, D.; Darde, M.-L.; Carme, B.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Microbiology and Infection</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">E221-E231</span>CODEN:
                <span class="NLM_cas:coden">CMINFM</span>;
        ISSN:<span class="NLM_cas:issn">1198-743X</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Atypical Toxoplasma gondii strains, unrelated to archetypal clonal lineages (I, II, III), have been reported more frequently over the last decade in areas other than Europe and North America.  A newly described form of toxoplasmosis, 'Amazonian toxoplasmosis' (AT), has been reported since 2002 in French Guiana.  It is characterized by severe cases and atypical strains linked to a neotropical forest-based cycle.  We report on the cases of AT that required intensive care management.  We performed a prospective observational study on hospitalized adults in the Intensive Care Unit (ICU) from 2002 to 2008.  Clin. and lab. data, microbiol. findings and outcomes were recorded.  Data, including the ICU simplified acute physiol. score and the pneumonia severity index, were calcd.  Epidemiol. risk factors for AT were assessed through questionnaires.  Eleven non-immunodeficient patients were admitted to the ICU in Cayenne for life-threatening pneumonia assocd. with disseminated toxoplasmosis.  Mech. ventilation was necessary in seven patients, four of whom required immediate orotracheal intubation.  Cardiac and ophthalmol. abnormalities were found in five and four patients, resp.  One patient died from multiple organ failure.  The genetic characterization of Toxoplasma DNA using six microsatellite markers revealed unique and atypical genotypes in eight patients.  All patients presented epidemiol. risk factors for AT.  In French Guiana, significant T. gondii-related infectious syndrome assocd. with the lungs, a high level of LDH activity and the reported risk factors for AT was strongly suggestive of disseminated toxoplasmosis with a possible trend toward life-threatening pneumonia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplzR3IgTJ7GrVg90H21EOLACvtfcHk0ljAnVETZSl9iA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOhtrvP&md5=70cb03dd2f6ddc9900ef5b1833d4224e</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1111%2Fj.1469-0691.2011.03648.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1469-0691.2011.03648.x%26sid%3Dliteratum%253Aachs%26aulast%3DDemar%26aufirst%3DM.%26aulast%3DHommel%26aufirst%3DD.%26aulast%3DDjossou%26aufirst%3DF.%26aulast%3DPeneau%26aufirst%3DC.%26aulast%3DBoukhari%26aufirst%3DR.%26aulast%3DLouvel%26aufirst%3DD.%26aulast%3DBourbigot%26aufirst%3DA.%2BM.%26aulast%3DNasser%26aufirst%3DV.%26aulast%3DAjzenberg%26aufirst%3DD.%26aulast%3DDarde%26aufirst%3DM.%2BL.%26aulast%3DCarme%26aufirst%3DB.%26atitle%3DAcute%2520toxoplasmoses%2520in%2520immunocompetent%2520patients%2520hospitalized%2520in%2520an%2520intensive%2520care%2520unit%2520in%2520French%2520Guiana%26jtitle%3DClin.%2520Microbiol.%2520Infect.%26date%3D2012%26volume%3D18%26issue%3D7%26spage%3DE221%26epage%3DE231%26doi%3D10.1111%2Fj.1469-0691.2011.03648.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorenzi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behnke, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namasivayam, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swapna, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadjithomas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karamycheva, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinney, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunk, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajioka, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajzenberg, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothroyd, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyle, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darde, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Miranda, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubey, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gennari, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gregory, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saeij, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howe, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenthal, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grigg, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kissinger, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roos, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Local admixture of amplified and diversified secreted pathogenesis determinants shapes mosaic Toxoplasma gondii genomes</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">10147</span>, <span class="refDoi"> DOI: 10.1038/ncomms10147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1038%2Fncomms10147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=26738725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC28XltFOrsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=10147&author=H.+Lorenziauthor=A.+Khanauthor=M.+S.+Behnkeauthor=S.+Namasivayamauthor=L.+S.+Swapnaauthor=M.+Hadjithomasauthor=S.+Karamychevaauthor=D.+Pinneyauthor=B.+P.+Brunkauthor=J.+W.+Ajiokaauthor=D.+Ajzenbergauthor=J.+C.+Boothroydauthor=J.+P.+Boyleauthor=M.+L.+Dardeauthor=M.+A.+Diaz-Mirandaauthor=J.+P.+Dubeyauthor=H.+M.+Fritzauthor=S.+M.+Gennariauthor=B.+D.+Gregoryauthor=K.+Kimauthor=J.+P.+Saeijauthor=C.+Suauthor=M.+W.+Whiteauthor=X.+Q.+Zhuauthor=D.+K.+Howeauthor=B.+M.+Rosenthalauthor=M.+E.+Griggauthor=J.+Parkinsonauthor=L.+Liuauthor=J.+C.+Kissingerauthor=D.+S.+Roosauthor=L.+D.+Sibley&title=Local+admixture+of+amplified+and+diversified+secreted+pathogenesis+determinants+shapes+mosaic+Toxoplasma+gondii+genomes&doi=10.1038%2Fncomms10147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Local admixture of amplified and diversified secreted pathogenesis determinants shapes mosaic Toxoplasma gondii genomes</span></div><div class="casAuthors">Lorenzi, Hernan; Khan, Asis; Behnke, Michael S.; Namasivayam, Sivaranjani; Swapna, Lakshmipuram S.; Hadjithomas, Michalis; Karamycheva, Svetlana; Pinney, Deborah; Brunk, Brian P.; Ajioka, James W.; Ajzenberg, Daniel; Boothroyd, John C.; Boyle, Jon P.; Darde, Marie L.; Diaz-Miranda, Maria A.; Dubey, Jitender P.; Fritz, Heather M.; Gennari, Solange M.; Gregory, Brian D.; Kim, Kami; Saeij, Jeroen P. J.; Su, Chunlei; White, Michael W.; Zhu, Xing-Quan; Howe, Daniel K.; Rosenthal, Benjamin M.; Grigg, Michael E.; Parkinson, John; Liu, Liang; Kissinger, Jessica C.; Roos, David S.; David Sibley, L.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10147</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Toxoplasma gondii is among the most prevalent parasites worldwide, infecting many wild and domestic animals and causing zoonotic infections in humans.  T. gondii differs substantially in its broad distribution from closely related parasites that typically have narrow, specialized host ranges.  To elucidate the genetic basis for these differences, we compared the genomes of 62 globally distributed T. gondii isolates to several closely related coccidian parasites.  Our findings reveal that tandem amplification and diversification of secretory pathogenesis determinants is the primary feature that distinguishes the closely related genomes of these biol. diverse parasites.  We further show that the unusual population structure of T. gondii is characterized by clade-specific inheritance of large conserved haploblocks that are significantly enriched in tandemly clustered secretory pathogenesis determinants.  The shared inheritance of these conserved haploblocks, which show a different ancestry than the genome as a whole, may thus influence transmission, host range, and pathogenicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqdDKqaMZXy87Vg90H21EOLACvtfcHk0lgIyjjZoO3xCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltFOrsw%253D%253D&md5=1952e8e223c43abfde12aa2f61a64cf3</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1038%2Fncomms10147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms10147%26sid%3Dliteratum%253Aachs%26aulast%3DLorenzi%26aufirst%3DH.%26aulast%3DKhan%26aufirst%3DA.%26aulast%3DBehnke%26aufirst%3DM.%2BS.%26aulast%3DNamasivayam%26aufirst%3DS.%26aulast%3DSwapna%26aufirst%3DL.%2BS.%26aulast%3DHadjithomas%26aufirst%3DM.%26aulast%3DKaramycheva%26aufirst%3DS.%26aulast%3DPinney%26aufirst%3DD.%26aulast%3DBrunk%26aufirst%3DB.%2BP.%26aulast%3DAjioka%26aufirst%3DJ.%2BW.%26aulast%3DAjzenberg%26aufirst%3DD.%26aulast%3DBoothroyd%26aufirst%3DJ.%2BC.%26aulast%3DBoyle%26aufirst%3DJ.%2BP.%26aulast%3DDarde%26aufirst%3DM.%2BL.%26aulast%3DDiaz-Miranda%26aufirst%3DM.%2BA.%26aulast%3DDubey%26aufirst%3DJ.%2BP.%26aulast%3DFritz%26aufirst%3DH.%2BM.%26aulast%3DGennari%26aufirst%3DS.%2BM.%26aulast%3DGregory%26aufirst%3DB.%2BD.%26aulast%3DKim%26aufirst%3DK.%26aulast%3DSaeij%26aufirst%3DJ.%2BP.%26aulast%3DSu%26aufirst%3DC.%26aulast%3DWhite%26aufirst%3DM.%2BW.%26aulast%3DZhu%26aufirst%3DX.%2BQ.%26aulast%3DHowe%26aufirst%3DD.%2BK.%26aulast%3DRosenthal%26aufirst%3DB.%2BM.%26aulast%3DGrigg%26aufirst%3DM.%2BE.%26aulast%3DParkinson%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DKissinger%26aufirst%3DJ.%2BC.%26aulast%3DRoos%26aufirst%3DD.%2BS.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DLocal%2520admixture%2520of%2520amplified%2520and%2520diversified%2520secreted%2520pathogenesis%2520determinants%2520shapes%2520mosaic%2520Toxoplasma%2520gondii%2520genomes%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D10147%26doi%3D10.1038%2Fncomms10147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roos, D. S.</span></span> <span> </span><span class="NLM_article-title">A biochemical and genetic model for parasite resistance to antifolates. Toxoplasma gondii provides insights into pyrimethamine and cycloguanil resistance in Plasmodium falciparum</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>273</i></span> (<span class="NLM_issue">6</span>),  <span class="NLM_fpage">3461</span>– <span class="NLM_lpage">3469</span>, <span class="refDoi"> DOI: 10.1074/jbc.273.6.3461</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1074%2Fjbc.273.6.3461" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=3461-3469&issue=6&author=M.+G.+Reynoldsauthor=D.+S.+Roos&title=A+biochemical+and+genetic+model+for+parasite+resistance+to+antifolates.+Toxoplasma+gondii+provides+insights+into+pyrimethamine+and+cycloguanil+resistance+in+Plasmodium+falciparum&doi=10.1074%2Fjbc.273.6.3461"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1074%2Fjbc.273.6.3461&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.273.6.3461%26sid%3Dliteratum%253Aachs%26aulast%3DReynolds%26aufirst%3DM.%2BG.%26aulast%3DRoos%26aufirst%3DD.%2BS.%26atitle%3DA%2520biochemical%2520and%2520genetic%2520model%2520for%2520parasite%2520resistance%2520to%2520antifolates.%2520Toxoplasma%2520gondii%2520provides%2520insights%2520into%2520pyrimethamine%2520and%2520cycloguanil%2520resistance%2520in%2520Plasmodium%2520falciparum%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26issue%3D6%26spage%3D3461%26epage%3D3469%26doi%3D10.1074%2Fjbc.273.6.3461" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Behnke, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fentress, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mashayekhi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">The polymorphic pseudokinase ROP5 controls virulence in <i>Toxoplasma gondii</i> by regulating the active kinase ROP18</span>. <i>PLoS Pathog.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>8</i></span>, <span class="NLM_elocation-id">e1002992</span> <span class="refDoi"> DOI: 10.1371/journal.ppat.1002992</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1371%2Fjournal.ppat.1002992" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=23144612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC38XhslCis7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2012&author=M.+S.+Behnkeauthor=S.+J.+Fentressauthor=M.+Mashayekhiauthor=L.+L.+Liauthor=G.+A.+Taylorauthor=L.+D.+Sibley&title=The+polymorphic+pseudokinase+ROP5+controls+virulence+in+Toxoplasma+gondii+by+regulating+the+active+kinase+ROP18&doi=10.1371%2Fjournal.ppat.1002992"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The polymorphic pseudokinase ROP5 controls virulence in Toxoplasma gondii by regulating the active kinase ROP18</span></div><div class="casAuthors">Behnke, Michael S.; Fentress, Sarah J.; Mashayekhi, Mona; Li, Lucy X.; Taylor, Gregory A.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">PLoS Pathogens</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e1002992</span>CODEN:
                <span class="NLM_cas:coden">PPLACN</span>;
        ISSN:<span class="NLM_cas:issn">1553-7374</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Secretory polymorphic serine/threonine kinases control pathogenesis of Toxoplasma gondii in the mouse.  Genetic studies show that the pseudokinase ROP5 is essential for acute virulence, but do not reveal its mechanism of action.  Here we demonstrate that ROP5 controls virulence by blocking IFN-γ mediated clearance in activated macrophages.  ROP5 was required for the catalytic activity of the active S/T kinase ROP18, which phosphorylates host immunity related GTPases (IRGs) and protects the parasite from clearance.  ROP5 directly regulated activity of ROP18 in vitro, and both proteins were necessary to avoid IRG recruitment and clearance in macrophages.  Clearance of both the Δrop5 and Δrop18 mutants was reversed in macrophages lacking Irgm3, which is required for IRG function, and the virulence defect was fully restored in Irgm3-/- mice.  Our findings establish that the pseudokinase ROP5 controls the activity of ROP18, thereby blocking IRG mediated clearance in macrophages.  Addnl., ROP5 has other functions that are also Irgm3 and IFN-γ dependent, indicting it plays a general role in governing virulence factors that block immunity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovOrvMpFAA67Vg90H21EOLACvtfcHk0lgIyjjZoO3xCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhslCis7vP&md5=4600462dbd8bc9d56720b8af2a92354b</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1371%2Fjournal.ppat.1002992&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.ppat.1002992%26sid%3Dliteratum%253Aachs%26aulast%3DBehnke%26aufirst%3DM.%2BS.%26aulast%3DFentress%26aufirst%3DS.%2BJ.%26aulast%3DMashayekhi%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DL.%2BL.%26aulast%3DTaylor%26aufirst%3DG.%2BA.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DThe%2520polymorphic%2520pseudokinase%2520ROP5%2520controls%2520virulence%2520in%2520Toxoplasma%2520gondii%2520by%2520regulating%2520the%2520active%2520kinase%2520ROP18%26jtitle%3DPLoS%2520Pathog.%26date%3D2012%26volume%3D8%26doi%3D10.1371%2Fjournal.ppat.1002992" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arribas, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Diego, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamallo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, J. J.</span></span> <span> </span><span class="NLM_article-title">A new murine model of severe acute toxoplasma encephalitis</span>. <i>J. Antimicrob. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>36</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">503</span>– <span class="NLM_lpage">513</span>, <span class="refDoi"> DOI: 10.1093/jac/36.3.503</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1093%2Fjac%2F36.3.503" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=8830014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADyaK2MXosFyit7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=1995&pages=503-513&issue=3&author=J.+R.+Arribasauthor=J.+A.+de+Diegoauthor=C.+Gamalloauthor=J.+J.+Vazquez&title=A+new+murine+model+of+severe+acute+toxoplasma+encephalitis&doi=10.1093%2Fjac%2F36.3.503"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">A new murine model of severe acute toxoplasma encephalitis</span></div><div class="casAuthors">Arribas, Jose Ramon; de Diego, Jose Antonio; Gamallo, Carlos; Vazquez, Juan Jose</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Antimicrobial Chemotherapy</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">503-12</span>CODEN:
                <span class="NLM_cas:coden">JACHDX</span>;
        ISSN:<span class="NLM_cas:issn">0305-7453</span>.
    
            (<span class="NLM_cas:orgname">Saunders</span>)
        </div><div class="casAbstract">The authors have developed a new murine model of toxoplasmic encephalitis based on the intracerebral inoculation of tachyzoites of the highly virulent RH strain of Toxoplasma gondii.  Intracerebral infection resulted in a mortality of 100% on day five.  Large inflammatory abscessed infiltrates developed by the second day after inoculation and expanded throughout the remaining period of observation.  Numerous tachyzoites were detectable in brain parenchyma by the second day of infection.  The marked and precocious histopathol. brain lesions produced by the RH strain are useful to detect therapeutic rather than prophylactic effects of drugs against toxoplasmic encephalitis.  In this model pyrimethamine, sulfadiazine and its combination were useful in terms of mortality, histopathol. and spread of infection whereas clindamycin showed no activity.  This murine model of toxoplasmic encephalitis is useful to evaluate antitoxoplasma agents with high therapeutic activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgJiBB1skBSbVg90H21EOLACvtfcHk0lhUVqgW1hrVRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXosFyit7s%253D&md5=0228d2d6edfca9548a4afdf36c69af93</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1093%2Fjac%2F36.3.503&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjac%252F36.3.503%26sid%3Dliteratum%253Aachs%26aulast%3DArribas%26aufirst%3DJ.%2BR.%26aulast%3Dde%2BDiego%26aufirst%3DJ.%2BA.%26aulast%3DGamallo%26aufirst%3DC.%26aulast%3DVazquez%26aufirst%3DJ.%2BJ.%26atitle%3DA%2520new%2520murine%2520model%2520of%2520severe%2520acute%2520toxoplasma%2520encephalitis%26jtitle%3DJ.%2520Antimicrob.%2520Chemother.%26date%3D1995%26volume%3D36%26issue%3D3%26spage%3D503%26epage%3D513%26doi%3D10.1093%2Fjac%2F36.3.503" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martins-Duarte, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Souza, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vommaro, R. C.</span></span> <span> </span><span class="NLM_article-title">Toxoplasma gondii: The effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model</span>. <i>Exp. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>133</i></span> (<span class="NLM_issue">3</span>),  <span class="NLM_fpage">294</span>– <span class="NLM_lpage">299</span>, <span class="refDoi"> DOI: 10.1016/j.exppara.2012.12.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1016%2Fj.exppara.2012.12.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=23270807" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC3sXislynuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=133&publication_year=2013&pages=294-299&issue=3&author=E.+S.+Martins-Duarteauthor=W.+de+Souzaauthor=R.+C.+Vommaro&title=Toxoplasma+gondii%3A+The+effect+of+fluconazole+combined+with+sulfadiazine+and+pyrimethamine+against+acute+toxoplasmosis+in+murine+model&doi=10.1016%2Fj.exppara.2012.12.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Toxoplasma gondii: The effect of fluconazole combined with sulfadiazine and pyrimethamine against acute toxoplasmosis in murine model</span></div><div class="casAuthors">Martins-Duarte, Erica S.; de Souza, Wanderley; Vommaro, Rossiane C.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Parasitology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">133</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">294-299</span>CODEN:
                <span class="NLM_cas:coden">EXPAAA</span>;
        ISSN:<span class="NLM_cas:issn">0014-4894</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Toxoplasma gondii is an important opportunistic pathogen for immunocompromised patients and responsible for toxoplasmic encephalitis, which is often lethal.  Treatment for this infection is limited to a restricted therapeutic arsenal.  In this work we tested the combination of fluconazole with the current treatment for acute toxoplasmosis on the murine model in vivo.  Different exptl. groups were treated with combinations of sulfadiazine plus pyrimethamine with fluconazole and pyrimethamine with fluconazole.  Fluconazole is an important antifungal triazole used against others CNS related opportunistic pathogens such as Cryptococcus neoformans and Candida spp.  The combinations of fluconazole plus sulfadiazine and pyrimethamine or fluconazole plus pyrimethamine were remarkably effective against T. gondii in vivo.  The 10-day treatment with 10 mg/kg/day of fluconazole combined with 40/1 mg/kg/day sulfadiazine and pyrimethamine resulted in 93% survival of CF1 mice acutely infected with the highly virulent T. gondii RH strain, vs. 36% of mice treated with just sulfadiazine and pyrimethamine.  Combinations of fluconazole with lower doses of sulfadiazine and pyrimethamine or with just pyrimethamine were also efficient in reducing the mortality of mice compared with the treatment without fluconazole.  The results obtained are promising for the treatment of human toxoplasmosis and point to the need to extend these studies to other murine models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5uXjaEjQY_LVg90H21EOLACvtfcHk0lhUVqgW1hrVRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXislynuro%253D&md5=49ecf69325804cef4da7fb4d10680e57</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.exppara.2012.12.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exppara.2012.12.011%26sid%3Dliteratum%253Aachs%26aulast%3DMartins-Duarte%26aufirst%3DE.%2BS.%26aulast%3Dde%2BSouza%26aufirst%3DW.%26aulast%3DVommaro%26aufirst%3DR.%2BC.%26atitle%3DToxoplasma%2520gondii%253A%2520The%2520effect%2520of%2520fluconazole%2520combined%2520with%2520sulfadiazine%2520and%2520pyrimethamine%2520against%2520acute%2520toxoplasmosis%2520in%2520murine%2520model%26jtitle%3DExp.%2520Parasitol.%26date%3D2013%26volume%3D133%26issue%3D3%26spage%3D294%26epage%3D299%26doi%3D10.1016%2Fj.exppara.2012.12.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Piketty, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Derouin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouveix, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pocidalo, J. J.</span></span> <span> </span><span class="NLM_article-title">In vivo assessment of antimicrobial agents against toxoplasma gondii by quantification of parasites in the blood, lungs, and brain of infected mice</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>34</i></span> (<span class="NLM_issue">8</span>),  <span class="NLM_fpage">1467</span>– <span class="NLM_lpage">1472</span>, <span class="refDoi"> DOI: 10.1128/AAC.34.8.1467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1128%2FAAC.34.8.1467" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1990&pages=1467-1472&issue=8&author=C.+Pikettyauthor=F.+Derouinauthor=B.+Rouveixauthor=J.+J.+Pocidalo&title=In+vivo+assessment+of+antimicrobial+agents+against+toxoplasma+gondii+by+quantification+of+parasites+in+the+blood%2C+lungs%2C+and+brain+of+infected+mice&doi=10.1128%2FAAC.34.8.1467"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1128%2FAAC.34.8.1467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.34.8.1467%26sid%3Dliteratum%253Aachs%26aulast%3DPiketty%26aufirst%3DC.%26aulast%3DDerouin%26aufirst%3DF.%26aulast%3DRouveix%26aufirst%3DB.%26aulast%3DPocidalo%26aufirst%3DJ.%2BJ.%26atitle%3DIn%2520vivo%2520assessment%2520of%2520antimicrobial%2520agents%2520against%2520toxoplasma%2520gondii%2520by%2520quantification%2520of%2520parasites%2520in%2520the%2520blood%252C%2520lungs%252C%2520and%2520brain%2520of%2520infected%2520mice%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D1990%26volume%3D34%26issue%3D8%26spage%3D1467%26epage%3D1472%26doi%3D10.1128%2FAAC.34.8.1467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, R. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mutai, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hafsat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sherman, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.-W.</span></span> <span> </span><span class="NLM_article-title">High-throughput screening and sensitized bacteria identify an M. tuberculosis dihydrofolate reductase inhibitor with whole cell activity</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span> (<span class="NLM_issue">6</span>), <span class="NLM_elocation-id">e39961</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0039961</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1371%2Fjournal.pone.0039961" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=22768185" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtVSks7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&issue=6&author=A.+Kumarauthor=M.+Zhangauthor=L.+Zhuauthor=R.+P.+Liaoauthor=C.+Mutaiauthor=S.+Hafsatauthor=D.+R.+Shermanauthor=M.-W.+Wang&title=High-throughput+screening+and+sensitized+bacteria+identify+an+M.+tuberculosis+dihydrofolate+reductase+inhibitor+with+whole+cell+activity&doi=10.1371%2Fjournal.pone.0039961"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">High-throughput screening and sensitized bacteria identify an M. tuberculosis dihydrofolate reductase inhibitor with whole cell activity</span></div><div class="casAuthors">Kumar, Anuradha; Zhang, Meng; Zhu, Linyun; Liao, Reiling P.; Mutai, Charles; Hafsat, Shittu; Sherman, David R.; Wang, Ming-Wei</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">e39961</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis, is a bacterial pathogen that claims roughly 1.4 million lives every year.  Current drug regimens are inefficient at clearing infection, requiring at least 6 mo of chemotherapy, and resistance to existing agents is rising.  There is an urgent need for new drugs that are more effective and faster acting.  The folate pathway has been successfully targeted in other pathogens and diseases, but has not yielded a lead drug against tuberculosis.  We developed a high-throughput screening assay against Mtb dihydrofolate reductase (DHFR), a crit. enzyme in the folate pathway, and screened a library consisting of 32,000 synthetic and natural product-derived compds.  One potent inhibitor contg. a quinazoline ring was identified.  This compd. was active against the wild-type lab. strain H37Rv (MIC99 = 207 μM).  In addn., an Mtb strain with artificially lowered DHFR levels showed increased sensitivity to this compd. (MIC99 = 70.7 μM), supporting that the inhibition was target-specific.  Our results demonstrate the potential to identify Mtb DHFR inhibitors with activity against whole cells, and indicate the power of using a recombinant strain of Mtb expressing lower levels of DHFR to facilitate the discovery of antimycobacterial agents.  With these new tools, we highlight the folate pathway as a potential target for new drugs to combat the tuberculosis epidemic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-F4lNfuNzN7Vg90H21EOLACvtfcHk0lhUVqgW1hrVRQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtVSks7rF&md5=dba80990d912522046fb14b6ec98dd93</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0039961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0039961%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DLiao%26aufirst%3DR.%2BP.%26aulast%3DMutai%26aufirst%3DC.%26aulast%3DHafsat%26aufirst%3DS.%26aulast%3DSherman%26aufirst%3DD.%2BR.%26aulast%3DWang%26aufirst%3DM.-W.%26atitle%3DHigh-throughput%2520screening%2520and%2520sensitized%2520bacteria%2520identify%2520an%2520M.%2520tuberculosis%2520dihydrofolate%2520reductase%2520inhibitor%2520with%2520whole%2520cell%2520activity%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26issue%3D6%26doi%3D10.1371%2Fjournal.pone.0039961" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lourido, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barks, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wildman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shokat, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, L. D.</span></span> <span> </span><span class="NLM_article-title">Optimizing small molecule inhibitors of calcium-dependent protein kinase 1 to prevent infection by <i>Toxoplasma gondii</i></span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">3068</span>– <span class="NLM_lpage">3077</span>, <span class="refDoi"> DOI: 10.1021/jm4001314</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm4001314" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjslSgt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=3068-3077&author=S.+Louridoauthor=C.+Zhangauthor=M.+S.+Lopezauthor=K.+Tangauthor=J.+Barksauthor=Q.+Wangauthor=S.+A.+Wildmanauthor=K.+M.+Shokatauthor=L.+D.+Sibley&title=Optimizing+small+molecule+inhibitors+of+calcium-dependent+protein+kinase+1+to+prevent+infection+by+Toxoplasma+gondii&doi=10.1021%2Fjm4001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Optimizing Small Molecule Inhibitors of Calcium-Dependent Protein Kinase 1 to Prevent Infection by Toxoplasma gondii</span></div><div class="casAuthors">Lourido, Sebastian; Zhang, Chao; Lopez, Michael S.; Tang, Keliang; Barks, Jennifer; Wang, Qiuling; Wildman, Scott A.; Shokat, Kevan M.; Sibley, L. David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3068-3077</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Toxoplasma gondii is sensitive to bulky pyrazolo [3,4-d] pyrimidine (PP) inhibitors due to the presence of a Gly gatekeeper in the essential calcium dependent protein kinase 1 (CDPK1).  Here we synthesized a no. of new derivs. of 3-methyl-benzyl-PP (3-MB-PP, or 1).  The potency of PP analogs in inhibiting CDPK1 enzyme activity in vitro (low nM IC50 values) and blocking parasite growth in host cell monolayers in vivo (low μM EC50 values) were highly correlated and occurred in a CDPK1-specific manner.  Chem. modification of the PP scaffold to increase half-life in the presence of microsomes in vitro led to identification of compds. with enhanced stability while retaining activity.  Several of these more potent compds. were able to prevent lethal infection with T. gondii in the mouse model.  Collectively, the strategies outlined here provide a route for development of more effective compds. for treatment of toxoplasmosis and perhaps related parasitic diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpBcv37M-6fobVg90H21EOLACvtfcHk0lhQQyGhcv5d9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjslSgt78%253D&md5=352bb9e5b5304656aab52da763202b68</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm4001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm4001314%26sid%3Dliteratum%253Aachs%26aulast%3DLourido%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DLopez%26aufirst%3DM.%2BS.%26aulast%3DTang%26aufirst%3DK.%26aulast%3DBarks%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DWildman%26aufirst%3DS.%2BA.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26aulast%3DSibley%26aufirst%3DL.%2BD.%26atitle%3DOptimizing%2520small%2520molecule%2520inhibitors%2520of%2520calcium-dependent%2520protein%2520kinase%25201%2520to%2520prevent%2520infection%2520by%2520Toxoplasma%2520gondii%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D3068%26epage%3D3077%26doi%3D10.1021%2Fjm4001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tobin, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knoll, L. J.</span></span> <span> </span><span class="NLM_article-title">A patatin-like protein protects Toxoplasma gondii from degradation in a nitric oxide-dependent manner</span>. <i>Infect. Immun.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>80</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1128/IAI.05543-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=10.1128%2FIAI.05543-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=22006568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;key=1%3ACAS%3A528%3ADC%252BC38XktlGitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2012&pages=55-61&issue=1&author=C.+M.+Tobinauthor=L.+J.+Knoll&title=A+patatin-like+protein+protects+Toxoplasma+gondii+from+degradation+in+a+nitric+oxide-dependent+manner&doi=10.1128%2FIAI.05543-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">A patatin-like protein protects Toxoplasma gondii from degradation in a nitric oxide-dependent manner</span></div><div class="casAuthors">Tobin, Crystal M.; Knoll, Laura J.</div><div class="citationInfo"><span class="NLM_cas:title">Infection and Immunity</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">80</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-61</span>CODEN:
                <span class="NLM_cas:coden">INFIBR</span>;
        ISSN:<span class="NLM_cas:issn">0019-9567</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Toxoplasma gondii is an obligate intracellular parasite that uses immune cells to disseminate throughout its host.  T. gondii can persist and even slowly replicate in activated host macrophages by reducing the antimicrobial effects of mols. such as nitric oxide (NO).  A T. gondii patatin-like protein called TgPL1 was previously shown to be important for survival in activated macrophages.  Here we show that a T. gondii mutant with a deletion of the TgPL1 gene (ΔTgPL1) is degraded in activated macrophages.  This degrdn. phenotype is abolished by the removal of NO by the use of an inducible NO synthase (iNOS) inhibitor or iNOS-deficient macrophages.  The exogenous addn. of NO to macrophages results in reduced parasite growth but not the degrdn. of ΔTgPL1 parasites.  These results suggest that NO is necessary but not sufficient for the degrdn. of ΔTgPL1 parasites in activated macrophages.  While some patatin-like proteins have phospholipase A2 (PLA2) activity, recombinant TgPL1 purified from Escherichia coli does not have phospholipase activity.  This result was not surprising, as TgPL1 contains a G-to-S change at the predicted catalytic serine residue.  An epitope-tagged version of TgPL1 partially colocalized with a dense granule protein in the parasitophorous vacuole space.  These results may suggest that TgPL1 moves to the parasitophorous vacuole to protect parasites from nitric oxide by an undetd. mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpU1uPDCKZvk7Vg90H21EOLACvtfcHk0lhQQyGhcv5d9Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktlGitw%253D%253D&md5=4adbe39d3ed61bdd9d57a539cbe58e5f</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1128%2FIAI.05543-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FIAI.05543-11%26sid%3Dliteratum%253Aachs%26aulast%3DTobin%26aufirst%3DC.%2BM.%26aulast%3DKnoll%26aufirst%3DL.%2BJ.%26atitle%3DA%2520patatin-like%2520protein%2520protects%2520Toxoplasma%2520gondii%2520from%2520degradation%2520in%2520a%2520nitric%2520oxide-dependent%2520manner%26jtitle%3DInfect.%2520Immun.%26date%3D2012%26volume%3D80%26issue%3D1%26spage%3D55%26epage%3D61%26doi%3D10.1128%2FIAI.05543-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6n1t" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6n1t','PDB','6n1t'); return false;">PDB: 6n1t</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6n1s" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6n1s','PDB','6n1s'); return false;">PDB: 6n1s</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i72"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01754">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_63131"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge on the <a class="ext-link" href="/">ACS Publications website</a> at DOI: <a class="ext-link" href="/doi/abs/10.1021/acs.jmedchem.8b01754">10.1021/acs.jmedchem.8b01754</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Molecular formula strings and some data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01754/suppl_file/jm8b01754_si_001.csv">CSV</a>)</p></li><li><p class="inline">Methods for TgDHFR-TS protein purification and crystallization with <b>3</b> and <b>29</b> with diffraction and refinement statistics data; methods for kinetic solubility, log <i>P</i>, human and mouse liver microsome clearance, and MDCK-MDR1 permeability determinations; CEREP 44 cross-reactivity safety assessment data; molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.8b01754/suppl_file/jm8b01754_si_002.pdf">PDF</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01754/suppl_file/jm8b01754_si_001.csv">jm8b01754_si_001.csv (2.31 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.8b01754/suppl_file/jm8b01754_si_002.pdf">jm8b01754_si_002.pdf (504.32 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Crystal structures of the TgDHFR-TS protein with bound compounds <b>3</b> and <b>29</b> have PDB codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6n1t">6n1t</a> and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6n1s">6n1s</a>, respectively. Authors will release the atomic coordinates and experimental data upon article publication.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b01754&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b01754%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-3%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b01754" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                2MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67998b843d43231a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
